# RGD-PIPELINE: ftp-file-extracts # MODULE: annotations-version-1.1.9 (Oct 10, 2019) # GENERATED-ON: 2025/02/01 # PURPOSE: annotations about active Mouse objects extracted from RGD database # ONTOLOGY: ChEBI: ChEBI Ontology # CONTACT: rgd.data@mcw.edu # FORMAT: tab delimited text # NOTES: multiple values in a single column are separated by '|' # #COLUMN INFORMATION: # #1 RGD_ID unique RGD_ID of the annotated object #2 OBJECT_SYMBOL official symbol of the annotated object #3 OBJECT_NAME official name of the annotated object #4 OBJECT_TYPE annotated object data type: one of ['gene','qtl','strain'] #5 TERM_ACC_ID ontology term accession id #6 TERM_NAME ontology term name #7 QUALIFIER optional qualifier #8 EVIDENCE evidence #9 WITH with info #10 ASPECT aspect #11 REFERENCES db references (Reference RGDID|PUBMED ID) #12 CREATED_DATE created date #13 ASSIGNED_BY assigned by #14 MESH_OMIM_ID MESH:xxx or OMIM:xxx id corresponding to RDO:xxx id found in TERM_ACC_ID column (RGD/CTD Disease Ontology annotations only) #15 CURATION_NOTES curation notes provided by RGD curators #16 ORIGINAL_REFERENCE original reference RGD_ID OBJECT_SYMBOL OBJECT_NAME OBJECT_TYPE TERM_ACC_ID TERM_NAME QUALIFIER EVIDENCE WITH ASPECT REFERENCES CREATED_DATE ASSIGNED_BY MESH_OMIM_ID CURATION_NOTES ORIGINAL_REFERENCE 10000553 Gm21992 predicted gene 21992 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:5013860 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of RBM14-RBM4 mRNA PMID:37042841 10000553 Gm21992 predicted gene 21992 gene CHEBI:17967 urethane increases expression ISO RGD:5013860 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in increased expression of RBM14-RBM4 mRNA PMID:28818685 10000553 Gm21992 predicted gene 21992 gene CHEBI:28201 rotenone decreases expression ISO RGD:5013860 E RGD:6480464 20181016 CTD MESH:D012402 Rotenone results in decreased expression of RBM14-RBM4 mRNA PMID:29955902 10000553 Gm21992 predicted gene 21992 gene CHEBI:53473 beryllium sulfate decreases expression ISO RGD:5013860 E RGD:6480464 20221004 CTD MESH:C020711 beryllium sulfate results in decreased expression of RBM14-RBM4 mRNA PMID:35679967 10000686 Adap2os ArfGAP with dual PH domains 2, opposite strand gene CHEBI:15443 inulin multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAP2OS mRNA PMID:36331819 10000686 Adap2os ArfGAP with dual PH domains 2, opposite strand gene CHEBI:32234 titanium dioxide decreases expression EXP E RGD:6480464 20191112 CTD MESH:C009495 titanium dioxide results in decreased expression of ADAP2OS mRNA PMID:29264374 10000686 Adap2os ArfGAP with dual PH domains 2, opposite strand gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADAP2OS mRNA PMID:36331819 10001705 Mir7648 microRNA 7648 gene CHEBI:17847 p-cresol decreases expression EXP E RGD:6480464 20200714 CTD MESH:C032538 4-cresol results in decreased expression of MIR7648 mRNA PMID:32105654 10001705 Mir7648 microRNA 7648 gene CHEBI:27563 arsenic atom decreases expression EXP E RGD:6480464 20240402 CTD MESH:D001151 Arsenic results in decreased expression of MIR7648 mRNA PMID:36463740 10001705 Mir7648 microRNA 7648 gene CHEBI:27789 1,2-dichloroethane decreases expression EXP E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in decreased expression of MIR7648 mRNA PMID:28960355 10001705 Mir7648 microRNA 7648 gene CHEBI:28618 1,4-dichlorobenzene decreases expression EXP E RGD:6480464 20200714 CTD MESH:C018511 4-dichlorobenzene results in decreased expression of MIR7648 mRNA PMID:32105654 10001705 Mir7648 microRNA 7648 gene CHEBI:47217 arsane decreases expression EXP E RGD:6480464 20240402 CTD MESH:D001151 Arsenic results in decreased expression of MIR7648 mRNA PMID:36463740 10001809 Gm22496 predicted gene, 22496 gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:1606604 E RGD:6480464 20230801 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of SNORD115-35 gene PMID:27153756 10001809 Gm22496 predicted gene, 22496 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1606604 E RGD:6480464 20230801 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of SNORD115-35 promoter PMID:27901495 10001809 Gm22496 predicted gene, 22496 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1606604 E RGD:6480464 20230801 CTD MESH:D014635 Valproic Acid results in increased methylation of SNORD115-35 gene PMID:29154799 10001825 Mecomos MDS1 and EVI1 complex locus, opposite strand gene CHEBI:132267 triptonide increases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of MECOMOS mRNA PMID:33045310 10002520 Mir7684 microRNA 7684 gene CHEBI:27789 1,2-dichloroethane decreases expression EXP E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in decreased expression of MIR7684 mRNA PMID:28960355 10002520 Mir7684 microRNA 7684 gene CHEBI:28741 sodium fluoride increases expression EXP E RGD:6480464 20180410 CTD MESH:D012969 Sodium Fluoride results in increased expression of MIR7684 mRNA PMID:29127033 10002576 Lrp8os3 low density lipoprotein receptor-related protein 8, apolipoprotein e receptor, opposite strand 3 gene CHEBI:132267 triptonide increases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of LRP8OS3 mRNA PMID:33045310 10002576 Lrp8os3 low density lipoprotein receptor-related protein 8, apolipoprotein e receptor, opposite strand 3 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in increased expression of LRP8OS3 mRNA PMID:32156529 10009900 Gm40318 predicted gene, 40318 gene CHEBI:10429 beta-lapachone increases expression ISO RGD:1344746 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in increased expression of S100P mRNA PMID:38218311 10009900 Gm40318 predicted gene, 40318 gene CHEBI:116509 diuron increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D004237 Diuron metabolite results in increased expression of S100P mRNA PMID:24172598 10009900 Gm40318 predicted gene, 40318 gene CHEBI:132082 entinostat increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C118739 entinostat results in increased expression of S100P mRNA PMID:27188386 10009900 Gm40318 predicted gene, 40318 gene CHEBI:132098 methoxyacetic acid multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C013598 methoxyacetic acid promotes the reaction [Promegestone results in increased expression of S100P mRNA] PMID:15103026 10009900 Gm40318 predicted gene, 40318 gene CHEBI:132844 glycidyl methacrylate decreases expression ISO RGD:1344746 E RGD:6480464 20230704 CTD MESH:C007870 glycidyl methacrylate results in decreased expression of S100P protein PMID:36641056 10009900 Gm40318 predicted gene, 40318 gene CHEBI:134751 avobenzone decreases expression ISO RGD:1344746 E RGD:6480464 20190910 CTD MESH:C049935 avobenzone results in decreased expression of S100P mRNA PMID:31016361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:138858 Azaspiracid increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C406592 azaspiracid results in increased expression of S100P mRNA PMID:28939011 10009900 Gm40318 predicted gene, 40318 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D014212 Tretinoin results in increased expression of S100P mRNA PMID:16249480|PMID:33167477 10009900 Gm40318 predicted gene, 40318 gene CHEBI:15422 ATP increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:D000255 Adenosine Triphosphate results in increased expression of S100P mRNA PMID:29733962 10009900 Gm40318 predicted gene, 40318 gene CHEBI:15600 (+)-catechin multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D002392 Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of S100P mRNA] PMID:21882252 10009900 Gm40318 predicted gene, 40318 gene CHEBI:16240 hydrogen peroxide affects expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D006861 Hydrogen Peroxide affects the expression of S100P mRNA PMID:20044591 10009900 Gm40318 predicted gene, 40318 gene CHEBI:16240 hydrogen peroxide increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of S100P mRNA PMID:12414654 10009900 Gm40318 predicted gene, 40318 gene CHEBI:16243 quercetin decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D011794 Quercetin results in decreased expression of S100P mRNA PMID:15309432 10009900 Gm40318 predicted gene, 40318 gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:1344746 E RGD:6480464 20220308 CTD MESH:D004958 Estradiol results in decreased expression of S100P mRNA PMID:31614463 10009900 Gm40318 predicted gene, 40318 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D004958 Estradiol results in increased expression of S100P mRNA PMID:15159206|PMID:18191855|PMID:19619570|PMID:21185374 10009900 Gm40318 predicted gene, 40318 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D004958 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of S100P mRNA; [Estradiol co-treated with TGFB1 protein] results in decreased expression of S100P mRNA PMID:19619570|PMID:30165855 10009900 Gm40318 predicted gene, 40318 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1344746 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of S100P mRNA PMID:37042841 10009900 Gm40318 predicted gene, 40318 gene CHEBI:16767 3,4-dichloroaniline increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C014464 3,4-dichloroaniline results in increased expression of S100P mRNA PMID:24172598 10009900 Gm40318 predicted gene, 40318 gene CHEBI:17026 progesterone increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D011374 Progesterone results in increased expression of S100P mRNA PMID:18497975 10009900 Gm40318 predicted gene, 40318 gene CHEBI:17263 estrone increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D004970 Estrone results in increased expression of S100P mRNA PMID:15159206 10009900 Gm40318 predicted gene, 40318 gene CHEBI:17347 testosterone increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D013739 Testosterone results in increased expression of S100P mRNA PMID:21592394 10009900 Gm40318 predicted gene, 40318 gene CHEBI:17347 testosterone multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D013739 [Testosterone co-treated with Calcitriol] results in increased expression of S100P mRNA PMID:21592394 10009900 Gm40318 predicted gene, 40318 gene CHEBI:17594 hydroquinone increases expression ISO RGD:1344746 E RGD:6480464 20190910 CTD MESH:C031927 hydroquinone results in increased expression of S100P mRNA PMID:31256213 10009900 Gm40318 predicted gene, 40318 gene CHEBI:17660 N(6)-dimethylallyladenine increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C001478 N(6)-(delta(2)-isopentenyl)adenine results in increased expression of S100P mRNA; N(6)-(delta(2)-isopentenyl)adenine results in increased expression of S100P protein PMID:16129123 10009900 Gm40318 predicted gene, 40318 gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1344746 E RGD:6480464 20190910 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of S100P mRNA PMID:31163220 10009900 Gm40318 predicted gene, 40318 gene CHEBI:17823 calcitriol increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D002117 Calcitriol results in increased expression of S100P mRNA PMID:21592394 10009900 Gm40318 predicted gene, 40318 gene CHEBI:17823 calcitriol multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D002117 [Testosterone co-treated with Calcitriol] results in increased expression of S100P mRNA PMID:21592394 10009900 Gm40318 predicted gene, 40318 gene CHEBI:2038 5-azacytidine increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D001374 Azacitidine results in increased expression of S100P mRNA PMID:19194470 10009900 Gm40318 predicted gene, 40318 gene CHEBI:22977 cadmium atom decreases methylation ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D002104 Cadmium results in decreased methylation of S100P gene PMID:25922126 10009900 Gm40318 predicted gene, 40318 gene CHEBI:22977 cadmium atom increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D002104 Cadmium results in increased expression of S100P mRNA; Cadmium results in increased expression of S100P protein PMID:22626610|PMID:25922126 10009900 Gm40318 predicted gene, 40318 gene CHEBI:23414 copper(II) sulfate increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D019327 Copper Sulfate results in increased expression of S100P mRNA PMID:19549813 10009900 Gm40318 predicted gene, 40318 gene CHEBI:23808 dimethylarsinous acid increases expression ISO RGD:1344746 E RGD:6480464 20230801 CTD MESH:C472511 dimethylarsinous acid results in increased expression of S100P mRNA PMID:23487506 10009900 Gm40318 predicted gene, 40318 gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of S100P intron PMID:30157460 10009900 Gm40318 predicted gene, 40318 gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D009151 Mustard Gas results in increased expression of S100P mRNA PMID:25102026 10009900 Gm40318 predicted gene, 40318 gene CHEBI:25812 ozone multiple interactions ISO RGD:1344746 E RGD:6480464 20211109 CTD MESH:D010126 [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC02481 mRNA] which results in increased expression of S100P mRNA PMID:33656867 10009900 Gm40318 predicted gene, 40318 gene CHEBI:26710 sodium chloride multiple interactions ISO RGD:1344746 E RGD:6480464 20250114 CTD MESH:D012965 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of S100P protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of S100P protein PMID:38598786 10009900 Gm40318 predicted gene, 40318 gene CHEBI:27363 zinc atom multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D015032 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of S100P mRNA PMID:16979875 10009900 Gm40318 predicted gene, 40318 gene CHEBI:27563 arsenic atom decreases methylation ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D001151 Arsenic results in decreased methylation of S100P gene PMID:25922126 10009900 Gm40318 predicted gene, 40318 gene CHEBI:27563 arsenic atom increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D001151 Arsenic results in increased expression of S100P mRNA PMID:25922126 10009900 Gm40318 predicted gene, 40318 gene CHEBI:27638 cobalt atom multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D003035 [tungsten carbide co-treated with Cobalt] results in decreased expression of S100P mRNA PMID:18078969 10009900 Gm40318 predicted gene, 40318 gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:1344746 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased secretion of S100P protein PMID:38460933 10009900 Gm40318 predicted gene, 40318 gene CHEBI:27881 resveratrol increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C059514 Resveratrol results in increased expression of S100P mRNA PMID:25888808 10009900 Gm40318 predicted gene, 40318 gene CHEBI:27899 cisplatin increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D002945 Cisplatin results in increased expression of S100P mRNA PMID:20726978|PMID:27594783 10009900 Gm40318 predicted gene, 40318 gene CHEBI:27899 cisplatin increases response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D002945 S100P protein results in increased susceptibility to Cisplatin PMID:20726978 10009900 Gm40318 predicted gene, 40318 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in increased expression of S100P mRNA PMID:27392435 10009900 Gm40318 predicted gene, 40318 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of S100P mRNA PMID:12377990 10009900 Gm40318 predicted gene, 40318 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of S100P mRNA PMID:19619570 10009900 Gm40318 predicted gene, 40318 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D013749 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of S100P mRNA PMID:19619570 10009900 Gm40318 predicted gene, 40318 gene CHEBI:28216 methylmercury chloride increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C004925 methylmercuric chloride results in increased expression of S100P mRNA PMID:28001369 10009900 Gm40318 predicted gene, 40318 gene CHEBI:28661 gamma-linolenic acid increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D017965 gamma-Linolenic Acid results in increased expression of S100P mRNA PMID:20664735 10009900 Gm40318 predicted gene, 40318 gene CHEBI:28680 cytarabine increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D003561 Cytarabine results in increased expression of S100P mRNA PMID:19194470 10009900 Gm40318 predicted gene, 40318 gene CHEBI:28694 copper atom multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D003300 [Disulfiram binds to Copper] which results in decreased expression of S100P mRNA; [NSC 689534 binds to Copper] which results in increased expression of S100P mRNA PMID:20971185|PMID:24690739 10009900 Gm40318 predicted gene, 40318 gene CHEBI:28869 menadione increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D024483 Vitamin K 3 results in increased expression of S100P mRNA PMID:12414654 10009900 Gm40318 predicted gene, 40318 gene CHEBI:28909 iprodione increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C033148 iprodione results in increased expression of S100P mRNA; iprodione results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:28925 mechlorethamine increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D008466 Mechlorethamine results in increased expression of S100P mRNA; Mechlorethamine results in increased expression of S100P protein PMID:15936073 10009900 Gm40318 predicted gene, 40318 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1344746 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in increased expression of S100P mRNA PMID:38568856 10009900 Gm40318 predicted gene, 40318 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D001564 Benzo(a)pyrene metabolite results in decreased expression of S100P mRNA PMID:26314263 10009900 Gm40318 predicted gene, 40318 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of S100P mRNA PMID:21632981|PMID:26238291 10009900 Gm40318 predicted gene, 40318 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1344746 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of S100P exon; Benzo(a)pyrene results in increased methylation of S100P promoter PMID:27901495 10009900 Gm40318 predicted gene, 40318 gene CHEBI:29865 benzo[a]pyrene multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D001564 [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of S100P mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of S100P mRNA] PMID:21882252 10009900 Gm40318 predicted gene, 40318 gene CHEBI:29866 arsenite(3-) decreases methylation ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C015001 arsenite results in decreased methylation of S100P promoter PMID:23974009 10009900 Gm40318 predicted gene, 40318 gene CHEBI:29866 arsenite(3-) increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C015001 arsenite results in increased expression of S100P mRNA PMID:23974009 10009900 Gm40318 predicted gene, 40318 gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:1344746 E RGD:6480464 20220405 CTD MESH:C015001 arsenite promotes the reaction [G3BP1 protein binds to S100P mRNA] PMID:32406909 10009900 Gm40318 predicted gene, 40318 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D003300 [Disulfiram binds to Copper] which results in decreased expression of S100P mRNA; [NSC 689534 binds to Copper] which results in increased expression of S100P mRNA PMID:20971185|PMID:24690739 10009900 Gm40318 predicted gene, 40318 gene CHEBI:30185 zinc(0) multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D015032 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of S100P mRNA PMID:16979875 10009900 Gm40318 predicted gene, 40318 gene CHEBI:30512 silver atom increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D012834 Silver results in increased expression of S100P mRNA PMID:28959546 10009900 Gm40318 predicted gene, 40318 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of S100P mRNA PMID:25895662 10009900 Gm40318 predicted gene, 40318 gene CHEBI:3090 bicalutamide increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C053541 bicalutamide results in increased expression of S100P mRNA PMID:15638997 10009900 Gm40318 predicted gene, 40318 gene CHEBI:31348 capecitabine increases response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C110904 S100P protein results in increased susceptibility to Capecitabine PMID:16734730 10009900 Gm40318 predicted gene, 40318 gene CHEBI:31941 oxaliplatin decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C030110 Oxaliplatin results in decreased expression of S100P mRNA PMID:17762391 10009900 Gm40318 predicted gene, 40318 gene CHEBI:31941 oxaliplatin increases response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C030110 S100P protein results in increased susceptibility to Oxaliplatin PMID:18636193 10009900 Gm40318 predicted gene, 40318 gene CHEBI:32692 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C016583 [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of S100P mRNA; Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased expression of S100P mRNA] PMID:21882252 10009900 Gm40318 predicted gene, 40318 gene CHEBI:33216 bisphenol A affects expression ISO RGD:1344746 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of S100P mRNA PMID:30903817 10009900 Gm40318 predicted gene, 40318 gene CHEBI:34342 3-methylcholanthrene multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D008748 Methylcholanthrene promotes the reaction [AHR protein binds to S100P promoter] PMID:20348232 10009900 Gm40318 predicted gene, 40318 gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:D004390 Chlorpyrifos results in increased expression of S100P mRNA; Chlorpyrifos results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:34768 furfural multiple interactions ISO RGD:1344746 E RGD:6480464 20250114 CTD MESH:D005662 [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of S100P protein; [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of S100P protein PMID:38598786 10009900 Gm40318 predicted gene, 40318 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1344746 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of S100P mRNA PMID:37042841 10009900 Gm40318 predicted gene, 40318 gene CHEBI:35038 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C013320 tris(2-butoxyethyl) phosphate affects the expression of S100P mRNA PMID:29024780 10009900 Gm40318 predicted gene, 40318 gene CHEBI:35176 zinc sulfate increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D019287 Zinc Sulfate results in increased expression of S100P mRNA PMID:19013360 10009900 Gm40318 predicted gene, 40318 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1344746 E RGD:6480464 20241001 CTD MESH:D019256 Cadmium Chloride results in decreased expression of S100P mRNA PMID:38382870 10009900 Gm40318 predicted gene, 40318 gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:1344746 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in increased expression of S100P mRNA PMID:38568856 10009900 Gm40318 predicted gene, 40318 gene CHEBI:35546 perfluorodecanoic acid decreases expression ISO RGD:1344746 E RGD:6480464 20240702 CTD MESH:C036567 perfluorodecanoic acid results in decreased expression of S100P mRNA PMID:38568856 10009900 Gm40318 predicted gene, 40318 gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of S100P protein PMID:26879310 10009900 Gm40318 predicted gene, 40318 gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C018021 cobaltous chloride results in decreased expression of S100P mRNA PMID:19376846 10009900 Gm40318 predicted gene, 40318 gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of S100P mRNA PMID:24449571 10009900 Gm40318 predicted gene, 40318 gene CHEBI:37537 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D013755 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of S100P mRNA PMID:16979875 10009900 Gm40318 predicted gene, 40318 gene CHEBI:38397 perfluorononanoic acid decreases expression ISO RGD:1344746 E RGD:6480464 20240702 CTD MESH:C101816 perfluoro-n-nonanoic acid results in decreased expression of S100P mRNA PMID:38568856 10009900 Gm40318 predicted gene, 40318 gene CHEBI:38665 ethoprophos increases expression ISO RGD:1344746 E RGD:6480464 20220208 CTD MESH:C474843 ethoprop results in increased expression of S100P mRNA; ethoprop results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:39185 thiamethoxam increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C416660 Thiamethoxam results in increased expression of S100P mRNA PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:39186 (E)-thiamethoxam increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C416660 Thiamethoxam results in increased expression of S100P mRNA PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:39421 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1344746 E RGD:6480464 20240702 CTD MESH:C076994 perfluorooctane sulfonic acid results in decreased expression of S100P mRNA PMID:38568856 10009900 Gm40318 predicted gene, 40318 gene CHEBI:39867 valproic acid increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D014635 Valproic Acid results in increased expression of S100P mRNA PMID:27188386|PMID:29154799 10009900 Gm40318 predicted gene, 40318 gene CHEBI:39867 valproic acid increases methylation ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D014635 Valproic Acid results in increased methylation of S100P gene PMID:29154799 10009900 Gm40318 predicted gene, 40318 gene CHEBI:4027 cyclophosphamide affects response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D003520 S100P protein affects the susceptibility to Cyclophosphamide PMID:16217747 10009900 Gm40318 predicted gene, 40318 gene CHEBI:4027 cyclophosphamide decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D003520 Cyclophosphamide results in decreased expression of S100P mRNA PMID:17403535 10009900 Gm40318 predicted gene, 40318 gene CHEBI:4031 cyclosporin A increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D016572 Cyclosporine results in increased expression of S100P mRNA PMID:20106945|PMID:21632981|PMID:25562108|PMID:27989131 10009900 Gm40318 predicted gene, 40318 gene CHEBI:4045 cyprodinil increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C108338 cyprodinil results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:40909 azoxystrobin increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C087670 azoxystrobin results in increased expression of S100P mRNA PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:44185 methotrexate affects response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D008727 S100P protein affects the susceptibility to Methotrexate PMID:16217747 10009900 Gm40318 predicted gene, 40318 gene CHEBI:45863 paclitaxel decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D017239 Paclitaxel results in decreased expression of S100P mRNA PMID:19682730 10009900 Gm40318 predicted gene, 40318 gene CHEBI:45863 paclitaxel increases response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D017239 S100P mRNA results in increased susceptibility to Paclitaxel; S100P protein results in increased susceptibility to Paclitaxel PMID:16322897|PMID:18636193 10009900 Gm40318 predicted gene, 40318 gene CHEBI:4610 dimethylselenide multiple interactions ISO RGD:1344746 E RGD:6480464 20211109 CTD MESH:C013503 [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of LINC02481 mRNA] which results in increased expression of S100P mRNA PMID:33656867 10009900 Gm40318 predicted gene, 40318 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D000082 Acetaminophen results in decreased expression of S100P mRNA; Acetaminophen results in decreased expression of S100P protein PMID:22230336|PMID:26690555 10009900 Gm40318 predicted gene, 40318 gene CHEBI:46345 5-fluorouracil affects response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D005472 S100P protein affects the susceptibility to Fluorouracil PMID:15352031 10009900 Gm40318 predicted gene, 40318 gene CHEBI:46345 5-fluorouracil decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D005472 Fluorouracil results in decreased expression of S100P protein PMID:15352031 10009900 Gm40318 predicted gene, 40318 gene CHEBI:46345 5-fluorouracil increases response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D005472 S100P protein results in increased susceptibility to Fluorouracil PMID:18636193 10009900 Gm40318 predicted gene, 40318 gene CHEBI:46557 zoledronic acid decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C088658 Zoledronic Acid results in decreased expression of S100P protein PMID:28871336 10009900 Gm40318 predicted gene, 40318 gene CHEBI:4659 disulfiram multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D004221 [Disulfiram binds to Copper] which results in decreased expression of S100P mRNA PMID:24690739 10009900 Gm40318 predicted gene, 40318 gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:1344746 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased secretion of S100P protein PMID:38460933 10009900 Gm40318 predicted gene, 40318 gene CHEBI:46938 zebularine increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C009131 pyrimidin-2-one beta-ribofuranoside results in increased expression of S100P mRNA PMID:19194470 10009900 Gm40318 predicted gene, 40318 gene CHEBI:47217 arsane decreases methylation ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D001151 Arsenic results in decreased methylation of S100P gene PMID:25922126 10009900 Gm40318 predicted gene, 40318 gene CHEBI:47217 arsane increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D001151 Arsenic results in increased expression of S100P mRNA PMID:25922126 10009900 Gm40318 predicted gene, 40318 gene CHEBI:47286 CU-O LINKAGE increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C030973 cupric oxide results in increased expression of S100P mRNA PMID:22077320 10009900 Gm40318 predicted gene, 40318 gene CHEBI:47898 4'-epidoxorubicin increases response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D015251 S100P protein results in increased susceptibility to Epirubicin PMID:18636193 10009900 Gm40318 predicted gene, 40318 gene CHEBI:4811 epoxiconazole increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C109476 epoxiconazole results in increased expression of S100P mRNA PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:4911 etoposide affects response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D005047 S100P protein affects the susceptibility to Etoposide PMID:16217747 10009900 Gm40318 predicted gene, 40318 gene CHEBI:4911 etoposide increases response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D005047 S100P protein results in increased susceptibility to Etoposide PMID:18636193 10009900 Gm40318 predicted gene, 40318 gene CHEBI:49553 copper(II) chloride decreases expression ISO RGD:1344746 E RGD:6480464 20240702 CTD MESH:C029892 cupric chloride results in decreased expression of S100P mRNA PMID:38568856 10009900 Gm40318 predicted gene, 40318 gene CHEBI:50102 N-methyl-N-nitrosourea decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D008770 Methylnitrosourea results in decreased expression of S100P mRNA PMID:25922126 10009900 Gm40318 predicted gene, 40318 gene CHEBI:5011 fenpyroximate increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C415144 fenpyroximate results in increased expression of S100P mRNA; fenpyroximate results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:50131 5-aza-2'-deoxycytidine affects expression ISO RGD:1344746 E RGD:6480464 20191114 CTD MESH:C014347 Decitabine affects the expression of S100P mRNA PMID:25922126 10009900 Gm40318 predicted gene, 40318 gene CHEBI:50131 5-aza-2'-deoxycytidine increases expression ISO RGD:1344746 E RGD:6480464 20191114 CTD MESH:C014347 Decitabine results in increased expression of S100P mRNA PMID:19194470 10009900 Gm40318 predicted gene, 40318 gene CHEBI:50131 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1344746 E RGD:6480464 20191114 CTD MESH:C014347 Decitabine inhibits the reaction [Smoke results in decreased expression of S100P mRNA] PMID:21095227 10009900 Gm40318 predicted gene, 40318 gene CHEBI:5063 fipronil increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C082360 fipronil results in increased expression of S100P mRNA; fipronil results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:50729 mitoxantrone affects response to substance ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D008942 S100P protein affects the susceptibility to Mitoxantrone PMID:16217747 10009900 Gm40318 predicted gene, 40318 gene CHEBI:51403 1,4-phenylenediamine increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C029728 4-phenylenediamine results in increased expression of S100P mRNA PMID:16314067 10009900 Gm40318 predicted gene, 40318 gene CHEBI:52497 maneb increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:D008344 Maneb results in increased expression of S100P mRNA; Maneb results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:53001 nickel sulfate increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C029938 nickel sulfate results in increased expression of S100P mRNA PMID:16314067 10009900 Gm40318 predicted gene, 40318 gene CHEBI:6402 leflunomide increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C045463 Leflunomide results in increased expression of S100P mRNA PMID:28988120 10009900 Gm40318 predicted gene, 40318 gene CHEBI:64090 tert-butyl hydroperoxide increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D020122 tert-Butylhydroperoxide results in increased expression of S100P mRNA PMID:12414654 10009900 Gm40318 predicted gene, 40318 gene CHEBI:64227 ciglitazone multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C039671 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of S100P mRNA; [ciglitazone binds to PPARG protein] which results in increased expression of S100P mRNA PMID:16197558 10009900 Gm40318 predicted gene, 40318 gene CHEBI:6716 medroxyprogesterone acetate increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D017258 Medroxyprogesterone Acetate results in increased expression of S100P mRNA PMID:18497975|PMID:19146866 10009900 Gm40318 predicted gene, 40318 gene CHEBI:6790 metalaxyl increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C028175 metalaxyl results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:69478 cannabidiol increases expression ISO RGD:1344746 E RGD:6480464 20211109 CTD MESH:D002185 Cannabidiol results in increased expression of S100P mRNA PMID:33244087 10009900 Gm40318 predicted gene, 40318 gene CHEBI:73390 promegestone increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D011397 Promegestone results in increased expression of S100P mRNA PMID:15103026 10009900 Gm40318 predicted gene, 40318 gene CHEBI:73390 promegestone multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D011397 methoxyacetic acid promotes the reaction [Promegestone results in increased expression of S100P mRNA] PMID:15103026 10009900 Gm40318 predicted gene, 40318 gene CHEBI:75408 sulindac sulfide increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C025462 sulindac sulfide results in increased expression of S100P mRNA PMID:16184548 10009900 Gm40318 predicted gene, 40318 gene CHEBI:7719 ochratoxin A increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C025589 ochratoxin A metabolite results in increased expression of S100P mRNA; ochratoxin A results in increased expression of S100P mRNA PMID:26314263 10009900 Gm40318 predicted gene, 40318 gene CHEBI:79516 Nonylphenol increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C025256 nonylphenol results in increased expression of S100P mRNA PMID:15159206 10009900 Gm40318 predicted gene, 40318 gene CHEBI:8069 phenobarbital affects expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D010634 Phenobarbital affects the expression of S100P mRNA PMID:19159669 10009900 Gm40318 predicted gene, 40318 gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1344746 E RGD:6480464 20220510 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether results in increased expression of S100P mRNA PMID:26705709 10009900 Gm40318 predicted gene, 40318 gene CHEBI:81760 difenoconazole increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C115058 difenoconazole results in increased expression of S100P mRNA; difenoconazole results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:81763 fludioxonil increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C108339 fludioxonil results in increased expression of S100P mRNA; fludioxonil results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:81781 tebuconazole increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C087114 tebuconazole results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:81848 dimethomorph increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C076154 dimethomorph results in increased expression of S100P mRNA; dimethomorph results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:81853 fenhexamid increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C451426 N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of S100P mRNA PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:81922 flusilazole increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C061365 flusilazole results in increased expression of S100P mRNA; flusilazole results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:81927 enilconazole increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C017435 enilconazole results in increased expression of S100P mRNA; enilconazole results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:82036 prothioconazole increases expression ISO RGD:1344746 E RGD:6480464 20221101 CTD MESH:C550005 prothioconazole results in increased expression of S100P mRNA PMID:35048155 10009900 Gm40318 predicted gene, 40318 gene CHEBI:82283 Tungsten carbide multiple interactions ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C002802 [tungsten carbide co-treated with Cobalt] results in decreased expression of S100P mRNA PMID:18078969 10009900 Gm40318 predicted gene, 40318 gene CHEBI:83113 fluxapyroxad increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C000591719 fluxapyroxad results in increased expression of S100P mRNA; fluxapyroxad results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:8434 prochloraz increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C045362 prochloraz results in increased expression of S100P mRNA; prochloraz results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:8489 propiconazole increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:C045950 propiconazole results in increased expression of S100P mRNA; propiconazole results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:C044387 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of S100P mRNA PMID:19013360 10009900 Gm40318 predicted gene, 40318 gene CHEBI:9141 silver(0) increases expression ISO RGD:1344746 E RGD:6480464 20190219 CTD MESH:D012834 Silver results in increased expression of S100P mRNA PMID:28959546 10009900 Gm40318 predicted gene, 40318 gene CHEBI:9495 thiram increases expression ISO RGD:1344746 E RGD:6480464 20201103 CTD MESH:D013893 Thiram results in increased expression of S100P protein PMID:32194361 10009900 Gm40318 predicted gene, 40318 gene CHEBI:955 2,6-dimethoxyphenol multiple interactions ISO RGD:1344746 E RGD:6480464 20250114 CTD MESH:C010120 [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in decreased expression of and affects the localization of S100P protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of S100P protein PMID:38598786 10010246 Spem3 SPEM family member 3 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:13208913 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of SPEM3 mRNA PMID:33212167 10010253 Chaer1 cardiac hypertrophy associated epigenetic regulator 1 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CHAER1 mRNA PMID:36331819 10010253 Chaer1 cardiac hypertrophy associated epigenetic regulator 1 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CHAER1 mRNA PMID:36331819 10015961 Gm38591 predicted gene, 38591 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:2289877 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of LEUTX 5' UTR PMID:27901495 10020222 Idi1-ps1 isopentenyl-diphosphate delta isomerase, pseudogene 1 gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions EXP E RGD:6480464 20241203 CTD MESH:D004051 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IDI1-PS1 mRNA PMID:39150890 10020222 Idi1-ps1 isopentenyl-diphosphate delta isomerase, pseudogene 1 gene CHEBI:34595 Butylbenzyl phthalate multiple interactions EXP E RGD:6480464 20241203 CTD MESH:C027561 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IDI1-PS1 mRNA PMID:39150890 10020222 Idi1-ps1 isopentenyl-diphosphate delta isomerase, pseudogene 1 gene CHEBI:34687 dibutyl phthalate multiple interactions EXP E RGD:6480464 20241203 CTD MESH:D003993 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IDI1-PS1 mRNA PMID:39150890 10020222 Idi1-ps1 isopentenyl-diphosphate delta isomerase, pseudogene 1 gene CHEBI:34698 diethyl phthalate multiple interactions EXP E RGD:6480464 20241203 CTD MESH:C007379 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IDI1-PS1 mRNA PMID:39150890 10020222 Idi1-ps1 isopentenyl-diphosphate delta isomerase, pseudogene 1 gene CHEBI:35459 diisononyl phthalate multiple interactions EXP E RGD:6480464 20241203 CTD MESH:C012125 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IDI1-PS1 mRNA PMID:39150890 10020222 Idi1-ps1 isopentenyl-diphosphate delta isomerase, pseudogene 1 gene CHEBI:79053 diisobutyl phthalate multiple interactions EXP E RGD:6480464 20241203 CTD MESH:C025605 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with diisononyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] affects the expression of IDI1-PS1 mRNA PMID:39150890 10021856 Percc1 proline and glutamate rich with coiled coil 1 gene CHEBI:34905 paraquat decreases expression ISO RGD:9344254 E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in decreased expression of PERCC1 mRNA PMID:32680482 10021856 Percc1 proline and glutamate rich with coiled coil 1 gene CHEBI:7553 niclosamide increases expression ISO RGD:14696710 E RGD:6480464 20230704 CTD MESH:D009534 Niclosamide results in increased expression of PERCC1 mRNA PMID:36318118 10023812 Gm41409 predicted gene, 41409 gene CHEBI:16243 quercetin increases expression ISO RGD:1346975 E RGD:6480464 20160901 CTD MESH:D011794 Quercetin results in increased expression of ZNF75A mRNA PMID:21632981 10023812 Gm41409 predicted gene, 41409 gene CHEBI:16842 formaldehyde increases expression ISO RGD:1346975 E RGD:6480464 20160901 CTD MESH:D005557 Formaldehyde results in increased expression of ZNF75A mRNA PMID:23649840 10023812 Gm41409 predicted gene, 41409 gene CHEBI:181914 Aflatoxin B2 alpha decreases methylation ISO RGD:1346975 E RGD:6480464 20211109 CTD MESH:C029753 aflatoxin B2 results in decreased methylation of ZNF75A exon PMID:30157460 10023812 Gm41409 predicted gene, 41409 gene CHEBI:23994 ethyl methanesulfonate increases expression ISO RGD:1346975 E RGD:6480464 20160901 CTD MESH:D005020 Ethyl Methanesulfonate results in increased expression of ZNF75A mRNA PMID:23649840 10023812 Gm41409 predicted gene, 41409 gene CHEBI:25255 methyl methanesulfonate increases expression ISO RGD:1346975 E RGD:6480464 20160901 CTD MESH:D008741 Methyl Methanesulfonate results in increased expression of ZNF75A mRNA PMID:23649840 10023812 Gm41409 predicted gene, 41409 gene CHEBI:25812 ozone multiple interactions ISO RGD:1346975 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of ZNF75A mRNA PMID:35430440 10023812 Gm41409 predicted gene, 41409 gene CHEBI:27363 zinc atom multiple interactions ISO RGD:1346975 E RGD:6480464 20160901 CTD MESH:D015032 [PCI 5002 co-treated with Zinc] results in increased expression of ZNF75A mRNA PMID:18593933 10023812 Gm41409 predicted gene, 41409 gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:1346975 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of ZNF75A mRNA PMID:30851411 10023812 Gm41409 predicted gene, 41409 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1346975 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite results in decreased expression of ZNF75A mRNA PMID:34032870 10023812 Gm41409 predicted gene, 41409 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1346975 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in increased expression of ZNF75A mRNA PMID:38568856 10023812 Gm41409 predicted gene, 41409 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1346975 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ZNF75A promoter PMID:27901495 10023812 Gm41409 predicted gene, 41409 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1346975 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ZNF75A 5' UTR; Benzo(a)pyrene results in decreased methylation of ZNF75A exon PMID:27901495 10023812 Gm41409 predicted gene, 41409 gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:1346975 E RGD:6480464 20220405 CTD MESH:C015001 arsenite promotes the reaction [G3BP1 protein binds to ZNF75A mRNA] PMID:32406909 10023812 Gm41409 predicted gene, 41409 gene CHEBI:30185 zinc(0) multiple interactions ISO RGD:1346975 E RGD:6480464 20160901 CTD MESH:D015032 [PCI 5002 co-treated with Zinc] results in increased expression of ZNF75A mRNA PMID:18593933 10023812 Gm41409 predicted gene, 41409 gene CHEBI:30812 iron dichloride decreases expression ISO RGD:1346975 E RGD:6480464 20231003 CTD MESH:C029451 ferrous chloride results in decreased expression of ZNF75A mRNA PMID:35984750 10023812 Gm41409 predicted gene, 41409 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1346975 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ZNF75A mRNA PMID:37042841 10023812 Gm41409 predicted gene, 41409 gene CHEBI:35038 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1346975 E RGD:6480464 20180515 CTD MESH:C013320 tris(2-butoxyethyl) phosphate affects the expression of ZNF75A mRNA PMID:29024780 10023812 Gm41409 predicted gene, 41409 gene CHEBI:39867 valproic acid affects expression ISO RGD:1346975 E RGD:6480464 20160901 CTD MESH:D014635 Valproic Acid affects the expression of ZNF75A mRNA PMID:25979313 10023812 Gm41409 predicted gene, 41409 gene CHEBI:39867 valproic acid increases expression ISO RGD:1346975 E RGD:6480464 20160901 CTD MESH:D014635 Valproic Acid results in increased expression of ZNF75A mRNA PMID:23179753 10023812 Gm41409 predicted gene, 41409 gene CHEBI:78320 2-hydroxypropanoic acid decreases expression ISO RGD:1346975 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of ZNF75A mRNA PMID:30851411 10023812 Gm41409 predicted gene, 41409 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1346975 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to ZNF75A gene] PMID:28238834 10032107 Gm38656 predicted gene, 38656 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D014212 Tretinoin results in decreased expression of SCGB1D2 mRNA PMID:23830798 10032107 Gm38656 predicted gene, 38656 gene CHEBI:15743 butanal increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:C018475 butyraldehyde results in increased expression of SCGB1D2 mRNA PMID:26079696 10032107 Gm38656 predicted gene, 38656 gene CHEBI:15948 lycopene decreases expression ISO RGD:708459 E RGD:6480464 20200701 CTD MESH:C015329 Lycopene results in decreased expression of SCGB1D2 mRNA PMID:15084515 10032107 Gm38656 predicted gene, 38656 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D004958 Estradiol results in increased expression of SCGB1D2 mRNA PMID:22609851 10032107 Gm38656 predicted gene, 38656 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D004958 [Estradiol co-treated with Progesterone] results in increased expression of SCGB1D2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of SCGB1D2 mRNA PMID:17404688|PMID:20660070 10032107 Gm38656 predicted gene, 38656 gene CHEBI:16842 formaldehyde increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D005557 Formaldehyde results in increased expression of SCGB1D2 mRNA PMID:23649840 10032107 Gm38656 predicted gene, 38656 gene CHEBI:17026 progesterone increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D011374 Progesterone results in increased expression of SCGB1D2 mRNA PMID:17404688 10032107 Gm38656 predicted gene, 38656 gene CHEBI:17026 progesterone multiple interactions ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D011374 [Estradiol co-treated with Progesterone] results in increased expression of SCGB1D2 mRNA; [Progesterone co-treated with Estradiol] results in increased expression of SCGB1D2 mRNA PMID:17404688|PMID:20660070 10032107 Gm38656 predicted gene, 38656 gene CHEBI:17153 propanal increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:C005556 propionaldehyde results in increased expression of SCGB1D2 mRNA PMID:26079696 10032107 Gm38656 predicted gene, 38656 gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D016604 Aflatoxin B1 affects the expression of SCGB1D2 protein PMID:20106945 10032107 Gm38656 predicted gene, 38656 gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of SCGB1D2 mRNA PMID:22100608 10032107 Gm38656 predicted gene, 38656 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D016604 Aflatoxin B1 results in increased expression of SCGB1D2 mRNA PMID:21641981 10032107 Gm38656 predicted gene, 38656 gene CHEBI:25255 methyl methanesulfonate increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D008741 Methyl Methanesulfonate results in increased expression of SCGB1D2 mRNA PMID:23649840 10032107 Gm38656 predicted gene, 38656 gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:1345787 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased expression of SCGB1D2 mRNA PMID:38460933 10032107 Gm38656 predicted gene, 38656 gene CHEBI:27889 lead(0) affects expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D007854 Lead affects the expression of SCGB1D2 mRNA PMID:22313790 10032107 Gm38656 predicted gene, 38656 gene CHEBI:28112 nickel atom decreases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D009532 Nickel results in decreased expression of SCGB1D2 mRNA PMID:24768652|PMID:25583101 10032107 Gm38656 predicted gene, 38656 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:C017947 sodium arsenite results in decreased expression of SCGB1D2 mRNA PMID:29301061 10032107 Gm38656 predicted gene, 38656 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1345787 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of SCGB1D2 promoter PMID:27901495 10032107 Gm38656 predicted gene, 38656 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1345787 E RGD:6480464 20200714 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of SCGB1D2 mRNA PMID:32234424 10032107 Gm38656 predicted gene, 38656 gene CHEBI:30621 diarsenic trioxide increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:C006632 Arsenic Trioxide results in increased expression of SCGB1D2 mRNA PMID:20458559 10032107 Gm38656 predicted gene, 38656 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:708459 E RGD:6480464 20200701 CTD MESH:D000643 Ammonium Chloride affects the expression of SCGB1D2 mRNA PMID:16483693 10032107 Gm38656 predicted gene, 38656 gene CHEBI:33234 vitamin E decreases expression ISO RGD:708459 E RGD:6480464 20200701 CTD MESH:D024502 Vitamin E results in decreased expression of SCGB1D2 mRNA PMID:15084515 10032107 Gm38656 predicted gene, 38656 gene CHEBI:34027 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:C016340 o,p'-DDT results in increased expression of SCGB1D2 mRNA PMID:22609851 10032107 Gm38656 predicted gene, 38656 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D016572 Cyclosporine results in decreased expression of SCGB1D2 mRNA PMID:20106945 10032107 Gm38656 predicted gene, 38656 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D000082 Acetaminophen results in decreased expression of SCGB1D2 mRNA PMID:29067470 10032107 Gm38656 predicted gene, 38656 gene CHEBI:46557 zoledronic acid increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:C088658 Zoledronic Acid results in increased expression of SCGB1D2 mRNA PMID:24714768 10032107 Gm38656 predicted gene, 38656 gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:1345787 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased expression of SCGB1D2 mRNA PMID:38460933 10032107 Gm38656 predicted gene, 38656 gene CHEBI:46790 2-methoxyethanol increases expression ISO RGD:708459 E RGD:6480464 20200701 CTD MESH:C005219 methyl cellosolve results in increased expression of SCGB1D2 mRNA PMID:21061450 10032107 Gm38656 predicted gene, 38656 gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of SCGB1D2 mRNA PMID:18936297 10032107 Gm38656 predicted gene, 38656 gene CHEBI:49900 arsenous acid increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:C032793 Arsenic Trioxide results in increased expression of SCGB1D2 mRNA PMID:20458559 10032107 Gm38656 predicted gene, 38656 gene CHEBI:5014 fenvalerate increases expression ISO RGD:708459 E RGD:6480464 20201103 CTD MESH:C017690 fenvalerate results in increased expression of SCGB1D2 mRNA PMID:30307764 10032107 Gm38656 predicted gene, 38656 gene CHEBI:50673 methimazole increases expression ISO RGD:708459 E RGD:6480464 20200701 CTD MESH:D008713 Methimazole results in increased expression of SCGB1D2 mRNA PMID:22504374 10032107 Gm38656 predicted gene, 38656 gene CHEBI:8069 phenobarbital increases expression ISO RGD:708459 E RGD:6480464 20200701 CTD MESH:D010634 Phenobarbital results in increased expression of SCGB1D2 mRNA PMID:12832660 10032107 Gm38656 predicted gene, 38656 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:708459 E RGD:6480464 20200701 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of SCGB1D2 mRNA PMID:27291303 10032107 Gm38656 predicted gene, 38656 gene CHEBI:84069 pentanal increases expression ISO RGD:1345787 E RGD:6480464 20200701 CTD MESH:C046012 pentanal results in increased expression of SCGB1D2 mRNA PMID:26079696 10032107 Gm38656 predicted gene, 38656 gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:708459 E RGD:6480464 20200701 CTD MESH:D011441 Propylthiouracil results in increased expression of SCGB1D2 mRNA PMID:22504374 10033261 Gm38812 predicted gene, 38812 gene CHEBI:25812 ozone multiple interactions ISO RGD:6480823 E RGD:6480464 20211109 CTD MESH:D010126 [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXA10-AS mRNA] which results in increased expression of HOXA10 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXA10-AS mRNA PMID:33656867 10033261 Gm38812 predicted gene, 38812 gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:6480823 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of HOXA10-AS mRNA PMID:33212167 10033261 Gm38812 predicted gene, 38812 gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:6480823 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of HOXA10-AS mRNA PMID:30851411 10033261 Gm38812 predicted gene, 38812 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:6480823 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of HOXA10-AS mRNA PMID:38568856 10033261 Gm38812 predicted gene, 38812 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:6480823 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of HOXA10-AS gene PMID:31601247 10033261 Gm38812 predicted gene, 38812 gene CHEBI:4610 dimethylselenide multiple interactions ISO RGD:6480823 E RGD:6480464 20211109 CTD MESH:C013503 [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXA10-AS mRNA] which results in increased expression of HOXA10 mRNA; [Ozone results in increased oxidation of dimethylselenide] which results in increased expression of HOXA10-AS mRNA PMID:33656867 10033261 Gm38812 predicted gene, 38812 gene CHEBI:78320 2-hydroxypropanoic acid decreases expression ISO RGD:6480823 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of HOXA10-AS mRNA PMID:30851411 10033261 Gm38812 predicted gene, 38812 gene CHEBI:81781 tebuconazole decreases expression ISO RGD:6480823 E RGD:6480464 20190219 CTD MESH:C087114 tebuconazole results in decreased expression of HOXA10-AS mRNA PMID:30458266 10034467 Gm39501 predicted gene, 39501 gene CHEBI:15743 butanal decreases expression ISO RGD:1604789 E RGD:6480464 20151215 CTD MESH:C018475 butyraldehyde results in decreased expression of DBF4B mRNA PMID:26079696 10034467 Gm39501 predicted gene, 39501 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1604789 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of DBF4B mRNA PMID:37042841 10034467 Gm39501 predicted gene, 39501 gene CHEBI:17347 testosterone decreases expression ISO RGD:1604789 E RGD:6480464 20151215 CTD MESH:D013739 Testosterone results in decreased expression of DBF4B mRNA PMID:21592394 10034467 Gm39501 predicted gene, 39501 gene CHEBI:17347 testosterone multiple interactions ISO RGD:1604789 E RGD:6480464 20151215 CTD MESH:D013739 [Testosterone co-treated with Calcitriol] results in decreased expression of DBF4B mRNA PMID:21592394 10034467 Gm39501 predicted gene, 39501 gene CHEBI:178012 FR900359 decreases phosphorylation ISO RGD:1604789 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in decreased phosphorylation of DBF4B protein PMID:37730182 10034467 Gm39501 predicted gene, 39501 gene CHEBI:17823 calcitriol decreases expression ISO RGD:1604789 E RGD:6480464 20151215 CTD MESH:D002117 Calcitriol results in decreased expression of DBF4B mRNA PMID:21592394 10034467 Gm39501 predicted gene, 39501 gene CHEBI:17823 calcitriol multiple interactions ISO RGD:1604789 E RGD:6480464 20151215 CTD MESH:D002117 [Testosterone co-treated with Calcitriol] results in decreased expression of DBF4B mRNA PMID:21592394 10034467 Gm39501 predicted gene, 39501 gene CHEBI:27470 folic acid decreases expression ISO RGD:1604789 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of DBF4B mRNA PMID:21867686 10034467 Gm39501 predicted gene, 39501 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:1604789 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of DBF4B mRNA PMID:23557933 10034467 Gm39501 predicted gene, 39501 gene CHEBI:27899 cisplatin decreases expression ISO RGD:1604789 E RGD:6480464 20170516 CTD MESH:D002945 Cisplatin results in decreased expression of DBF4B mRNA PMID:27392435 10034467 Gm39501 predicted gene, 39501 gene CHEBI:28619 acrylamide decreases expression ISO RGD:1604789 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of DBF4B mRNA PMID:32763439 10034467 Gm39501 predicted gene, 39501 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1604789 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of DBF4B mRNA PMID:29803840 10034467 Gm39501 predicted gene, 39501 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1604789 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of DBF4B promoter PMID:27901495 10034467 Gm39501 predicted gene, 39501 gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1604789 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in increased expression of DBF4B mRNA PMID:25895662 10034467 Gm39501 predicted gene, 39501 gene CHEBI:33007 chromium(6+) multiple interactions ISO RGD:1604789 E RGD:6480464 20240702 CTD MESH:C074702 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of DBF4B mRNA PMID:38479592 10034467 Gm39501 predicted gene, 39501 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1604789 E RGD:6480464 20180515 CTD MESH:C006780 bisphenol A results in decreased expression of DBF4B mRNA PMID:29275510|PMID:33670352|PMID:36232920 10034467 Gm39501 predicted gene, 39501 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1604789 E RGD:6480464 20180116 CTD MESH:C006780 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DBF4B mRNA PMID:28628672 10034467 Gm39501 predicted gene, 39501 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1604789 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DBF4B mRNA PMID:28628672 10034467 Gm39501 predicted gene, 39501 gene CHEBI:34911 permethrin increases expression ISO RGD:1604789 E RGD:6480464 20230606 CTD MESH:D026023 Permethrin results in increased expression of DBF4B mRNA PMID:37047231 10034467 Gm39501 predicted gene, 39501 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:1604789 E RGD:6480464 20241001 CTD MESH:D019256 Cadmium Chloride results in decreased expression of DBF4B protein PMID:38185225 10034467 Gm39501 predicted gene, 39501 gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:1604789 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of DBF4B mRNA PMID:24449571 10034467 Gm39501 predicted gene, 39501 gene CHEBI:38658 dicrotophos increases expression ISO RGD:1604789 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in increased expression of DBF4B mRNA PMID:28302478 10034467 Gm39501 predicted gene, 39501 gene CHEBI:38940 sunitinib decreases expression ISO RGD:1604789 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of DBF4B mRNA PMID:31533062 10034467 Gm39501 predicted gene, 39501 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:1604789 E RGD:6480464 20151215 CTD MESH:D014635 [Hydralazine co-treated with Valproic Acid] results in increased expression of DBF4B mRNA PMID:17183730 10034467 Gm39501 predicted gene, 39501 gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:1604789 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DBF4B mRNA PMID:28628672 10034467 Gm39501 predicted gene, 39501 gene CHEBI:46195 paracetamol increases expression ISO RGD:1604789 E RGD:6480464 20151215 CTD MESH:D000082 Acetaminophen results in increased expression of DBF4B mRNA PMID:22230336 10034467 Gm39501 predicted gene, 39501 gene CHEBI:48843 disodium selenite decreases expression ISO RGD:1604789 E RGD:6480464 20151215 CTD MESH:D018038 Sodium Selenite results in decreased expression of DBF4B mRNA PMID:18175754 10034467 Gm39501 predicted gene, 39501 gene CHEBI:49662 indometacin multiple interactions ISO RGD:1604789 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DBF4B mRNA PMID:28628672 10034467 Gm39501 predicted gene, 39501 gene CHEBI:5775 hydralazine multiple interactions ISO RGD:1604789 E RGD:6480464 20151215 CTD MESH:D006830 [Hydralazine co-treated with Valproic Acid] results in increased expression of DBF4B mRNA PMID:17183730 10034467 Gm39501 predicted gene, 39501 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1604789 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to DBF4B gene] PMID:28238834 10035815 Gm38999 predicted gene, 38999 gene CHEBI:132082 entinostat increases expression ISO RGD:7778770 E RGD:6480464 20161228 CTD MESH:C118739 entinostat results in increased expression of C19ORF84 mRNA PMID:27188386 10035815 Gm38999 predicted gene, 38999 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:7778770 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of C19ORF84 mRNA PMID:35811015 10035815 Gm38999 predicted gene, 38999 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:7778770 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of C19ORF84 mRNA PMID:37042841 10035815 Gm38999 predicted gene, 38999 gene CHEBI:181914 Aflatoxin B2 alpha increases methylation ISO RGD:7778770 E RGD:6480464 20211109 CTD MESH:C029753 aflatoxin B2 results in increased methylation of C19ORF84 promoter PMID:30157460 10035815 Gm38999 predicted gene, 38999 gene CHEBI:31638 fulvestrant increases methylation ISO RGD:7778770 E RGD:6480464 20220308 CTD MESH:C070081 Fulvestrant results in increased methylation of C19ORF84 gene PMID:31601247 10035815 Gm38999 predicted gene, 38999 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:7778770 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of C19ORF84 mRNA PMID:37042841 10035815 Gm38999 predicted gene, 38999 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:7778770 E RGD:6480464 20221101 CTD MESH:C039961 S-(1,2-dichlorovinyl)cysteine results in increased expression of C19ORF84 mRNA PMID:35811015 10035815 Gm38999 predicted gene, 38999 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:7778770 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of C19ORF84 mRNA PMID:35811015 10036941 Fam237a family with sequence similarity 237, member A gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:12799605 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of FAM237A 5' UTR; Benzo(a)pyrene results in increased methylation of FAM237A promoter PMID:27901495 10043395 Dep1 diabetic embryopathy 1 gene CHEBI:27470 folic acid increases expression EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in increased expression of DEP1 mRNA PMID:25629700 10043395 Dep1 diabetic embryopathy 1 gene CHEBI:32234 titanium dioxide decreases expression EXP E RGD:6480464 20191112 CTD MESH:C009495 titanium dioxide results in decreased expression of DEP1 mRNA PMID:29264374 10043395 Dep1 diabetic embryopathy 1 gene CHEBI:35456 cadmium dichloride affects expression EXP E RGD:6480464 20150602 CTD MESH:D019256 Cadmium Chloride affects the expression of DEP1 mRNA PMID:18974090 10043399 Phxr2 per-hexamer repeat gene 2 gene CHEBI:44185 methotrexate affects expression EXP E RGD:6480464 20150602 CTD MESH:D008727 Methotrexate affects the expression of PHXR2 mRNA PMID:18502557 10043399 Phxr2 per-hexamer repeat gene 2 gene CHEBI:4811 epoxiconazole increases expression EXP E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in increased expression of PHXR2 mRNA PMID:35436446 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:132267 triptonide increases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of LRRC31 mRNA PMID:33045310 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:1346329 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in increased expression of LRRC31 mRNA PMID:33167477 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:1346329 E RGD:6480464 20150602 CTD MESH:D004958 Estradiol results in decreased expression of LRRC31 mRNA PMID:20106945 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1346329 E RGD:6480464 20150602 CTD MESH:D016604 Aflatoxin B1 affects the expression of LRRC31 protein PMID:20106945 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:1346329 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of LRRC31 mRNA PMID:22100608|PMID:27153756 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:1346329 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of LRRC31 gene PMID:27153756 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:25255 methyl methanesulfonate decreases expression ISO RGD:1346329 E RGD:6480464 20150602 CTD MESH:D008741 Methyl Methanesulfonate results in decreased expression of LRRC31 mRNA PMID:23649840 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:27470 folic acid decreases expression EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of LRRC31 mRNA PMID:25629700 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:27789 1,2-dichloroethane affects expression EXP E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride affects the expression of LRRC31 mRNA PMID:28960355 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1346329 E RGD:6480464 20150602 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of LRRC31 mRNA PMID:21296121 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1346329 E RGD:6480464 20160822 CTD MESH:D013749 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of LRRC31 mRNA PMID:26159488 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1346329 E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in decreased expression of LRRC31 mRNA PMID:29301061 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20220405 CTD MESH:C017947 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRC31 mRNA PMID:34876320 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:29852 methylarsonic acid multiple interactions EXP E RGD:6480464 20220405 CTD MESH:C020300 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRC31 mRNA PMID:34876320 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:1346329 E RGD:6480464 20150602 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of LRRC31 mRNA PMID:20106945|PMID:32234424 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1346329 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of LRRC31 exon; Benzo(a)pyrene results in increased methylation of LRRC31 promoter PMID:27901495 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:1346329 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol A co-treated with Fulvestrant] affects the methylation of LRRC31 gene PMID:31601247 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1561499 E RGD:6480464 20150602 CTD MESH:C006780 bisphenol A results in decreased expression of LRRC31 mRNA PMID:25181051 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:1346329 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of LRRC31 gene PMID:31601247 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1346329 E RGD:6480464 20220308 CTD MESH:C006780 [bisphenol A co-treated with Fulvestrant] affects the methylation of LRRC31 gene PMID:31601247 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1561499 E RGD:6480464 20230307 CTD MESH:C006780 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of LRRC31 mRNA PMID:36041667 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1561499 E RGD:6480464 20230307 CTD MESH:C543008 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of LRRC31 mRNA PMID:36041667 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:34568 Benzo[ghi]perylene increases expression EXP E RGD:6480464 20160119 CTD MESH:C006718 1,12-benzoperylene results in increased expression of LRRC31 mRNA PMID:26377693 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:34575 bisphenol F multiple interactions EXP E RGD:6480464 20191112 CTD MESH:C008745 [bisphenol F co-treated with LIF protein] results in decreased expression of LRRC31 mRNA PMID:30951980 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:34575 bisphenol F multiple interactions ISO RGD:1561499 E RGD:6480464 20230307 CTD MESH:C008745 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of LRRC31 mRNA PMID:36041667 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:1346329 E RGD:6480464 20200915 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of LRRC31 mRNA PMID:32588087 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:38397 perfluorononanoic acid increases expression ISO RGD:1346329 E RGD:6480464 20220111 CTD MESH:C101816 perfluoro-n-nonanoic acid results in increased expression of LRRC31 mRNA PMID:32588087 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:39421 perfluorooctane-1-sulfonic acid affects expression ISO RGD:1346329 E RGD:6480464 20231031 CTD MESH:C076994 perfluorooctane sulfonic acid affects the expression of LRRC31 mRNA PMID:36864359 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1346329 E RGD:6480464 20150602 CTD MESH:D016572 Cyclosporine results in decreased expression of LRRC31 mRNA PMID:20106945|PMID:27989131 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1346329 E RGD:6480464 20180515 CTD MESH:D000082 Acetaminophen results in decreased expression of LRRC31 mRNA PMID:29067470 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:4791 endosulfan multiple interactions ISO RGD:1346329 E RGD:6480464 20160822 CTD MESH:D004726 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of LRRC31 mRNA PMID:26159488 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:48765 dimethylarsinic acid multiple interactions EXP E RGD:6480464 20220405 CTD MESH:D002101 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRC31 mRNA PMID:34876320 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:5001 fenofibrate increases expression ISO RGD:1346329 E RGD:6480464 20150825 CTD MESH:D011345 Fenofibrate results in increased expression of LRRC31 mRNA PMID:25572481 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of LRRC31 mRNA; Nanotubes, Carbon results in decreased expression of LRRC31 mRNA PMID:25554681 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1346329 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to LRRC31 gene] PMID:28238834 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:81781 tebuconazole decreases expression ISO RGD:1346329 E RGD:6480464 20190219 CTD MESH:C087114 tebuconazole results in decreased expression of LRRC31 mRNA PMID:30458266 10043434 Lrrc31 leucine rich repeat containing 31 gene CHEBI:84070 sodium arsenate multiple interactions EXP E RGD:6480464 20220405 CTD MESH:C009277 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of LRRC31 mRNA PMID:34876320 10044040 Gm4924 predicted gene 4924 gene CHEBI:16170 mercury(0) increases expression ISO RGD:1350909 E RGD:6480464 20150609 CTD MESH:D008628 Mercury results in increased expression of ZNF80 mRNA PMID:16823088 10044040 Gm4924 predicted gene 4924 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:620184 E RGD:6480464 20170321 CTD MESH:D016604 Aflatoxin B1 results in increased expression of GIOT1 mRNA PMID:23630614 10044040 Gm4924 predicted gene 4924 gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:1350909 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of ZNF80 gene PMID:27153756 10044040 Gm4924 predicted gene 4924 gene CHEBI:25195 mercury atom increases expression ISO RGD:1350909 E RGD:6480464 20150609 CTD MESH:D008628 Mercury results in increased expression of ZNF80 mRNA PMID:16823088 10044040 Gm4924 predicted gene 4924 gene CHEBI:28112 nickel atom increases expression ISO RGD:1350909 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in increased expression of ZNF80 mRNA PMID:24768652|PMID:25583101 10044040 Gm4924 predicted gene 4924 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:620184 E RGD:6480464 20200609 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of GIOT1 mRNA PMID:32109520|PMID:34747641 10044040 Gm4924 predicted gene 4924 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:620184 E RGD:6480464 20170321 CTD MESH:C017947 sodium arsenite results in increased expression of GIOT1 mRNA PMID:21297353 10044040 Gm4924 predicted gene 4924 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1350909 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ZNF80 promoter PMID:27901495 10044040 Gm4924 predicted gene 4924 gene CHEBI:33128 C60 fullerene increases expression ISO RGD:620184 E RGD:6480464 20170321 CTD MESH:C069837 fullerene C60 results in increased expression of GIOT1 mRNA PMID:19167457 10044040 Gm4924 predicted gene 4924 gene CHEBI:33216 bisphenol A increases expression ISO RGD:620184 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of GIOT1 mRNA PMID:34947998 10044040 Gm4924 predicted gene 4924 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1350909 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ZNF80 mRNA PMID:37042841 10044040 Gm4924 predicted gene 4924 gene CHEBI:351346 phenethyl isothiocyanate decreases expression ISO RGD:620184 E RGD:6480464 20170321 CTD MESH:C058305 phenethyl isothiocyanate results in decreased expression of GIOT1 mRNA PMID:17616710 10044040 Gm4924 predicted gene 4924 gene CHEBI:35456 cadmium dichloride increases methylation ISO RGD:620184 E RGD:6480464 20170321 CTD MESH:D019256 Cadmium Chloride results in increased methylation of GIOT1 promoter PMID:22457795 10044040 Gm4924 predicted gene 4924 gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:1350909 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of ZNF80 mRNA PMID:24449571 10044040 Gm4924 predicted gene 4924 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1350909 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to ZNF80 gene] PMID:28238834 10044040 Gm4924 predicted gene 4924 gene CHEBI:92658 kenpaullone decreases expression ISO RGD:620184 E RGD:6480464 20211109 CTD MESH:C119620 kenpaullone results in decreased expression of GIOT1 mRNA PMID:17993264 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:132448 perfluorohexanesulfonic acid increases expression EXP E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of SPRR2A3 mRNA PMID:37995155 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:17234 glucose multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SPRR2A3 mRNA PMID:37567420 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:17634 D-glucose multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SPRR2A3 mRNA PMID:37567420 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:25812 ozone increases expression EXP E RGD:6480464 20231205 CTD MESH:D010126 Ozone results in increased expression of SPRR2A3 mRNA PMID:33026818 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:28757 fructose multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D005632 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SPRR2A3 mRNA PMID:37567420 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:29678 sodium arsenite decreases expression EXP E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of SPRR2A3 mRNA PMID:37682722 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20220405 CTD MESH:C017947 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR2A3 mRNA PMID:34876320 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:29852 methylarsonic acid multiple interactions EXP E RGD:6480464 20220405 CTD MESH:C020300 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR2A3 mRNA PMID:34876320 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:3020 benzalkonium chloride increases expression EXP E RGD:6480464 20190219 CTD MESH:D001548 Benzalkonium Compounds results in increased expression of SPRR2A3 mRNA PMID:30171875 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:34575 bisphenol F increases expression EXP E RGD:6480464 20191112 CTD MESH:C008745 bisphenol F results in increased expression of SPRR2A3 mRNA PMID:30951980 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:39483 sodium dichromate increases expression EXP E RGD:6480464 20201103 CTD MESH:C016104 sodium bichromate results in increased expression of SPRR2A3 mRNA PMID:31558096 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:42758 aldehydo-D-glucose multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in increased expression of SPRR2A3 mRNA PMID:37567420 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:46666 crocidolite asbestos increases expression EXP E RGD:6480464 20200915 CTD MESH:D017638 Asbestos, Crocidolite results in increased expression of SPRR2A3 mRNA PMID:29279043 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:46676 tremolite asbestos increases expression EXP E RGD:6480464 20200915 CTD MESH:C005846 tremolite results in increased expression of SPRR2A3 mRNA PMID:29279043 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:48765 dimethylarsinic acid multiple interactions EXP E RGD:6480464 20220405 CTD MESH:D002101 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR2A3 mRNA PMID:34876320 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:50594 carbon nanotube increases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon results in increased expression of SPRR2A3 mRNA PMID:27106021 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:64213 cantharidin increases expression EXP E RGD:6480464 20230704 CTD MESH:D002193 Cantharidin results in increased expression of SPRR2A3 mRNA PMID:36907384 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:65585 carnosic acid decreases expression EXP E RGD:6480464 20230404 CTD MESH:C018381 salvin results in decreased expression of SPRR2A3 protein PMID:35926579 10044125 Sprr2a3 small proline-rich protein 2A3 gene CHEBI:84070 sodium arsenate multiple interactions EXP E RGD:6480464 20220405 CTD MESH:C009277 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of SPRR2A3 mRNA PMID:34876320 10044188 Magef1 MAGE family member F1 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1348798 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of MAGEF1 mRNA PMID:37042841 10044188 Magef1 MAGE family member F1 gene CHEBI:17967 urethane decreases expression ISO RGD:1348798 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in decreased expression of MAGEF1 mRNA PMID:28818685 10044188 Magef1 MAGE family member F1 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:1348798 E RGD:6480464 20160712 CTD MESH:D019327 Copper Sulfate results in decreased expression of MAGEF1 mRNA PMID:19549813 10044188 Magef1 MAGE family member F1 gene CHEBI:27899 cisplatin increases expression ISO RGD:1348798 E RGD:6480464 20180220 CTD MESH:D002945 Cisplatin results in increased expression of MAGEF1 mRNA PMID:27594783 10044188 Magef1 MAGE family member F1 gene CHEBI:28869 menadione affects expression ISO RGD:1348798 E RGD:6480464 20160712 CTD MESH:D024483 Vitamin K 3 affects the expression of MAGEF1 mRNA PMID:20044591 10044188 Magef1 MAGE family member F1 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1348798 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of MAGEF1 mRNA PMID:38568856 10044188 Magef1 MAGE family member F1 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1348798 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of MAGEF1 promoter PMID:27901495 10044188 Magef1 MAGE family member F1 gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:1348798 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of MAGEF1 gene PMID:31601247 10044188 Magef1 MAGE family member F1 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:1348798 E RGD:6480464 20220308 CTD MESH:C006780 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of MAGEF1 gene PMID:31601247 10044188 Magef1 MAGE family member F1 gene CHEBI:34718 1-chloro-2,4-dinitrobenzene decreases expression ISO RGD:1348798 E RGD:6480464 20160712 CTD MESH:D004137 Dinitrochlorobenzene results in decreased expression of MAGEF1 mRNA PMID:17374397 10044188 Magef1 MAGE family member F1 gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:1348798 E RGD:6480464 20160712 CTD MESH:C018021 cobaltous chloride results in decreased expression of MAGEF1 mRNA PMID:19320972 10044188 Magef1 MAGE family member F1 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1348798 E RGD:6480464 20160712 CTD MESH:D016572 Cyclosporine results in decreased expression of MAGEF1 mRNA PMID:25562108 10044188 Magef1 MAGE family member F1 gene CHEBI:41922 diethylstilbestrol decreases expression ISO RGD:1348798 E RGD:6480464 20230704 CTD MESH:D004054 Diethylstilbestrol results in decreased expression of MAGEF1 mRNA PMID:36621641 10044188 Magef1 MAGE family member F1 gene CHEBI:43572 kojic acid increases expression ISO RGD:1348798 E RGD:6480464 20160712 CTD MESH:C011890 kojic acid results in increased expression of MAGEF1 mRNA PMID:16595896 10044188 Magef1 MAGE family member F1 gene CHEBI:46195 paracetamol decreases expression ISO RGD:1348798 E RGD:6480464 20160712 CTD MESH:D000082 Acetaminophen results in decreased expression of MAGEF1 mRNA PMID:21420995 10044188 Magef1 MAGE family member F1 gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of MAGEF1 mRNA; Nanotubes, Carbon results in decreased expression of MAGEF1 mRNA PMID:25554681 10044188 Magef1 MAGE family member F1 gene CHEBI:53001 nickel sulfate decreases expression ISO RGD:1348798 E RGD:6480464 20160712 CTD MESH:C029938 nickel sulfate results in decreased expression of MAGEF1 mRNA PMID:17374397 10044188 Magef1 MAGE family member F1 gene CHEBI:53076 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:1348798 E RGD:6480464 20160712 CTD MESH:D010081 Oxazolone results in decreased expression of MAGEF1 mRNA PMID:17374397 10044188 Magef1 MAGE family member F1 gene CHEBI:72564 temozolomide increases expression ISO RGD:1348798 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in increased expression of MAGEF1 mRNA PMID:31758290 10044188 Magef1 MAGE family member F1 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:1348798 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to MAGEF1 gene] PMID:28238834 10044188 Magef1 MAGE family member F1 gene CHEBI:8069 phenobarbital affects expression ISO RGD:1348798 E RGD:6480464 20160712 CTD MESH:D010634 Phenobarbital affects the expression of MAGEF1 mRNA PMID:19159669 10044188 Magef1 MAGE family member F1 gene CHEBI:9495 thiram decreases expression ISO RGD:1348798 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of MAGEF1 mRNA PMID:38568856 10044188 Magef1 MAGE family member F1 gene CHEBI:9763 trovafloxacin increases expression EXP E RGD:6480464 20221101 CTD MESH:C080163 trovafloxacin results in increased expression of MAGEF1 mRNA PMID:35537566 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:132267 triptonide increases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of CMC4 mRNA PMID:33045310 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:2308876 E RGD:6480464 20221101 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CMC4 mRNA PMID:35301059 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:2308876 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of CMC4 gene PMID:27153756 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:25255 methyl methanesulfonate increases expression ISO RGD:2308876 E RGD:6480464 20150707 CTD MESH:D008741 Methyl Methanesulfonate results in increased expression of CMC4 mRNA PMID:23649840 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:2308876 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of CMC4 5' UTR PMID:27901495 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in decreased expression of CMC4 mRNA PMID:32156529 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of CMC4 mRNA PMID:38074096 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:34575 bisphenol F decreases expression EXP E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of CMC4 mRNA PMID:38685157 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:35038 tris(2-butoxyethyl) phosphate affects expression ISO RGD:2308876 E RGD:6480464 20180515 CTD MESH:C013320 tris(2-butoxyethyl) phosphate affects the expression of CMC4 mRNA PMID:29024780 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:2308876 E RGD:6480464 20221101 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CMC4 mRNA PMID:35301059 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:2308876 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of CMC4 gene PMID:29154799 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:2308876 E RGD:6480464 20180220 CTD MESH:D016572 Cyclosporine results in decreased expression of CMC4 mRNA PMID:25562108 10045908 Cmc4 C-X9-C motif containing 4 gene CHEBI:641 N-methyl-4-phenylpyridinium increases expression ISO RGD:2308876 E RGD:6480464 20170725 CTD MESH:D015655 1-Methyl-4-phenylpyridinium results in increased expression of CMC4 mRNA PMID:24810058 10050 A2m alpha-2-macroglobulin gene CHEBI:116509 diuron decreases expression ISO RGD:735738 E RGD:6480464 20230905 CTD MESH:D004237 Diuron results in decreased expression of A2M mRNA PMID:35967413 10050 A2m alpha-2-macroglobulin gene CHEBI:132267 triptonide increases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of A2M mRNA; triptonide results in increased expression of PZP mRNA PMID:33045310 10050 A2m alpha-2-macroglobulin gene CHEBI:132448 perfluorohexanesulfonic acid increases expression EXP E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of A2M mRNA PMID:37995155 10050 A2m alpha-2-macroglobulin gene CHEBI:132471 (+)-schisandrin B multiple interactions ISO RGD:2004 E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of A2M mRNA] PMID:31150632 10050 A2m alpha-2-macroglobulin gene CHEBI:132844 glycidyl methacrylate increases expression ISO RGD:735738 E RGD:6480464 20230704 CTD MESH:C007870 glycidyl methacrylate results in increased expression of A2M protein PMID:36641056 10050 A2m alpha-2-macroglobulin gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20250128 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PZP mRNA PMID:20938992 10050 A2m alpha-2-macroglobulin gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:735738 E RGD:6480464 20190507 CTD MESH:D014212 Tretinoin results in decreased expression of A2M protein PMID:30093655 10050 A2m alpha-2-macroglobulin gene CHEBI:15367 all-trans-retinoic acid multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D014212 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of A2M mRNA PMID:36189433 10050 A2m alpha-2-macroglobulin gene CHEBI:15379 dioxygen multiple interactions ISO RGD:2004 E RGD:6480464 20220510 CTD MESH:D010100 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of A2M mRNA PMID:33729688 10050 A2m alpha-2-macroglobulin gene CHEBI:15443 inulin multiple interactions EXP E RGD:6480464 20250128 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PZP mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of A2ML1 mRNA PMID:36331819 10050 A2m alpha-2-macroglobulin gene CHEBI:15866 2-deoxy-D-glucose increases uptake ISO RGD:735738 E RGD:6480464 20190910 CTD MESH:D003847 A2M protein modified form results in increased uptake of Deoxyglucose PMID:25720493 10050 A2m alpha-2-macroglobulin gene CHEBI:15866 2-deoxy-D-glucose multiple interactions ISO RGD:735738 E RGD:6480464 20190910 CTD MESH:D003847 HSPA5 protein affects the reaction [A2M protein modified form results in increased uptake of Deoxyglucose] PMID:25720493 10050 A2m alpha-2-macroglobulin gene CHEBI:16164 pyrogallol increases expression EXP E RGD:6480464 20121218 CTD MESH:D011748 Pyrogallol results in increased expression of A2M mRNA PMID:20362636 10050 A2m alpha-2-macroglobulin gene CHEBI:16164 pyrogallol multiple interactions EXP E RGD:6480464 20121218 CTD MESH:D011748 Silymarin inhibits the reaction [Pyrogallol results in increased expression of A2M mRNA] PMID:20362636 10050 A2m alpha-2-macroglobulin gene CHEBI:16170 mercury(0) decreases expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D008628 Mercury results in decreased expression of A2M mRNA PMID:17547211 10050 A2m alpha-2-macroglobulin gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20250128 CTD MESH:D000431 Ethanol results in increased expression of A2ML1 mRNA PMID:30319688 10050 A2m alpha-2-macroglobulin gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20161228 CTD MESH:D008070 Lipopolysaccharides results in increased expression of A2M mRNA PMID:27339419 10050 A2m alpha-2-macroglobulin gene CHEBI:16412 lipopolysaccharide increases expression ISO RGD:2004 E RGD:6480464 20161228 CTD MESH:D008070 Lipopolysaccharides results in increased expression of A2M mRNA PMID:11779202 10050 A2m alpha-2-macroglobulin gene CHEBI:164200 triclosan decreases expression ISO RGD:735738 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in decreased expression of A2M mRNA PMID:30510588 10050 A2m alpha-2-macroglobulin gene CHEBI:16469 17beta-estradiol affects expression ISO RGD:2004 E RGD:6480464 20230606 CTD MESH:D004958 Estradiol affects the expression of A2M mRNA PMID:32145629 10050 A2m alpha-2-macroglobulin gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:2004 E RGD:6480464 20210406 CTD MESH:D004958 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of A2M mRNA PMID:32741896 10050 A2m alpha-2-macroglobulin gene CHEBI:16482 naphthalene affects binding EXP E RGD:6480464 20120412 CTD MESH:C031721 naphthalene metabolite binds to A2M protein PMID:15892573 10050 A2m alpha-2-macroglobulin gene CHEBI:16482 naphthalene increases expression ISO RGD:2004 E RGD:6480464 20150127 CTD MESH:C031721 naphthalene analog results in increased expression of A2M mRNA PMID:24976557 10050 A2m alpha-2-macroglobulin gene CHEBI:16573 carbonyl sulfide increases expression ISO RGD:2004 E RGD:6480464 20121009 CTD MESH:C010063 carbonyl sulfide results in increased expression of A2M mRNA PMID:19395590 10050 A2m alpha-2-macroglobulin gene CHEBI:16586 6-aminohexanoic acid decreases expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D015119 Aminocaproic Acid results in decreased expression of A2M protein PMID:11304663 10050 A2m alpha-2-macroglobulin gene CHEBI:16602 trichloroethene decreases expression ISO RGD:2004 E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in decreased expression of A2M mRNA PMID:33387578 10050 A2m alpha-2-macroglobulin gene CHEBI:16602 trichloroethene increases methylation ISO RGD:2004 E RGD:6480464 20170110 CTD MESH:D014241 Trichloroethylene results in increased methylation of A2M gene PMID:27618143 10050 A2m alpha-2-macroglobulin gene CHEBI:16643 L-methionine multiple interactions EXP E RGD:6480464 20250128 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PZP mRNA PMID:20938992 10050 A2m alpha-2-macroglobulin gene CHEBI:167162 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:735738 E RGD:6480464 20220208 CTD MESH:C011669 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of A2M mRNA PMID:34480604 10050 A2m alpha-2-macroglobulin gene CHEBI:16827 corticosterone increases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D003345 Corticosterone results in increased expression of A2M mRNA PMID:15755911 10050 A2m alpha-2-macroglobulin gene CHEBI:17026 progesterone affects expression EXP E RGD:6480464 20120412 CTD MESH:D011374 Progesterone affects the expression of A2M mRNA PMID:17251523 10050 A2m alpha-2-macroglobulin gene CHEBI:17026 progesterone decreases expression EXP E RGD:6480464 20131008 CTD MESH:D011374 Progesterone results in decreased expression of A2M mRNA PMID:22238285 10050 A2m alpha-2-macroglobulin gene CHEBI:17153 propanal increases expression ISO RGD:735738 E RGD:6480464 20150825 CTD MESH:C005556 propionaldehyde results in increased expression of A2M mRNA PMID:26079696 10050 A2m alpha-2-macroglobulin gene CHEBI:17234 glucose multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PZP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of A2M mRNA PMID:37567420 10050 A2m alpha-2-macroglobulin gene CHEBI:17243 mono(2-ethylhexyl) phthalate increases expression ISO RGD:2004 E RGD:6480464 20240305 CTD MESH:C016599 mono-(2-ethylhexyl)phthalate results in increased expression of A2M mRNA PMID:38113427 10050 A2m alpha-2-macroglobulin gene CHEBI:17243 mono(2-ethylhexyl) phthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C016599 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of A2M mRNA PMID:36189433 10050 A2m alpha-2-macroglobulin gene CHEBI:17347 testosterone multiple interactions ISO RGD:2004 E RGD:6480464 20210406 CTD MESH:D013739 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of A2M mRNA PMID:32741896 10050 A2m alpha-2-macroglobulin gene CHEBI:175901 gemcitabine increases expression ISO RGD:735738 E RGD:6480464 20230207 CTD MESH:C056507 Gemcitabine results in increased expression of A2M protein PMID:20531411 10050 A2m alpha-2-macroglobulin gene CHEBI:17634 D-glucose multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PZP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of A2M mRNA PMID:37567420 10050 A2m alpha-2-macroglobulin gene CHEBI:17650 cortisol multiple interactions ISO RGD:735738 E RGD:6480464 20220208 CTD MESH:D006854 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of A2M mRNA PMID:34480604 10050 A2m alpha-2-macroglobulin gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:735738 E RGD:6480464 20190910 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of A2M mRNA PMID:31163220 10050 A2m alpha-2-macroglobulin gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression EXP E RGD:6480464 20210608 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of A2M mRNA PMID:33484791 10050 A2m alpha-2-macroglobulin gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions EXP E RGD:6480464 20210608 CTD MESH:D004051 Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of A2M mRNA] PMID:33484791 10050 A2m alpha-2-macroglobulin gene CHEBI:177802 Cuprizon increases expression ISO RGD:2004 E RGD:6480464 20210907 CTD MESH:D003471 Cuprizone results in increased expression of A2M mRNA PMID:27523638 10050 A2m alpha-2-macroglobulin gene CHEBI:17833 gentamycin decreases expression ISO RGD:2004 E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in decreased expression of A2M mRNA PMID:33387578 10050 A2m alpha-2-macroglobulin gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions EXP E RGD:6480464 20250128 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PZP mRNA; [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of A2ML1 mRNA PMID:36331819 10050 A2m alpha-2-macroglobulin gene CHEBI:18388 apigenin multiple interactions ISO RGD:2004 E RGD:6480464 20120814 CTD MESH:D047310 Apigenin inhibits the reaction [Cadmium Chloride results in increased expression of A2M protein] PMID:15618353 10050 A2m alpha-2-macroglobulin gene CHEBI:18721 3-chloropropane-1,2-diol decreases expression ISO RGD:2004 E RGD:6480464 20171010 CTD MESH:D000517 alpha-Chlorohydrin results in decreased expression of A2M mRNA PMID:28522335 10050 A2m alpha-2-macroglobulin gene CHEBI:22977 cadmium atom affects binding ISO RGD:735738 E RGD:6480464 20150512 CTD MESH:D002104 A2M protein binds to Cadmium PMID:23896426 10050 A2m alpha-2-macroglobulin gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:735738 E RGD:6480464 20230801 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of A2M mRNA PMID:36602393 10050 A2m alpha-2-macroglobulin gene CHEBI:23115 chlorohydrocarbon multiple interactions ISO RGD:2004 E RGD:6480464 20210112 CTD MESH:D006843 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of A2M mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of A2M mRNA PMID:30744511 10050 A2m alpha-2-macroglobulin gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:735738 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of A2M mRNA PMID:19549813 10050 A2m alpha-2-macroglobulin gene CHEBI:24527 herbicide multiple interactions EXP E RGD:6480464 20250128 CTD MESH:D006540 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PZP mRNA PMID:37567420 10050 A2m alpha-2-macroglobulin gene CHEBI:24814 indole-3-methanol affects expression ISO RGD:2004 E RGD:6480464 20120613 CTD MESH:C016517 indole-3-carbinol affects the expression of A2M mRNA PMID:21396975 10050 A2m alpha-2-macroglobulin gene CHEBI:2504 aflatoxin B1 decreases expression EXP E RGD:6480464 20120501 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of A2M mRNA; Aflatoxin B1 results in decreased expression of PZP mRNA PMID:19770486 10050 A2m alpha-2-macroglobulin gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:735738 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of A2M mRNA PMID:27153756 10050 A2m alpha-2-macroglobulin gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:735738 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of A2M gene PMID:27153756 10050 A2m alpha-2-macroglobulin gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:2004 E RGD:6480464 20180703 CTD MESH:D016604 Aflatoxin B1 results in increased expression of A2M mRNA PMID:25378103 10050 A2m alpha-2-macroglobulin gene CHEBI:25195 mercury atom decreases expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D008628 Mercury results in decreased expression of A2M mRNA PMID:17547211 10050 A2m alpha-2-macroglobulin gene CHEBI:25812 ozone decreases expression EXP E RGD:6480464 20250128 CTD MESH:D010126 Ozone results in decreased expression of PZP mRNA PMID:33026818 10050 A2m alpha-2-macroglobulin gene CHEBI:25812 ozone multiple interactions ISO RGD:2004 E RGD:6480464 20231205 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of A2M mRNA; [Air Pollutants results in increased abundance of Ozone] which results in increased expression of A2M protein PMID:33317425 10050 A2m alpha-2-macroglobulin gene CHEBI:25812 ozone multiple interactions ISO RGD:735738 E RGD:6480464 20230704 CTD MESH:D010126 [Ozone results in increased abundance of Soot metabolite] which results in decreased expression of A2M mRNA PMID:28410501 10050 A2m alpha-2-macroglobulin gene CHEBI:27363 zinc atom affects binding ISO RGD:735738 E RGD:6480464 20150512 CTD MESH:D015032 A2M protein binds to Zinc PMID:23896426 10050 A2m alpha-2-macroglobulin gene CHEBI:27385 tetrachloromethane affects expression EXP E RGD:6480464 20250128 CTD MESH:D002251 Carbon Tetrachloride affects the expression of A2ML1 mRNA PMID:31919559 10050 A2m alpha-2-macroglobulin gene CHEBI:27385 tetrachloromethane increases expression ISO RGD:2004 E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of A2M mRNA PMID:31150632 10050 A2m alpha-2-macroglobulin gene CHEBI:27385 tetrachloromethane multiple interactions ISO RGD:2004 E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of A2M mRNA] PMID:31150632 10050 A2m alpha-2-macroglobulin gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20250128 CTD MESH:D005492 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PZP mRNA PMID:20938992 10050 A2m alpha-2-macroglobulin gene CHEBI:27568 selenium atom increases expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in increased expression of A2M mRNA PMID:18997278 10050 A2m alpha-2-macroglobulin gene CHEBI:27568 selenium atom multiple interactions ISO RGD:735738 E RGD:6480464 20120918 CTD MESH:D012643 Selenium inhibits the reaction [T-2 Toxin results in decreased expression of A2M mRNA]; Selenium promotes the reaction [T-2 Toxin results in decreased expression of A2M protein] PMID:21144892 10050 A2m alpha-2-macroglobulin gene CHEBI:2761 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D000966 Antimony Potassium Tartrate results in decreased expression of A2M mRNA PMID:17547211 10050 A2m alpha-2-macroglobulin gene CHEBI:27684 phenylmercury acetate increases expression ISO RGD:735738 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in increased expression of A2M mRNA PMID:26272509 10050 A2m alpha-2-macroglobulin gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:735738 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of A2M mRNA PMID:27188386 10050 A2m alpha-2-macroglobulin gene CHEBI:27889 lead(0) affects binding ISO RGD:735738 E RGD:6480464 20150512 CTD MESH:D007854 A2M protein binds to Lead PMID:23896426 10050 A2m alpha-2-macroglobulin gene CHEBI:27899 cisplatin affects binding ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D002945 Cisplatin binds to A2M protein PMID:16773208 10050 A2m alpha-2-macroglobulin gene CHEBI:27899 cisplatin increases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D002945 Cisplatin results in increased expression of A2M mRNA PMID:18289764 10050 A2m alpha-2-macroglobulin gene CHEBI:27915 melamine increases expression ISO RGD:2004 E RGD:6480464 20130514 CTD MESH:C011907 melamine results in increased expression of A2M PMID:23052191 10050 A2m alpha-2-macroglobulin gene CHEBI:28001 vancomycin increases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D014640 Vancomycin results in increased expression of A2M mRNA PMID:18289764 10050 A2m alpha-2-macroglobulin gene CHEBI:28088 genistein decreases expression EXP E RGD:6480464 20200804 CTD MESH:D019833 Genistein results in decreased expression of A2M mRNA PMID:32186404 10050 A2m alpha-2-macroglobulin gene CHEBI:28088 genistein increases expression EXP E RGD:6480464 20250128 CTD MESH:D019833 Genistein results in increased expression of A2ML1 mRNA PMID:32186404 10050 A2m alpha-2-macroglobulin gene CHEBI:28112 nickel atom affects binding ISO RGD:735738 E RGD:6480464 20150512 CTD MESH:D009532 A2M protein binds to Nickel PMID:23896426 10050 A2m alpha-2-macroglobulin gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2004 E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of A2M mRNA PMID:34747641 10050 A2m alpha-2-macroglobulin gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20120501 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of A2M mRNA PMID:19770486|PMID:33956508 10050 A2m alpha-2-macroglobulin gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2004 E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of A2M mRNA PMID:21215274|PMID:32109520|PMID:33387578 10050 A2m alpha-2-macroglobulin gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20250128 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PZP mRNA PMID:17942748 10050 A2m alpha-2-macroglobulin gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:2004 E RGD:6480464 20120918 CTD MESH:D013749 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of A2M mRNA] PMID:21215274 10050 A2m alpha-2-macroglobulin gene CHEBI:28216 methylmercury chloride increases expression ISO RGD:2004 E RGD:6480464 20200211 CTD MESH:C004925 methylmercuric chloride results in increased expression of A2M mRNA PMID:31378766 10050 A2m alpha-2-macroglobulin gene CHEBI:28216 methylmercury chloride multiple interactions ISO RGD:2004 E RGD:6480464 20210112 CTD MESH:C004925 [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride co-treated with Dibenzofurans, Polychlorinated co-treated with Polychlorinated Dibenzodioxins] results in decreased expression of A2M mRNA; [Hydrocarbons, Chlorinated co-treated with Polychlorinated Biphenyls co-treated with methylmercuric chloride] results in decreased expression of A2M mRNA PMID:30744511 10050 A2m alpha-2-macroglobulin gene CHEBI:28262 dimethyl sulfoxide increases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D004121 Dimethyl Sulfoxide results in increased expression of A2M mRNA PMID:12883083 10050 A2m alpha-2-macroglobulin gene CHEBI:28358 rac-lactic acid increases secretion ISO RGD:735738 E RGD:6480464 20190910 CTD MESH:D019344 A2M protein modified form results in increased secretion of Lactic Acid PMID:25720493 10050 A2m alpha-2-macroglobulin gene CHEBI:28358 rac-lactic acid multiple interactions ISO RGD:735738 E RGD:6480464 20190910 CTD MESH:D019344 HSPA5 protein affects the reaction [A2M protein modified form results in increased secretion of Lactic Acid] PMID:25720493 10050 A2m alpha-2-macroglobulin gene CHEBI:28619 acrylamide decreases expression EXP E RGD:6480464 20220705 CTD MESH:D020106 Acrylamide results in decreased expression of A2M mRNA PMID:35032568 10050 A2m alpha-2-macroglobulin gene CHEBI:28669 bacitracin increases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D001414 Bacitracin results in increased expression of A2M mRNA PMID:18289764 10050 A2m alpha-2-macroglobulin gene CHEBI:28694 copper atom affects binding ISO RGD:735738 E RGD:6480464 20150512 CTD MESH:D003300 A2M protein binds to Copper PMID:23896426 10050 A2m alpha-2-macroglobulin gene CHEBI:28694 copper atom increases expression ISO RGD:2004 E RGD:6480464 20120717 CTD MESH:D003300 Copper results in increased expression of A2M mRNA PMID:22465980 10050 A2m alpha-2-macroglobulin gene CHEBI:28748 doxorubicin decreases expression EXP E RGD:6480464 20250128 CTD MESH:D004317 Doxorubicin results in decreased expression of PZP mRNA PMID:15033991 10050 A2m alpha-2-macroglobulin gene CHEBI:28748 doxorubicin decreases expression ISO RGD:735738 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of A2M mRNA PMID:29803840 10050 A2m alpha-2-macroglobulin gene CHEBI:28757 fructose multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D005632 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PZP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of A2M mRNA PMID:37567420 10050 A2m alpha-2-macroglobulin gene CHEBI:28869 menadione affects expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D024483 Vitamin K 3 affects the expression of A2M mRNA PMID:20044591 10050 A2m alpha-2-macroglobulin gene CHEBI:29073 L-ascorbic acid multiple interactions ISO RGD:735738 E RGD:6480464 20220208 CTD MESH:D001205 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of A2M mRNA PMID:34480604 10050 A2m alpha-2-macroglobulin gene CHEBI:29678 sodium arsenite affects expression EXP E RGD:6480464 20250128 CTD MESH:C017947 sodium arsenite affects the expression of PZP mRNA PMID:17450228 10050 A2m alpha-2-macroglobulin gene CHEBI:29678 sodium arsenite decreases expression EXP E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of A2M mRNA; sodium arsenite results in decreased expression of PZP mRNA PMID:37682722 10050 A2m alpha-2-macroglobulin gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:735738 E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in decreased expression of A2M mRNA PMID:29301061 10050 A2m alpha-2-macroglobulin gene CHEBI:29678 sodium arsenite increases expression EXP E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in increased expression of A2M mRNA PMID:16014739 10050 A2m alpha-2-macroglobulin gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20250128 CTD MESH:C017947 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of A2ML1 mRNA PMID:34876320 10050 A2m alpha-2-macroglobulin gene CHEBI:29747 cholate multiple interactions ISO RGD:2004 E RGD:6480464 20170117 CTD MESH:D020355 [cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of A2M mRNA; [cocoa butter co-treated with Cholesterol, Dietary co-treated with Cholates] results in increased expression of A2M protein PMID:25814186 10050 A2m alpha-2-macroglobulin gene CHEBI:29852 methylarsonic acid multiple interactions EXP E RGD:6480464 20250128 CTD MESH:C020300 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of A2ML1 mRNA PMID:34876320 10050 A2m alpha-2-macroglobulin gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20250128 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of PZP mRNA PMID:19770486 10050 A2m alpha-2-macroglobulin gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:735738 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of A2M mRNA PMID:22316170 10050 A2m alpha-2-macroglobulin gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:735738 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of A2M exon; Benzo(a)pyrene results in increased methylation of A2M promoter PMID:27901495 10050 A2m alpha-2-macroglobulin gene CHEBI:29865 benzo[a]pyrene multiple interactions ISO RGD:735738 E RGD:6480464 20121113 CTD MESH:D001564 [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of A2M mRNA; [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of A2M mRNA; [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of A2M mRNA; [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of A2M mRNA PMID:17690111 10050 A2m alpha-2-macroglobulin gene CHEBI:30052 copper(0) affects binding ISO RGD:735738 E RGD:6480464 20150512 CTD MESH:D003300 A2M protein binds to Copper PMID:23896426 10050 A2m alpha-2-macroglobulin gene CHEBI:30052 copper(0) increases expression ISO RGD:2004 E RGD:6480464 20120717 CTD MESH:D003300 Copper results in increased expression of A2M mRNA PMID:22465980 10050 A2m alpha-2-macroglobulin gene CHEBI:30185 zinc(0) affects binding ISO RGD:735738 E RGD:6480464 20150512 CTD MESH:D015032 A2M protein binds to Zinc PMID:23896426 10050 A2m alpha-2-macroglobulin gene CHEBI:30304 antimony(0) decreases expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D000965 Antimony results in decreased expression of A2M mRNA PMID:17547211 10050 A2m alpha-2-macroglobulin gene CHEBI:30563 silicon dioxide increases expression EXP E RGD:6480464 20140715 CTD MESH:D012822 Silicon Dioxide results in increased expression of A2M mRNA PMID:23221170 10050 A2m alpha-2-macroglobulin gene CHEBI:30563 silicon dioxide increases expression ISO RGD:2004 E RGD:6480464 20240806 CTD MESH:D012822 Silicon Dioxide results in increased expression of A2M mRNA PMID:34779285 10050 A2m alpha-2-macroglobulin gene CHEBI:30563 silicon dioxide increases expression ISO RGD:735738 E RGD:6480464 20140610 CTD MESH:D012822 Silicon Dioxide analog results in increased expression of A2M mRNA PMID:23806026 10050 A2m alpha-2-macroglobulin gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:735738 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of A2M protein PMID:30093655 10050 A2m alpha-2-macroglobulin gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of A2M mRNA PMID:16483693 10050 A2m alpha-2-macroglobulin gene CHEBI:31653 glafenine increases expression ISO RGD:2004 E RGD:6480464 20160412 CTD MESH:D005897 Glafenine results in increased expression of A2M mRNA PMID:24136188 10050 A2m alpha-2-macroglobulin gene CHEBI:31767 lead diacetate affects expression ISO RGD:2004 E RGD:6480464 20120918 CTD MESH:C008261 lead acetate affects the expression of A2M mRNA PMID:21864555 10050 A2m alpha-2-macroglobulin gene CHEBI:31767 lead diacetate decreases expression ISO RGD:2004 E RGD:6480464 20130312 CTD MESH:C008261 lead acetate results in decreased expression of A2M mRNA PMID:22641619 10050 A2m alpha-2-macroglobulin gene CHEBI:31823 mercury dichloride increases expression ISO RGD:735738 E RGD:6480464 20161025 CTD MESH:D008627 Mercuric Chloride results in increased expression of A2M mRNA PMID:27188386 10050 A2m alpha-2-macroglobulin gene CHEBI:32234 titanium dioxide increases expression EXP E RGD:6480464 20250128 CTD MESH:C009495 titanium dioxide results in increased expression of A2ML1 mRNA PMID:27760801 10050 A2m alpha-2-macroglobulin gene CHEBI:32396 6-aminohexanoate decreases expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D015119 Aminocaproic Acid results in decreased expression of A2M protein PMID:11304663 10050 A2m alpha-2-macroglobulin gene CHEBI:32497 thioacetamide increases expression ISO RGD:2004 E RGD:6480464 20140408 CTD MESH:D013853 Thioacetamide results in increased expression of A2M mRNA PMID:16297948|PMID:23411599 10050 A2m alpha-2-macroglobulin gene CHEBI:32497 thioacetamide multiple interactions ISO RGD:2004 E RGD:6480464 20180116 CTD MESH:D013853 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of A2M mRNA PMID:28943392 10050 A2m alpha-2-macroglobulin gene CHEBI:32506 4,4'-diaminodiphenylmethane decreases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in decreased expression of A2M mRNA PMID:18289764 10050 A2m alpha-2-macroglobulin gene CHEBI:32509 pirinixic acid decreases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in decreased expression of A2M mRNA PMID:16940010 10050 A2m alpha-2-macroglobulin gene CHEBI:32509 pirinixic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of A2M mRNA PMID:19710929 10050 A2m alpha-2-macroglobulin gene CHEBI:33083 fluoranthene multiple interactions ISO RGD:735738 E RGD:6480464 20121113 CTD MESH:C007738 [Benzo(a)pyrene co-treated with fluoranthene] affects the expression of A2M mRNA PMID:17690111 10050 A2m alpha-2-macroglobulin gene CHEBI:33216 bisphenol A affects expression ISO RGD:2004 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of A2M mRNA PMID:25181051|PMID:32145629 10050 A2m alpha-2-macroglobulin gene CHEBI:33216 bisphenol A affects expression ISO RGD:735738 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of A2M mRNA PMID:30903817 10050 A2m alpha-2-macroglobulin gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230117 CTD MESH:C006780 bisphenol A results in decreased expression of A2M mRNA PMID:32156529|PMID:35479511 10050 A2m alpha-2-macroglobulin gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2004 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of A2M mRNA PMID:34947998 10050 A2m alpha-2-macroglobulin gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20250128 CTD MESH:C006780 bisphenol A results in increased expression of A2ML1 mRNA; bisphenol A results in increased expression of PZP mRNA PMID:30245210|PMID:32156529 10050 A2m alpha-2-macroglobulin gene CHEBI:33216 bisphenol A increases expression ISO RGD:2004 E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in increased expression of A2M mRNA PMID:30816183 10050 A2m alpha-2-macroglobulin gene CHEBI:33216 bisphenol A increases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of A2M promoter; bisphenol A results in increased methylation of A2ML1 promoter PMID:27312807 10050 A2m alpha-2-macroglobulin gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:735738 E RGD:6480464 20180116 CTD MESH:C006780 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of A2M mRNA PMID:28628672 10050 A2m alpha-2-macroglobulin gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:2004 E RGD:6480464 20120501 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of A2M mRNA PMID:19692669 10050 A2m alpha-2-macroglobulin gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions ISO RGD:735738 E RGD:6480464 20180116 CTD MESH:C543008 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of A2M mRNA PMID:28628672 10050 A2m alpha-2-macroglobulin gene CHEBI:34572 allethrin multiple interactions ISO RGD:2004 E RGD:6480464 20230905 CTD MESH:D000487 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of A2M protein PMID:34896426 10050 A2m alpha-2-macroglobulin gene CHEBI:34575 bisphenol F decreases expression EXP E RGD:6480464 20250128 CTD MESH:C008745 bisphenol F results in decreased expression of A2ML1 mRNA PMID:38685157 10050 A2m alpha-2-macroglobulin gene CHEBI:34575 bisphenol F increases expression EXP E RGD:6480464 20250128 CTD MESH:C008745 bisphenol F results in increased expression of PZP mRNA PMID:38685157 10050 A2m alpha-2-macroglobulin gene CHEBI:34631 chlorpyrifos increases expression EXP E RGD:6480464 20210706 CTD MESH:D004390 Chlorpyrifos results in increased expression of A2M mRNA PMID:32715474 10050 A2m alpha-2-macroglobulin gene CHEBI:34648 clofibric acid affects expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D002995 Clofibric Acid affects the expression of A2M mRNA PMID:17602206 10050 A2m alpha-2-macroglobulin gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:735738 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of A2M mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of A2M mRNA PMID:28628672 10050 A2m alpha-2-macroglobulin gene CHEBI:34873 N-nitrosodiethylamine decreases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D004052 Diethylnitrosamine results in decreased expression of A2M mRNA PMID:20360939 10050 A2m alpha-2-macroglobulin gene CHEBI:34873 N-nitrosodiethylamine increases expression ISO RGD:2004 E RGD:6480464 20170516 CTD MESH:D004052 Diethylnitrosamine results in increased expression of A2M mRNA; Diethylnitrosamine results in increased expression of A2M protein PMID:27565560|PMID:29698782 10050 A2m alpha-2-macroglobulin gene CHEBI:34873 N-nitrosodiethylamine multiple interactions ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D004052 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of A2M mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of A2M protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of A2M promoter; [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of A2M mRNA; caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of A2M mRNA] PMID:20360939|PMID:20935162|PMID:25374375|PMID:28943392 10050 A2m alpha-2-macroglobulin gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:735738 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of A2M mRNA PMID:37042841 10050 A2m alpha-2-macroglobulin gene CHEBI:35038 tris(2-butoxyethyl) phosphate affects expression ISO RGD:735738 E RGD:6480464 20180515 CTD MESH:C013320 tris(2-butoxyethyl) phosphate affects the expression of A2M mRNA PMID:29024780 10050 A2m alpha-2-macroglobulin gene CHEBI:35299 dibenz[a,h]anthracene multiple interactions ISO RGD:735738 E RGD:6480464 20121113 CTD MESH:C026486 [Benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of A2M mRNA PMID:17690111 10050 A2m alpha-2-macroglobulin gene CHEBI:35455 1-naphthyl isothiocyanate affects expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D015058 1-Naphthylisothiocyanate affects the expression of A2M mRNA PMID:18289764 10050 A2m alpha-2-macroglobulin gene CHEBI:35455 1-naphthyl isothiocyanate increases expression ISO RGD:2004 E RGD:6480464 20160315 CTD MESH:D015058 1-Naphthylisothiocyanate results in increased expression of A2M mRNA PMID:12883083|PMID:25380136 10050 A2m alpha-2-macroglobulin gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:2004 E RGD:6480464 20120814 CTD MESH:D019256 Cadmium Chloride results in increased expression of A2M mRNA; Cadmium Chloride results in increased expression of A2M protein PMID:15618353|PMID:25993096 10050 A2m alpha-2-macroglobulin gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:2004 E RGD:6480464 20120814 CTD MESH:D019256 Apigenin inhibits the reaction [Cadmium Chloride results in increased expression of A2M protein]; N(6),N(6)-dimethyladenine inhibits the reaction [Cadmium Chloride results in increased expression of A2M protein] PMID:15618353 10050 A2m alpha-2-macroglobulin gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:735738 E RGD:6480464 20230801 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of A2M mRNA PMID:36602393 10050 A2m alpha-2-macroglobulin gene CHEBI:35546 perfluorodecanoic acid increases expression EXP E RGD:6480464 20140114 CTD MESH:C036567 perfluorodecanoic acid results in increased expression of A2M mRNA PMID:23567314 10050 A2m alpha-2-macroglobulin gene CHEBI:35549 perfluorooctanoic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid affects the expression of A2M mRNA PMID:19429403 10050 A2m alpha-2-macroglobulin gene CHEBI:35549 perfluorooctanoic acid decreases expression ISO RGD:735738 E RGD:6480464 20230704 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of A2M mRNA PMID:36251517 10050 A2m alpha-2-macroglobulin gene CHEBI:35559 furan decreases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:C039281 furan results in decreased expression of A2M mRNA PMID:15120968 10050 A2m alpha-2-macroglobulin gene CHEBI:35559 furan increases expression ISO RGD:2004 E RGD:6480464 20160119 CTD MESH:C039281 furan results in increased expression of A2M mRNA PMID:26194646 10050 A2m alpha-2-macroglobulin gene CHEBI:35807 N-nitrosodimethylamine decreases expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D004128 Dimethylnitrosamine results in decreased expression of A2M mRNA PMID:17547211 10050 A2m alpha-2-macroglobulin gene CHEBI:35807 N-nitrosodimethylamine increases expression ISO RGD:2004 E RGD:6480464 20160315 CTD MESH:D004128 Dimethylnitrosamine results in increased expression of A2M mRNA PMID:25380136 10050 A2m alpha-2-macroglobulin gene CHEBI:35860 1-methylphenanthrene multiple interactions ISO RGD:735738 E RGD:6480464 20121113 CTD MESH:C041507 [Benzo(a)pyrene co-treated with 1-methylphenanthrene] affects the expression of A2M mRNA PMID:17690111 10050 A2m alpha-2-macroglobulin gene CHEBI:35861 dibenzo[a,l]pyrene multiple interactions ISO RGD:735738 E RGD:6480464 20121113 CTD MESH:C041517 [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of A2M mRNA PMID:17690111 10050 A2m alpha-2-macroglobulin gene CHEBI:36386 dichloroacetic acid decreases expression EXP E RGD:6480464 20171114 CTD MESH:D003999 Dichloroacetic Acid results in decreased expression of A2M mRNA; Dichloroacetic Acid results in decreased expression of PZP mRNA PMID:28962523 10050 A2m alpha-2-macroglobulin gene CHEBI:36467 ciguatoxin CTX1B affects expression EXP E RGD:6480464 20250128 CTD MESH:D002922 Ciguatoxins affects the expression of PZP mRNA PMID:18353800 10050 A2m alpha-2-macroglobulin gene CHEBI:36904 elemental selenium increases expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in increased expression of A2M mRNA PMID:18997278 10050 A2m alpha-2-macroglobulin gene CHEBI:36904 elemental selenium multiple interactions ISO RGD:735738 E RGD:6480464 20120918 CTD MESH:D012643 Selenium inhibits the reaction [T-2 Toxin results in decreased expression of A2M mRNA]; Selenium promotes the reaction [T-2 Toxin results in decreased expression of A2M protein] PMID:21144892 10050 A2m alpha-2-macroglobulin gene CHEBI:3750 clofibrate increases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D002994 Clofibrate results in increased expression of A2M mRNA PMID:12883083 10050 A2m alpha-2-macroglobulin gene CHEBI:37537 phorbol 13-acetate 12-myristate increases expression ISO RGD:2004 E RGD:6480464 20161025 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in increased expression of A2M mRNA PMID:2440878 10050 A2m alpha-2-macroglobulin gene CHEBI:38211 potassium bromate decreases expression ISO RGD:735738 E RGD:6480464 20190219 CTD MESH:C019536 potassium bromate results in decreased expression of A2M mRNA PMID:30008028 10050 A2m alpha-2-macroglobulin gene CHEBI:38221 fumonisin B1 decreases expression EXP E RGD:6480464 20250128 CTD MESH:C056933 fumonisin B1 results in decreased expression of PZP mRNA PMID:16221962 10050 A2m alpha-2-macroglobulin gene CHEBI:38940 sunitinib decreases expression ISO RGD:735738 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of A2M mRNA PMID:31533062 10050 A2m alpha-2-macroglobulin gene CHEBI:39098 pyrethrins decreases expression ISO RGD:2004 E RGD:6480464 20230905 CTD MESH:D011722 Pyrethrins results in decreased expression of A2M protein PMID:34896426 10050 A2m alpha-2-macroglobulin gene CHEBI:39421 perfluorooctane-1-sulfonic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:C076994 perfluorooctane sulfonic acid affects the expression of A2M mRNA PMID:19429403 10050 A2m alpha-2-macroglobulin gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20250128 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PZP mRNA; [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of A2ML1 mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of PZP mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of A2ML1 mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PZP mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of A2ML1 mRNA PMID:36331819 10050 A2m alpha-2-macroglobulin gene CHEBI:39426 perfluorobutyric acid decreases expression ISO RGD:735738 E RGD:6480464 20230704 CTD MESH:C033094 perfluorobutyric acid results in decreased expression of A2M mRNA PMID:36251517 10050 A2m alpha-2-macroglobulin gene CHEBI:39478 buta-1,3-diene decreases expression EXP E RGD:6480464 20250128 CTD MESH:C031763 1,3-butadiene results in decreased expression of PZP mRNA PMID:29038090 10050 A2m alpha-2-macroglobulin gene CHEBI:39483 sodium dichromate affects expression ISO RGD:2004 E RGD:6480464 20120717 CTD MESH:C016104 sodium bichromate affects the expression of A2M mRNA PMID:22110744 10050 A2m alpha-2-macroglobulin gene CHEBI:39483 sodium dichromate increases expression ISO RGD:2004 E RGD:6480464 20150825 CTD MESH:C016104 sodium bichromate results in increased expression of A2M mRNA PMID:25993096 10050 A2m alpha-2-macroglobulin gene CHEBI:39867 valproic acid affects expression ISO RGD:735738 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of A2M mRNA PMID:25979313 10050 A2m alpha-2-macroglobulin gene CHEBI:39867 valproic acid decreases expression ISO RGD:735738 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased expression of A2M mRNA PMID:29154799|PMID:29501571 10050 A2m alpha-2-macroglobulin gene CHEBI:39867 valproic acid decreases methylation ISO RGD:735738 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of A2M gene PMID:29154799 10050 A2m alpha-2-macroglobulin gene CHEBI:39867 valproic acid increases expression ISO RGD:735738 E RGD:6480464 20170516 CTD MESH:D014635 Valproic Acid results in increased expression of A2M mRNA PMID:28001369 10050 A2m alpha-2-macroglobulin gene CHEBI:40279 allopurinol increases expression ISO RGD:2004 E RGD:6480464 20241203 CTD MESH:D000493 Allopurinol results in increased expression of A2M mRNA PMID:37876353 10050 A2m alpha-2-macroglobulin gene CHEBI:40287 7-nitroindazole increases activity ISO RGD:2004 E RGD:6480464 20170303 CTD MESH:C080122 7-nitroindazole results in increased activity of A2M PMID:19240864 10050 A2m alpha-2-macroglobulin gene CHEBI:4031 cyclosporin A decreases expression EXP E RGD:6480464 20120501 CTD MESH:D016572 Cyclosporine results in decreased expression of A2M mRNA PMID:19770486 10050 A2m alpha-2-macroglobulin gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:735738 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of A2M mRNA PMID:20106945|PMID:25562108|PMID:27989131 10050 A2m alpha-2-macroglobulin gene CHEBI:4031 cyclosporin A increases expression ISO RGD:2004 E RGD:6480464 20120501 CTD MESH:D016572 Cyclosporine results in increased expression of A2M mRNA PMID:21865292 10050 A2m alpha-2-macroglobulin gene CHEBI:4035 cyhalothrin multiple interactions ISO RGD:2004 E RGD:6480464 20230905 CTD MESH:C037304 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of A2M protein PMID:34896426 10050 A2m alpha-2-macroglobulin gene CHEBI:4042 cypermethrin multiple interactions ISO RGD:2004 E RGD:6480464 20230905 CTD MESH:C017160 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of A2M protein PMID:34896426 10050 A2m alpha-2-macroglobulin gene CHEBI:41879 dexamethasone decreases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D003907 Dexamethasone results in decreased expression of A2M mRNA PMID:12971794 10050 A2m alpha-2-macroglobulin gene CHEBI:41879 dexamethasone increases expression ISO RGD:735738 E RGD:6480464 20160705 CTD MESH:D003907 Dexamethasone results in increased expression of A2M mRNA PMID:25047013 10050 A2m alpha-2-macroglobulin gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:735738 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of A2M mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of A2M mRNA PMID:28628672 10050 A2m alpha-2-macroglobulin gene CHEBI:42758 aldehydo-D-glucose multiple interactions EXP E RGD:6480464 20231031 CTD MESH:D005947 [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Herbicides] results in increased expression of PZP mRNA; [lard co-treated with Cholesterol, Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of A2M mRNA PMID:37567420 10050 A2m alpha-2-macroglobulin gene CHEBI:43602 obeticholic acid decreases expression ISO RGD:735738 E RGD:6480464 20170516 CTD MESH:C464660 obeticholic acid results in decreased expression of A2M mRNA PMID:27939613 10050 A2m alpha-2-macroglobulin gene CHEBI:4469 (S)-amphetamine increases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D003913 Dextroamphetamine results in increased expression of A2M mRNA PMID:16715494 10050 A2m alpha-2-macroglobulin gene CHEBI:46024 trichostatin A increases expression ISO RGD:735738 E RGD:6480464 20140909 CTD MESH:C012589 trichostatin A results in increased expression of A2M mRNA PMID:24935251 10050 A2m alpha-2-macroglobulin gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20250128 CTD MESH:D000082 Acetaminophen affects the expression of PZP mRNA PMID:17562736 10050 A2m alpha-2-macroglobulin gene CHEBI:46195 paracetamol decreases expression ISO RGD:2004 E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of A2M mRNA PMID:33387578 10050 A2m alpha-2-macroglobulin gene CHEBI:46195 paracetamol increases expression ISO RGD:2004 E RGD:6480464 20120501 CTD MESH:D000082 Acetaminophen results in increased expression of A2M mRNA PMID:12883083|PMID:8878780 10050 A2m alpha-2-macroglobulin gene CHEBI:46676 tremolite asbestos increases expression EXP E RGD:6480464 20250128 CTD MESH:C005846 tremolite results in increased expression of A2ML1 mRNA PMID:29279043 10050 A2m alpha-2-macroglobulin gene CHEBI:472805 ouabain affects expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D010042 Ouabain affects the expression of A2M protein PMID:17268060 10050 A2m alpha-2-macroglobulin gene CHEBI:47381 diclofenac increases expression EXP E RGD:6480464 20180313 CTD MESH:D004008 Diclofenac results in increased expression of A2M mRNA; Diclofenac results in increased expression of A2ML1 mRNA PMID:26934552 10050 A2m alpha-2-macroglobulin gene CHEBI:47519 ketoconazole decreases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D007654 Ketoconazole results in decreased expression of A2M mRNA PMID:18289764 10050 A2m alpha-2-macroglobulin gene CHEBI:47807 sulforaphane decreases expression ISO RGD:735738 E RGD:6480464 20200609 CTD MESH:C016766 sulforaphane results in decreased expression of A2M mRNA PMID:31838189 10050 A2m alpha-2-macroglobulin gene CHEBI:4791 endosulfan decreases expression ISO RGD:2004 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of A2M mRNA PMID:29391264 10050 A2m alpha-2-macroglobulin gene CHEBI:48765 dimethylarsinic acid decreases expression ISO RGD:2004 E RGD:6480464 20231031 CTD MESH:D002101 Cacodylic Acid results in decreased expression of A2M mRNA PMID:37567419 10050 A2m alpha-2-macroglobulin gene CHEBI:48765 dimethylarsinic acid multiple interactions EXP E RGD:6480464 20250128 CTD MESH:D002101 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of A2ML1 mRNA PMID:34876320 10050 A2m alpha-2-macroglobulin gene CHEBI:4903 17alpha-ethynylestradiol decreases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in decreased expression of A2M mRNA PMID:17557909 10050 A2m alpha-2-macroglobulin gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20250128 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PZP mRNA PMID:17942748 10050 A2m alpha-2-macroglobulin gene CHEBI:49662 indometacin multiple interactions ISO RGD:735738 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of A2M mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of A2M mRNA PMID:28628672 10050 A2m alpha-2-macroglobulin gene CHEBI:49900 arsenous acid decreases expression ISO RGD:735738 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of A2M protein PMID:30093655 10050 A2m alpha-2-macroglobulin gene CHEBI:5014 fenvalerate multiple interactions ISO RGD:2004 E RGD:6480464 20230905 CTD MESH:C017690 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of A2M protein PMID:34896426 10050 A2m alpha-2-macroglobulin gene CHEBI:50594 carbon nanotube increases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon results in increased expression of A2M PMID:21654424 10050 A2m alpha-2-macroglobulin gene CHEBI:50866 3H-1,2-dithiole-3-thione increases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:C049325 1,2-dithiol-3-thione results in increased expression of A2M mRNA PMID:19162173 10050 A2m alpha-2-macroglobulin gene CHEBI:5132 flutamide decreases expression ISO RGD:2004 E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in decreased expression of A2M mRNA PMID:24136188 10050 A2m alpha-2-macroglobulin gene CHEBI:5132 flutamide increases expression ISO RGD:2004 E RGD:6480464 20140909 CTD MESH:D005485 Flutamide results in increased expression of A2M mRNA PMID:24793618 10050 A2m alpha-2-macroglobulin gene CHEBI:53444 potassium dichromate decreases expression EXP E RGD:6480464 20250128 CTD MESH:D011192 Potassium Dichromate results in decreased expression of PZP mRNA PMID:23608068 10050 A2m alpha-2-macroglobulin gene CHEBI:60281 N(6),N(6)-dimethyladenine multiple interactions ISO RGD:2004 E RGD:6480464 20120814 CTD MESH:C001020 N(6),N(6)-dimethyladenine inhibits the reaction [Cadmium Chloride results in increased expression of A2M protein] PMID:15618353 10050 A2m alpha-2-macroglobulin gene CHEBI:6030 isoniazide increases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D007538 Isoniazid results in increased expression of A2M mRNA PMID:12883083 10050 A2m alpha-2-macroglobulin gene CHEBI:6067 isotretinoin increases expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D015474 Isotretinoin results in increased expression of A2M mRNA PMID:20436886 10050 A2m alpha-2-macroglobulin gene CHEBI:61057 tacrolimus hydrate increases expression ISO RGD:2004 E RGD:6480464 20120501 CTD MESH:D016559 Tacrolimus results in increased expression of A2M mRNA PMID:21865292 10050 A2m alpha-2-macroglobulin gene CHEBI:62878 XAV939 multiple interactions ISO RGD:735738 E RGD:6480464 20220208 CTD MESH:C544261 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of A2M mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of A2M mRNA PMID:34480604 10050 A2m alpha-2-macroglobulin gene CHEBI:64163 diquat decreases expression EXP E RGD:6480464 20250128 CTD MESH:D004178 Diquat results in decreased expression of PZP mRNA PMID:36851058 10050 A2m alpha-2-macroglobulin gene CHEBI:64317 isoprenaline increases expression EXP E RGD:6480464 20121113 CTD MESH:D007545 Isoproterenol results in increased expression of A2M mRNA PMID:21335049 10050 A2m alpha-2-macroglobulin gene CHEBI:65585 carnosic acid decreases expression EXP E RGD:6480464 20230404 CTD MESH:C018381 salvin results in decreased expression of A2M protein PMID:35926579 10050 A2m alpha-2-macroglobulin gene CHEBI:67895 corosolic acid increases expression ISO RGD:735738 E RGD:6480464 20240430 CTD MESH:C113861 corosolic acid results in increased expression of A2M mRNA PMID:37939859 10050 A2m alpha-2-macroglobulin gene CHEBI:6820 methapyrilene decreases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D008701 Methapyrilene results in decreased expression of A2M mRNA PMID:15120968 10050 A2m alpha-2-macroglobulin gene CHEBI:70241 Actein increases expression ISO RGD:2004 E RGD:6480464 20170303 CTD MESH:C096064 actein results in increased expression of A2M mRNA; actein results in increased expression of A2M protein PMID:19527300|PMID:29969672 10050 A2m alpha-2-macroglobulin gene CHEBI:71957 XL147 multiple interactions EXP E RGD:6480464 20180220 CTD MESH:C581157 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of A2M mRNA PMID:27935865 10050 A2m alpha-2-macroglobulin gene CHEBI:75261 arotinoid acid multiple interactions ISO RGD:735738 E RGD:6480464 20220208 CTD MESH:C038864 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of A2M mRNA PMID:34480604 10050 A2m alpha-2-macroglobulin gene CHEBI:7590 nitrofen increases expression ISO RGD:2004 E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in increased expression of A2M mRNA PMID:33484710 10050 A2m alpha-2-macroglobulin gene CHEBI:76290 PhIP increases expression ISO RGD:2004 E RGD:6480464 20140107 CTD MESH:C049584 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of A2M mRNA PMID:15059925 10050 A2m alpha-2-macroglobulin gene CHEBI:77006 17beta-estradiol 3-benzoate increases methylation ISO RGD:2004 E RGD:6480464 20180116 CTD MESH:C074283 estradiol 3-benzoate results in increased methylation of A2M promoter PMID:27415467 10050 A2m alpha-2-macroglobulin gene CHEBI:77006 17beta-estradiol 3-benzoate multiple interactions ISO RGD:2004 E RGD:6480464 20210406 CTD MESH:C074283 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of A2M mRNA PMID:32741896 10050 A2m alpha-2-macroglobulin gene CHEBI:77013 beta-naphthoflavone decreases expression ISO RGD:2004 E RGD:6480464 20140204 CTD MESH:D019324 beta-Naphthoflavone results in decreased expression of A2M mRNA PMID:12883083 10050 A2m alpha-2-macroglobulin gene CHEBI:7719 ochratoxin A decreases expression ISO RGD:735738 E RGD:6480464 20190219 CTD MESH:C025589 ochratoxin A results in decreased expression of A2M mRNA PMID:30008028 10050 A2m alpha-2-macroglobulin gene CHEBI:7719 ochratoxin A increases expression ISO RGD:2004 E RGD:6480464 20120717 CTD MESH:C025589 ochratoxin A results in increased expression of A2M mRNA PMID:12700408 10050 A2m alpha-2-macroglobulin gene CHEBI:7735 olanzapine affects phosphorylation ISO RGD:735738 E RGD:6480464 20171010 CTD MESH:C076029 olanzapine affects the phosphorylation of A2M protein PMID:25821032 10050 A2m alpha-2-macroglobulin gene CHEBI:7789 orphenadrine affects expression ISO RGD:2004 E RGD:6480464 20140311 CTD MESH:D009966 Orphenadrine affects the expression of A2M mRNA PMID:23665939 10050 A2m alpha-2-macroglobulin gene CHEBI:78320 2-hydroxypropanoic acid increases secretion ISO RGD:735738 E RGD:6480464 20190910 CTD MESH:D019344 A2M protein modified form results in increased secretion of Lactic Acid PMID:25720493 10050 A2m alpha-2-macroglobulin gene CHEBI:78320 2-hydroxypropanoic acid multiple interactions ISO RGD:735738 E RGD:6480464 20190910 CTD MESH:D019344 HSPA5 protein affects the reaction [A2M protein modified form results in increased secretion of Lactic Acid] PMID:25720493 10050 A2m alpha-2-macroglobulin gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:735738 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of A2M mRNA PMID:27188386 10050 A2m alpha-2-macroglobulin gene CHEBI:8062 phenethyl caffeate multiple interactions ISO RGD:2004 E RGD:6480464 20130903 CTD MESH:C055494 caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in decreased expression of A2M mRNA] PMID:20360939 10050 A2m alpha-2-macroglobulin gene CHEBI:80630 irinotecan increases expression ISO RGD:2004 E RGD:6480464 20181113 CTD MESH:D000077146 Irinotecan results in increased expression of A2M mRNA PMID:20097248 10050 A2m alpha-2-macroglobulin gene CHEBI:8064 phenformin decreases expression ISO RGD:2004 E RGD:6480464 20200114 CTD MESH:D010629 Phenformin results in decreased expression of A2M mRNA PMID:31324951 10050 A2m alpha-2-macroglobulin gene CHEBI:8069 phenobarbital affects expression ISO RGD:735738 E RGD:6480464 20121009 CTD MESH:D010634 Phenobarbital affects the expression of A2M mRNA PMID:19159669 10050 A2m alpha-2-macroglobulin gene CHEBI:8069 phenobarbital decreases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in decreased expression of A2M mRNA PMID:19162173 10050 A2m alpha-2-macroglobulin gene CHEBI:8069 phenobarbital multiple interactions ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D010634 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of A2M mRNA; [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of A2M protein; [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of A2M promoter PMID:20935162|PMID:25374375 10050 A2m alpha-2-macroglobulin gene CHEBI:80774 tauroursodeoxycholic acid decreases expression ISO RGD:2004 E RGD:6480464 20141111 CTD MESH:C031655 ursodoxicoltaurine results in decreased expression of A2M mRNA PMID:15885361 10050 A2m alpha-2-macroglobulin gene CHEBI:81520 2,3',4,4',5-Pentachlorobiphenyl decreases expression EXP E RGD:6480464 20250128 CTD MESH:C070055 2,3',4,4',5-pentachlorobiphenyl results in decreased expression of PZP mRNA PMID:31388691 10050 A2m alpha-2-macroglobulin gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression EXP E RGD:6480464 20250128 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of A2ML1 mRNA; 2,2',4,4',5-brominated diphenyl ether affects the expression of PZP mRNA PMID:38648751 10050 A2m alpha-2-macroglobulin gene CHEBI:8207 (+)-pilocarpine increases expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:D010862 Pilocarpine results in increased expression of A2M mRNA PMID:17971868 10050 A2m alpha-2-macroglobulin gene CHEBI:83493 perfluoroundecanoic acid decreases expression EXP E RGD:6480464 20211207 CTD MESH:C101814 perfluoroundecanoic acid results in decreased expression of A2M mRNA PMID:23567314 10050 A2m alpha-2-macroglobulin gene CHEBI:8382 prednisone decreases expression ISO RGD:735738 E RGD:6480464 20120412 CTD MESH:D011241 Prednisone results in decreased expression of A2M protein PMID:11304663 10050 A2m alpha-2-macroglobulin gene CHEBI:84070 sodium arsenate multiple interactions EXP E RGD:6480464 20250128 CTD MESH:C009277 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of A2ML1 mRNA PMID:34876320 10050 A2m alpha-2-macroglobulin gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2004 E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of A2M mRNA PMID:24780913 10050 A2m alpha-2-macroglobulin gene CHEBI:91091 CHIR 99021 multiple interactions ISO RGD:735738 E RGD:6480464 20220208 CTD MESH:C473711 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF protein co-treated with FGF9 protein] results in increased expression of A2M mRNA; [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of A2M mRNA; [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of A2M mRNA PMID:34480604 10050 A2m alpha-2-macroglobulin gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:735738 E RGD:6480464 20161220 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in increased expression of A2M mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of A2M mRNA PMID:27188386|PMID:34480604 10050 A2m alpha-2-macroglobulin gene CHEBI:9150 simvastatin decreases expression ISO RGD:2004 E RGD:6480464 20120501 CTD MESH:D019821 Simvastatin results in decreased expression of A2M mRNA PMID:16414398 10050 A2m alpha-2-macroglobulin gene CHEBI:9168 sirolimus increases expression ISO RGD:2004 E RGD:6480464 20120501 CTD MESH:D020123 Sirolimus results in increased expression of A2M mRNA PMID:21865292 10050 A2m alpha-2-macroglobulin gene CHEBI:9195 Soman increases expression ISO RGD:2004 E RGD:6480464 20141111 CTD MESH:D012999 Soman results in increased expression of A2M mRNA PMID:19281266 10050 A2m alpha-2-macroglobulin gene CHEBI:920 2,4-dinitrotoluene affects expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of A2M mRNA PMID:21346803 10050 A2m alpha-2-macroglobulin gene CHEBI:9288 streptozocin multiple interactions EXP E RGD:6480464 20210608 CTD MESH:D013311 [Streptozocin co-treated with Dietary Fats] results in increased expression of A2M mRNA; Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of A2M mRNA] PMID:33484791 10050 A2m alpha-2-macroglobulin gene CHEBI:9381 T-2 toxin decreases expression ISO RGD:735738 E RGD:6480464 20141111 CTD MESH:D013605 T-2 Toxin results in decreased expression of A2M mRNA; T-2 Toxin results in decreased expression of A2M protein PMID:21144892 10050 A2m alpha-2-macroglobulin gene CHEBI:9381 T-2 toxin multiple interactions ISO RGD:735738 E RGD:6480464 20141111 CTD MESH:D013605 Selenium inhibits the reaction [T-2 Toxin results in decreased expression of A2M mRNA]; Selenium promotes the reaction [T-2 Toxin results in decreased expression of A2M protein] PMID:21144892 10050 A2m alpha-2-macroglobulin gene CHEBI:957 2,6-dinitrotoluene affects expression ISO RGD:2004 E RGD:6480464 20120412 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of A2M mRNA PMID:21346803 10050 A2m alpha-2-macroglobulin gene CHEBI:9986 vinclozolin increases expression ISO RGD:2004 E RGD:6480464 20141111 CTD MESH:C025643 vinclozolin results in increased expression of A2M mRNA PMID:22570695 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:132267 triptonide decreases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in decreased expression of ABCD3 mRNA PMID:33045310 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:132471 (+)-schisandrin B multiple interactions ISO RGD:2007 E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABCD3 mRNA] PMID:31150632 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:133152 2-bromohexadecanoic acid multiple interactions ISO RGD:736620 E RGD:6480464 20240702 CTD MESH:C022776 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ABCD3 protein] PMID:38195004 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:144441 triacsin C decreases expression ISO RGD:736620 E RGD:6480464 20190903 CTD MESH:C034613 triacsin C results in decreased expression of ABCD3 mRNA PMID:16704987 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:2007 E RGD:6480464 20150127 CTD MESH:D014212 Tretinoin results in decreased expression of ABCD3 mRNA PMID:24977338 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:736620 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in decreased expression of ABCD3 mRNA PMID:33167477 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:736620 E RGD:6480464 20120501 CTD MESH:D014212 Tretinoin results in increased expression of ABCD3 mRNA PMID:21934132 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:15600 (+)-catechin multiple interactions ISO RGD:736620 E RGD:6480464 20141014 CTD MESH:D002392 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of ABCD3 mRNA PMID:24763279 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:15843 arachidonic acid decreases expression ISO RGD:736620 E RGD:6480464 20161213 CTD MESH:D016718 Arachidonic Acid results in decreased expression of ABCD3 mRNA PMID:16704987 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:15930 atrazine decreases expression ISO RGD:736620 E RGD:6480464 20141014 CTD MESH:D001280 Atrazine results in decreased expression of ABCD3 mRNA PMID:22378314 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:16196 oleic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D019301 PPARA protein promotes the reaction [Oleic Acid results in increased expression of ABCD3 mRNA] PMID:18489776 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:16243 quercetin decreases expression ISO RGD:736620 E RGD:6480464 20121009 CTD MESH:D011794 Quercetin results in decreased expression of ABCD3 mRNA PMID:21632981 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:164200 triclosan increases expression EXP E RGD:6480464 20190219 CTD MESH:D014260 Triclosan results in increased expression of ABCD3 mRNA; Triclosan results in increased expression of ABCD3 protein PMID:30238133 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:16469 17beta-estradiol affects expression ISO RGD:736620 E RGD:6480464 20120412 CTD MESH:D004958 Estradiol affects the expression of ABCD3 mRNA PMID:14699072 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:736620 E RGD:6480464 20130723 CTD MESH:D004958 [Estradiol co-treated with Progesterone] results in increased expression of ABCD3 mRNA PMID:20660070 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:16602 trichloroethene decreases expression ISO RGD:2007 E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in decreased expression of ABCD3 mRNA PMID:33387578 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:736620 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of ABCD3 mRNA PMID:37042841 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:16842 formaldehyde increases expression ISO RGD:736620 E RGD:6480464 20140408 CTD MESH:D005557 Formaldehyde results in increased expression of ABCD3 mRNA PMID:23649840 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:17026 progesterone multiple interactions ISO RGD:736620 E RGD:6480464 20130723 CTD MESH:D011374 [Estradiol co-treated with Progesterone] results in increased expression of ABCD3 mRNA PMID:20660070 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:17300 tetrachloroethene increases expression EXP E RGD:6480464 20180116 CTD MESH:D013750 Tetrachloroethylene results in increased expression of ABCD3 mRNA PMID:28973375 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:17347 testosterone decreases expression ISO RGD:736620 E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in decreased expression of ABCD3 mRNA PMID:21592394 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:17347 testosterone multiple interactions ISO RGD:736620 E RGD:6480464 20120412 CTD MESH:D013739 [Testosterone co-treated with Calcitriol] results in increased expression of ABCD3 mRNA PMID:21592394 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:2007 E RGD:6480464 20241203 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of and results in increased activity of and affects the localization of ABCD3 protein PMID:11341945 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:178012 FR900359 decreases phosphorylation ISO RGD:736620 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in decreased phosphorylation of ABCD3 protein PMID:37730182 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:17823 calcitriol increases expression ISO RGD:736620 E RGD:6480464 20120412 CTD MESH:D002117 Calcitriol results in increased expression of ABCD3 mRNA PMID:21592394 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:17823 calcitriol multiple interactions ISO RGD:736620 E RGD:6480464 20120412 CTD MESH:D002117 [Testosterone co-treated with Calcitriol] results in increased expression of ABCD3 mRNA PMID:21592394 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:17833 gentamycin decreases expression ISO RGD:2007 E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in decreased expression of ABCD3 mRNA PMID:33387578 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:18145 (R,R,R)-alpha-tocopherol multiple interactions EXP E RGD:6480464 20200915 CTD MESH:D024502 alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD3 mRNA] PMID:29065513 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:188851 Muraglitazar increases expression ISO RGD:2007 E RGD:6480464 20220104 CTD MESH:C500085 muraglitazar results in increased expression of ABCD3 mRNA PMID:21515302 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABCD3 mRNA PMID:37325564 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:736620 E RGD:6480464 20221101 CTD MESH:D002104 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ABCD3 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABCD3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ABCD3 protein PMID:35301059|PMID:38195004 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:736620 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of ABCD3 mRNA PMID:19549813 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:24814 indole-3-methanol affects expression ISO RGD:2007 E RGD:6480464 20120613 CTD MESH:C016517 indole-3-carbinol affects the expression of ABCD3 mRNA PMID:21396975 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:736620 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of ABCD3 gene PMID:27153756 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:25255 methyl methanesulfonate increases expression ISO RGD:736620 E RGD:6480464 20140408 CTD MESH:D008741 Methyl Methanesulfonate results in increased expression of ABCD3 mRNA PMID:23649840 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:2564 aldrin increases expression EXP E RGD:6480464 20140107 CTD MESH:D000452 Aldrin results in increased expression of ABCD3 mRNA PMID:18579281 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:25812 ozone multiple interactions EXP E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ABCD3 mRNA PMID:34911549 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:2663 amiodarone increases expression EXP E RGD:6480464 20150127 CTD MESH:D000638 Amiodarone results in increased expression of ABCD3 mRNA PMID:24489787 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20160822 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ABCD3 mRNA PMID:27339419|PMID:31919559 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:2007 E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ABCD3 mRNA PMID:31150632 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:27385 tetrachloromethane multiple interactions ISO RGD:2007 E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABCD3 mRNA] PMID:31150632 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ABCD3 mRNA] PMID:22206623 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:27684 phenylmercury acetate increases expression ISO RGD:736620 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in increased expression of ABCD3 mRNA PMID:26272509 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:736620 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCD3 mRNA PMID:27188386 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:27789 1,2-dichloroethane decreases expression EXP E RGD:6480464 20170613 CTD MESH:C024565 ethylene dichloride results in decreased expression of ABCD3 mRNA PMID:28189721|PMID:28960355 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:27856 acetamide decreases expression ISO RGD:2007 E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in decreased expression of ABCD3 mRNA PMID:31881176 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:736620 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in increased expression of ABCD3 mRNA PMID:23557933 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:27902 tetracycline decreases expression EXP E RGD:6480464 20150127 CTD MESH:D013752 Tetracycline results in decreased expression of ABCD3 mRNA PMID:24489787 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:27902 tetracycline increases expression EXP E RGD:6480464 20120412 CTD MESH:D013752 Tetracycline results in increased expression of ABCD3 mRNA PMID:16917069 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:28112 nickel atom decreases expression ISO RGD:736620 E RGD:6480464 20150609 CTD MESH:D009532 Nickel results in decreased expression of ABCD3 mRNA PMID:23195993 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:28112 nickel atom increases expression ISO RGD:736620 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in increased expression of ABCD3 mRNA PMID:25583101 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ABCD3 mRNA PMID:21570461 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2007 E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ABCD3 mRNA PMID:21215274|PMID:33387578 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:28201 rotenone decreases expression ISO RGD:2007 E RGD:6480464 20221101 CTD MESH:D012402 Rotenone results in decreased expression of ABCD3 protein PMID:35544339 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:736620 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of ABCD3 mRNA PMID:33212167 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:736620 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of ABCD3 mRNA PMID:30851411 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:28445 vincristine multiple interactions ISO RGD:736620 E RGD:6480464 20161213 CTD MESH:D014750 [Vincristine results in decreased susceptibility to Vincristine] which results in decreased expression of ABCD3 mRNA PMID:19944135 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:28509 chloroethene increases expression EXP E RGD:6480464 20130514 CTD MESH:D014752 Vinyl Chloride results in increased expression of ABCD3 mRNA PMID:18579281 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:28619 acrylamide increases expression ISO RGD:2007 E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in increased expression of ABCD3 mRNA PMID:28959563 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:28694 copper atom multiple interactions ISO RGD:736620 E RGD:6480464 20150512 CTD MESH:D003300 [AP1S1 gene mutant form affects the metabolism of Copper] which results in decreased expression of ABCD3 protein PMID:23423674 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:28741 sodium fluoride decreases expression EXP E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in decreased expression of ABCD3 protein PMID:28918527 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:736620 E RGD:6480464 20171010 CTD MESH:C017947 sodium arsenite results in increased expression of ABCD3 mRNA PMID:28595984 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:29865 benzo[a]pyrene multiple interactions ISO RGD:2007 E RGD:6480464 20121113 CTD MESH:D001564 [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of ABCD3 mRNA PMID:18711122 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:736620 E RGD:6480464 20150512 CTD MESH:D003300 [AP1S1 gene mutant form affects the metabolism of Copper] which results in decreased expression of ABCD3 protein PMID:23423674 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2007 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ABCD3 mRNA PMID:16483693 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:31653 glafenine decreases expression ISO RGD:2007 E RGD:6480464 20160412 CTD MESH:D005897 Glafenine results in decreased expression of ABCD3 mRNA PMID:24136188 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:32195 Tesaglitazar increases expression ISO RGD:2007 E RGD:6480464 20170303 CTD MESH:C501413 tesaglitazar results in increased expression of ABCD3 mRNA PMID:21515302 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:32497 thioacetamide decreases expression ISO RGD:2007 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of ABCD3 mRNA PMID:34492290 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:32506 4,4'-diaminodiphenylmethane decreases expression ISO RGD:2007 E RGD:6480464 20190507 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in decreased expression of ABCD3 mRNA PMID:30723492 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:32509 pirinixic acid increases expression EXP E RGD:6480464 20121113 CTD MESH:C006253 pirinixic acid results in increased expression of ABCD3 mRNA; pirinixic acid results in increased expression of ABCD3 protein PMID:15375163|PMID:17118139|PMID:17426115|PMID:17690133|PMID:18301758|PMID:18593727|PMID:20059764|PMID:20813756|PMID:23811191 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:32509 pirinixic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ABCD3 mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of ABCD3 mRNA] PMID:18489776|PMID:20059764 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:33083 fluoranthene multiple interactions ISO RGD:2007 E RGD:6480464 20121113 CTD MESH:C007738 [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ABCD3 mRNA PMID:18711122 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:33216 bisphenol A affects expression ISO RGD:2007 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of ABCD3 mRNA PMID:25181051|PMID:30903817 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2007 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of ABCD3 mRNA PMID:34947998 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:33216 bisphenol A decreases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in decreased methylation of ABCD3 promoter PMID:27312807 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:34372 4,4'-sulfonyldiphenol affects expression ISO RGD:736620 E RGD:6480464 20230117 CTD MESH:C543008 bisphenol S affects the expression of ABCD3 protein PMID:31945527 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:34575 bisphenol F increases expression EXP E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in increased expression of ABCD3 mRNA PMID:38685157 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:34581 Bisphenol B increases expression ISO RGD:736620 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of ABCD3 protein PMID:34186270 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:34648 clofibric acid increases expression EXP E RGD:6480464 20130312 CTD MESH:D002995 Clofibric Acid results in increased expression of ABCD3 mRNA PMID:22539621 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:736620 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ABCD3 mRNA PMID:37042841 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:35299 dibenz[a,h]anthracene multiple interactions ISO RGD:2007 E RGD:6480464 20121113 CTD MESH:C026486 [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of ABCD3 mRNA; [1,2,5,6-dibenzanthracene co-treated with fluoranthene] affects the expression of ABCD3 mRNA PMID:18711122 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABCD3 mRNA PMID:37325564 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:736620 E RGD:6480464 20221101 CTD MESH:D019256 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ABCD3 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ABCD3 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ABCD3 protein PMID:35301059|PMID:38195004 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:35549 perfluorooctanoic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid affects the expression of ABCD3 mRNA PMID:18281256 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:35549 perfluorooctanoic acid increases expression EXP E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ABCD3 mRNA; perfluorooctanoic acid results in increased expression of ABCD3 protein PMID:17681415|PMID:37422089 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:2007 E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ABCD3 mRNA; perfluorooctanoic acid results in increased expression of ABCD3 protein PMID:19162173|PMID:28511854|PMID:34958885 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:35559 furan increases methylation ISO RGD:2007 E RGD:6480464 20120918 CTD MESH:C039281 furan results in increased methylation of ABCD3 gene PMID:22079235 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:736620 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of ABCD3 mRNA PMID:24449571 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:35861 dibenzo[a,l]pyrene multiple interactions ISO RGD:2007 E RGD:6480464 20121113 CTD MESH:C041517 [1,2,5,6-dibenzanthracene co-treated with dibenzo(a,l)pyrene] affects the expression of ABCD3 mRNA; [Benzo(a)pyrene co-treated with dibenzo(a,l)pyrene] affects the expression of ABCD3 mRNA PMID:18711122 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:36386 dichloroacetic acid increases expression EXP E RGD:6480464 20171114 CTD MESH:D003999 Dichloroacetic Acid results in increased expression of ABCD3 mRNA PMID:28962523 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20120515 CTD MESH:D002994 Clofibrate results in increased expression of ABCD3 mRNA PMID:17585979 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:3750 clofibrate increases expression ISO RGD:2007 E RGD:6480464 20120613 CTD MESH:D002994 Clofibrate results in increased expression of ABCD3 mRNA PMID:12851107 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:3750 clofibrate multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D002994 [Clofibrate co-treated with Acetaminophen] affects the expression of ABCD3 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ABCD3 mRNA] PMID:17585979 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:38658 dicrotophos decreases expression ISO RGD:736620 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in decreased expression of ABCD3 mRNA PMID:28302478 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:3908 coumestrol decreases expression ISO RGD:736620 E RGD:6480464 20130409 CTD MESH:D003375 Coumestrol results in decreased expression of ABCD3 mRNA PMID:19167446 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:39178 clothianidin decreases expression ISO RGD:736620 E RGD:6480464 20200519 CTD MESH:C480342 clothianidin results in decreased expression of ABCD3 mRNA PMID:31626844 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression ISO RGD:2007 E RGD:6480464 20120412 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of ABCD3 mRNA PMID:18692542 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20210209 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of ABCD3 protein PMID:32991729 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:39867 valproic acid affects expression ISO RGD:736620 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ABCD3 mRNA PMID:25979313 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:39867 valproic acid increases expression EXP E RGD:6480464 20150127 CTD MESH:D014635 Valproic Acid results in increased expression of ABCD3 mRNA PMID:24489787 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:39867 valproic acid increases expression ISO RGD:736620 E RGD:6480464 20160119 CTD MESH:D014635 Valproic Acid results in increased expression of ABCD3 mRNA PMID:23179753|PMID:24383497|PMID:25192806|PMID:26272509|PMID:28001369|PMID:29154799|PMID:29501571 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:736620 E RGD:6480464 20161025 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCD3 mRNA PMID:27188386 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:40036 amitrole decreases expression ISO RGD:2007 E RGD:6480464 20240702 CTD MESH:D000640 Amitrole results in decreased expression of ABCD3 mRNA PMID:38685447 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:736620 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of ABCD3 mRNA PMID:20106945|PMID:25562108 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:41774 tamoxifen decreases expression EXP E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen results in decreased expression of ABCD3 mRNA PMID:17555576 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:44185 methotrexate increases expression ISO RGD:736620 E RGD:6480464 20121113 CTD MESH:D008727 Methotrexate results in increased expression of ABCD3 mRNA PMID:17400583 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:45716 vorinostat increases expression ISO RGD:736620 E RGD:6480464 20161213 CTD MESH:C111237 vorinostat results in increased expression of ABCD3 mRNA PMID:27188386 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:46024 trichostatin A increases expression ISO RGD:736620 E RGD:6480464 20161025 CTD MESH:C012589 trichostatin A results in increased expression of ABCD3 mRNA PMID:27188386 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of ABCD3 mRNA PMID:17562736 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:46195 paracetamol multiple interactions EXP E RGD:6480464 20120515 CTD MESH:D000082 [Clofibrate co-treated with Acetaminophen] affects the expression of ABCD3 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ABCD3 mRNA] PMID:17585979 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:47612 bezafibrate increases expression EXP E RGD:6480464 20120717 CTD MESH:D001629 Bezafibrate results in increased expression of ABCD3 protein PMID:19124612|PMID:20594415 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:4791 endosulfan decreases expression ISO RGD:2007 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of ABCD3 mRNA PMID:29391264 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:736620 E RGD:6480464 20121009 CTD MESH:C045651 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABCD3 mRNA PMID:22079256 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:4811 epoxiconazole decreases expression EXP E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in decreased expression of ABCD3 mRNA PMID:35436446 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:49662 indometacin decreases expression ISO RGD:2007 E RGD:6480464 20230704 CTD MESH:D007213 Indomethacin results in decreased expression of ABCD3 mRNA PMID:36868495 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:5001 fenofibrate increases expression EXP E RGD:6480464 20120412 CTD MESH:D011345 Fenofibrate results in increased expression of ABCD3 mRNA PMID:17118139 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ABCD3 mRNA; Nanotubes, Carbon results in decreased expression of ABCD3 mRNA PMID:25620056 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:5062 finasteride increases expression ISO RGD:2007 E RGD:6480464 20160412 CTD MESH:D018120 Finasteride results in increased expression of ABCD3 mRNA PMID:24136188 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:50648 9-cis-retinoic acid increases expression ISO RGD:2007 E RGD:6480464 20191114 CTD MESH:C103303 Alitretinoin results in increased expression of ABCD3 mRNA PMID:16648578 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:50673 methimazole decreases expression ISO RGD:2007 E RGD:6480464 20240702 CTD MESH:D008713 Methimazole results in decreased expression of ABCD3 mRNA PMID:38685447 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:50859 bexarotene increases expression ISO RGD:2007 E RGD:6480464 20170303 CTD MESH:C095105 bexarotene results in increased expression of ABCD3 mRNA PMID:16648578|PMID:23292798 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:50866 3H-1,2-dithiole-3-thione increases expression ISO RGD:2007 E RGD:6480464 20120412 CTD MESH:C049325 1,2-dithiol-3-thione results in increased expression of ABCD3 mRNA PMID:19162173 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:6078 ivermectin decreases expression ISO RGD:736620 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ABCD3 protein PMID:32959892 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:63618 pravastatin decreases expression EXP E RGD:6480464 20180220 CTD MESH:D017035 Pravastatin results in decreased expression of ABCD3 mRNA PMID:27225895 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:63632 topotecan affects response to substance ISO RGD:736620 E RGD:6480464 20120412 CTD MESH:D019772 ABCD3 protein affects the susceptibility to Topotecan PMID:16217747 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:63933 Aroclor 1254 decreases expression EXP E RGD:6480464 20131210 CTD MESH:D020111 Chlorodiphenyl (54% Chlorine) results in decreased expression of ABCD3 mRNA PMID:23650126 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:6402 leflunomide decreases expression ISO RGD:736620 E RGD:6480464 20180410 CTD MESH:C045463 leflunomide results in decreased expression of ABCD3 mRNA PMID:28988120|PMID:29427785 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:64294 7-ketocholesterol decreases expression EXP E RGD:6480464 20200915 CTD MESH:C003001 7-ketocholesterol results in decreased expression of ABCD3 mRNA PMID:29065513 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:64294 7-ketocholesterol multiple interactions EXP E RGD:6480464 20200915 CTD MESH:C003001 alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD3 mRNA]; argan oil inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD3 mRNA] PMID:29065513 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:6809 methamphetamine increases expression EXP E RGD:6480464 20151215 CTD MESH:D008694 Methamphetamine results in increased expression of ABCD3 mRNA PMID:26307267 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:6820 methapyrilene decreases expression ISO RGD:2007 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in decreased expression of ABCD3 mRNA PMID:30467583 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:72564 temozolomide increases expression ISO RGD:736620 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in increased expression of ABCD3 mRNA PMID:31758290 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ABCD3 mRNA PMID:22206623 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D019813 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in decreased expression of ABCD3 mRNA] PMID:22206623 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:75170 zaragozic acid A affects expression EXP E RGD:6480464 20180220 CTD MESH:C075117 squalestatin 1 affects the expression of ABCD3 mRNA PMID:27225895 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:75170 zaragozic acid A increases expression ISO RGD:2007 E RGD:6480464 20180220 CTD MESH:C075117 squalestatin 1 results in increased expression of ABCD3 mRNA PMID:27225895 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:75249 potassium chromate decreases expression ISO RGD:736620 E RGD:6480464 20130903 CTD MESH:C027373 potassium chromate(VI) results in decreased expression of ABCD3 mRNA PMID:22079256 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:75249 potassium chromate multiple interactions ISO RGD:736620 E RGD:6480464 20130903 CTD MESH:C027373 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ABCD3 mRNA PMID:22079256 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:75455 2-palmitoylglycerol increases expression ISO RGD:736620 E RGD:6480464 20240109 CTD MESH:C114956 2-palmitoylglycerol results in increased expression of ABCD3 mRNA PMID:37199045 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:75701 sarin decreases expression ISO RGD:736620 E RGD:6480464 20131112 CTD MESH:D012524 Sarin results in decreased expression of ABCD3 mRNA PMID:19522546 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:76604 MeIQx increases expression ISO RGD:736620 E RGD:6480464 20140107 CTD MESH:C036990 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of ABCD3 mRNA PMID:20816883 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:78320 2-hydroxypropanoic acid decreases expression ISO RGD:736620 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of ABCD3 mRNA PMID:30851411 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:736620 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCD3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCD3 mRNA PMID:27188386 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:78576 aflatoxin M1 decreases expression ISO RGD:736620 E RGD:6480464 20190910 CTD MESH:D016607 Aflatoxin M1 results in decreased expression of ABCD3 mRNA PMID:30928695 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression EXP E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of ABCD3 mRNA PMID:38648751 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether affects expression EXP E RGD:6480464 20200310 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether affects the expression of ABCD3 mRNA PMID:30294300 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:81925 fomesafen increases expression EXP E RGD:6480464 20141111 CTD MESH:C088563 fomesafen results in increased expression of ABCD3 mRNA PMID:22539621 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:81927 enilconazole decreases expression EXP E RGD:6480464 20210112 CTD MESH:C017435 enilconazole results in decreased expression of ABCD3 mRNA PMID:30853599 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:82029 Oxyfluorfen increases expression EXP E RGD:6480464 20161213 CTD MESH:C016027 oxyfluorofen results in increased expression of ABCD3 mRNA PMID:22539621 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:8249 piroxicam decreases expression ISO RGD:736620 E RGD:6480464 20120412 CTD MESH:D010894 Piroxicam results in decreased expression of ABCD3 mRNA PMID:21858171 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:8489 propiconazole decreases expression EXP E RGD:6480464 20120412 CTD MESH:C045950 propiconazole results in decreased expression of ABCD3 mRNA PMID:21278054 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:736620 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCD3 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ABCD3 mRNA PMID:27188386 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:9168 sirolimus decreases expression ISO RGD:736620 E RGD:6480464 20230502 CTD MESH:D020123 Sirolimus results in decreased expression of ABCD3 protein PMID:36214828 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:9352 sulindac increases expression ISO RGD:2007 E RGD:6480464 20160412 CTD MESH:D013467 Sulindac results in increased expression of ABCD3 mRNA PMID:24136188 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:9495 thiram decreases expression ISO RGD:736620 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of ABCD3 mRNA PMID:38568856 10051 Abcd3 ATP-binding cassette, sub-family D member 3 gene CHEBI:9753 troglitazone increases expression ISO RGD:2007 E RGD:6480464 20120918 CTD MESH:C057693 troglitazone results in increased expression of ABCD3 mRNA PMID:21515302 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression EXP E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of ABL2 mRNA PMID:37995155 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:15368 acrolein multiple interactions ISO RGD:1352263 E RGD:6480464 20210112 CTD MESH:D000171 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ABL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ABL2 mRNA PMID:32699268 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:15743 butanal increases expression ISO RGD:1352263 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in increased expression of ABL2 mRNA PMID:26079696 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:15891 taurine increases expression ISO RGD:1352263 E RGD:6480464 20120412 CTD MESH:D013654 Taurine results in increased expression of ABL2 mRNA PMID:16579726 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:16236 ethanol affects splicing EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the splicing of ABL2 mRNA PMID:30319688 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:16240 hydrogen peroxide multiple interactions EXP E RGD:6480464 20200211 CTD MESH:D006861 [Hydrogen Peroxide co-treated with N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride] results in increased phosphorylation of ABL2 protein PMID:31494107 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20161228 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of ABL2 mRNA PMID:22024136 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20161228 CTD MESH:D008070 [Lipopolysaccharides co-treated with IL4] results in increased expression of ABL2 mRNA; Lipopolysaccharides affects the reaction [IL4 protein results in increased expression of ABL2 mRNA] PMID:22024136 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:1352263 E RGD:6480464 20220308 CTD MESH:D004958 Estradiol results in increased expression of ABL2 mRNA PMID:31614463 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:1352263 E RGD:6480464 20190611 CTD MESH:D004958 [Estradiol co-treated with TGFB1 protein] results in increased expression of ABL2 mRNA PMID:30165855 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:1352263 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of ABL2 mRNA PMID:37042841 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:17151 xylitol increases expression ISO RGD:1352263 E RGD:6480464 20200804 CTD MESH:D014993 Xylitol results in increased expression of ABL2 mRNA PMID:32275922 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:17347 testosterone decreases expression ISO RGD:1352263 E RGD:6480464 20211109 CTD MESH:D013739 Testosterone results in decreased expression of ABL2 mRNA PMID:33359661 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:178012 FR900359 decreases phosphorylation ISO RGD:1352263 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in decreased phosphorylation of ABL2 protein PMID:37730182 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:17833 gentamycin increases expression ISO RGD:1590898 E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in increased expression of ABL2 mRNA PMID:33387578 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:18243 dopamine decreases expression ISO RGD:1590898 E RGD:6480464 20120918 CTD MESH:D004298 Dopamine results in decreased expression of ABL2 mRNA PMID:21983523 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:22977 cadmium atom increases expression ISO RGD:1352263 E RGD:6480464 20151013 CTD MESH:D002104 Cadmium results in increased expression of ABL2 mRNA PMID:21120746 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:23414 copper(II) sulfate increases expression ISO RGD:1352263 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in increased expression of ABL2 mRNA PMID:19549813 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:2504 aflatoxin B1 increases expression EXP E RGD:6480464 20120501 CTD MESH:D016604 Aflatoxin B1 results in increased expression of ABL2 mRNA PMID:19770486 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:1352263 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of ABL2 intron PMID:30157460 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:25812 ozone multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ABL2 mRNA PMID:27106289 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:25812 ozone multiple interactions ISO RGD:1352263 E RGD:6480464 20210112 CTD MESH:D010126 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ABL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ABL2 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of ABL2 mRNA PMID:32699268 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:27563 arsenic atom multiple interactions ISO RGD:1352263 E RGD:6480464 20200915 CTD MESH:D001151 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABL2 mRNA PMID:32525701 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:1352263 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABL2 mRNA PMID:27188386 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:27732 caffeine decreases phosphorylation ISO RGD:1352263 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine results in decreased phosphorylation of ABL2 protein PMID:35688186 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:27889 lead(0) decreases expression ISO RGD:1352263 E RGD:6480464 20120412 CTD MESH:D007854 Lead results in decreased expression of ABL2 mRNA PMID:19921347 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1352263 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in decreased expression of ABL2 mRNA PMID:27392435 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:27998 tungsten decreases expression EXP E RGD:6480464 20190910 CTD MESH:D014414 Tungsten results in decreased expression of ABL2 mRNA PMID:30912803 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:28112 nickel atom increases expression ISO RGD:1352263 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in increased expression of ABL2 mRNA PMID:24768652|PMID:25583101 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1352263 E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ABL2 mRNA PMID:22298810 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1352263 E RGD:6480464 20120613 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ABL2 mRNA PMID:21296121 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:28177 theophylline decreases expression ISO RGD:1352263 E RGD:6480464 20120515 CTD MESH:D013806 Theophylline results in decreased expression of ABL2 mRNA PMID:16083514 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:1352263 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of ABL2 mRNA PMID:33212167 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:28358 rac-lactic acid increases expression ISO RGD:1352263 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of ABL2 mRNA PMID:30851411 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:28694 copper atom multiple interactions ISO RGD:1352263 E RGD:6480464 20120717 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in increased expression of ABL2 mRNA PMID:20971185 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:28748 doxorubicin decreases expression ISO RGD:1352263 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of ABL2 mRNA PMID:29803840 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:28794 coumarin affects phosphorylation ISO RGD:1352263 E RGD:6480464 20221004 CTD MESH:C030123 coumarin affects the phosphorylation of ABL2 protein PMID:35688186 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:1352263 E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in decreased expression of ABL2 mRNA PMID:29301061 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1352263 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in increased expression of ABL2 mRNA PMID:12760830|PMID:38568856 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1352263 E RGD:6480464 20190219 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ABL2 intron PMID:30157460 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:1352263 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ABL2 3' UTR PMID:27901495 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:1352263 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ABL2 promoter PMID:27901495 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:1352263 E RGD:6480464 20220405 CTD MESH:C015001 arsenite inhibits the reaction [G3BP1 protein binds to ABL2 mRNA] PMID:32406909 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:30052 copper(0) multiple interactions ISO RGD:1352263 E RGD:6480464 20120717 CTD MESH:D003300 [NSC 689534 binds to Copper] which results in increased expression of ABL2 mRNA PMID:20971185 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:30563 silicon dioxide increases expression ISO RGD:1352263 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in increased expression of ABL2 mRNA; Silicon Dioxide results in increased expression of ABL2 mRNA PMID:25351596|PMID:25895662 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:30614 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1352263 E RGD:6480464 20140805 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ABL2 mRNA PMID:20018196 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:32234 titanium dioxide decreases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ABL2 promoter PMID:35295148 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:32497 thioacetamide increases expression ISO RGD:1590898 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in increased expression of ABL2 mRNA PMID:34492290 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:33083 fluoranthene multiple interactions EXP E RGD:6480464 20170725 CTD MESH:C007738 [1-methylanthracene co-treated with fluoranthene] results in increased expression of ABL2 mRNA PMID:28329830 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:33128 C60 fullerene decreases expression ISO RGD:1590898 E RGD:6480464 20120717 CTD MESH:C069837 fullerene C60 results in decreased expression of ABL2 mRNA PMID:19167457 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:33216 bisphenol A affects expression ISO RGD:1590898 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of ABL2 mRNA PMID:25181051 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:33216 bisphenol A decreases expression ISO RGD:1590898 E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in decreased expression of ABL2 mRNA PMID:30816183|PMID:32528016 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:33216 bisphenol A increases expression ISO RGD:1590898 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of ABL2 mRNA PMID:34947998 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:3387 carbamazepine affects expression ISO RGD:1352263 E RGD:6480464 20140715 CTD MESH:D002220 Carbamazepine affects the expression of ABL2 mRNA PMID:24752500 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:34031 1,1-dichloroethene increases expression EXP E RGD:6480464 20170725 CTD MESH:C029297 vinylidene chloride results in increased expression of ABL2 mRNA PMID:26682919 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:34567 benzo[e]pyrene increases methylation ISO RGD:1352263 E RGD:6480464 20190219 CTD MESH:C026487 benzo(e)pyrene results in increased methylation of ABL2 intron PMID:30157460 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:34575 bisphenol F multiple interactions ISO RGD:1352263 E RGD:6480464 20180116 CTD MESH:C008745 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA PMID:28628672 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in decreased expression of ABL2 mRNA PMID:37019170 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1352263 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA PMID:28628672 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:34911 permethrin multiple interactions ISO RGD:1590898 E RGD:6480464 20210810 CTD MESH:D026023 [Permethrin co-treated with DEET] results in increased methylation of ABL2 gene PMID:33148267 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:1352263 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ABL2 mRNA PMID:37042841 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:1352263 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in increased expression of ABL2 mRNA PMID:38568856 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:36740 alpha-pinene multiple interactions ISO RGD:1352263 E RGD:6480464 20210112 CTD MESH:C005451 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of ABL2 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of ABL2 mRNA PMID:32699268 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:38397 perfluorononanoic acid increases expression ISO RGD:1352263 E RGD:6480464 20220111 CTD MESH:C101816 perfluoro-n-nonanoic acid results in increased expression of ABL2 mRNA PMID:32588087 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:39867 valproic acid affects splicing ISO RGD:1590898 E RGD:6480464 20180828 CTD MESH:D014635 Valproic Acid affects the splicing of ABL2 mRNA PMID:29427782 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:39867 valproic acid decreases expression ISO RGD:1590898 E RGD:6480464 20180828 CTD MESH:D014635 Valproic Acid results in decreased expression of ABL2 mRNA PMID:29427782 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:4031 cyclosporin A increases expression ISO RGD:1352263 E RGD:6480464 20120412 CTD MESH:D016572 Cyclosporine results in increased expression of ABL2 mRNA PMID:20106945 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:1352263 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA PMID:28628672 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:46195 paracetamol increases expression ISO RGD:1352263 E RGD:6480464 20180515 CTD MESH:D000082 Acetaminophen results in increased expression of ABL2 mRNA PMID:29067470 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:46666 crocidolite asbestos affects expression ISO RGD:1352263 E RGD:6480464 20161115 CTD MESH:D017638 Asbestos, Crocidolite affects the expression of ABL2 mRNA PMID:25757056 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:46666 crocidolite asbestos increases expression ISO RGD:1352263 E RGD:6480464 20161115 CTD MESH:D017638 Asbestos, Crocidolite results in increased expression of ABL2 mRNA PMID:18687144|PMID:25351596 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:47217 arsane multiple interactions ISO RGD:1352263 E RGD:6480464 20200915 CTD MESH:D001151 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABL2 mRNA PMID:32525701 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:47381 diclofenac affects expression ISO RGD:1352263 E RGD:6480464 20140715 CTD MESH:D004008 Diclofenac affects the expression of ABL2 mRNA PMID:24752500 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1352263 E RGD:6480464 20121009 CTD MESH:C045651 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ABL2 mRNA PMID:22079256 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:49662 indometacin multiple interactions ISO RGD:1352263 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABL2 mRNA PMID:28628672 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:5002 fenoldopam increases expression ISO RGD:1590898 E RGD:6480464 20120918 CTD MESH:D018818 Fenoldopam results in increased expression of ABL2 mRNA PMID:21983523 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:50292 cadmium sulfate increases expression ISO RGD:1352263 E RGD:6480464 20150310 CTD MESH:C037123 cadmium sulfate results in increased expression of ABL2 mRNA PMID:12064557|PMID:14676411 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:50883 boron nitride increases expression ISO RGD:1352263 E RGD:6480464 20190409 CTD MESH:C017282 boron nitride results in increased expression of ABL2 mRNA PMID:30644070 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:53444 potassium dichromate decreases expression EXP E RGD:6480464 20140610 CTD MESH:D011192 Potassium Dichromate results in decreased expression of ABL2 mRNA PMID:23608068 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:53620 methylisothiazolinone increases expression ISO RGD:1352263 E RGD:6480464 20200714 CTD MESH:C011506 2-methyl-4-isothiazolin-3-one results in increased expression of ABL2 mRNA PMID:31629900 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:6820 methapyrilene increases methylation ISO RGD:1352263 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in increased methylation of ABL2 intron PMID:30157460 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:69478 cannabidiol multiple interactions ISO RGD:1352263 E RGD:6480464 20210209 CTD MESH:D002185 [Dronabinol co-treated with Cannabidiol] results in increased expression of ABL2 mRNA PMID:26504004 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:7071 N,N-diethyl-m-toluamide multiple interactions ISO RGD:1590898 E RGD:6480464 20210810 CTD MESH:D003671 [Permethrin co-treated with DEET] results in increased methylation of ABL2 gene PMID:33148267 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:75249 potassium chromate increases expression ISO RGD:1352263 E RGD:6480464 20130903 CTD MESH:C027373 potassium chromate(VI) results in increased expression of ABL2 mRNA PMID:22079256 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:75249 potassium chromate multiple interactions ISO RGD:1352263 E RGD:6480464 20130903 CTD MESH:C027373 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of ABL2 mRNA PMID:22079256 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:78320 2-hydroxypropanoic acid increases expression ISO RGD:1352263 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of ABL2 mRNA PMID:30851411 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:1352263 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABL2 mRNA PMID:27188386 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:78543 ponatinib decreases activity ISO RGD:1352263 E RGD:6480464 20170303 CTD MESH:C545373 ponatinib results in decreased activity of ABL2 protein PMID:19878872 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:8069 phenobarbital affects expression ISO RGD:1352263 E RGD:6480464 20121009 CTD MESH:D010634 Phenobarbital affects the expression of ABL2 mRNA PMID:19159669 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:84070 sodium arsenate decreases expression EXP E RGD:6480464 20170303 CTD MESH:C009277 sodium arsenate results in decreased expression of ABL2 mRNA PMID:21795629 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:84070 sodium arsenate multiple interactions ISO RGD:1352263 E RGD:6480464 20200915 CTD MESH:C009277 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of ABL2 mRNA PMID:32525701 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:1352263 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ABL2 mRNA PMID:27188386 10053 Abl2 ABL proto-oncogene 2, non-receptor tyrosine kinase gene CHEBI:9495 thiram increases expression ISO RGD:1352263 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in increased expression of ABL2 mRNA PMID:38568856 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:136608 Theaflavin 3,3'-digallate affects expression ISO RGD:1346421 E RGD:6480464 20240402 CTD MESH:C585473 theaflavin-3,3'-digallate affects the expression of MALRD1 mRNA PMID:34925699 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:1346421 E RGD:6480464 20200714 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of MALRD1 mRNA PMID:32234424 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:1346421 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of MALRD1 intron PMID:30157460 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:27744 glyphosate affects methylation ISO RGD:2320868 E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate affects the methylation of MALRD1 gene PMID:35440735 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:29678 sodium arsenite decreases expression EXP E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of MALRD1 mRNA PMID:37682722 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:1346421 E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in increased expression of MALRD1 mRNA PMID:29301061 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:1346421 E RGD:6480464 20190219 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of MALRD1 intron PMID:30157460 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2320868 E RGD:6480464 20170613 CTD MESH:C006780 bisphenol A results in decreased expression of MALRD1 mRNA PMID:25181051 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:33216 bisphenol A increases methylation ISO RGD:2320868 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of MALRD1 gene PMID:28505145 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:34567 benzo[e]pyrene decreases methylation ISO RGD:1346421 E RGD:6480464 20190219 CTD MESH:C026487 benzo(e)pyrene results in decreased methylation of MALRD1 intron PMID:30157460 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:34911 permethrin multiple interactions ISO RGD:2320868 E RGD:6480464 20210810 CTD MESH:D026023 [Permethrin co-treated with DEET] results in increased methylation of MALRD1 gene PMID:33148267 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:1346421 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of MALRD1 mRNA PMID:24449571 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:4488 diallyl disulfide multiple interactions ISO RGD:1346421 E RGD:6480464 20230801 CTD MESH:C028009 diallyl disulfide inhibits the reaction [tobacco tar analog results in increased expression of MALRD1 mRNA] PMID:36758788 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:4918 O-methyleugenol decreases expression ISO RGD:1346421 E RGD:6480464 20200714 CTD MESH:C005223 methyleugenol results in decreased expression of MALRD1 mRNA PMID:32234424 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:6402 leflunomide increases expression ISO RGD:1346421 E RGD:6480464 20180410 CTD MESH:C045463 leflunomide results in increased expression of MALRD1 mRNA PMID:28988120 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:6456 lidocaine increases expression ISO RGD:2320868 E RGD:6480464 20220705 CTD MESH:D008012 Lidocaine results in increased expression of MALRD1 mRNA PMID:35283115 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:6820 methapyrilene decreases methylation ISO RGD:1346421 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in decreased methylation of MALRD1 intron PMID:30157460 10053762 Malrd1 MAM and LDL receptor class A domain containing 1 gene CHEBI:7071 N,N-diethyl-m-toluamide multiple interactions ISO RGD:2320868 E RGD:6480464 20210810 CTD MESH:D003671 [Permethrin co-treated with DEET] results in increased methylation of MALRD1 gene PMID:33148267 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:116509 diuron increases expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D004237 Diuron results in increased expression of ACADL mRNA PMID:21551480 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:131843 meldonium increases expression EXP E RGD:6480464 20201103 CTD MESH:C050147 3-(2,2,2-trimethylhydrazine)propionate results in increased expression of ACADL mRNA PMID:32389661 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:132448 perfluorohexanesulfonic acid increases expression EXP E RGD:6480464 20171010 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of ACADL mRNA PMID:28558994 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:132471 (+)-schisandrin B multiple interactions ISO RGD:2011 E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACADL mRNA] PMID:31150632 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20121009 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of ACADL mRNA] PMID:19467301 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20160315 CTD MESH:D002794 [Choline deficiency co-treated with Methionine deficiency] results in increased expression of ACADL mRNA PMID:25178843 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:15443 inulin multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACADL mRNA PMID:36331819 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:15756 hexadecanoic acid multiple interactions ISO RGD:733759 E RGD:6480464 20241203 CTD MESH:D019308 [Glucose co-treated with Palmitic Acid] results in decreased expression of ACADL mRNA PMID:39265716 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:16196 oleic acid multiple interactions ISO RGD:733759 E RGD:6480464 20190312 CTD MESH:D019301 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACADL mRNA; [GW 7647 co-treated with Oleic Acid] results in decreased expression of ACADL mRNA PMID:30611723 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:16236 ethanol affects splicing EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the splicing of ACADL mRNA PMID:30319688 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol results in increased expression of ACADL mRNA PMID:30319688 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20130212 CTD MESH:D000431 [Ethanol co-treated with Zinc] results in increased expression of ACADL mRNA PMID:19637192 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:16330 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:733759 E RGD:6480464 20190910 CTD MESH:D013196 Dihydrotestosterone results in increased expression of ACADL mRNA PMID:29581250 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:164200 triclosan decreases expression ISO RGD:733759 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in decreased expression of ACADL mRNA PMID:30510588 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:16469 17beta-estradiol decreases expression EXP E RGD:6480464 20130723 CTD MESH:D004958 Estradiol results in decreased expression of ACADL mRNA PMID:19484750 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D004958 [Estradiol co-treated with Testosterone] results in increased expression of ACADL mRNA PMID:11375906 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:16494 lipoic acid multiple interactions ISO RGD:2011 E RGD:6480464 20140610 CTD MESH:D008063 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of ACADL mRNA] PMID:22464149 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20140408 CTD MESH:D014241 Trichloroethylene results in increased expression of ACADL mRNA PMID:23575800|PMID:28973375 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:16643 L-methionine multiple interactions EXP E RGD:6480464 20160315 CTD MESH:D008715 [Choline deficiency co-treated with Methionine deficiency] results in increased expression of ACADL mRNA PMID:25178843 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:17026 progesterone increases expression ISO RGD:2011 E RGD:6480464 20130723 CTD MESH:D011374 Progesterone results in increased expression of ACADL mRNA PMID:20726854 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:17234 glucose multiple interactions ISO RGD:733759 E RGD:6480464 20241203 CTD MESH:D005947 [Glucose co-treated with Palmitic Acid] results in decreased expression of ACADL mRNA PMID:39265716 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:17296 aniline increases nitrosation ISO RGD:2011 E RGD:6480464 20120918 CTD MESH:C023650 aniline results in increased nitrosation of ACADL protein PMID:21708182 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:17300 tetrachloroethene increases expression EXP E RGD:6480464 20180116 CTD MESH:D013750 Tetrachloroethylene results in increased expression of ACADL mRNA PMID:28973375 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:17347 testosterone multiple interactions ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D013739 [Estradiol co-treated with Testosterone] results in increased expression of ACADL mRNA PMID:11375906 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:17634 D-glucose multiple interactions ISO RGD:733759 E RGD:6480464 20241203 CTD MESH:D005947 [Glucose co-treated with Palmitic Acid] results in decreased expression of ACADL mRNA PMID:39265716 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression EXP E RGD:6480464 20240402 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of ACADL mRNA PMID:35550907 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression EXP E RGD:6480464 20120412 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of ACADL mRNA PMID:19850644 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:2011 E RGD:6480464 20130312 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of ACADL mRNA PMID:22672789 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004051 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACADL mRNA] PMID:19850644 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACADL mRNA PMID:36331819 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:22977 cadmium atom increases oxidation EXP E RGD:6480464 20140513 CTD MESH:D002104 Cadmium results in increased oxidation of ACADL protein PMID:24496640 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:23995 N-ethyl-N-nitrosourea increases expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D005038 Ethylnitrosourea results in increased expression of ACADL mRNA PMID:15954086 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:733759 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of ACADL gene PMID:27153756 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:2663 amiodarone affects expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D000638 Amiodarone affects the expression of ACADL mRNA PMID:19483382 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27086 tributylstannane increases expression EXP E RGD:6480464 20140715 CTD MESH:C011559 tributyltin results in increased expression of ACADL mRNA PMID:23428407 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27363 zinc atom multiple interactions EXP E RGD:6480464 20130212 CTD MESH:D015032 [Ethanol co-treated with Zinc] results in increased expression of ACADL mRNA PMID:19637192 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27363 zinc atom multiple interactions ISO RGD:733759 E RGD:6480464 20130212 CTD MESH:D015032 Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of ACADL protein] PMID:19637192 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:2011 E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACADL mRNA PMID:31150632 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27385 tetrachloromethane multiple interactions EXP E RGD:6480464 20240206 CTD MESH:D002251 [Dietary Fats co-treated with Carbon Tetrachloride] results in increased expression of ACADL mRNA; alisol B inhibits the reaction [[Dietary Fats co-treated with Carbon Tetrachloride] results in increased expression of ACADL mRNA] PMID:35745142 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27385 tetrachloromethane multiple interactions ISO RGD:2011 E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACADL mRNA] PMID:31150632 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27470 folic acid decreases expression EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of ACADL mRNA PMID:25629700 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACADL mRNA PMID:22206623 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27684 phenylmercury acetate increases expression ISO RGD:733759 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in increased expression of ACADL mRNA PMID:26272509 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:733759 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACADL mRNA PMID:27188386 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of ACADL protein PMID:37208198 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27856 acetamide decreases expression ISO RGD:2011 E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in decreased expression of ACADL mRNA PMID:31881176 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20160822 CTD MESH:C059514 resveratrol results in increased expression of ACADL protein PMID:25505154 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27881 resveratrol multiple interactions ISO RGD:2011 E RGD:6480464 20240402 CTD MESH:C059514 Resveratrol inhibits the reaction [Dietary Fats results in decreased expression of ACADL mRNA] PMID:36989710 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27889 lead(0) decreases expression ISO RGD:733759 E RGD:6480464 20120412 CTD MESH:D007854 Lead results in decreased expression of ACADL mRNA PMID:19921347 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27902 tetracycline decreases expression EXP E RGD:6480464 20120412 CTD MESH:D013752 Tetracycline results in decreased expression of ACADL mRNA PMID:19427351 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:27902 tetracycline multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013752 bicyclol inhibits the reaction [Tetracycline results in decreased expression of ACADL mRNA] PMID:19427351 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28112 nickel atom decreases expression ISO RGD:733759 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in decreased expression of ACADL mRNA PMID:24768652|PMID:25583101 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2011 E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ACADL mRNA PMID:34747641 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACADL mRNA PMID:11752688 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733759 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACADL mRNA PMID:20106945 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733759 E RGD:6480464 20120613 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACADL mRNA PMID:21296121 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120515 CTD MESH:D013749 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ACADL promoter] PMID:19654925 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28201 rotenone increases expression ISO RGD:2011 E RGD:6480464 20221101 CTD MESH:D012402 Rotenone results in increased expression of ACADL protein PMID:35544339 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28428 beta-hexachlorocyclohexane decreases expression EXP E RGD:6480464 20171010 CTD MESH:C023888 beta-hexachlorocyclohexane results in decreased expression of ACADL mRNA; beta-hexachlorocyclohexane results in decreased expression of ACADL protein PMID:28397872 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28694 copper atom multiple interactions ISO RGD:2011 E RGD:6480464 20151013 CTD MESH:D003300 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADL mRNA PMID:25813056 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28741 sodium fluoride decreases expression EXP E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in decreased expression of ACADL protein PMID:28918527 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28748 doxorubicin decreases expression EXP E RGD:6480464 20120412 CTD MESH:D004317 Doxorubicin results in decreased expression of ACADL mRNA; Doxorubicin results in decreased expression of ACADL protein PMID:16144979|PMID:26873546|PMID:38395252 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28748 doxorubicin decreases expression ISO RGD:2011 E RGD:6480464 20240806 CTD MESH:D004317 Doxorubicin results in decreased expression of ACADL mRNA PMID:38395252 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28748 doxorubicin increases expression EXP E RGD:6480464 20151013 CTD MESH:D004317 Doxorubicin results in increased expression of ACADL mRNA; Doxorubicin results in increased expression of ACADL protein PMID:21251210|PMID:31768571 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28748 doxorubicin multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004317 [Doxorubicin co-treated with MT2A protein] results in decreased expression of ACADL protein; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADL mRNA]; sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of ACADL protein] PMID:16144979|PMID:21251210|PMID:38395252 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28748 doxorubicin multiple interactions ISO RGD:2011 E RGD:6480464 20240806 CTD MESH:D004317 SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADL mRNA] PMID:38395252 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:28757 fructose multiple interactions ISO RGD:2011 E RGD:6480464 20151013 CTD MESH:D005632 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADL mRNA PMID:25813056 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:733759 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ACADL promoter PMID:27901495 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ACADL mRNA PMID:22228805 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20120918 CTD MESH:D001564 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ACADL mRNA] PMID:22228805 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:29866 arsenite(3-) decreases expression EXP E RGD:6480464 20210504 CTD MESH:C015001 arsenite results in decreased expression of ACADL mRNA PMID:33053406 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:30052 copper(0) multiple interactions ISO RGD:2011 E RGD:6480464 20151013 CTD MESH:D003300 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADL mRNA PMID:25813056 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:30185 zinc(0) multiple interactions EXP E RGD:6480464 20130212 CTD MESH:D015032 [Ethanol co-treated with Zinc] results in increased expression of ACADL mRNA PMID:19637192 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:30185 zinc(0) multiple interactions ISO RGD:733759 E RGD:6480464 20130212 CTD MESH:D015032 Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of ACADL protein] PMID:19637192 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:3023 benzbromarone affects expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D001553 Benzbromarone affects the expression of ACADL mRNA PMID:19483382 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:30314 (R)-lipoic acid multiple interactions ISO RGD:2011 E RGD:6480464 20140610 CTD MESH:D008063 Thioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of ACADL mRNA] PMID:22464149 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:30621 diarsenic trioxide increases expression EXP E RGD:6480464 20240402 CTD MESH:C006632 Arsenic Trioxide results in increased expression of ACADL mRNA PMID:35676786 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:30956 trichloroacetic acid increases expression EXP E RGD:6480464 20140408 CTD MESH:D014238 Trichloroacetic Acid results in increased expression of ACADL mRNA PMID:23575800 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ACADL mRNA PMID:16483693 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:31236 aripiprazole decreases expression ISO RGD:2011 E RGD:6480464 20170228 CTD MESH:C094645 Aripiprazole results in decreased expression of ACADL mRNA PMID:17868501 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:32195 Tesaglitazar increases expression ISO RGD:2011 E RGD:6480464 20170303 CTD MESH:C501413 tesaglitazar results in increased expression of ACADL mRNA PMID:21515302 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:32234 titanium dioxide decreases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ACADL gene PMID:35295148 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:32497 thioacetamide affects expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D013853 Thioacetamide affects the expression of ACADL mRNA PMID:19483382 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:32497 thioacetamide decreases expression ISO RGD:2011 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of ACADL mRNA PMID:34492290 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:32509 pirinixic acid affects expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid affects the expression of ACADL mRNA PMID:19483382 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:32509 pirinixic acid increases expression EXP E RGD:6480464 20150127 CTD MESH:C006253 pirinixic acid results in increased expression of ACADL mRNA PMID:15375163|PMID:16282640|PMID:16357043|PMID:17426115|PMID:17950772|PMID:18301758|PMID:18467677|PMID:20059764|PMID:20813756|PMID:20936131|PMID:23811191|PMID:25270620 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:32509 pirinixic acid increases expression ISO RGD:2011 E RGD:6480464 20121113 CTD MESH:C006253 pirinixic acid results in increased expression of ACADL mRNA PMID:19162173|PMID:22484513|PMID:33983380 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:32509 pirinixic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACADL mRNA; [pirinixic acid co-treated with PPARA] results in increased expression of ACADL mRNA; PPARA protein promotes the reaction [pirinixic acid results in increased expression of ACADL mRNA] PMID:17950772|PMID:18467677|PMID:19710929|PMID:20059764|PMID:20813756 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of ACADL mRNA PMID:33221593 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2011 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of ACADL mRNA PMID:34947998 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:33216 bisphenol A decreases expression ISO RGD:733759 E RGD:6480464 20210608 CTD MESH:C006780 bisphenol A analog results in decreased expression of ACADL mRNA; bisphenol A results in decreased expression of ACADL mRNA PMID:32763284 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:33216 bisphenol A increases expression ISO RGD:2011 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of ACADL mRNA PMID:25181051 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:34575 bisphenol F increases expression ISO RGD:733759 E RGD:6480464 20210608 CTD MESH:C008745 4,4'-bisphenol F results in increased expression of ACADL mRNA PMID:32763284 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in decreased expression of ACADL mRNA PMID:37019170 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:34678 Di-n-hexyl phthalate decreases expression ISO RGD:733759 E RGD:6480464 20210309 CTD MESH:C027387 di-n-hexyl phthalate results in decreased expression of ACADL mRNA PMID:33043605 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:34687 dibutyl phthalate increases expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of ACADL mRNA PMID:21266533 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:34873 N-nitrosodiethylamine decreases expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D004052 Diethylnitrosamine results in decreased expression of ACADL mRNA PMID:11323195 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:34905 paraquat affects expression ISO RGD:2011 E RGD:6480464 20130514 CTD MESH:D010269 Paraquat affects the expression of ACADL mRNA PMID:18198484 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:35549 perfluorooctanoic acid affects expression EXP E RGD:6480464 20120613 CTD MESH:C023036 perfluorooctanoic acid affects the expression of ACADL mRNA PMID:18281256|PMID:19429403 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:35549 perfluorooctanoic acid increases expression EXP E RGD:6480464 20140311 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACADL mRNA PMID:17681415|PMID:18467677|PMID:20936131|PMID:23626681|PMID:28558994|PMID:30711707 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACADL mRNA PMID:19162173 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:35549 perfluorooctanoic acid multiple interactions EXP E RGD:6480464 20140311 CTD MESH:C023036 [perfluorooctanoic acid co-treated with Dietary Fats, Unsaturated] results in increased expression of ACADL mRNA PMID:23626681 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:35559 furan affects binding ISO RGD:2011 E RGD:6480464 20120918 CTD MESH:C039281 furan binds to ACADL protein PMID:22240984 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:36386 dichloroacetic acid increases expression EXP E RGD:6480464 20140408 CTD MESH:D003999 Dichloroacetic Acid results in increased expression of ACADL mRNA PMID:23575800|PMID:28962523 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:3750 clofibrate affects expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D002994 Clofibrate affects the expression of ACADL mRNA PMID:19483382 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20150127 CTD MESH:D002994 Clofibrate results in increased expression of ACADL mRNA PMID:17585979|PMID:23811191|PMID:25270620 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:3750 clofibrate increases expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D002994 Clofibrate results in increased expression of ACADL mRNA; Clofibrate results in increased expression of ACADL protein PMID:12851107|PMID:16470657|PMID:18670166|PMID:33983380|PMID:9815135 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:3750 clofibrate multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D002994 [Clofibrate co-treated with Acetaminophen] affects the expression of ACADL mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACADL mRNA] PMID:17585979 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:38397 perfluorononanoic acid increases expression EXP E RGD:6480464 20220111 CTD MESH:C101816 perfluoro-n-nonanoic acid results in increased expression of ACADL mRNA PMID:28558994 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:38940 sunitinib decreases expression ISO RGD:733759 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of ACADL mRNA PMID:31533062 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression EXP E RGD:6480464 20130416 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of ACADL mRNA PMID:19429403|PMID:20936131|PMID:28558994 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of ACADL mRNA PMID:18692542 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACADL mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACADL mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ACADL mRNA PMID:36331819 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:39483 sodium dichromate increases expression ISO RGD:2011 E RGD:6480464 20130723 CTD MESH:C016104 sodium bichromate results in increased expression of ACADL mRNA PMID:12325037 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:39867 valproic acid decreases expression ISO RGD:733759 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased expression of ACADL mRNA; Valproic Acid results in decreased expression of ACADL protein PMID:29154799|PMID:29501571 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:40036 amitrole increases expression ISO RGD:2011 E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in increased expression of ACADL mRNA PMID:30047161 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:4031 cyclosporin A decreases expression EXP E RGD:6480464 20140408 CTD MESH:D016572 Cyclosporine results in decreased expression of ACADL mRNA PMID:23830897 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D016572 Cyclosporine results in decreased expression of ACADL mRNA PMID:19224547 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:733759 E RGD:6480464 20140408 CTD MESH:D016572 Cyclosporine results in decreased expression of ACADL mRNA PMID:20106945|PMID:23830897|PMID:27989131 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:41879 dexamethasone decreases expression EXP E RGD:6480464 20210504 CTD MESH:D003907 Dexamethasone results in decreased expression of ACADL protein PMID:33567340 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:41922 diethylstilbestrol increases expression ISO RGD:2011 E RGD:6480464 20230606 CTD MESH:D004054 Diethylstilbestrol results in increased expression of ACADL mRNA PMID:37077353 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:42758 aldehydo-D-glucose multiple interactions ISO RGD:733759 E RGD:6480464 20241203 CTD MESH:D005947 [Glucose co-treated with Palmitic Acid] results in decreased expression of ACADL mRNA PMID:39265716 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:45863 paclitaxel decreases expression ISO RGD:733759 E RGD:6480464 20161213 CTD MESH:D017239 Paclitaxel results in decreased expression of ACADL protein PMID:15907983 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:46195 paracetamol affects expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of ACADL protein PMID:16687475 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:46195 paracetamol decreases expression ISO RGD:733759 E RGD:6480464 20180515 CTD MESH:D000082 Acetaminophen results in decreased expression of ACADL mRNA PMID:29067470 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:46195 paracetamol increases expression EXP E RGD:6480464 20120717 CTD MESH:D000082 Acetaminophen results in increased expression of ACADL protein PMID:21329376 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:46195 paracetamol multiple interactions EXP E RGD:6480464 20120515 CTD MESH:D000082 [Clofibrate co-treated with Acetaminophen] affects the expression of ACADL mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACADL mRNA] PMID:17585979 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:46345 5-fluorouracil increases expression ISO RGD:733759 E RGD:6480464 20120814 CTD MESH:D005472 Fluorouracil results in increased expression of ACADL protein PMID:15585135|PMID:16803524 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:46557 zoledronic acid decreases expression EXP E RGD:6480464 20180116 CTD MESH:C088658 zoledronic acid results in decreased expression of ACADL mRNA PMID:28871336 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:47519 ketoconazole increases expression ISO RGD:2011 E RGD:6480464 20230606 CTD MESH:D007654 Ketoconazole results in increased expression of ACADL mRNA PMID:37077353 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:47612 bezafibrate increases expression EXP E RGD:6480464 20120613 CTD MESH:D001629 Bezafibrate results in increased expression of ACADL mRNA; Bezafibrate results in increased expression of ACADL protein PMID:12782154 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:47612 bezafibrate multiple interactions EXP E RGD:6480464 20120613 CTD MESH:D001629 PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADL mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADL protein] PMID:12782154 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20190312 CTD MESH:C016766 sulforaphane results in increased expression of ACADL mRNA PMID:30529165 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:4886 L-ethionine affects expression ISO RGD:2011 E RGD:6480464 20121106 CTD MESH:D005001 Ethionine affects the expression of ACADL mRNA PMID:19483382 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ACADL mRNA PMID:17942748 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:49662 indometacin decreases expression ISO RGD:2011 E RGD:6480464 20230704 CTD MESH:D007213 Indomethacin results in decreased expression of ACADL mRNA PMID:36868495 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:49900 arsenous acid increases expression EXP E RGD:6480464 20240402 CTD MESH:C032793 Arsenic Trioxide results in increased expression of ACADL mRNA PMID:35676786 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:5001 fenofibrate increases expression EXP E RGD:6480464 20121113 CTD MESH:D011345 Fenofibrate results in increased expression of ACADL mRNA PMID:17690133 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:50594 carbon nanotube increases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of ACADL mRNA; Nanotubes, Carbon results in increased expression of ACADL mRNA PMID:25620056 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:50673 methimazole increases expression ISO RGD:2011 E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in increased expression of ACADL mRNA PMID:30047161 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:5132 flutamide decreases expression EXP E RGD:6480464 20120412 CTD MESH:D005485 Flutamide results in decreased expression of ACADL mRNA PMID:17702527 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:5132 flutamide increases expression ISO RGD:2011 E RGD:6480464 20121113 CTD MESH:D005485 Flutamide results in increased expression of ACADL protein PMID:17311803 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:6078 ivermectin decreases expression ISO RGD:733759 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ACADL protein PMID:32959892 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:61057 tacrolimus hydrate decreases expression EXP E RGD:6480464 20150127 CTD MESH:D016559 Tacrolimus results in decreased expression of ACADL mRNA PMID:25270620 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:63005 sodium nitrate multiple interactions EXP E RGD:6480464 20151013 CTD MESH:C031618 sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of ACADL protein] PMID:21251210 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:63933 Aroclor 1254 decreases expression EXP E RGD:6480464 20150127 CTD MESH:D020111 Chlorodiphenyl (54% Chlorine) results in decreased expression of ACADL mRNA PMID:25270620 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D012970 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACADL mRNA PMID:19001666 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:64317 isoprenaline decreases expression ISO RGD:2011 E RGD:6480464 20160412 CTD MESH:D007545 Isoproterenol results in decreased expression of ACADL mRNA PMID:25045214 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:64317 isoprenaline multiple interactions ISO RGD:2011 E RGD:6480464 20160412 CTD MESH:D007545 [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADL mRNA; Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADL mRNA]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADL mRNA]] PMID:25045214|PMID:30303030 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:6820 methapyrilene decreases expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D008701 Methapyrilene results in decreased expression of ACADL mRNA PMID:16393664 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:6925 microcystin-LR decreases expression EXP E RGD:6480464 20171010 CTD MESH:C057862 cyanoginosin LR results in decreased expression of ACADL protein PMID:26984711 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:70778 GW 7647 multiple interactions ISO RGD:733759 E RGD:6480464 20190312 CTD MESH:C453899 [GW 7647 co-treated with Oleic Acid] results in decreased expression of ACADL mRNA PMID:30611723 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:73755 1,2-dimethylhydrazine decreases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ACADL mRNA PMID:22206623 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACADL mRNA PMID:22206623 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:7590 nitrofen increases expression ISO RGD:2011 E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in increased expression of ACADL mRNA PMID:33484710 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:76326 N-nitrosomorpholine decreases expression ISO RGD:2011 E RGD:6480464 20140107 CTD MESH:C002741 N-nitrosomorpholine results in decreased expression of ACADL protein PMID:19716841 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:77260 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO RGD:2011 E RGD:6480464 20140805 CTD MESH:D009853 Omeprazole affects the expression of ACADL mRNA PMID:19483382 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:7772 omeprazole affects expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D009853 Omeprazole affects the expression of ACADL mRNA PMID:19483382 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:733759 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACADL mRNA PMID:27188386 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:79997 GW 4064 decreases expression ISO RGD:733759 E RGD:6480464 20190312 CTD MESH:C412815 GW 4064 results in decreased expression of ACADL mRNA PMID:30611723 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:79997 GW 4064 multiple interactions ISO RGD:733759 E RGD:6480464 20190312 CTD MESH:C412815 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACADL mRNA PMID:30611723 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:8069 phenobarbital affects expression ISO RGD:733759 E RGD:6480464 20121009 CTD MESH:D010634 Phenobarbital affects the expression of ACADL mRNA PMID:19159669 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:81104 Alisol B multiple interactions EXP E RGD:6480464 20240206 CTD MESH:C457232 alisol B inhibits the reaction [[Dietary Fats co-treated with Carbon Tetrachloride] results in increased expression of ACADL mRNA] PMID:35745142 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:8113 phlorizin decreases expression EXP E RGD:6480464 20121009 CTD MESH:D010695 Phlorhizin results in decreased expression of ACADL mRNA PMID:22538082 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:83258 fenamidone increases expression EXP E RGD:6480464 20180116 CTD MESH:C540355 fenamidone results in increased expression of ACADL mRNA PMID:27029645 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:8502 6-propyl-2-thiouracil affects expression ISO RGD:2011 E RGD:6480464 20120412 CTD MESH:D011441 Propylthiouracil affects the expression of ACADL mRNA PMID:19483382 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2011 E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in increased expression of ACADL mRNA PMID:30047161 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:733759 E RGD:6480464 20151103 CTD MESH:C044387 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of ACADL protein PMID:19637192 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:88217 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO RGD:733759 E RGD:6480464 20151103 CTD MESH:C044387 Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine results in decreased expression of ACADL protein] PMID:19637192 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20231205 CTD MESH:C028577 monobutyl phthalate results in increased expression of ACADL mRNA PMID:36736749 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:733759 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACADL mRNA PMID:27188386 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:9168 sirolimus multiple interactions ISO RGD:2011 E RGD:6480464 20160412 CTD MESH:D020123 Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADL mRNA]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADL mRNA]] PMID:25045214 10056 Acadl acyl-Coenzyme A dehydrogenase, long-chain gene CHEBI:9753 troglitazone increases expression ISO RGD:2011 E RGD:6480464 20120918 CTD MESH:C057693 troglitazone results in increased expression of ACADL protein PMID:21315101 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:735259 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of ACADM mRNA PMID:38218311 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:10429 beta-lapachone increases expression ISO RGD:735259 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in increased expression of ACADM mRNA PMID:38218311 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:131843 meldonium decreases expression EXP E RGD:6480464 20201103 CTD MESH:C050147 3-(2,2,2-trimethylhydrazine)propionate results in decreased expression of ACADM mRNA PMID:32389661 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:132267 triptonide decreases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in decreased expression of ACADM mRNA PMID:33045310 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:132471 (+)-schisandrin B multiple interactions ISO RGD:2012 E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACADM mRNA] PMID:31150632 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:136608 Theaflavin 3,3'-digallate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C585473 theaflavin-3,3'-digallate inhibits the reaction [LEP gene mutant form affects the expression of ACADM mRNA] PMID:36105184 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20121009 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of ACADM mRNA] PMID:19467301 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20160315 CTD MESH:D002794 [Choline deficiency co-treated with Methionine deficiency] results in increased expression of ACADM mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ACADM mRNA PMID:22872676|PMID:25178843 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:15365 acetylsalicylic acid increases expression ISO RGD:735259 E RGD:6480464 20150714 CTD MESH:D001241 Aspirin results in increased expression of ACADM mRNA; Aspirin results in increased expression of ACADM protein PMID:25743752 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:735259 E RGD:6480464 20160607 CTD MESH:D014212 Tretinoin results in increased expression of ACADM mRNA PMID:23830798 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:15379 dioxygen decreases expression ISO RGD:2012 E RGD:6480464 20150825 CTD MESH:D010100 Oxygen deficiency results in decreased expression of ACADM mRNA PMID:25937560 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20190312 CTD MESH:D010100 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACADM mRNA PMID:30529165 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:15379 dioxygen multiple interactions ISO RGD:2012 E RGD:6480464 20150825 CTD MESH:D010100 Trimetazidine promotes the reaction [Oxygen deficiency results in decreased expression of ACADM mRNA] PMID:25937560 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:15443 inulin multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACADM mRNA PMID:36331819 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:15756 hexadecanoic acid multiple interactions ISO RGD:2012 E RGD:6480464 20170110 CTD MESH:D019308 [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA]; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA] PMID:26190035 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:15930 atrazine multiple interactions EXP E RGD:6480464 20140513 CTD MESH:D001280 Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of ACADM mRNA] PMID:24440342 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16113 cholesterol multiple interactions EXP E RGD:6480464 20140513 CTD MESH:D002784 [lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of ACADM mRNA; Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of ACADM mRNA] PMID:24440342 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16118 berberine multiple interactions EXP E RGD:6480464 20150512 CTD MESH:D001599 Berberine inhibits the reaction [Ethanol results in decreased expression of ACADM mRNA] PMID:25455889 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16171 NMN zwitterion multiple interactions EXP E RGD:6480464 20150414 CTD MESH:D009537 Nicotinamide Mononucleotide inhibits the reaction [MIR34A mRNA results in decreased expression of ACADM mRNA] PMID:23834033 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16196 oleic acid multiple interactions ISO RGD:2012 E RGD:6480464 20170110 CTD MESH:D019301 [Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA; Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA]; quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA] PMID:26190035 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16196 oleic acid multiple interactions ISO RGD:735259 E RGD:6480464 20190312 CTD MESH:D019301 [Farnesol analog co-treated with Oleic Acid] results in increased expression of ACADM mRNA; [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACADM mRNA PMID:30611723 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16236 ethanol affects splicing EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the splicing of ACADM mRNA PMID:30319688 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16236 ethanol decreases expression EXP E RGD:6480464 20140513 CTD MESH:D000431 Ethanol results in decreased expression of ACADM mRNA; Ethanol results in decreased expression of ACADM protein PMID:20637825|PMID:24146112|PMID:25455889|PMID:28935932 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16236 ethanol decreases expression ISO RGD:2012 E RGD:6480464 20140513 CTD MESH:D000431 Ethanol results in decreased expression of ACADM protein PMID:24146112 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20120412 CTD MESH:D000431 Ethanol results in increased expression of ACADM mRNA PMID:18620774 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20120613 CTD MESH:D000431 [Ethanol co-treated with Diethylhexyl Phthalate] results in increased expression of ACADM mRNA; Berberine inhibits the reaction [Ethanol results in decreased expression of ACADM mRNA]; Cannabidiol inhibits the reaction [Ethanol results in decreased expression of ACADM mRNA]; dioscin inhibits the reaction [Ethanol results in decreased expression of ACADM protein]; tectoridin inhibits the reaction [Ethanol results in decreased expression of ACADM mRNA] PMID:20637825|PMID:24146112|PMID:25455889|PMID:28935932|PMID:32325186 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16236 ethanol multiple interactions ISO RGD:2012 E RGD:6480464 20140513 CTD MESH:D000431 dioscin inhibits the reaction [Ethanol results in decreased expression of ACADM protein] PMID:24146112 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16412 lipopolysaccharide decreases expression EXP E RGD:6480464 20161228 CTD MESH:D008070 Lipopolysaccharides results in decreased expression of ACADM mRNA PMID:18940942 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16469 17beta-estradiol decreases expression EXP E RGD:6480464 20130723 CTD MESH:D004958 Estradiol results in decreased expression of ACADM mRNA PMID:14664709|PMID:19484750 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:2012 E RGD:6480464 20160705 CTD MESH:D004958 [bisphenol A co-treated with Estradiol] results in decreased expression of ACADM mRNA PMID:26496021 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16598 DDE decreases expression ISO RGD:735259 E RGD:6480464 20171010 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene results in decreased expression of ACADM protein PMID:28397872 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20140408 CTD MESH:D014241 Trichloroethylene results in increased expression of ACADM mRNA PMID:23575800 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16643 L-methionine multiple interactions EXP E RGD:6480464 20160315 CTD MESH:D008715 [Choline deficiency co-treated with Methionine deficiency] results in increased expression of ACADM mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ACADM mRNA PMID:22872676|PMID:25178843 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:735259 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of ACADM mRNA PMID:37042841 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20221206 CTD MESH:D008550 Melatonin inhibits the reaction [Cisplatin results in decreased expression of ACADM mRNA] PMID:35367536 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:16796 melatonin multiple interactions ISO RGD:2012 E RGD:6480464 20230704 CTD MESH:D008550 Melatonin inhibits the reaction [Cisplatin results in decreased expression of ACADM mRNA] PMID:36006825 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:168138 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO RGD:735259 E RGD:6480464 20210504 CTD MESH:C507616 2-amino-14,16-dimethyloctadecan-3-ol results in decreased expression of ACADM protein PMID:32044396 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17059 2-methylcholine affects expression ISO RGD:735259 E RGD:6480464 20121113 CTD MESH:C044887 beta-methylcholine affects the expression of ACADM mRNA PMID:21179406 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17230 homocysteine increases expression EXP E RGD:6480464 20170303 CTD MESH:D006710 Homocysteine results in increased expression of ACADM mRNA; Homocysteine results in increased expression of ACADM protein PMID:26993217 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17243 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:735259 E RGD:6480464 20240702 CTD MESH:C016599 mono-(2-ethylhexyl)phthalate results in decreased expression of ACADM mRNA PMID:38685446 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17243 mono(2-ethylhexyl) phthalate increases expression EXP E RGD:6480464 20200915 CTD MESH:C016599 mono-(2-ethylhexyl)phthalate results in increased expression of ACADM mRNA PMID:32522588 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17300 tetrachloroethene increases expression EXP E RGD:6480464 20180116 CTD MESH:D013750 Tetrachloroethylene results in increased expression of ACADM mRNA PMID:28973375 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17347 testosterone decreases expression EXP E RGD:6480464 20120412 CTD MESH:D013739 Testosterone deficiency results in decreased expression of ACADM mRNA PMID:21045173 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17347 testosterone multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013739 Testosterone inhibits the reaction [Testosterone deficiency results in decreased expression of ACADM mRNA] PMID:21045173 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17351 linoleic acid increases expression ISO RGD:2012 E RGD:6480464 20170303 CTD MESH:D019787 Linoleic Acid results in increased expression of ACADM mRNA PMID:23056435 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:174690 clenbuterol increases expression EXP E RGD:6480464 20120412 CTD MESH:D002976 Clenbuterol results in increased expression of ACADM mRNA PMID:17446185 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression EXP E RGD:6480464 20130122 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of ACADM mRNA PMID:19245819|PMID:19850644|PMID:20123618|PMID:32325186 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:735259 E RGD:6480464 20120613 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of ACADM mRNA PMID:21354252 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004051 [Ethanol co-treated with Diethylhexyl Phthalate] results in increased expression of ACADM mRNA; [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of ACADM mRNA; PPARA gene mutant form inhibits the reaction [Diethylhexyl Phthalate results in increased expression of ACADM mRNA]; PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACADM mRNA] PMID:19850644|PMID:20123618|PMID:28433925|PMID:32325186 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17823 calcitriol increases expression ISO RGD:735259 E RGD:6480464 20120412 CTD MESH:D002117 Calcitriol results in increased expression of ACADM mRNA PMID:16002434 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17833 gentamycin decreases expression ISO RGD:2012 E RGD:6480464 20161228 CTD MESH:D005839 Gentamicins results in decreased expression of ACADM mRNA PMID:22061828|PMID:33387578 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17833 gentamycin increases expression ISO RGD:2012 E RGD:6480464 20161228 CTD MESH:D005839 Gentamicins results in increased expression of ACADM mRNA PMID:22061828 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:17992 sucrose multiple interactions EXP E RGD:6480464 20140513 CTD MESH:D013395 [lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of ACADM mRNA; Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of ACADM mRNA] PMID:24440342 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACADM mRNA PMID:36331819 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:18406 AICA ribonucleotide increases expression ISO RGD:735259 E RGD:6480464 20150714 CTD MESH:C031143 AICA ribonucleotide results in increased expression of ACADM mRNA; AICA ribonucleotide results in increased expression of ACADM protein PMID:25743752 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:18406 AICA ribonucleotide multiple interactions ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:C031143 AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of ACADM mRNA] PMID:19699196 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:18721 3-chloropropane-1,2-diol affects expression ISO RGD:2012 E RGD:6480464 20170516 CTD MESH:D000517 alpha-Chlorohydrin affects the expression of ACADM protein PMID:26597043 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:18721 3-chloropropane-1,2-diol decreases expression ISO RGD:2012 E RGD:6480464 20170516 CTD MESH:D000517 alpha-Chlorohydrin analog results in decreased expression of ACADM protein PMID:26597043 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:18721 3-chloropropane-1,2-diol increases expression ISO RGD:2012 E RGD:6480464 20171010 CTD MESH:D000517 alpha-Chlorohydrin results in increased expression of ACADM mRNA PMID:28522335 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:188851 Muraglitazar increases expression ISO RGD:2012 E RGD:6480464 20220104 CTD MESH:C500085 muraglitazar results in increased expression of ACADM mRNA PMID:21515302 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:22977 cadmium atom increases oxidation EXP E RGD:6480464 20140513 CTD MESH:D002104 Cadmium results in increased oxidation of ACADM protein PMID:24496640 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:735259 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of ACADM mRNA PMID:19549813 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:735259 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of ACADM mRNA PMID:27153756 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:25434 bis(2-chloroethyl) sulfide increases expression EXP E RGD:6480464 20120412 CTD MESH:D009151 Mustard Gas results in increased expression of ACADM mRNA PMID:15674844 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:25812 ozone multiple interactions ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D010126 [Ozone co-treated with Chlorine] results in increased expression of ACADM mRNA PMID:18636392 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:2663 amiodarone increases expression EXP E RGD:6480464 20150127 CTD MESH:D000638 Amiodarone results in increased expression of ACADM mRNA PMID:24489787 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27086 tributylstannane increases expression EXP E RGD:6480464 20141014 CTD MESH:C011559 tributyltin results in increased expression of ACADM mRNA PMID:23428407|PMID:24848799 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27385 tetrachloromethane affects expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D002251 Carbon Tetrachloride affects the expression of ACADM mRNA PMID:15963342|PMID:16239168 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACADM mRNA PMID:17522070|PMID:31150632 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27385 tetrachloromethane increases expression EXP E RGD:6480464 20200804 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of ACADM mRNA PMID:31919559 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27385 tetrachloromethane multiple interactions ISO RGD:2012 E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACADM mRNA] PMID:31150632 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27470 folic acid decreases expression EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of ACADM mRNA PMID:25629700 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20140408 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACADM mRNA; [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ACADM mRNA PMID:22206623|PMID:22872676 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27789 1,2-dichloroethane increases expression EXP E RGD:6480464 20200310 CTD MESH:C024565 ethylene dichloride results in increased expression of ACADM mRNA PMID:28960355 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20130212 CTD MESH:C059514 resveratrol results in increased expression of ACADM mRNA PMID:18755807|PMID:19934007 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27881 resveratrol increases expression ISO RGD:735259 E RGD:6480464 20160822 CTD MESH:C059514 resveratrol results in increased expression of ACADM mRNA PMID:26443543 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27881 resveratrol multiple interactions EXP E RGD:6480464 20130212 CTD MESH:C059514 [resveratrol co-treated with Dietary Fats] results in increased expression of ACADM mRNA; SIRT1 protein promotes the reaction [resveratrol results in increased expression of ACADM mRNA] PMID:19934007|PMID:26423427 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27881 resveratrol multiple interactions ISO RGD:735259 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in increased expression of ACADM mRNA PMID:23557933 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27889 lead(0) affects expression ISO RGD:735259 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the expression of ACADM mRNA PMID:28903495 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27899 cisplatin decreases expression EXP E RGD:6480464 20221206 CTD MESH:D002945 Cisplatin results in decreased expression of ACADM mRNA PMID:35367536 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27899 cisplatin decreases expression ISO RGD:2012 E RGD:6480464 20230704 CTD MESH:D002945 Cisplatin results in decreased expression of ACADM mRNA PMID:36006825 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27899 cisplatin increases expression ISO RGD:735259 E RGD:6480464 20180220 CTD MESH:D002945 Cisplatin results in increased expression of ACADM mRNA PMID:27594783 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20221206 CTD MESH:D002945 Melatonin inhibits the reaction [Cisplatin results in decreased expression of ACADM mRNA] PMID:35367536 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27899 cisplatin multiple interactions ISO RGD:2012 E RGD:6480464 20230704 CTD MESH:D002945 Melatonin inhibits the reaction [Cisplatin results in decreased expression of ACADM mRNA] PMID:36006825 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27902 tetracycline decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D013752 Tetracycline results in decreased expression of ACADM mRNA PMID:17522070 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:27928 parathion increases expression EXP E RGD:6480464 20220607 CTD MESH:D010278 Parathion results in increased expression of ACADM mRNA PMID:34813904 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28112 nickel atom decreases expression ISO RGD:735259 E RGD:6480464 20150609 CTD MESH:D009532 Nickel results in decreased expression of ACADM mRNA PMID:23195993 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ACADM mRNA PMID:21570461|PMID:36222588 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20210907 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACADM mRNA PMID:33956508 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2012 E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACADM mRNA PMID:21215274 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACADM mRNA PMID:15328365 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2012 E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACADM mRNA PMID:34747641 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of ACADM mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACADM mRNA PMID:17942748|PMID:28433925 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28177 theophylline decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D013806 Theophylline results in decreased expression of ACADM mRNA PMID:17522070 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:735259 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of ACADM mRNA PMID:30851411 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28428 beta-hexachlorocyclohexane decreases expression EXP E RGD:6480464 20171010 CTD MESH:C023888 beta-hexachlorocyclohexane results in decreased expression of ACADM mRNA; beta-hexachlorocyclohexane results in decreased expression of ACADM protein PMID:28397872 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28428 beta-hexachlorocyclohexane decreases expression ISO RGD:735259 E RGD:6480464 20171010 CTD MESH:C023888 beta-hexachlorocyclohexane results in decreased expression of ACADM mRNA; beta-hexachlorocyclohexane results in decreased expression of ACADM protein PMID:28397872 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28593 quinidine decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D011802 Quinidine results in decreased expression of ACADM mRNA PMID:17522070 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28600 farnesol multiple interactions ISO RGD:735259 E RGD:6480464 20190312 CTD MESH:D005204 [Farnesol analog co-treated with Oleic Acid] results in increased expression of ACADM mRNA PMID:30611723 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28694 copper atom decreases expression ISO RGD:2012 E RGD:6480464 20120717 CTD MESH:D003300 Copper results in decreased expression of ACADM mRNA PMID:22465980 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28694 copper atom multiple interactions ISO RGD:2012 E RGD:6480464 20151013 CTD MESH:D003300 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADM mRNA PMID:25813056 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28748 doxorubicin decreases expression EXP E RGD:6480464 20160607 CTD MESH:D004317 Doxorubicin results in decreased expression of ACADM mRNA; Doxorubicin results in decreased expression of ACADM protein PMID:26873546|PMID:38395252 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28748 doxorubicin decreases expression ISO RGD:2012 E RGD:6480464 20240806 CTD MESH:D004317 Doxorubicin results in decreased expression of ACADM mRNA PMID:38395252 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28748 doxorubicin decreases expression ISO RGD:735259 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of ACADM mRNA PMID:29803840 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28748 doxorubicin multiple interactions EXP E RGD:6480464 20160607 CTD MESH:D004317 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of ACADM mRNA; SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADM mRNA] PMID:26873546|PMID:38395252 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28748 doxorubicin multiple interactions ISO RGD:2012 E RGD:6480464 20240806 CTD MESH:D004317 SIRT6 protein inhibits the reaction [Doxorubicin results in decreased expression of ACADM mRNA] PMID:38395252 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:28757 fructose multiple interactions ISO RGD:2012 E RGD:6480464 20151013 CTD MESH:D005632 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADM mRNA PMID:25813056 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:29287 gold atom decreases expression ISO RGD:735259 E RGD:6480464 20230502 CTD MESH:D006046 Gold analog results in decreased expression of ACADM mRNA PMID:36057382 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:29310 dichlorine multiple interactions ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D002713 [Ozone co-treated with Chlorine] results in increased expression of ACADM mRNA PMID:18636392 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:735259 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of ACADM mRNA PMID:38568856 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:29678 sodium arsenite increases expression ISO RGD:2012 E RGD:6480464 20190507 CTD MESH:C017947 sodium arsenite results in increased expression of ACADM protein PMID:29459688 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:735259 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ACADM promoter PMID:27901495 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20180410 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ACADM protein PMID:29145655 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120412 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ACADM mRNA PMID:21715664 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:30050 gold(0) decreases expression ISO RGD:735259 E RGD:6480464 20230502 CTD MESH:D006046 Gold analog results in decreased expression of ACADM mRNA PMID:36057382 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:30052 copper(0) decreases expression ISO RGD:2012 E RGD:6480464 20120717 CTD MESH:D003300 Copper results in decreased expression of ACADM mRNA PMID:22465980 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:30052 copper(0) multiple interactions ISO RGD:2012 E RGD:6480464 20151013 CTD MESH:D003300 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADM mRNA PMID:25813056 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ACADM mRNA PMID:16483693 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:31653 glafenine decreases expression ISO RGD:2012 E RGD:6480464 20160412 CTD MESH:D005897 Glafenine results in decreased expression of ACADM mRNA PMID:24136188 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:32195 Tesaglitazar increases expression ISO RGD:2012 E RGD:6480464 20170303 CTD MESH:C501413 tesaglitazar results in increased expression of ACADM mRNA PMID:21515302 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:32234 titanium dioxide decreases expression EXP E RGD:6480464 20140211 CTD MESH:C009495 titanium dioxide results in decreased expression of ACADM mRNA PMID:23557971 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:32234 titanium dioxide decreases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ACADM gene; titanium dioxide results in decreased methylation of ACADM promoter PMID:35295148 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:32497 thioacetamide decreases expression ISO RGD:2012 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of ACADM mRNA PMID:34492290 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:32509 pirinixic acid increases expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in increased expression of ACADM mRNA; pirinixic acid results in increased expression of ACADM protein PMID:11798191|PMID:15226431|PMID:15375163|PMID:16377806|PMID:17426115|PMID:17932310|PMID:18301758|PMID:20059764|PMID:20813756|PMID:23811191 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:32509 pirinixic acid increases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in increased expression of ACADM mRNA; pirinixic acid results in increased expression of ACADM protein PMID:15018640|PMID:19162173|PMID:33983380 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:32509 pirinixic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C006253 PPARA protein promotes the reaction [pirinixic acid results in increased expression of ACADM mRNA]; PPARGC1B protein inhibits the reaction [pirinixic acid results in increased expression of ACADM mRNA] PMID:17932310|PMID:20059764 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:735259 E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACADM mRNA PMID:19710929 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:33007 chromium(6+) affects expression ISO RGD:735259 E RGD:6480464 20190507 CTD MESH:C074702 chromium hexavalent ion affects the expression of ACADM mRNA PMID:30690063 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in decreased expression of ACADM mRNA PMID:30566610|PMID:33221593 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2012 E RGD:6480464 20180703 CTD MESH:C006780 bisphenol A results in decreased expression of ACADM mRNA PMID:24105817|PMID:34947998 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:33216 bisphenol A decreases expression ISO RGD:735259 E RGD:6480464 20210608 CTD MESH:C006780 bisphenol A analog results in decreased expression of ACADM mRNA; bisphenol A results in decreased expression of ACADM mRNA; bisphenol A results in decreased expression of ACADM protein PMID:32763284|PMID:34186270 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of ACADM mRNA PMID:37105096 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:33216 bisphenol A increases expression ISO RGD:2012 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of ACADM mRNA PMID:25181051 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:33216 bisphenol A increases expression ISO RGD:735259 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of ACADM protein PMID:37567409 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:33216 bisphenol A increases methylation ISO RGD:2012 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of ACADM gene PMID:28505145 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20180116 CTD MESH:C006780 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of ACADM mRNA PMID:28433925 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:2012 E RGD:6480464 20160705 CTD MESH:C006780 [bisphenol A co-treated with Estradiol] results in decreased expression of ACADM mRNA PMID:26496021 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP E RGD:6480464 20180116 CTD MESH:C014024 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in increased expression of ACADM mRNA PMID:28433925 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:34575 bisphenol F increases expression ISO RGD:735259 E RGD:6480464 20210608 CTD MESH:C008745 4,4'-bisphenol F results in increased expression of ACADM mRNA; bisphenol F results in increased expression of ACADM protein PMID:32763284|PMID:34186270 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:34581 Bisphenol B increases expression ISO RGD:735259 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of ACADM protein PMID:34186270 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:34648 clofibric acid multiple interactions ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D002995 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ACADM mRNA PMID:17602206 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:34678 Di-n-hexyl phthalate decreases expression ISO RGD:735259 E RGD:6480464 20210309 CTD MESH:C027387 di-n-hexyl phthalate results in decreased expression of ACADM mRNA PMID:33043605 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:34687 dibutyl phthalate increases expression EXP E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of ACADM mRNA PMID:21266533 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP E RGD:6480464 20140715 CTD MESH:D015056 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ACADM mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACADM mRNA PMID:23428407|PMID:24848799 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:34873 N-nitrosodiethylamine multiple interactions ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D004052 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ACADM mRNA PMID:17602206 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:34887 nickel dichloride decreases expression ISO RGD:735259 E RGD:6480464 20120717 CTD MESH:C022838 nickel chloride results in decreased expression of ACADM mRNA PMID:17312168 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:34967 rimonabant affects expression EXP E RGD:6480464 20210202 CTD MESH:D000077285 Rimonabant affects the expression of ACADM mRNA PMID:19030233 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:34967 rimonabant multiple interactions EXP E RGD:6480464 20210202 CTD MESH:D000077285 Rimonabant inhibits the reaction [Dietary Fats results in increased expression of ACADM mRNA] PMID:19030233 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:735259 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ACADM mRNA PMID:37042841 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35255 chloroform decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D002725 Chloroform results in decreased expression of ACADM mRNA PMID:17522070 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35455 1-naphthyl isothiocyanate decreases expression EXP E RGD:6480464 20210810 CTD MESH:D015058 1-Naphthylisothiocyanate results in decreased expression of ACADM mRNA PMID:33749747 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35455 1-naphthyl isothiocyanate decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D015058 1-Naphthylisothiocyanate results in decreased expression of ACADM mRNA PMID:17522070 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35455 1-naphthyl isothiocyanate multiple interactions EXP E RGD:6480464 20210810 CTD MESH:D015058 Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ACADM mRNA] PMID:33749747 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:735259 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in decreased expression of ACADM mRNA PMID:38568856 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35456 cadmium dichloride increases expression EXP E RGD:6480464 20151215 CTD MESH:D019256 Cadmium Chloride results in increased expression of ACADM mRNA PMID:26352046 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:735259 E RGD:6480464 20150310 CTD MESH:D019256 Cadmium Chloride results in increased expression of ACADM protein PMID:24527689 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35549 perfluorooctanoic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid affects the expression of ACADM mRNA PMID:19429403 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35549 perfluorooctanoic acid increases expression EXP E RGD:6480464 20140311 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACADM mRNA; perfluorooctanoic acid results in increased expression of ACADM protein PMID:17681415|PMID:21499893|PMID:23626681|PMID:34252412 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACADM mRNA PMID:16221955 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:735259 E RGD:6480464 20171010 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACADM mRNA; perfluorooctanoic acid results in increased expression of ACADM protein PMID:26879310|PMID:32068100|PMID:37302725 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35549 perfluorooctanoic acid multiple interactions EXP E RGD:6480464 20140311 CTD MESH:C023036 [perfluorooctanoic acid co-treated with Dietary Fats, Unsaturated] results in increased expression of ACADM mRNA PMID:23626681 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:35549 perfluorooctanoic acid multiple interactions ISO RGD:735259 E RGD:6480464 20120717 CTD MESH:C023036 [PPARA co-treated with perfluorooctanoic acid] results in increased expression of ACADM mRNA; [PPARA co-treated with perfluorooctanoic acid] results in increased expression of ACADM protein PMID:19751795 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:36386 dichloroacetic acid increases expression EXP E RGD:6480464 20171114 CTD MESH:D003999 Dichloroacetic Acid results in increased expression of ACADM mRNA PMID:28962523 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20140610 CTD MESH:D002994 Clofibrate results in increased expression of ACADM mRNA PMID:17585979|PMID:19124612|PMID:23811191 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:3750 clofibrate increases expression ISO RGD:2012 E RGD:6480464 20120717 CTD MESH:D002994 Clofibrate results in increased expression of ACADM mRNA; Clofibrate results in increased expression of ACADM protein PMID:11328961|PMID:12851107|PMID:15018640|PMID:16470657|PMID:17522070|PMID:18670166|PMID:33983380|PMID:9815135 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:3750 clofibrate multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D002994 [Clofibrate co-treated with Acetaminophen] affects the expression of ACADM mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACADM mRNA] PMID:17585979 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:38658 dicrotophos decreases expression ISO RGD:735259 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in decreased expression of ACADM mRNA PMID:28302478 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:39421 perfluorooctane-1-sulfonic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:C076994 perfluorooctane sulfonic acid affects the expression of ACADM mRNA PMID:19429403 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression EXP E RGD:6480464 20130416 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of ACADM mRNA; perfluorooctane sulfonic acid results in increased expression of ACADM protein PMID:20936131|PMID:26178269 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of ACADM mRNA PMID:18692542 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACADM mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACADM mRNA; [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of ACADM mRNA PMID:36331819 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:39483 sodium dichromate increases expression EXP E RGD:6480464 20201103 CTD MESH:C016104 sodium bichromate results in increased expression of ACADM mRNA PMID:31558096 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:39501 2,2,2-tetramine multiple interactions ISO RGD:2012 E RGD:6480464 20120717 CTD MESH:D014266 Trientine inhibits the reaction [Streptozocin results in decreased expression of ACADM protein] PMID:19634143 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:39867 valproic acid decreases expression ISO RGD:735259 E RGD:6480464 20181016 CTD MESH:D014635 Valproic Acid results in decreased expression of ACADM protein PMID:29501571 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:39867 valproic acid increases expression ISO RGD:735259 E RGD:6480464 20140513 CTD MESH:D014635 Valproic Acid results in increased expression of ACADM mRNA PMID:23179753|PMID:28001369 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:39867 valproic acid increases methylation ISO RGD:735259 E RGD:6480464 20181016 CTD MESH:D014635 Valproic Acid results in increased methylation of ACADM gene PMID:29501571 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:39867 valproic acid increases response to substance ISO RGD:735259 E RGD:6480464 20120412 CTD MESH:D014635 ACADM gene results in increased susceptibility to Valproic Acid PMID:9090694 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:40279 allopurinol increases expression EXP E RGD:6480464 20210810 CTD MESH:D000493 Allopurinol results in increased expression of ACADM mRNA PMID:33749747 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:40279 allopurinol multiple interactions EXP E RGD:6480464 20210810 CTD MESH:D000493 Allopurinol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of ACADM mRNA] PMID:33749747 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:735259 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of ACADM mRNA PMID:20106945|PMID:25562108 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:40909 azoxystrobin increases expression ISO RGD:735259 E RGD:6480464 20210810 CTD MESH:C087670 azoxystrobin results in increased expression of ACADM mRNA PMID:33512557 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:41774 tamoxifen affects expression EXP E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen affects the expression of ACADM mRNA PMID:17555576 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:41879 dexamethasone decreases expression EXP E RGD:6480464 20210504 CTD MESH:D003907 Dexamethasone results in decreased expression of ACADM protein PMID:33567340 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:41879 dexamethasone decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D003907 Dexamethasone results in decreased expression of ACADM mRNA PMID:17522070 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20140715 CTD MESH:D003907 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of ACADM mRNA; [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACADM mRNA PMID:23428407|PMID:24848799 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:41922 diethylstilbestrol increases expression ISO RGD:2012 E RGD:6480464 20230606 CTD MESH:D004054 Diethylstilbestrol results in increased expression of ACADM mRNA PMID:37077353 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:44185 methotrexate increases expression ISO RGD:735259 E RGD:6480464 20121113 CTD MESH:D008727 Methotrexate results in increased expression of ACADM mRNA PMID:17400583 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:46195 paracetamol decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen results in decreased expression of ACADM mRNA PMID:17522070 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:46195 paracetamol decreases expression ISO RGD:735259 E RGD:6480464 20180515 CTD MESH:D000082 Acetaminophen results in decreased expression of ACADM mRNA PMID:29067470 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:46195 paracetamol increases expression EXP E RGD:6480464 20120717 CTD MESH:D000082 Acetaminophen results in increased expression of ACADM protein PMID:21329376 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:46195 paracetamol increases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen results in increased expression of ACADM mRNA; Acetaminophen results in increased expression of ACADM protein PMID:15800402|PMID:33387578 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:46195 paracetamol multiple interactions EXP E RGD:6480464 20120515 CTD MESH:D000082 [Clofibrate co-treated with Acetaminophen] affects the expression of ACADM mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACADM mRNA] PMID:17585979 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:46557 zoledronic acid decreases expression EXP E RGD:6480464 20180116 CTD MESH:C088658 zoledronic acid results in decreased expression of ACADM mRNA PMID:28871336 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:47519 ketoconazole increases expression ISO RGD:2012 E RGD:6480464 20230606 CTD MESH:D007654 Ketoconazole results in increased expression of ACADM mRNA PMID:37077353 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:47612 bezafibrate increases expression EXP E RGD:6480464 20120613 CTD MESH:D001629 Bezafibrate results in increased expression of ACADM mRNA PMID:19124612 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:47612 bezafibrate multiple interactions EXP E RGD:6480464 20120613 CTD MESH:D001629 Bezafibrate inhibits the reaction [CYP19A1 gene mutant form results in decreased expression of ACADM mRNA]; Bezafibrate inhibits the reaction [SLC27A2 gene mutant form results in decreased expression of ACADM mRNA]; PPARA protein affects the susceptibility to [Bezafibrate results in increased expression of ACADM mRNA] PMID:11929713|PMID:19124612 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:47612 bezafibrate multiple interactions ISO RGD:2012 E RGD:6480464 20170110 CTD MESH:D001629 Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA] PMID:26190035 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20190312 CTD MESH:C016766 sulforaphane results in increased expression of ACADM mRNA PMID:30529165 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:4791 endosulfan decreases expression ISO RGD:2012 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of ACADM mRNA PMID:29391264 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:735259 E RGD:6480464 20121009 CTD MESH:C045651 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ACADM mRNA PMID:22079256 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:4846 erythromycin estolate decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D004918 Erythromycin Estolate results in decreased expression of ACADM mRNA PMID:17522070 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:48607 lithium chloride decreases expression EXP E RGD:6480464 20160510 CTD MESH:D018021 Lithium Chloride results in decreased expression of ACADM mRNA; Lithium Chloride results in decreased expression of ACADM protein PMID:26993217 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:4903 17alpha-ethynylestradiol affects expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol affects the expression of ACADM mRNA PMID:17555576 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:4903 17alpha-ethynylestradiol decreases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in decreased expression of ACADM mRNA PMID:16174780 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:4903 17alpha-ethynylestradiol decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in decreased expression of ACADM mRNA PMID:16174780 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ACADM mRNA PMID:17942748 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ACADM mRNA PMID:12075121 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACADM mRNA PMID:17942748 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:4911 etoposide affects response to substance ISO RGD:735259 E RGD:6480464 20120412 CTD MESH:D005047 ACADM protein affects the susceptibility to Etoposide PMID:16217747 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:49662 indometacin decreases expression ISO RGD:2012 E RGD:6480464 20230704 CTD MESH:D007213 Indomethacin results in decreased expression of ACADM mRNA PMID:36868495 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:5001 fenofibrate increases expression EXP E RGD:6480464 20121113 CTD MESH:D011345 Fenofibrate results in increased expression of ACADM mRNA PMID:11798191|PMID:17690133|PMID:19124612|PMID:33408297 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:5001 fenofibrate increases expression ISO RGD:735259 E RGD:6480464 20150825 CTD MESH:D011345 Fenofibrate results in increased expression of ACADM mRNA PMID:24752549|PMID:25572481 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:5001 fenofibrate multiple interactions EXP E RGD:6480464 20210608 CTD MESH:D011345 PPARA protein affects the reaction [Fenofibrate results in increased expression of ACADM mRNA] PMID:33408297 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:50223 (+)-dexrazoxane multiple interactions EXP E RGD:6480464 20170303 CTD MESH:D064730 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of ACADM mRNA PMID:26873546 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ACADM mRNA; Nanotubes, Carbon results in decreased expression of ACADM mRNA PMID:25554681 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:50594 carbon nanotube increases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of ACADM mRNA; Nanotubes, Carbon results in increased expression of ACADM mRNA PMID:25620056 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:50859 bexarotene increases expression ISO RGD:2012 E RGD:6480464 20170303 CTD MESH:C095105 bexarotene results in increased expression of ACADM mRNA PMID:23292798 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:5132 flutamide affects expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D005485 Flutamide affects the expression of ACADM mRNA PMID:21525395 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:5132 flutamide decreases expression EXP E RGD:6480464 20120918 CTD MESH:D005485 Flutamide results in decreased expression of ACADM mRNA PMID:17702527|PMID:19442681 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:53154 8'-apo-beta,psi-caroten-8'-al increases expression ISO RGD:735259 E RGD:6480464 20120412 CTD MESH:C004984 apocarotenal results in increased expression of ACADM mRNA PMID:17034753 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:53444 potassium dichromate increases expression ISO RGD:735259 E RGD:6480464 20130611 CTD MESH:D011192 Potassium Dichromate results in increased expression of ACADM mRNA PMID:11678601 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:6067 isotretinoin decreases expression ISO RGD:735259 E RGD:6480464 20120412 CTD MESH:D015474 Isotretinoin results in decreased expression of ACADM mRNA PMID:20436886 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:6078 ivermectin decreases expression ISO RGD:735259 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ACADM protein PMID:32959892 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:63933 Aroclor 1254 decreases expression EXP E RGD:6480464 20131210 CTD MESH:D020111 Chlorodiphenyl (54% Chlorine) results in decreased expression of ACADM mRNA PMID:23650126 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:641 N-methyl-4-phenylpyridinium increases expression EXP E RGD:6480464 20160210 CTD MESH:D015655 1-Methyl-4-phenylpyridinium results in increased expression of ACADM protein PMID:26558463 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:64227 ciglitazone multiple interactions ISO RGD:735259 E RGD:6480464 20120412 CTD MESH:C039671 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACADM mRNA; [ciglitazone binds to PPARG protein] which results in increased expression of ACADM mRNA PMID:16197558 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:64243 monosodium L-glutamate increases expression EXP E RGD:6480464 20200331 CTD MESH:D012970 Sodium Glutamate results in increased expression of ACADM mRNA PMID:19724016 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D012970 SRT1720 inhibits the reaction [Sodium Glutamate results in increased expression of ACADM mRNA] PMID:19724016 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:64317 isoprenaline decreases activity ISO RGD:2012 E RGD:6480464 20120515 CTD MESH:D007545 Isoproterenol results in decreased activity of ACADM protein PMID:19826179 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:64317 isoprenaline decreases expression ISO RGD:2012 E RGD:6480464 20160412 CTD MESH:D007545 Isoproterenol results in decreased expression of ACADM mRNA PMID:25045214 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:64317 isoprenaline multiple interactions ISO RGD:2012 E RGD:6480464 20160412 CTD MESH:D007545 [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADM mRNA; Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADM mRNA]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADM mRNA]] PMID:25045214|PMID:30303030 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:66395 miquelianin multiple interactions ISO RGD:2012 E RGD:6480464 20170124 CTD MESH:C443401 quercetin 3-O-glucuronide inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of ACADM mRNA] PMID:26190035 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:6925 microcystin-LR decreases expression EXP E RGD:6480464 20171010 CTD MESH:C057862 cyanoginosin LR results in decreased expression of ACADM protein PMID:26984711 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:69478 cannabidiol multiple interactions EXP E RGD:6480464 20211207 CTD MESH:D002185 Cannabidiol inhibits the reaction [Ethanol results in decreased expression of ACADM mRNA] PMID:28935932 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:70778 GW 7647 increases expression ISO RGD:2012 E RGD:6480464 20200519 CTD MESH:C453899 GW 7647 results in increased expression of ACADM mRNA PMID:31628012 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:70778 GW 7647 increases expression ISO RGD:735259 E RGD:6480464 20190312 CTD MESH:C453899 GW 7647 results in increased expression of ACADM mRNA PMID:30611723 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:72544 flavonoids increases expression ISO RGD:2012 E RGD:6480464 20170303 CTD MESH:D005419 Flavonoids results in increased expression of ACADM mRNA PMID:18035473 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:72754 bisphenol AF increases expression ISO RGD:735259 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of ACADM protein PMID:34186270 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:73726 GW 501516 multiple interactions ISO RGD:735259 E RGD:6480464 20170303 CTD MESH:C425931 [GW 501516 binds to PPARD protein] which results in increased expression of ACADM mRNA PMID:16197558 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:73755 1,2-dimethylhydrazine decreases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ACADM mRNA PMID:22206623 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACADM mRNA PMID:22206623 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:74023 dioscin multiple interactions EXP E RGD:6480464 20140513 CTD MESH:C019357 dioscin inhibits the reaction [Ethanol results in decreased expression of ACADM protein] PMID:24146112 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:74023 dioscin multiple interactions ISO RGD:2012 E RGD:6480464 20140513 CTD MESH:C019357 dioscin inhibits the reaction [Ethanol results in decreased expression of ACADM protein] PMID:24146112 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:75249 potassium chromate decreases expression ISO RGD:735259 E RGD:6480464 20130903 CTD MESH:C027373 potassium chromate(VI) results in decreased expression of ACADM mRNA PMID:22079256 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:75249 potassium chromate multiple interactions ISO RGD:735259 E RGD:6480464 20130903 CTD MESH:C027373 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ACADM mRNA PMID:22079256 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:76290 PhIP decreases expression ISO RGD:2012 E RGD:6480464 20211012 CTD MESH:C049584 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of ACADM mRNA PMID:33945839 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:77565 2,3,7,8-tetrabromodibenzodioxine decreases expression EXP E RGD:6480464 20170516 CTD MESH:C066841 2,3,7,8-tetrabromodibenzo-4-dioxin results in decreased expression of ACADM protein PMID:27604104 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:78320 2-hydroxypropanoic acid decreases expression ISO RGD:735259 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of ACADM mRNA PMID:30851411 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:78510 dorsomorphin decreases expression ISO RGD:2012 E RGD:6480464 20161228 CTD MESH:C516138 dorsomorphin results in decreased expression of ACADM mRNA PMID:19699196 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:2012 E RGD:6480464 20161228 CTD MESH:C516138 dorsomorphin promotes the reaction [Phenylephrine results in decreased expression of ACADM mRNA] PMID:19699196 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:78576 aflatoxin M1 decreases expression ISO RGD:735259 E RGD:6480464 20190910 CTD MESH:D016607 Aflatoxin M1 results in decreased expression of ACADM mRNA PMID:30928695 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:79997 GW 4064 decreases expression ISO RGD:735259 E RGD:6480464 20190312 CTD MESH:C412815 GW 4064 results in decreased expression of ACADM mRNA PMID:30611723 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:79997 GW 4064 multiple interactions ISO RGD:735259 E RGD:6480464 20190312 CTD MESH:C412815 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACADM mRNA PMID:30611723 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:8069 phenobarbital decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in decreased expression of ACADM mRNA PMID:19162173 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:8093 phenylephrine decreases expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D010656 Phenylephrine results in decreased expression of ACADM mRNA PMID:19699196 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:8093 phenylephrine multiple interactions ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:D010656 AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of ACADM mRNA]; dorsomorphin promotes the reaction [Phenylephrine results in decreased expression of ACADM mRNA] PMID:19699196 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:8113 phlorizin decreases expression EXP E RGD:6480464 20121009 CTD MESH:D010695 Phlorhizin results in decreased expression of ACADM mRNA PMID:22538082 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:81543 Tributyltin oxide decreases expression ISO RGD:2012 E RGD:6480464 20161213 CTD MESH:C005961 bis(tri-n-butyltin)oxide results in decreased expression of ACADM mRNA PMID:17553608 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression EXP E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of ACADM mRNA PMID:38648751 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:82195 Clofop multiple interactions ISO RGD:735259 E RGD:6480464 20141111 CTD MESH:C006012 [fenofibric acid binds to PPARA protein] which results in increased expression of ACADM mRNA PMID:16197558 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:83197 picoxystrobin increases expression ISO RGD:735259 E RGD:6480464 20210810 CTD MESH:C556557 picoxystrobin results in increased expression of ACADM mRNA PMID:33512557 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:8630 pterostilbene increases expression ISO RGD:735259 E RGD:6480464 20160822 CTD MESH:C107773 pterostilbene results in increased expression of ACADM mRNA PMID:26443543 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:8633 puerarin increases expression EXP E RGD:6480464 20200114 CTD MESH:C033607 puerarin results in increased expression of ACADM mRNA PMID:31273855 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20231205 CTD MESH:C028577 monobutyl phthalate results in increased expression of ACADM mRNA PMID:36736749 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:735259 E RGD:6480464 20240206 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ACADM protein PMID:37664457 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:9168 sirolimus multiple interactions ISO RGD:2012 E RGD:6480464 20160412 CTD MESH:D020123 Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADM mRNA]; TNF protein inhibits the reaction [Sirolimus inhibits the reaction [Isoproterenol results in decreased expression of ACADM mRNA]] PMID:25045214 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:920 2,4-dinitrotoluene affects expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of ACADM mRNA PMID:21346803 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:9288 streptozocin decreases expression ISO RGD:2012 E RGD:6480464 20120717 CTD MESH:D013311 Streptozocin results in decreased expression of ACADM protein PMID:19634143 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:9288 streptozocin multiple interactions ISO RGD:2012 E RGD:6480464 20120717 CTD MESH:D013311 Trientine inhibits the reaction [Streptozocin results in decreased expression of ACADM protein] PMID:19634143 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:9428 tectoridin multiple interactions EXP E RGD:6480464 20141111 CTD MESH:C120040 tectoridin inhibits the reaction [Ethanol results in decreased expression of ACADM mRNA] PMID:20637825 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:94688 5-methyl-4-oxido-2-pyrazin-4-iumcarboxylic acid increases expression ISO RGD:735259 E RGD:6480464 20170307 CTD MESH:C027696 acipimox results in increased expression of ACADM mRNA PMID:25352640 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:94789 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine multiple interactions ISO RGD:2012 E RGD:6480464 20170307 CTD MESH:D014292 Trimetazidine promotes the reaction [Oxygen deficiency results in decreased expression of ACADM mRNA] PMID:25937560 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:957 2,6-dinitrotoluene affects expression ISO RGD:2012 E RGD:6480464 20120412 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of ACADM mRNA PMID:21346803 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:9753 troglitazone decreases expression EXP E RGD:6480464 20120613 CTD MESH:C057693 troglitazone results in decreased expression of ACADM mRNA PMID:11056218 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:9753 troglitazone increases expression EXP E RGD:6480464 20120501 CTD MESH:C057693 troglitazone results in increased expression of ACADM protein PMID:18495193 10057 Acadm acyl-Coenzyme A dehydrogenase, medium chain gene CHEBI:9753 troglitazone increases expression ISO RGD:2012 E RGD:6480464 20120918 CTD MESH:C057693 troglitazone results in increased expression of ACADM mRNA PMID:21515302 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:735407 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of ACADVL mRNA PMID:38218311 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:10429 beta-lapachone increases expression ISO RGD:735407 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in increased expression of ACADVL mRNA PMID:38218311 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:131843 meldonium affects expression EXP E RGD:6480464 20201103 CTD MESH:C050147 3-(2,2,2-trimethylhydrazine)propionate affects the expression of ACADVL mRNA PMID:32389661 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:149906 Tanshinone I increases expression ISO RGD:735407 E RGD:6480464 20200602 CTD MESH:C021751 tanshinone results in increased expression of ACADVL mRNA PMID:15849732 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:735407 E RGD:6480464 20140408 CTD MESH:D014212 Tretinoin results in increased expression of ACADVL mRNA PMID:23724009|PMID:33167477 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:15930 atrazine increases expression ISO RGD:735407 E RGD:6480464 20141014 CTD MESH:D001280 Atrazine results in increased expression of ACADVL mRNA PMID:22378314 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:16196 oleic acid multiple interactions ISO RGD:735407 E RGD:6480464 20190312 CTD MESH:D019301 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACADVL mRNA; [GW 7647 co-treated with Oleic Acid] results in increased expression of ACADVL mRNA PMID:30611723 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:16236 ethanol multiple interactions ISO RGD:735407 E RGD:6480464 20181016 CTD MESH:D000431 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ACADVL mRNA PMID:29432896 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:16243 quercetin increases expression ISO RGD:735407 E RGD:6480464 20120412 CTD MESH:D011794 Quercetin results in increased expression of ACADVL protein PMID:15221776 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:16325 lithocholic acid decreases expression EXP E RGD:6480464 20121218 CTD MESH:D008095 Lithocholic Acid results in decreased expression of ACADVL mRNA PMID:20359477 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:16469 17beta-estradiol decreases expression EXP E RGD:6480464 20130723 CTD MESH:D004958 Estradiol results in decreased expression of ACADVL mRNA PMID:19484750 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:16509 1,4-benzoquinone decreases expression ISO RGD:735407 E RGD:6480464 20210309 CTD MESH:C004532 quinone results in decreased expression of ACADVL mRNA PMID:32478940 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20120412 CTD MESH:D014241 Trichloroethylene results in increased expression of ACADVL mRNA; Trichloroethylene results in increased expression of ACADVL protein PMID:20709644 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression EXP E RGD:6480464 20120412 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of ACADVL mRNA PMID:19850644 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:2014 E RGD:6480464 20130312 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of ACADVL mRNA PMID:22672789 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:735407 E RGD:6480464 20120613 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of ACADVL mRNA PMID:21354252 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004051 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACADVL mRNA] PMID:19850644 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:188851 Muraglitazar increases expression ISO RGD:2014 E RGD:6480464 20220104 CTD MESH:C500085 muraglitazar results in increased expression of ACADVL mRNA PMID:21515302 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:22977 cadmium atom increases oxidation EXP E RGD:6480464 20140513 CTD MESH:D002104 Cadmium results in increased oxidation of ACADVL protein PMID:24496640 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:735407 E RGD:6480464 20221101 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACADVL mRNA PMID:35301059 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:2504 aflatoxin B1 increases expression EXP E RGD:6480464 20120501 CTD MESH:D016604 Aflatoxin B1 results in increased expression of ACADVL mRNA PMID:19770486 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:26710 sodium chloride multiple interactions ISO RGD:735407 E RGD:6480464 20250114 CTD MESH:D012965 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ACADVL protein PMID:38598786 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:27086 tributylstannane increases expression EXP E RGD:6480464 20140715 CTD MESH:C011559 tributyltin results in increased expression of ACADVL mRNA PMID:23428407 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:27363 zinc atom increases expression ISO RGD:2014 E RGD:6480464 20120412 CTD MESH:D015032 Zinc results in increased expression of ACADVL mRNA PMID:17074742 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20150127 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACADVL mRNA PMID:25270620 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:27563 arsenic atom multiple interactions ISO RGD:735407 E RGD:6480464 20200915 CTD MESH:D001151 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ACADVL mRNA PMID:32525701 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:2762 antimycin A decreases expression ISO RGD:735407 E RGD:6480464 20210810 CTD MESH:D000968 Antimycin A results in decreased expression of ACADVL mRNA PMID:33512557 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:735407 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of ACADVL protein PMID:38460933 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:27856 acetamide decreases expression ISO RGD:2014 E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in decreased expression of ACADVL mRNA PMID:31881176 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:27899 cisplatin multiple interactions ISO RGD:735407 E RGD:6480464 20120412 CTD MESH:D002945 [Piroxicam co-treated with Cisplatin] results in decreased expression of ACADVL mRNA PMID:21858171 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:27902 tetracycline decreases expression EXP E RGD:6480464 20150127 CTD MESH:D013752 Tetracycline results in decreased expression of ACADVL mRNA PMID:24489787 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ACADVL mRNA PMID:21570461 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735407 E RGD:6480464 20130312 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACADVL mRNA PMID:11489354|PMID:20106945|PMID:21632981|PMID:21807756 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:28201 rotenone decreases expression ISO RGD:735407 E RGD:6480464 20210810 CTD MESH:D012402 Rotenone results in decreased expression of ACADVL mRNA PMID:33512557 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:28201 rotenone increases expression ISO RGD:2014 E RGD:6480464 20221101 CTD MESH:D012402 Rotenone results in increased expression of ACADVL protein PMID:35544339 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:735407 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of ACADVL mRNA; aristolochic acid I results in increased expression of ACADVL protein PMID:33212167 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:28694 copper atom decreases expression ISO RGD:2014 E RGD:6480464 20120717 CTD MESH:D003300 Copper deficiency results in decreased expression of ACADVL mRNA; Copper results in decreased expression of ACADVL mRNA PMID:19821111|PMID:22465980 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:28694 copper atom multiple interactions ISO RGD:2014 E RGD:6480464 20151013 CTD MESH:D003300 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADVL mRNA PMID:25813056 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:28748 doxorubicin affects expression ISO RGD:735407 E RGD:6480464 20180515 CTD MESH:D004317 Doxorubicin affects the expression of ACADVL protein PMID:29385562 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:28748 doxorubicin decreases expression EXP E RGD:6480464 20120412 CTD MESH:D004317 Doxorubicin results in decreased expression of ACADVL mRNA; Doxorubicin results in decreased expression of ACADVL protein PMID:16144979|PMID:26873546|PMID:34246718 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:28757 fructose multiple interactions ISO RGD:2014 E RGD:6480464 20160510 CTD MESH:D005632 [Fructose co-treated with bisphenol A] results in increased expression of ACADVL protein; [Fructose co-treated with Copper deficiency] results in decreased expression of ACADVL mRNA PMID:25813056|PMID:26930160 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:2877 aspartame multiple interactions EXP E RGD:6480464 20200317 CTD MESH:D001218 [Fats, Unsaturated co-treated with Aspartame] affects the expression of ACADVL mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADVL mRNA PMID:23783067 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:28885 butan-1-ol multiple interactions ISO RGD:735407 E RGD:6480464 20181016 CTD MESH:D020001 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ACADVL mRNA PMID:29432896 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:29287 gold atom multiple interactions ISO RGD:735407 E RGD:6480464 20171010 CTD MESH:D006046 [Polyethyleneimine binds to Gold] which results in decreased expression of ACADVL mRNA PMID:28433809 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:29678 sodium arsenite increases expression ISO RGD:2014 E RGD:6480464 20190507 CTD MESH:C017947 sodium arsenite results in increased expression of ACADVL protein PMID:29459688 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:29699 tunicamycin increases expression ISO RGD:735407 E RGD:6480464 20141014 CTD MESH:D014415 Tunicamycin results in increased expression of ACADVL mRNA PMID:22378314 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:735407 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ACADVL promoter PMID:27901495 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20120918 CTD MESH:D001564 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ACADVL mRNA] PMID:22228805 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:30050 gold(0) multiple interactions ISO RGD:735407 E RGD:6480464 20171010 CTD MESH:D006046 [Polyethyleneimine binds to Gold] which results in decreased expression of ACADVL mRNA PMID:28433809 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:30052 copper(0) decreases expression ISO RGD:2014 E RGD:6480464 20120717 CTD MESH:D003300 Copper deficiency results in decreased expression of ACADVL mRNA; Copper results in decreased expression of ACADVL mRNA PMID:19821111|PMID:22465980 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:30052 copper(0) multiple interactions ISO RGD:2014 E RGD:6480464 20151013 CTD MESH:D003300 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADVL mRNA PMID:25813056 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:30185 zinc(0) increases expression ISO RGD:2014 E RGD:6480464 20120412 CTD MESH:D015032 Zinc results in increased expression of ACADVL mRNA PMID:17074742 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2014 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ACADVL mRNA PMID:16483693 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:735407 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ACADVL gene PMID:31601247 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:32195 Tesaglitazar increases expression ISO RGD:2014 E RGD:6480464 20170303 CTD MESH:C501413 tesaglitazar results in increased expression of ACADVL mRNA PMID:21515302 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:32497 thioacetamide decreases expression ISO RGD:2014 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of ACADVL mRNA PMID:34492290 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:32509 pirinixic acid increases expression EXP E RGD:6480464 20120918 CTD MESH:C006253 pirinixic acid results in increased expression of ACADVL mRNA PMID:16357043|PMID:17426115|PMID:18301758|PMID:18467677 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:32509 pirinixic acid increases expression ISO RGD:2014 E RGD:6480464 20121113 CTD MESH:C006253 pirinixic acid results in increased expression of ACADVL mRNA PMID:19162173|PMID:22484513|PMID:27665778 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:32509 pirinixic acid increases expression ISO RGD:735407 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in increased expression of ACADVL mRNA PMID:18518955 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:32509 pirinixic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C006253 PPARA protein promotes the reaction [pirinixic acid results in increased expression of ACADVL mRNA] PMID:18467677 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:33216 bisphenol A affects expression ISO RGD:735407 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of ACADVL mRNA PMID:30903817 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2014 E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in decreased expression of ACADVL mRNA PMID:30816183|PMID:32528016|PMID:34947998 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:33216 bisphenol A decreases expression ISO RGD:735407 E RGD:6480464 20230307 CTD MESH:C006780 bisphenol A results in decreased expression of ACADVL protein PMID:34186270 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:33216 bisphenol A increases expression ISO RGD:2014 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of ACADVL mRNA; bisphenol A results in increased expression of ACADVL protein PMID:25181051|PMID:32145629 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:33216 bisphenol A increases expression ISO RGD:735407 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of ACADVL protein PMID:37567409 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:33216 bisphenol A increases methylation ISO RGD:2014 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of ACADVL gene PMID:28505145 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:2014 E RGD:6480464 20160510 CTD MESH:C006780 [Fructose co-treated with bisphenol A] results in increased expression of ACADVL protein PMID:26930160 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:735407 E RGD:6480464 20220308 CTD MESH:C006780 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ACADVL gene PMID:31601247 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:34039 1,2,4-trimethylbenzene decreases expression ISO RGD:2014 E RGD:6480464 20120918 CTD MESH:C010313 pseudocumene results in decreased expression of ACADVL protein PMID:17337753 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:735407 E RGD:6480464 20230801 CTD MESH:C009407 2,5,2',5'-tetrachlorobiphenyl results in decreased expression of ACADVL mRNA PMID:36804509 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:34372 4,4'-sulfonyldiphenol affects methylation EXP E RGD:6480464 20230207 CTD MESH:C543008 bisphenol S affects the methylation of ACADVL gene PMID:31683443 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:735407 E RGD:6480464 20230307 CTD MESH:C543008 bisphenol S results in increased expression of ACADVL protein PMID:34186270 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:34575 bisphenol F increases expression ISO RGD:735407 E RGD:6480464 20230307 CTD MESH:C008745 bisphenol F results in increased expression of ACADVL protein PMID:34186270 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:34581 Bisphenol B increases expression ISO RGD:735407 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of ACADVL protein PMID:34186270 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in decreased expression of ACADVL mRNA PMID:37019170 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:34687 dibutyl phthalate increases expression ISO RGD:2014 E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of ACADVL mRNA PMID:21266533 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:34768 furfural multiple interactions ISO RGD:735407 E RGD:6480464 20250114 CTD MESH:D005662 [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of ACADVL protein; [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ACADVL protein PMID:38598786 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP E RGD:6480464 20140715 CTD MESH:D015056 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACADVL mRNA PMID:23428407 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:735407 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ACADVL mRNA PMID:37042841 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:35176 zinc sulfate increases expression ISO RGD:2014 E RGD:6480464 20120412 CTD MESH:D019287 Zinc Sulfate results in increased expression of ACADVL mRNA PMID:17074742 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:735407 E RGD:6480464 20221101 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACADVL mRNA PMID:35301059 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:35549 perfluorooctanoic acid increases expression EXP E RGD:6480464 20121009 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACADVL mRNA; perfluorooctanoic acid results in increased expression of ACADVL protein PMID:17681415|PMID:18467677|PMID:19429403|PMID:19751795|PMID:21499893 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:2014 E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACADVL mRNA PMID:19162173 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:735407 E RGD:6480464 20171010 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACADVL protein PMID:26879310 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:35549 perfluorooctanoic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C023036 PPARA affects the reaction [perfluorooctanoic acid results in increased expression of ACADVL mRNA]; PPARA affects the reaction [perfluorooctanoic acid results in increased expression of ACADVL protein]; PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of ACADVL mRNA] PMID:18467677|PMID:19751795 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:35559 furan decreases methylation ISO RGD:2014 E RGD:6480464 20120918 CTD MESH:C039281 furan results in decreased methylation of ACADVL gene PMID:22079235 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:3750 clofibrate increases expression ISO RGD:2014 E RGD:6480464 20120717 CTD MESH:D002994 Clofibrate results in increased expression of ACADVL mRNA PMID:18670166|PMID:27665778 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:37825 p-toluidine decreases expression ISO RGD:2014 E RGD:6480464 20170516 CTD MESH:C029370 4-toluidine results in decreased expression of ACADVL mRNA PMID:27638505 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:38604 pyrimidifen decreases expression ISO RGD:735407 E RGD:6480464 20210810 CTD MESH:C476509 pyrimidifen results in decreased expression of ACADVL mRNA PMID:33512557 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression EXP E RGD:6480464 20130416 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of ACADVL mRNA PMID:19429403|PMID:20936131 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression ISO RGD:2014 E RGD:6480464 20120412 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of ACADVL mRNA PMID:18692542 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:39867 valproic acid affects expression ISO RGD:735407 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ACADVL mRNA PMID:25979313 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:39867 valproic acid decreases expression ISO RGD:735407 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased expression of ACADVL mRNA PMID:29154799 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:39867 valproic acid increases expression ISO RGD:735407 E RGD:6480464 20161025 CTD MESH:D014635 Valproic Acid results in increased expression of ACADVL mRNA PMID:23179753|PMID:27188386 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:4031 cyclosporin A decreases expression EXP E RGD:6480464 20120501 CTD MESH:D016572 Cyclosporine results in decreased expression of ACADVL mRNA PMID:19770486 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:4031 cyclosporin A increases expression ISO RGD:735407 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in increased expression of ACADVL mRNA PMID:25562108 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:40909 azoxystrobin decreases expression ISO RGD:735407 E RGD:6480464 20210810 CTD MESH:C087670 azoxystrobin results in decreased expression of ACADVL mRNA PMID:33512557 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20140715 CTD MESH:D003907 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACADVL mRNA PMID:23428407 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:42588 4-hydroxyphenyl retinamide increases expression EXP E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in increased expression of ACADVL mRNA PMID:28973697 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:42588 4-hydroxyphenyl retinamide increases expression ISO RGD:735407 E RGD:6480464 20120412 CTD MESH:D017313 Fenretinide results in increased expression of ACADVL mRNA PMID:16671099 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:44185 methotrexate increases expression ISO RGD:735407 E RGD:6480464 20121113 CTD MESH:D008727 Methotrexate results in increased expression of ACADVL mRNA PMID:17400583 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:46195 paracetamol decreases expression ISO RGD:735407 E RGD:6480464 20180313 CTD MESH:D000082 Acetaminophen results in decreased expression of ACADVL mRNA PMID:26690555 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:46195 paracetamol increases expression ISO RGD:735407 E RGD:6480464 20150825 CTD MESH:D000082 Acetaminophen results in increased expression of ACADVL mRNA PMID:25704631 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:735407 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion of ACADVL protein PMID:38460933 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:47217 arsane multiple interactions ISO RGD:735407 E RGD:6480464 20200915 CTD MESH:D001151 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ACADVL mRNA PMID:32525701 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:47612 bezafibrate affects response to substance ISO RGD:735407 E RGD:6480464 20120613 CTD MESH:D001629 ACADVL protein affects the susceptibility to Bezafibrate; ACADVL protein mutant form affects the susceptibility to Bezafibrate PMID:17999356|PMID:20060901 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:47612 bezafibrate increases activity ISO RGD:735407 E RGD:6480464 20120613 CTD MESH:D001629 Bezafibrate results in increased activity of ACADVL protein PMID:17999356 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:47612 bezafibrate increases expression EXP E RGD:6480464 20120918 CTD MESH:D001629 Bezafibrate results in increased expression of ACADVL mRNA; Bezafibrate results in increased expression of ACADVL protein PMID:12782154|PMID:17118139|PMID:22338096 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:47612 bezafibrate increases expression ISO RGD:735407 E RGD:6480464 20120613 CTD MESH:D001629 Bezafibrate results in increased expression of ACADVL mRNA PMID:17999356 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:47612 bezafibrate multiple interactions EXP E RGD:6480464 20120613 CTD MESH:D001629 Butyrates promotes the reaction [Bezafibrate results in increased expression of ACADVL mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADVL mRNA]; PPARA protein affects the reaction [Bezafibrate results in increased expression of ACADVL protein] PMID:12782154|PMID:22338096 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:47612 bezafibrate multiple interactions ISO RGD:735407 E RGD:6480464 20120613 CTD MESH:D001629 Bezafibrate inhibits the reaction [ACADVL protein mutant form results in decreased oxidation of Fatty Acids] PMID:20060901 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20190312 CTD MESH:C016766 sulforaphane results in increased expression of ACADVL mRNA PMID:30529165 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:4791 endosulfan decreases expression ISO RGD:2014 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of ACADVL mRNA PMID:29391264 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:4811 epoxiconazole decreases expression EXP E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in decreased expression of ACADVL mRNA PMID:35436446 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:49662 indometacin decreases expression ISO RGD:2014 E RGD:6480464 20230704 CTD MESH:D007213 Indomethacin results in decreased expression of ACADVL mRNA PMID:36868495 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:5001 fenofibrate increases expression EXP E RGD:6480464 20120412 CTD MESH:D011345 Fenofibrate results in increased expression of ACADVL mRNA PMID:17118139 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:5001 fenofibrate increases expression ISO RGD:2014 E RGD:6480464 20170516 CTD MESH:D011345 Fenofibrate results in increased expression of ACADVL mRNA PMID:27665778 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:5001 fenofibrate increases expression ISO RGD:735407 E RGD:6480464 20190219 CTD MESH:D011345 Fenofibrate results in increased expression of ACADVL mRNA PMID:24752549 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:50131 5-aza-2'-deoxycytidine increases expression ISO RGD:735407 E RGD:6480464 20191114 CTD MESH:C014347 Decitabine results in increased expression of ACADVL mRNA PMID:19151715 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:50729 mitoxantrone decreases expression EXP E RGD:6480464 20211012 CTD MESH:D008942 Mitoxantrone results in decreased expression of ACADVL protein PMID:34246718 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:5132 flutamide decreases expression ISO RGD:2014 E RGD:6480464 20140909 CTD MESH:D005485 Flutamide results in decreased expression of ACADVL mRNA PMID:24793618 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:5132 flutamide increases expression ISO RGD:2014 E RGD:6480464 20120412 CTD MESH:D005485 Flutamide results in increased expression of ACADVL mRNA PMID:21525395 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:5296 gemfibrozil affects expression ISO RGD:2014 E RGD:6480464 20170516 CTD MESH:D015248 Gemfibrozil affects the expression of ACADVL mRNA PMID:27665778 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:5613 haloperidol decreases expression ISO RGD:735407 E RGD:6480464 20211207 CTD MESH:D006220 Haloperidol results in decreased expression of ACADVL protein PMID:34122009 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:6067 isotretinoin decreases expression ISO RGD:735407 E RGD:6480464 20120412 CTD MESH:D015474 Isotretinoin results in decreased expression of ACADVL mRNA PMID:20436886 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:6078 ivermectin decreases expression ISO RGD:735407 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ACADVL protein PMID:32959892 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:63933 Aroclor 1254 decreases expression EXP E RGD:6480464 20131210 CTD MESH:D020111 Chlorodiphenyl (54% Chlorine) results in decreased expression of ACADVL mRNA PMID:23650126 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:6402 leflunomide increases expression ISO RGD:2014 E RGD:6480464 20161213 CTD MESH:C045463 leflunomide results in increased expression of ACADVL mRNA PMID:24136188 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:64227 ciglitazone multiple interactions ISO RGD:735407 E RGD:6480464 20120412 CTD MESH:C039671 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACADVL mRNA PMID:16197558 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200317 CTD MESH:D012970 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADVL mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ACADVL mRNA PMID:23783067 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:64317 isoprenaline decreases expression ISO RGD:2014 E RGD:6480464 20211109 CTD MESH:D007545 Isoproterenol results in decreased expression of ACADVL mRNA PMID:30303030 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:64317 isoprenaline multiple interactions ISO RGD:2014 E RGD:6480464 20211109 CTD MESH:D007545 [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADVL mRNA PMID:30303030 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:6820 methapyrilene decreases expression ISO RGD:2014 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in decreased expression of ACADVL mRNA PMID:30467583 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:6925 microcystin-LR decreases expression EXP E RGD:6480464 20171010 CTD MESH:C057862 cyanoginosin LR results in decreased expression of ACADVL protein PMID:26984711 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:69478 cannabidiol decreases expression ISO RGD:735407 E RGD:6480464 20211207 CTD MESH:D002185 Cannabidiol results in decreased expression of ACADVL protein PMID:34122009 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:70778 GW 7647 increases expression ISO RGD:735407 E RGD:6480464 20190312 CTD MESH:C453899 GW 7647 results in increased expression of ACADVL mRNA PMID:30611723 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:70778 GW 7647 multiple interactions ISO RGD:735407 E RGD:6480464 20190312 CTD MESH:C453899 [GW 7647 co-treated with Oleic Acid] results in increased expression of ACADVL mRNA PMID:30611723 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:72544 flavonoids decreases expression ISO RGD:2014 E RGD:6480464 20170303 CTD MESH:D005419 Flavonoids results in decreased expression of ACADVL mRNA PMID:18035473 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:72754 bisphenol AF increases expression ISO RGD:735407 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of ACADVL protein PMID:34186270 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:73726 GW 501516 multiple interactions ISO RGD:735407 E RGD:6480464 20170303 CTD MESH:C425931 [GW 501516 binds to PPARD protein] which results in increased expression of ACADVL mRNA PMID:16197558 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:73755 1,2-dimethylhydrazine decreases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ACADVL mRNA PMID:22206623 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:75455 2-palmitoylglycerol increases expression ISO RGD:735407 E RGD:6480464 20240109 CTD MESH:C114956 2-palmitoylglycerol results in increased expression of ACADVL mRNA PMID:37199045 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:79997 GW 4064 multiple interactions ISO RGD:735407 E RGD:6480464 20190312 CTD MESH:C412815 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACADVL mRNA PMID:30611723 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression EXP E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of ACADVL mRNA PMID:38648751 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP E RGD:6480464 20241105 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACADVL mRNA PMID:38040069 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:81892 Brodifacoum increases expression ISO RGD:2014 E RGD:6480464 20171114 CTD MESH:C013418 bromfenacoum results in increased expression of ACADVL protein PMID:28903499 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:82195 Clofop multiple interactions ISO RGD:735407 E RGD:6480464 20141111 CTD MESH:C006012 [fenofibric acid binds to PPARA protein] which results in increased expression of ACADVL mRNA PMID:16197558 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:8249 piroxicam multiple interactions ISO RGD:735407 E RGD:6480464 20120412 CTD MESH:D010894 [Piroxicam co-treated with Cisplatin] results in decreased expression of ACADVL mRNA PMID:21858171 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:83197 picoxystrobin decreases expression ISO RGD:735407 E RGD:6480464 20210810 CTD MESH:C556557 picoxystrobin results in decreased expression of ACADVL mRNA PMID:33512557 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:83258 fenamidone increases expression EXP E RGD:6480464 20180116 CTD MESH:C540355 fenamidone results in increased expression of ACADVL mRNA PMID:27029645 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:84070 sodium arsenate multiple interactions ISO RGD:735407 E RGD:6480464 20200915 CTD MESH:C009277 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ACADVL mRNA PMID:32525701 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:8489 propiconazole decreases expression EXP E RGD:6480464 20120412 CTD MESH:C045950 propiconazole results in decreased expression of ACADVL mRNA PMID:21278054 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:8502 6-propyl-2-thiouracil decreases expression ISO RGD:2014 E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in decreased expression of ACADVL mRNA PMID:24780913 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:91091 CHIR 99021 decreases expression EXP E RGD:6480464 20190611 CTD MESH:C473711 Chir 99021 results in decreased expression of ACADVL mRNA PMID:29883716 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:91108 SB 431542 increases expression ISO RGD:735407 E RGD:6480464 20161220 CTD MESH:C459179 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ACADVL protein PMID:25670856 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:735407 E RGD:6480464 20240206 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ACADVL protein PMID:37664457 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:9195 Soman increases expression ISO RGD:2014 E RGD:6480464 20141111 CTD MESH:D012999 Soman results in increased expression of ACADVL mRNA PMID:19281266 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:9516 thapsigargin increases expression ISO RGD:735407 E RGD:6480464 20141014 CTD MESH:D019284 Thapsigargin results in increased expression of ACADVL mRNA PMID:22378314 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:955 2,6-dimethoxyphenol multiple interactions ISO RGD:735407 E RGD:6480464 20250114 CTD MESH:C010120 [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization of ACADVL protein PMID:38598786 10058 Acadvl acyl-Coenzyme A dehydrogenase, very long chain gene CHEBI:9753 troglitazone increases expression ISO RGD:2014 E RGD:6480464 20120918 CTD MESH:C057693 troglitazone results in increased expression of ACADVL mRNA PMID:21515302 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:132448 perfluorohexanesulfonic acid increases expression EXP E RGD:6480464 20160822 CTD MESH:C471071 perfluorohexanesulfonic acid results in increased expression of ACAT1 mRNA PMID:21705711 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:132471 (+)-schisandrin B multiple interactions ISO RGD:2016 E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACAT1 mRNA] PMID:31150632 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:135697 sarpogrelate multiple interactions ISO RGD:737017 E RGD:6480464 20170307 CTD MESH:C064294 sarpogrelate inhibits the reaction [Serotonin results in increased expression of ACAT1 protein]; sarpogrelate metabolite inhibits the reaction [Serotonin results in increased expression of ACAT1 protein] PMID:16157345 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:1391 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:2016 E RGD:6480464 20201215 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ACAT1 mRNA PMID:30071829 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:149838 Cryptotanshinone decreases expression ISO RGD:737017 E RGD:6480464 20250114 CTD MESH:C037886 cryptotanshinone results in decreased expression of ACAT1 mRNA PMID:38936533 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:15930 atrazine decreases expression ISO RGD:737017 E RGD:6480464 20141014 CTD MESH:D001280 Atrazine results in decreased expression of ACAT1 mRNA PMID:22378314 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:16130 DDT decreases expression ISO RGD:2016 E RGD:6480464 20210907 CTD MESH:D003634 DDT results in decreased expression of ACAT1 mRNA; DDT results in decreased expression of ACAT1 protein PMID:32508177 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:16196 oleic acid multiple interactions ISO RGD:737017 E RGD:6480464 20190312 CTD MESH:D019301 [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of ACAT1 mRNA; [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACAT1 mRNA PMID:30611723 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:16243 quercetin decreases expression ISO RGD:737017 E RGD:6480464 20121009 CTD MESH:D011794 Quercetin results in decreased expression of ACAT1 mRNA PMID:21632981 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:2016 E RGD:6480464 20230606 CTD MESH:D004958 Estradiol results in increased expression of ACAT1 mRNA PMID:32145629 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:2016 E RGD:6480464 20160705 CTD MESH:D004958 [bisphenol A co-treated with Estradiol] results in decreased expression of ACAT1 mRNA PMID:26496021 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:737017 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of ACAT1 mRNA PMID:37042841 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:166975 soybean oil decreases activity ISO RGD:2016 E RGD:6480464 20210105 CTD MESH:D013024 Soybean Oil results in decreased activity of ACAT1 protein PMID:12559476 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:16755 chenodeoxycholic acid decreases expression ISO RGD:737017 E RGD:6480464 20180220 CTD MESH:D002635 Chenodeoxycholic Acid results in decreased expression of ACAT1 mRNA PMID:27174168 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:16796 melatonin multiple interactions EXP E RGD:6480464 20221206 CTD MESH:D008550 Melatonin inhibits the reaction [Cisplatin results in decreased expression of ACAT1 mRNA] PMID:35367536 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:16796 melatonin multiple interactions ISO RGD:2016 E RGD:6480464 20230704 CTD MESH:D008550 Melatonin inhibits the reaction [Cisplatin results in decreased expression of ACAT1 mRNA] PMID:36006825 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:17303 morphine decreases expression ISO RGD:2016 E RGD:6480464 20130416 CTD MESH:D009020 Morphine results in decreased expression of ACAT1 protein PMID:23056601 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:17303 morphine multiple interactions ISO RGD:2016 E RGD:6480464 20130416 CTD MESH:D009020 Morphine deficiency affects the reaction [Morphine results in decreased expression of ACAT1 protein] PMID:23056601 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:17712 9H-xanthine multiple interactions ISO RGD:2016 E RGD:6480464 20120717 CTD MESH:D019820 [Xanthine co-treated with XDH protein] results in decreased expression of ACAT1 protein PMID:19464573 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:17833 gentamycin increases expression ISO RGD:2016 E RGD:6480464 20161228 CTD MESH:D005839 Gentamicins results in increased expression of ACAT1 mRNA PMID:22061828 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:17967 urethane decreases expression ISO RGD:737017 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in decreased expression of ACAT1 mRNA PMID:28818685 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:18145 (R,R,R)-alpha-tocopherol multiple interactions ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:D024502 alpha-Tocopherol inhibits the reaction [iron(II)-ascorbic acid complex results in decreased activity of ACAT1 protein] PMID:10656290 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:18721 3-chloropropane-1,2-diol increases expression ISO RGD:2016 E RGD:6480464 20170516 CTD MESH:D000517 alpha-Chlorohydrin analog results in increased expression of ACAT1 protein PMID:26597043 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:188851 Muraglitazar increases expression ISO RGD:2016 E RGD:6480464 20220104 CTD MESH:C500085 muraglitazar results in increased expression of ACAT1 mRNA PMID:21515302 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:232102 1-aminobenzotriazole multiple interactions EXP E RGD:6480464 20241119 CTD MESH:C033020 1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of ACAT1 protein] PMID:32435916 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:737017 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of ACAT1 mRNA PMID:19549813 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:23924 enzyme inhibitor multiple interactions ISO RGD:737017 E RGD:6480464 20161228 CTD MESH:D004791 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ACAT1 protein PMID:23301498 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:2504 aflatoxin B1 decreases expression EXP E RGD:6480464 20120501 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of ACAT1 mRNA PMID:19770486 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:254496 7,12-dimethyltetraphene decreases expression EXP E RGD:6480464 20240604 CTD MESH:D015127 9,10-Dimethyl-1,2-benzanthracene results in decreased expression of ACAT1 protein PMID:38307155 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:25812 ozone increases expression ISO RGD:2016 E RGD:6480464 20210209 CTD MESH:D010126 Ozone results in increased expression of ACAT1 protein PMID:33146391 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:2663 amiodarone increases expression EXP E RGD:6480464 20150127 CTD MESH:D000638 Amiodarone results in increased expression of ACAT1 mRNA PMID:24489787 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:26710 sodium chloride multiple interactions ISO RGD:737017 E RGD:6480464 20250114 CTD MESH:D012965 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of ACAT1 protein PMID:38598786 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27086 tributylstannane multiple interactions ISO RGD:2016 E RGD:6480464 20191112 CTD MESH:C011559 [bisphenol A co-treated with tributyltin] results in increased expression of ACAT1 mRNA PMID:31129395 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20200804 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACAT1 mRNA PMID:31919559 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:2016 E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACAT1 mRNA PMID:31150632 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27385 tetrachloromethane multiple interactions ISO RGD:2016 E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACAT1 mRNA] PMID:31150632 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACAT1 mRNA PMID:22206623 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:737017 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased secretion of ACAT1 protein PMID:38460933 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27856 acetamide decreases expression ISO RGD:2016 E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in decreased expression of ACAT1 mRNA PMID:31881176 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:737017 E RGD:6480464 20160822 CTD MESH:C059514 Resveratrol inhibits the reaction [GBA1 protein mutant form results in decreased expression of ACAT1 protein] PMID:26027833 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27899 cisplatin decreases expression EXP E RGD:6480464 20221206 CTD MESH:D002945 Cisplatin results in decreased expression of ACAT1 mRNA PMID:35367536 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27899 cisplatin decreases expression ISO RGD:2016 E RGD:6480464 20230704 CTD MESH:D002945 Cisplatin results in decreased expression of ACAT1 mRNA PMID:36006825 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27899 cisplatin increases expression ISO RGD:737017 E RGD:6480464 20170516 CTD MESH:D002945 Cisplatin results in increased expression of ACAT1 mRNA PMID:27392435 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27899 cisplatin multiple interactions EXP E RGD:6480464 20221206 CTD MESH:D002945 Melatonin inhibits the reaction [Cisplatin results in decreased expression of ACAT1 mRNA] PMID:35367536 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:2016 E RGD:6480464 20230704 CTD MESH:D002945 Melatonin inhibits the reaction [Cisplatin results in decreased expression of ACAT1 mRNA] PMID:36006825 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:27902 tetracycline decreases expression EXP E RGD:6480464 20150127 CTD MESH:D013752 Tetracycline results in decreased expression of ACAT1 mRNA PMID:24489787 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28001 vancomycin increases expression EXP E RGD:6480464 20120412 CTD MESH:D014640 Vancomycin results in increased expression of ACAT1 mRNA PMID:18930951 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20140909 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ACAT1 mRNA PMID:24680724 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20120501 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACAT1 mRNA PMID:19770486 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2016 E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACAT1 mRNA PMID:21215274|PMID:34747641 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28201 rotenone multiple interactions ISO RGD:737017 E RGD:6480464 20140311 CTD MESH:D012402 [7-ketocholesterol co-treated with Rotenone] results in decreased expression of ACAT1 mRNA; [Stigmasterol co-treated with Rotenone] results in decreased expression of ACAT1 mRNA PMID:23454145 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:737017 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of ACAT1 mRNA PMID:33212167 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28600 farnesol increases expression ISO RGD:737017 E RGD:6480464 20190312 CTD MESH:D005204 Farnesol analog results in increased expression of ACAT1 mRNA PMID:30611723 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28619 acrylamide decreases expression EXP E RGD:6480464 20220705 CTD MESH:D020106 Acrylamide results in decreased expression of ACAT1 mRNA PMID:34896238 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28619 acrylamide multiple interactions EXP E RGD:6480464 20220705 CTD MESH:D020106 Acrylamide inhibits the reaction [Streptozocin results in decreased expression of ACAT1 mRNA] PMID:34896238 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28694 copper atom decreases expression ISO RGD:2016 E RGD:6480464 20120717 CTD MESH:D003300 Copper results in decreased expression of ACAT1 mRNA PMID:22465980 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:737017 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of ACAT1 mRNA PMID:29803840 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28787 nitroglycerin increases expression ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:D005996 Nitroglycerin results in increased expression of ACAT1 mRNA PMID:12102619 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28790 serotonin increases expression ISO RGD:737017 E RGD:6480464 20160607 CTD MESH:D012701 Serotonin results in increased expression of ACAT1 mRNA alternative form PMID:16157345 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28790 serotonin multiple interactions ISO RGD:737017 E RGD:6480464 20160607 CTD MESH:D012701 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Serotonin results in increased expression of ACAT1 protein]; AG 1879 inhibits the reaction [Serotonin results in increased expression of ACAT1 protein]; guanosine 5'-O-(2-thiodiphosphate) inhibits the reaction [Serotonin results in increased expression of ACAT1 protein]; rottlerin inhibits the reaction [Serotonin results in increased expression of ACAT1 protein]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of ACAT1 protein]; sarpogrelate metabolite inhibits the reaction [Serotonin results in increased expression of ACAT1 protein]; Serotonin results in increased expression of and results in increased activity of ACAT1 protein PMID:16157345 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:28824 stigmasterol multiple interactions ISO RGD:737017 E RGD:6480464 20140311 CTD MESH:D013265 [Stigmasterol co-treated with KNG1 protein modified form] results in decreased expression of ACAT1 mRNA; [Stigmasterol co-treated with Oligomycins] results in decreased expression of ACAT1 mRNA; [Stigmasterol co-treated with Rotenone] results in decreased expression of ACAT1 mRNA PMID:23454145 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:29678 sodium arsenite decreases expression EXP E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in decreased expression of ACAT1 mRNA PMID:37668303 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:737017 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of ACAT1 mRNA PMID:38568856 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:2016 E RGD:6480464 20190507 CTD MESH:C017947 sodium arsenite results in increased expression of ACAT1 protein PMID:29459688 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:29699 tunicamycin decreases expression EXP E RGD:401842386|PMID:27813192 20231018 RGD MESH:D014415 tunicamycin decreases expression of Acat1 mRNA in liver 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:29699 tunicamycin decreases expression ISO RGD:737017 E RGD:6480464 20141014 CTD MESH:D014415 Tunicamycin results in decreased expression of ACAT1 mRNA PMID:22378314 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:29699 tunicamycin multiple interactions EXP E RGD:401842386|PMID:27813192 20231018 RGD MESH:D014415 naltrexone inhibits the reaction [tunicamycin decreases expression of Acat1 mRNA in liver] 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20120501 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ACAT1 mRNA PMID:19770486 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:737017 E RGD:6480464 20200714 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ACAT1 mRNA PMID:32234424 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ACAT1 mRNA PMID:22228805 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:737017 E RGD:6480464 20220405 CTD MESH:C015001 arsenite promotes the reaction [G3BP1 protein binds to ACAT1 mRNA] PMID:32406909 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:30052 copper(0) decreases expression ISO RGD:2016 E RGD:6480464 20120717 CTD MESH:D003300 Copper results in decreased expression of ACAT1 mRNA PMID:22465980 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:30621 diarsenic trioxide increases expression ISO RGD:737017 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in increased expression of ACAT1 mRNA PMID:22521957 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ACAT1 mRNA PMID:16483693 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:31767 lead diacetate decreases expression EXP E RGD:6480464 20120814 CTD MESH:C008261 lead acetate results in decreased expression of ACAT1 mRNA PMID:21829687 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:32195 Tesaglitazar increases expression ISO RGD:2016 E RGD:6480464 20170303 CTD MESH:C501413 tesaglitazar results in increased expression of ACAT1 mRNA PMID:21515302 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:737017 E RGD:6480464 20190910 CTD MESH:C009495 titanium dioxide results in decreased expression of ACAT1 protein PMID:30910687 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:32234 titanium dioxide increases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of ACAT1 gene PMID:35295148 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:32497 thioacetamide decreases expression ISO RGD:2016 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of ACAT1 mRNA PMID:34492290 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:32506 4,4'-diaminodiphenylmethane decreases expression ISO RGD:2016 E RGD:6480464 20160315 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in decreased expression of ACAT1 mRNA PMID:25380136 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:32509 pirinixic acid increases expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in increased expression of ACAT1 mRNA; pirinixic acid results in increased expression of ACAT1 protein PMID:15226431|PMID:18301758|PMID:20813756|PMID:23811191 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:32509 pirinixic acid increases expression ISO RGD:2016 E RGD:6480464 20121113 CTD MESH:C006253 pirinixic acid results in increased expression of ACAT1 mRNA PMID:16940010|PMID:17164430|PMID:19162173|PMID:22484513 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:32509 pirinixic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ACAT1 mRNA PMID:19710929 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of ACAT1 mRNA PMID:33221593 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2016 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of ACAT1 mRNA PMID:25181051 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:737017 E RGD:6480464 20230307 CTD MESH:C006780 bisphenol A results in decreased expression of ACAT1 protein PMID:34186270 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:2016 E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in increased expression of ACAT1 mRNA PMID:30816183|PMID:32528016|PMID:34947998 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:737017 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of ACAT1 protein PMID:37567409 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:2016 E RGD:6480464 20160705 CTD MESH:C006780 [bisphenol A co-treated with Estradiol] results in decreased expression of ACAT1 mRNA; [bisphenol A co-treated with tributyltin] results in increased expression of ACAT1 mRNA PMID:26496021|PMID:31129395 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34031 1,1-dichloroethene decreases expression EXP E RGD:6480464 20170725 CTD MESH:C029297 vinylidene chloride results in decreased expression of ACAT1 mRNA PMID:26682919 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34039 1,2,4-trimethylbenzene decreases expression ISO RGD:2016 E RGD:6480464 20120918 CTD MESH:C010313 pseudocumene results in decreased expression of ACAT1 protein PMID:17337753 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions ISO RGD:737017 E RGD:6480464 20180116 CTD MESH:C543008 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ACAT1 mRNA PMID:28628672 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34566 Benzo[b]fluorene increases expression ISO RGD:2016 E RGD:6480464 20241001 CTD MESH:C041512 benzo(b)fluorene results in increased expression of ACAT1 mRNA PMID:38903859 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34575 bisphenol F increases expression EXP E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in increased expression of ACAT1 mRNA PMID:38685157 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34575 bisphenol F increases expression ISO RGD:737017 E RGD:6480464 20230307 CTD MESH:C008745 bisphenol F results in increased expression of ACAT1 protein PMID:34186270 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34575 bisphenol F multiple interactions ISO RGD:737017 E RGD:6480464 20180116 CTD MESH:C008745 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACAT1 mRNA PMID:28628672 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34581 Bisphenol B increases expression ISO RGD:737017 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of ACAT1 protein PMID:34186270 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34687 dibutyl phthalate decreases expression EXP E RGD:6480464 20121113 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ACAT1 mRNA PMID:17361019|PMID:21266533 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34687 dibutyl phthalate increases expression ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of ACAT1 mRNA PMID:21266533 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34768 furfural multiple interactions ISO RGD:737017 E RGD:6480464 20250114 CTD MESH:D005662 [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of ACAT1 protein PMID:38598786 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737017 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACAT1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ACAT1 mRNA PMID:28628672 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:34873 N-nitrosodiethylamine multiple interactions ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:D004052 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of ACAT1 mRNA PMID:18253720 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:35455 1-naphthyl isothiocyanate decreases expression ISO RGD:2016 E RGD:6480464 20160315 CTD MESH:D015058 1-Naphthylisothiocyanate results in decreased expression of ACAT1 mRNA PMID:25380136|PMID:30723492 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:2016 E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of ACAT1 mRNA PMID:33453195 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:737017 E RGD:6480464 20150310 CTD MESH:D019256 Cadmium Chloride results in increased expression of ACAT1 protein PMID:24527689 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:35549 perfluorooctanoic acid increases expression EXP E RGD:6480464 20190507 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACAT1 mRNA PMID:30657992 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:2016 E RGD:6480464 20120501 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACAT1 mRNA; perfluorooctanoic acid results in increased expression of ACAT1 protein PMID:16221955|PMID:19162173|PMID:28511854|PMID:34958885 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:737017 E RGD:6480464 20171010 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACAT1 protein PMID:26879310 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:35559 furan affects binding ISO RGD:2016 E RGD:6480464 20120918 CTD MESH:C039281 furan binds to ACAT1 protein PMID:22240984 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:35591 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:D011285 Pregnenolone Carbonitrile results in decreased expression of ACAT1 mRNA PMID:19162173 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:35807 N-nitrosodimethylamine decreases expression ISO RGD:2016 E RGD:6480464 20160315 CTD MESH:D004128 Dimethylnitrosamine results in decreased expression of ACAT1 mRNA PMID:25380136 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:737017 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of ACAT1 mRNA PMID:24449571 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20140610 CTD MESH:D002994 Clofibrate results in increased expression of ACAT1 mRNA PMID:23811191 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:3750 clofibrate increases expression ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:D002994 Clofibrate results in increased expression of ACAT1 protein PMID:16470657 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:38309 GDP-beta-S multiple interactions ISO RGD:737017 E RGD:6480464 20160607 CTD MESH:C023427 guanosine 5'-O-(2-thiodiphosphate) inhibits the reaction [Serotonin results in increased expression of ACAT1 protein] PMID:16157345 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:38658 dicrotophos decreases expression ISO RGD:737017 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in decreased expression of ACAT1 mRNA PMID:28302478 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:39421 perfluorooctane-1-sulfonic acid decreases expression EXP E RGD:6480464 20180515 CTD MESH:C076994 perfluorooctane sulfonic acid results in decreased expression of ACAT1 protein PMID:26178269 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression EXP E RGD:6480464 20130416 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of ACAT1 mRNA PMID:20936131|PMID:21705711 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of ACAT1 mRNA PMID:18692542|PMID:19162173 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20130416 CTD MESH:C076994 PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in increased expression of ACAT1 mRNA] PMID:20936131 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:39501 2,2,2-tetramine multiple interactions ISO RGD:2016 E RGD:6480464 20120717 CTD MESH:D014266 Trientine inhibits the reaction [Streptozocin results in decreased expression of ACAT1 protein] PMID:19634143 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:39867 valproic acid affects expression ISO RGD:737017 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ACAT1 mRNA PMID:25979313 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:39867 valproic acid decreases expression ISO RGD:737017 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased expression of ACAT1 mRNA PMID:29154799 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:39867 valproic acid increases expression EXP E RGD:6480464 20150127 CTD MESH:D014635 Valproic Acid results in increased expression of ACAT1 mRNA PMID:24489787 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:39867 valproic acid increases expression ISO RGD:737017 E RGD:6480464 20140513 CTD MESH:D014635 Valproic Acid results in increased expression of ACAT1 mRNA PMID:23179753 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:4031 cyclosporin A decreases expression EXP E RGD:6480464 20140408 CTD MESH:D016572 Cyclosporine results in decreased expression of ACAT1 mRNA PMID:19770486|PMID:23830897 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:737017 E RGD:6480464 20140408 CTD MESH:D016572 Cyclosporine results in decreased expression of ACAT1 mRNA PMID:20106945|PMID:23830897 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:41774 tamoxifen decreases expression ISO RGD:2016 E RGD:6480464 20121113 CTD MESH:D013629 Tamoxifen results in decreased expression of ACAT1 mRNA PMID:17630414 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:41774 tamoxifen increases expression ISO RGD:2016 E RGD:6480464 20121113 CTD MESH:D013629 Tamoxifen results in increased expression of ACAT1 mRNA PMID:17630414 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:41774 tamoxifen multiple interactions ISO RGD:2016 E RGD:6480464 20121113 CTD MESH:D013629 [Tamoxifen co-treated with bexarotene] results in increased expression of ACAT1 mRNA PMID:17630414 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:737017 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACAT1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ACAT1 mRNA PMID:28628672 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of ACAT1 mRNA PMID:17562736 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:46195 paracetamol decreases expression ISO RGD:737017 E RGD:6480464 20150825 CTD MESH:D000082 Acetaminophen results in decreased expression of ACAT1 mRNA PMID:25704631|PMID:29067470 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:46195 paracetamol increases expression EXP E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen results in increased expression of ACAT1 protein PMID:11752693 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:46645 isobutanol multiple interactions ISO RGD:737017 E RGD:6480464 20181016 CTD MESH:C040507 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ACAT1 mRNA PMID:29432896 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:46666 crocidolite asbestos increases expression ISO RGD:737017 E RGD:6480464 20180828 CTD MESH:D017638 Asbestos, Crocidolite results in increased expression of ACAT1 mRNA PMID:29523930 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:737017 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased secretion of ACAT1 protein PMID:38460933 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:46790 2-methoxyethanol increases expression ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:C005219 methyl cellosolve results in increased expression of ACAT1 mRNA PMID:21427058 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:47318 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime multiple interactions ISO RGD:737017 E RGD:6480464 20190312 CTD MESH:C475093 [6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime co-treated with Oleic Acid] results in increased expression of ACAT1 mRNA PMID:30611723 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:4791 endosulfan decreases expression ISO RGD:2016 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of ACAT1 mRNA PMID:29391264 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:4811 epoxiconazole decreases expression EXP E RGD:6480464 20141111 CTD MESH:C109476 epoxiconazole results in decreased expression of ACAT1 mRNA PMID:22334560 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:48517 7H-xanthine multiple interactions ISO RGD:2016 E RGD:6480464 20121218 CTD MESH:D019820 [Xanthine co-treated with XDH protein] results in decreased expression of ACAT1 protein PMID:19464573 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:49662 indometacin decreases expression ISO RGD:2016 E RGD:6480464 20230704 CTD MESH:D007213 Indomethacin results in decreased expression of ACAT1 mRNA PMID:36868495 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:49662 indometacin multiple interactions ISO RGD:737017 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ACAT1 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ACAT1 mRNA PMID:28628672 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:49900 arsenous acid increases expression ISO RGD:737017 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in increased expression of ACAT1 mRNA PMID:22521957 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:5001 fenofibrate increases expression ISO RGD:737017 E RGD:6480464 20190219 CTD MESH:D011345 Fenofibrate results in increased expression of ACAT1 mRNA PMID:24752549 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:5001 fenofibrate multiple interactions ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:D011345 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of ACAT1 mRNA PMID:18253720 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:50594 carbon nanotube increases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of ACAT1 mRNA; Nanotubes, Carbon results in increased expression of ACAT1 mRNA PMID:25620056 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:5062 finasteride increases expression ISO RGD:2016 E RGD:6480464 20160412 CTD MESH:D018120 Finasteride results in increased expression of ACAT1 mRNA PMID:24136188 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:50859 bexarotene increases expression ISO RGD:2016 E RGD:6480464 20170303 CTD MESH:C095105 bexarotene results in increased expression of ACAT1 mRNA PMID:16648578|PMID:17630414 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:50859 bexarotene multiple interactions ISO RGD:2016 E RGD:6480464 20170303 CTD MESH:C095105 [Tamoxifen co-treated with bexarotene] results in increased expression of ACAT1 mRNA PMID:17630414 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:51397 1,3-dinitrobenzene increases oxidation ISO RGD:2016 E RGD:6480464 20150512 CTD MESH:C017906 3-dinitrobenzene results in increased oxidation of ACAT1 protein PMID:25716674 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:53444 potassium dichromate increases expression ISO RGD:737017 E RGD:6480464 20121009 CTD MESH:D011192 Potassium Dichromate results in increased expression of ACAT1 mRNA PMID:18332044 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:5613 haloperidol decreases expression ISO RGD:737017 E RGD:6480464 20211207 CTD MESH:D006220 Haloperidol results in decreased expression of ACAT1 protein PMID:34122009 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:6078 ivermectin decreases expression ISO RGD:737017 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ACAT1 protein PMID:32959892 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:63618 pravastatin decreases expression EXP E RGD:6480464 20180220 CTD MESH:D017035 Pravastatin results in decreased expression of ACAT1 mRNA PMID:27225895 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:63618 pravastatin decreases expression ISO RGD:2016 E RGD:6480464 20180220 CTD MESH:D017035 Pravastatin results in decreased expression of ACAT1 mRNA PMID:27225895 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:63919 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol increases expression ISO RGD:2016 E RGD:6480464 20241001 CTD MESH:C033729 fluorotelomer alcohols results in increased expression of ACAT1 mRNA PMID:38903859 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:6402 leflunomide increases expression ISO RGD:2016 E RGD:6480464 20161213 CTD MESH:C045463 leflunomide results in increased expression of ACAT1 mRNA PMID:24136188 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:641 N-methyl-4-phenylpyridinium increases expression EXP E RGD:6480464 20160210 CTD MESH:D015655 1-Methyl-4-phenylpyridinium results in increased expression of ACAT1 protein PMID:26558463 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:64294 7-ketocholesterol multiple interactions ISO RGD:737017 E RGD:6480464 20140311 CTD MESH:C003001 [7-ketocholesterol co-treated with KNG1 protein modified form] results in decreased expression of ACAT1 mRNA; [7-ketocholesterol co-treated with Rotenone] results in decreased expression of ACAT1 mRNA PMID:23454145 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:64482 phosphatidylcholine decreases activity ISO RGD:2016 E RGD:6480464 20170228 CTD MESH:D010713 Phosphatidylcholines results in decreased activity of ACAT1 protein PMID:12559476 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:6820 methapyrilene decreases expression ISO RGD:2016 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in decreased expression of ACAT1 mRNA PMID:30467583 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:70436 platycodin D decreases activity ISO RGD:737017 E RGD:6480464 20190910 CTD MESH:C108953 platycodin D results in decreased activity of ACAT1 protein PMID:16626693 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:72564 temozolomide increases expression ISO RGD:737017 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in increased expression of ACAT1 mRNA PMID:31758290 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:72754 bisphenol AF increases expression ISO RGD:737017 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of ACAT1 protein PMID:34186270 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ACAT1 mRNA PMID:22206623 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ACAT1 mRNA PMID:22206623 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:75170 zaragozic acid A decreases expression EXP E RGD:6480464 20180220 CTD MESH:C075117 squalestatin 1 results in decreased expression of ACAT1 mRNA PMID:27225895 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:75170 zaragozic acid A increases expression ISO RGD:2016 E RGD:6480464 20180220 CTD MESH:C075117 squalestatin 1 results in increased expression of ACAT1 mRNA PMID:27225895 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:79997 GW 4064 decreases expression ISO RGD:737017 E RGD:6480464 20190312 CTD MESH:C412815 GW 4064 results in decreased expression of ACAT1 mRNA PMID:30611723 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:79997 GW 4064 multiple interactions ISO RGD:737017 E RGD:6480464 20190312 CTD MESH:C412815 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACAT1 mRNA PMID:30611723 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:80630 irinotecan increases response to substance ISO RGD:737017 E RGD:6480464 20181113 CTD MESH:D000077146 ACAT1 protein results in increased susceptibility to Irinotecan PMID:16734730 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:8069 phenobarbital affects expression EXP E RGD:6480464 20130514 CTD MESH:D010634 Phenobarbital affects the expression of ACAT1 mRNA PMID:23091169 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:8069 phenobarbital decreases expression EXP E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in decreased expression of ACAT1 mRNA PMID:19482888 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:8069 phenobarbital increases expression ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in increased expression of ACAT1 mRNA PMID:19162173 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:8069 phenobarbital multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D010634 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ACAT1 mRNA] PMID:19482888 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:8113 phlorizin decreases expression EXP E RGD:6480464 20121009 CTD MESH:D010695 Phlorhizin results in decreased expression of ACAT1 mRNA PMID:22538082 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP E RGD:6480464 20241105 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACAT1 mRNA PMID:38040069 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:81758 cyproconazole decreases expression EXP E RGD:6480464 20141111 CTD MESH:C093628 cyproconazole results in decreased expression of ACAT1 mRNA PMID:22334560 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:82163 rac-1,2-dichloropropane decreases expression EXP E RGD:6480464 20200915 CTD MESH:C004765 propylene dichloride results in decreased expression of ACAT1 protein PMID:32435916 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:82163 rac-1,2-dichloropropane multiple interactions EXP E RGD:6480464 20200915 CTD MESH:C004765 1-aminobenzotriazole affects the reaction [propylene dichloride results in decreased expression of ACAT1 protein] PMID:32435916 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:8228 pioglitazone decreases expression ISO RGD:737017 E RGD:6480464 20120515 CTD MESH:C060836 pioglitazone results in decreased expression of ACAT1 mRNA PMID:15381068 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:83197 picoxystrobin increases expression ISO RGD:737017 E RGD:6480464 20210810 CTD MESH:C556557 picoxystrobin results in increased expression of ACAT1 mRNA PMID:33512557 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:8489 propiconazole decreases expression EXP E RGD:6480464 20120918 CTD MESH:C045950 propiconazole results in decreased expression of ACAT1 mRNA PMID:21278054|PMID:22334560 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:8899 rottlerin multiple interactions ISO RGD:737017 E RGD:6480464 20160607 CTD MESH:C085746 rottlerin inhibits the reaction [Serotonin results in increased expression of ACAT1 protein] PMID:16157345 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:9288 streptozocin decreases expression EXP E RGD:6480464 20220705 CTD MESH:D013311 Streptozocin results in decreased expression of ACAT1 mRNA PMID:34896238 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:9288 streptozocin decreases expression ISO RGD:2016 E RGD:6480464 20120717 CTD MESH:D013311 Streptozocin results in decreased expression of ACAT1 protein PMID:19634143 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:9288 streptozocin multiple interactions EXP E RGD:6480464 20220705 CTD MESH:D013311 Acrylamide inhibits the reaction [Streptozocin results in decreased expression of ACAT1 mRNA] PMID:34896238 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:9288 streptozocin multiple interactions ISO RGD:2016 E RGD:6480464 20120717 CTD MESH:D013311 Trientine inhibits the reaction [Streptozocin results in decreased expression of ACAT1 protein] PMID:19634143 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:9495 thiram decreases expression ISO RGD:737017 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of ACAT1 mRNA PMID:38568856 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:957 2,6-dinitrotoluene affects expression ISO RGD:2016 E RGD:6480464 20120412 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of ACAT1 mRNA PMID:21346803 10060 Acat1 acetyl-Coenzyme A acetyltransferase 1 gene CHEBI:9753 troglitazone increases expression ISO RGD:2016 E RGD:6480464 20120918 CTD MESH:C057693 troglitazone results in increased expression of ACAT1 mRNA PMID:21515302 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:10110 zidovudine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D015215 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ASIC2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ASIC2 mRNA PMID:16931933 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:132471 (+)-schisandrin B multiple interactions ISO RGD:2017 E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ASIC2 mRNA] PMID:31150632 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ASIC2 gene PMID:20938992 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:15365 acetylsalicylic acid decreases expression ISO RGD:2017 E RGD:6480464 20120918 CTD MESH:D001241 Aspirin results in decreased expression of ASIC2 mRNA PMID:11588175 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:737359 E RGD:6480464 20120501 CTD MESH:D014212 Tretinoin results in increased expression of ASIC2 mRNA PMID:21934132 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:15422 ATP multiple interactions ISO RGD:2017 E RGD:6480464 20120412 CTD MESH:D000255 [Acids binds to and affects the activity of ASIC2 protein] which results in increased secretion of Adenosine Triphosphate PMID:19860742 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:15930 atrazine affects methylation ISO RGD:2017 E RGD:6480464 20190219 CTD MESH:D001280 Atrazine affects the methylation of ASIC2 gene PMID:28931070|PMID:35440735 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:164200 triclosan decreases expression ISO RGD:737359 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in decreased expression of ASIC2 mRNA PMID:30510588 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20120412 CTD MESH:D004958 Estradiol affects the expression of ASIC2 mRNA PMID:15598610 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:165219 PCB138 multiple interactions EXP E RGD:6480464 20201208 CTD MESH:C029790 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASIC2 mRNA PMID:25510870 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:16643 L-methionine multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ASIC2 gene PMID:20938992 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ASIC2 mRNA PMID:37325564 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:737359 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of ASIC2 gene; Aflatoxin B1 results in decreased methylation of ASIC2 intron; Aflatoxin B1 results in decreased methylation of ASIC2 promoter PMID:27153756|PMID:30157460 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:2679 amphetamine affects localization ISO RGD:2017 E RGD:6480464 20191114 CTD MESH:D000661 Amphetamine affects the localization of ASIC2 protein PMID:20566346 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:2017 E RGD:6480464 20120412 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ASIC2 mRNA PMID:16644059|PMID:31150632 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:27385 tetrachloromethane multiple interactions ISO RGD:2017 E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ASIC2 mRNA] PMID:31150632 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:27470 folic acid decreases expression ISO RGD:737359 E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of ASIC2 mRNA PMID:21867686 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D005492 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ASIC2 gene PMID:20938992 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:737359 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of ASIC2 gene PMID:25304211 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:27684 phenylmercury acetate decreases expression ISO RGD:737359 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in decreased expression of ASIC2 mRNA PMID:26272509 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:737359 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASIC2 mRNA PMID:27188386 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:27744 glyphosate affects methylation ISO RGD:2017 E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate affects the methylation of ASIC2 gene PMID:35440735 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:27744 glyphosate increases methylation ISO RGD:2017 E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased methylation of ASIC2 gene PMID:31011160 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2017 E RGD:6480464 20200609 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ASIC2 mRNA PMID:32109520 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASIC2 mRNA PMID:17942748 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:737359 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite results in increased expression of ASIC2 mRNA PMID:34032870 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:737359 E RGD:6480464 20190219 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ASIC2 intron; Benzo(a)pyrene affects the methylation of ASIC2 promoter PMID:27901495|PMID:30157460 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:29865 benzo[a]pyrene decreases methylation EXP E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ASIC2 intron PMID:27901495 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:737359 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ASIC2 3' UTR; Benzo(a)pyrene results in increased methylation of ASIC2 exon PMID:27901495 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20120515 CTD MESH:D001564 Benzo(a)pyrene promotes the reaction [AHR protein binds to ASIC2 promoter] PMID:19654925 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:29866 arsenite(3-) increases methylation ISO RGD:737359 E RGD:6480464 20141111 CTD MESH:C015001 arsenite results in increased methylation of ASIC2 promoter PMID:23974009 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:30563 silicon dioxide increases expression ISO RGD:737359 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in increased expression of ASIC2 mRNA PMID:25895662 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2017 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ASIC2 mRNA PMID:16483693 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:31638 fulvestrant multiple interactions ISO RGD:737359 E RGD:6480464 20220308 CTD MESH:C070081 [bisphenol A co-treated with Fulvestrant] affects the methylation of ASIC2 gene PMID:31601247 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:32234 titanium dioxide decreases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ASIC2 gene; titanium dioxide results in decreased methylation of ASIC2 promoter PMID:35295148 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:32234 titanium dioxide increases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of ASIC2 promoter PMID:35295148 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:33216 bisphenol A affects expression ISO RGD:2017 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of ASIC2 mRNA PMID:25181051 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in increased expression of ASIC2 mRNA PMID:32156529 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:33216 bisphenol A increases methylation ISO RGD:2017 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of ASIC2 gene PMID:28505145 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:33216 bisphenol A increases methylation ISO RGD:737359 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in increased methylation of ASIC2 gene PMID:31601247 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:737359 E RGD:6480464 20220308 CTD MESH:C006780 [bisphenol A co-treated with Fulvestrant] affects the methylation of ASIC2 gene PMID:31601247 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP E RGD:6480464 20150414 CTD MESH:C014024 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASIC2 mRNA PMID:25510870 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20150414 CTD MESH:C009407 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of ASIC2 mRNA PMID:25510870 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases methylation ISO RGD:737359 E RGD:6480464 20220308 CTD MESH:C543008 bisphenol S results in decreased methylation of ASIC2 gene PMID:31601247 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:34372 4,4'-sulfonyldiphenol increases methylation EXP E RGD:6480464 20220208 CTD MESH:C543008 bisphenol S results in increased methylation of ASIC2 exon PMID:33297965 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:34567 benzo[e]pyrene increases methylation ISO RGD:737359 E RGD:6480464 20190219 CTD MESH:C026487 benzo(e)pyrene results in increased methylation of ASIC2 intron PMID:30157460 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:34682 diazinon affects expression ISO RGD:2017 E RGD:6480464 20141111 CTD MESH:D003976 Diazinon affects the expression of ASIC2 mRNA PMID:22546817 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:34887 nickel dichloride affects expression ISO RGD:2017 E RGD:6480464 20141111 CTD MESH:C022838 nickel chloride affects the expression of ASIC2 mRNA PMID:22546817 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ASIC2 mRNA PMID:37325564 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:41879 dexamethasone decreases expression ISO RGD:2017 E RGD:6480464 20120918 CTD MESH:D003907 Dexamethasone results in decreased expression of ASIC2 mRNA PMID:11588175 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:44032 indinavir multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D019469 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ASIC2 mRNA PMID:16931933 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:44185 methotrexate increases expression ISO RGD:737359 E RGD:6480464 20151110 CTD MESH:D008727 Methotrexate results in increased expression of ASIC2 mRNA PMID:24449571 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:47217 arsane affects methylation ISO RGD:737359 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of ASIC2 gene PMID:25304211 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:47381 diclofenac decreases expression ISO RGD:2017 E RGD:6480464 20120918 CTD MESH:D004008 Diclofenac results in decreased expression of ASIC2 mRNA PMID:11588175 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:48843 disodium selenite decreases expression ISO RGD:737359 E RGD:6480464 20120412 CTD MESH:D018038 Sodium Selenite results in decreased expression of ASIC2 mRNA PMID:18175754 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ASIC2 mRNA PMID:17942748 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:2017 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ASIC2 mRNA PMID:12075121 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ASIC2 mRNA PMID:17942748 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:5014 fenvalerate increases expression ISO RGD:2017 E RGD:6480464 20201103 CTD MESH:C017690 fenvalerate results in increased expression of ASIC2 mRNA PMID:30307764 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:5855 ibuprofen decreases expression ISO RGD:2017 E RGD:6480464 20120918 CTD MESH:D007052 Ibuprofen results in decreased expression of ASIC2 mRNA PMID:11588175 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:63577 lamivudine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D019259 [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ASIC2 mRNA; [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ASIC2 mRNA PMID:16931933 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:63621 saquinavir multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D019258 [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ASIC2 mRNA PMID:16931933 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:6820 methapyrilene increases methylation ISO RGD:737359 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in increased methylation of ASIC2 intron PMID:30157460 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:6842 methoxychlor affects methylation ISO RGD:2017 E RGD:6480464 20230905 CTD MESH:D008731 Methoxychlor affects the methylation of ASIC2 gene PMID:35440735 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ASIC2 mRNA PMID:22206623 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:737359 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASIC2 mRNA PMID:27188386 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:737359 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to ASIC2 gene] PMID:28238834 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:8207 (+)-pilocarpine decreases expression ISO RGD:2017 E RGD:6480464 20120412 CTD MESH:D010862 Pilocarpine results in decreased expression of ASIC2 mRNA alternative form PMID:11162239 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:82527 Ptaquiloside decreases expression EXP E RGD:6480464 20141111 CTD MESH:C043680 ptaquiloside results in decreased expression of ASIC2 mRNA PMID:23274088 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2017 E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of ASIC2 mRNA PMID:24780913 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:737359 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ASIC2 mRNA PMID:27188386 10061 Asic2 acid-sensing ion channel 2 gene CHEBI:9986 vinclozolin affects expression ISO RGD:2017 E RGD:6480464 20141111 CTD MESH:C025643 vinclozolin affects the expression of ASIC2 mRNA PMID:19015723 10064 Acly ATP citrate lyase gene CHEBI:10607 n-propyl gallate affects expression ISO RGD:2018 E RGD:6480464 20141111 CTD MESH:D011435 Propyl Gallate affects the expression of ACLY mRNA PMID:18539377 10064 Acly ATP citrate lyase gene CHEBI:116509 diuron decreases expression ISO RGD:10065 E RGD:6480464 20230905 CTD MESH:D004237 Diuron results in decreased expression of ACLY mRNA PMID:35967413 10064 Acly ATP citrate lyase gene CHEBI:132824 spathulenol multiple interactions ISO RGD:10065 E RGD:6480464 20240806 CTD MESH:C013258 [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA PMID:38000518 10064 Acly ATP citrate lyase gene CHEBI:134716 brexpiprazole decreases expression ISO RGD:10065 E RGD:6480464 20240109 CTD MESH:C000591922 brexpiprazole results in decreased expression of ACLY mRNA; brexpiprazole results in decreased expression of ACLY protein PMID:37347510 10064 Acly ATP citrate lyase gene CHEBI:134751 avobenzone increases expression ISO RGD:10065 E RGD:6480464 20190910 CTD MESH:C049935 avobenzone results in increased expression of ACLY mRNA PMID:31016361 10064 Acly ATP citrate lyase gene CHEBI:135338 guggulsterone multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C023617 pregna-4,17-diene-3,16-dione inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA] PMID:31421115 10064 Acly ATP citrate lyase gene CHEBI:139523 Rosavin increases expression ISO RGD:10065 E RGD:6480464 20190219 CTD MESH:C529148 rosavin results in increased expression of ACLY mRNA PMID:20706672 10064 Acly ATP citrate lyase gene CHEBI:15351 acetyl-CoA affects abundance EXP E RGD:6480464 20240604 CTD MESH:D000105 ACLY protein affects the abundance of Acetyl Coenzyme A PMID:36933457 10064 Acly ATP citrate lyase gene CHEBI:15351 acetyl-CoA increases abundance EXP E RGD:6480464 20170613 CTD MESH:D000105 ACLY protein results in increased abundance of Acetyl Coenzyme A PMID:28077572 10064 Acly ATP citrate lyase gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACLY gene PMID:20938992 10064 Acly ATP citrate lyase gene CHEBI:15368 acrolein multiple interactions ISO RGD:10065 E RGD:6480464 20231205 CTD MESH:D000171 [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of ACLY mRNA PMID:32845096 10064 Acly ATP citrate lyase gene CHEBI:15379 dioxygen increases phosphorylation ISO RGD:10065 E RGD:6480464 20190910 CTD MESH:D010100 Oxygen deficiency results in increased phosphorylation of ACLY protein PMID:26087400 10064 Acly ATP citrate lyase gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20190312 CTD MESH:D010100 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ACLY mRNA PMID:30529165 10064 Acly ATP citrate lyase gene CHEBI:15396 (R)-camphor multiple interactions ISO RGD:10065 E RGD:6480464 20240806 CTD MESH:D002164 [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA PMID:38000518 10064 Acly ATP citrate lyase gene CHEBI:15443 inulin multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ACLY mRNA PMID:36331819 10064 Acly ATP citrate lyase gene CHEBI:15756 hexadecanoic acid increases expression EXP E RGD:6480464 20191210 CTD MESH:D019308 Palmitic Acid results in increased expression of ACLY mRNA PMID:31421115 10064 Acly ATP citrate lyase gene CHEBI:15756 hexadecanoic acid multiple interactions EXP E RGD:6480464 20191210 CTD MESH:D019308 acanthoic acid inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA]; GW 3965 inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA]; pregna-4,17-diene-3,16-dione inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA] PMID:31421115 10064 Acly ATP citrate lyase gene CHEBI:15930 atrazine multiple interactions EXP E RGD:6480464 20140513 CTD MESH:D001280 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of ACLY mRNA PMID:24440342 10064 Acly ATP citrate lyase gene CHEBI:16112 chlorogenic acid increases expression ISO RGD:10065 E RGD:6480464 20121218 CTD MESH:D002726 Chlorogenic Acid results in increased expression of ACLY mRNA PMID:20706672 10064 Acly ATP citrate lyase gene CHEBI:16113 cholesterol multiple interactions EXP E RGD:6480464 20140513 CTD MESH:D002784 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of ACLY mRNA; [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Ethinyl Estradiol] results in increased expression of ACLY mRNA PMID:24440342 10064 Acly ATP citrate lyase gene CHEBI:16196 oleic acid decreases expression ISO RGD:10065 E RGD:6480464 20200310 CTD MESH:D019301 Oleic Acid results in decreased expression of ACLY mRNA PMID:31340670 10064 Acly ATP citrate lyase gene CHEBI:16196 oleic acid multiple interactions ISO RGD:10065 E RGD:6480464 20190312 CTD MESH:D019301 [[Vehicle Emissions results in increased abundance of Particulate Matter] which co-treated with Oleic Acid] results in decreased expression of ACLY mRNA; [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACLY mRNA PMID:30611723|PMID:31340670 10064 Acly ATP citrate lyase gene CHEBI:16236 ethanol affects splicing EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the splicing of ACLY mRNA PMID:30319688 10064 Acly ATP citrate lyase gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20160510 CTD MESH:D000431 Ethanol results in increased expression of ACLY mRNA PMID:12036955|PMID:19167417 10064 Acly ATP citrate lyase gene CHEBI:16236 ethanol increases expression ISO RGD:2018 E RGD:6480464 20120918 CTD MESH:D000431 Ethanol results in increased expression of ACLY mRNA PMID:16946407|PMID:19371623 10064 Acly ATP citrate lyase gene CHEBI:16236 ethanol multiple interactions ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D000431 [Fish Oils co-treated with Ethanol] results in increased expression of ACLY mRNA PMID:17347304 10064 Acly ATP citrate lyase gene CHEBI:16243 quercetin decreases activity EXP E RGD:6480464 20120412 CTD MESH:D011794 Quercetin results in decreased activity of ACLY protein PMID:17032037 10064 Acly ATP citrate lyase gene CHEBI:16243 quercetin decreases expression EXP E RGD:6480464 20120412 CTD MESH:D011794 Quercetin results in decreased expression of ACLY mRNA PMID:17032037 10064 Acly ATP citrate lyase gene CHEBI:16243 quercetin decreases expression ISO RGD:10065 E RGD:6480464 20161213 CTD MESH:D011794 Quercetin results in decreased expression of ACLY mRNA PMID:20596804 10064 Acly ATP citrate lyase gene CHEBI:16433 trans-caffeic acid multiple interactions ISO RGD:10065 E RGD:6480464 20180116 CTD MESH:C040048 [Metformin co-treated with caffeic acid] results in decreased expression of ACLY protein PMID:28576465 10064 Acly ATP citrate lyase gene CHEBI:16469 17beta-estradiol decreases expression EXP E RGD:6480464 20130723 CTD MESH:D004958 Estradiol results in decreased expression of ACLY mRNA PMID:19484750 10064 Acly ATP citrate lyase gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:2018 E RGD:6480464 20230606 CTD MESH:D004958 Estradiol results in decreased expression of ACLY mRNA PMID:32145629 10064 Acly ATP citrate lyase gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:10065 E RGD:6480464 20220308 CTD MESH:D004958 Estradiol results in increased expression of ACLY mRNA PMID:31614463 10064 Acly ATP citrate lyase gene CHEBI:165219 PCB138 decreases expression ISO RGD:2018 E RGD:6480464 20201208 CTD MESH:C029790 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of ACLY protein PMID:21673325 10064 Acly ATP citrate lyase gene CHEBI:16643 L-methionine multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACLY gene PMID:20938992 10064 Acly ATP citrate lyase gene CHEBI:16716 benzene affects expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D001554 Benzene affects the expression of ACLY mRNA PMID:15878777 10064 Acly ATP citrate lyase gene CHEBI:16742 orotic acid increases expression ISO RGD:2018 E RGD:6480464 20240806 CTD MESH:D009963 Orotic Acid results in increased expression of ACLY mRNA PMID:17203948 10064 Acly ATP citrate lyase gene CHEBI:168262 Ganoderic acid A decreases expression ISO RGD:10065 E RGD:6480464 20210504 CTD MESH:C515005 ganoderic acid A results in decreased expression of ACLY mRNA PMID:29852127 10064 Acly ATP citrate lyase gene CHEBI:168262 Ganoderic acid A multiple interactions EXP E RGD:6480464 20210504 CTD MESH:C515005 [Dietary Fats co-treated with ganoderic acid A] affects the expression of ACLY mRNA PMID:29852127 10064 Acly ATP citrate lyase gene CHEBI:16827 corticosterone multiple interactions ISO RGD:2018 E RGD:6480464 20120501 CTD MESH:D003345 [Corticosterone co-treated with oleoyl-estrone] affects the expression of ACLY mRNA PMID:19545626 10064 Acly ATP citrate lyase gene CHEBI:16842 formaldehyde decreases expression ISO RGD:10065 E RGD:6480464 20140408 CTD MESH:D005557 Formaldehyde results in decreased expression of ACLY mRNA PMID:23649840 10064 Acly ATP citrate lyase gene CHEBI:16899 D-mannitol increases expression EXP E RGD:6480464 20150127 CTD MESH:D008353 Mannitol results in increased expression of ACLY mRNA PMID:25270620 10064 Acly ATP citrate lyase gene CHEBI:16971 benzene-1,2,4-triol increases expression ISO RGD:10065 E RGD:6480464 20120412 CTD MESH:C013038 hydroxyhydroquinone results in increased expression of ACLY mRNA PMID:17572062 10064 Acly ATP citrate lyase gene CHEBI:17234 glucose increases expression ISO RGD:10065 E RGD:6480464 20180313 CTD MESH:D005947 Glucose deficiency results in increased expression of ACLY mRNA; Glucose deficiency results in increased expression of ACLY protein PMID:26811028 10064 Acly ATP citrate lyase gene CHEBI:17234 glucose increases expression ISO RGD:2018 E RGD:6480464 20140513 CTD MESH:D005947 Glucose results in increased expression of ACLY mRNA PMID:24349266 10064 Acly ATP citrate lyase gene CHEBI:173086 ferrostatin-1 multiple interactions ISO RGD:10065 E RGD:6480464 20250114 CTD MESH:C573944 ferrostatin-1 inhibits the reaction [darolutamide results in decreased expression of ACLY mRNA] PMID:39309439 10064 Acly ATP citrate lyase gene CHEBI:17347 testosterone increases expression EXP E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in increased expression of ACLY mRNA PMID:16579987 10064 Acly ATP citrate lyase gene CHEBI:17351 linoleic acid decreases expression ISO RGD:2018 E RGD:6480464 20170303 CTD MESH:D019787 Linoleic Acid results in decreased expression of ACLY mRNA PMID:14563831 10064 Acly ATP citrate lyase gene CHEBI:17395 cis-caffeic acid multiple interactions ISO RGD:10065 E RGD:6480464 20180116 CTD MESH:C040048 [Metformin co-treated with caffeic acid] results in decreased expression of ACLY protein PMID:28576465 10064 Acly ATP citrate lyase gene CHEBI:175090 Oleacein decreases activity ISO RGD:10065 E RGD:6480464 20210706 CTD MESH:C578055 oleacein results in decreased activity of ACLY protein PMID:31150784 10064 Acly ATP citrate lyase gene CHEBI:17578 toluene decreases expression ISO RGD:10065 E RGD:6480464 20200609 CTD MESH:D014050 Toluene results in decreased expression of ACLY mRNA PMID:26717081 10064 Acly ATP citrate lyase gene CHEBI:17578 toluene increases methylation ISO RGD:10065 E RGD:6480464 20200609 CTD MESH:D014050 Toluene results in increased methylation of ACLY gene PMID:26717081 10064 Acly ATP citrate lyase gene CHEBI:17580 linalool multiple interactions ISO RGD:10065 E RGD:6480464 20240806 CTD MESH:C018584 [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA PMID:38000518 10064 Acly ATP citrate lyase gene CHEBI:17634 D-glucose increases expression ISO RGD:10065 E RGD:6480464 20180313 CTD MESH:D005947 Glucose deficiency results in increased expression of ACLY mRNA; Glucose deficiency results in increased expression of ACLY protein PMID:26811028 10064 Acly ATP citrate lyase gene CHEBI:17634 D-glucose increases expression ISO RGD:2018 E RGD:6480464 20140513 CTD MESH:D005947 Glucose results in increased expression of ACLY mRNA PMID:24349266 10064 Acly ATP citrate lyase gene CHEBI:17650 cortisol increases expression ISO RGD:10065 E RGD:6480464 20190702 CTD MESH:D006854 Hydrocortisone results in increased expression of ACLY mRNA PMID:30776459 10064 Acly ATP citrate lyase gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression EXP E RGD:6480464 20120412 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of ACLY mRNA PMID:19850644|PMID:35550907 10064 Acly ATP citrate lyase gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004051 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA; [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACLY mRNA; PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACLY mRNA] PMID:19850644|PMID:28433925|PMID:35739755 10064 Acly ATP citrate lyase gene CHEBI:178012 FR900359 affects phosphorylation ISO RGD:10065 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 affects the phosphorylation of ACLY protein PMID:37730182 10064 Acly ATP citrate lyase gene CHEBI:17967 urethane increases expression ISO RGD:10065 E RGD:6480464 20171114 CTD MESH:D014520 Urethane results in increased expression of ACLY mRNA PMID:28818685 10064 Acly ATP citrate lyase gene CHEBI:17992 sucrose multiple interactions EXP E RGD:6480464 20140513 CTD MESH:D013395 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Atrazine] results in increased expression of ACLY mRNA; [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Ethinyl Estradiol] results in increased expression of ACLY mRNA PMID:24440342 10064 Acly ATP citrate lyase gene CHEBI:181914 Aflatoxin B2 alpha decreases methylation ISO RGD:10065 E RGD:6480464 20211109 CTD MESH:C029753 aflatoxin B2 results in decreased methylation of ACLY exon; aflatoxin B2 results in decreased methylation of ACLY intron PMID:30157460 10064 Acly ATP citrate lyase gene CHEBI:18208 benzylpenicillin increases expression EXP E RGD:6480464 20161213 CTD MESH:D010400 Penicillin G results in increased expression of ACLY mRNA PMID:27503388 10064 Acly ATP citrate lyase gene CHEBI:18208 benzylpenicillin multiple interactions EXP E RGD:6480464 20161213 CTD MESH:D010400 [Penicillin G co-treated with Erythromycin] results in increased expression of ACLY mRNA PMID:27503388 10064 Acly ATP citrate lyase gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ACLY mRNA PMID:36331819 10064 Acly ATP citrate lyase gene CHEBI:18407 hydrogen cyanide decreases expression EXP E RGD:6480464 20211109 CTD MESH:D006856 Hydrogen Cyanide results in decreased expression of ACLY mRNA PMID:33914522 10064 Acly ATP citrate lyase gene CHEBI:192461 toosendanin decreases expression ISO RGD:10065 E RGD:6480464 20240903 CTD MESH:C036454 toosendanin results in decreased expression of ACLY mRNA PMID:38570025 10064 Acly ATP citrate lyase gene CHEBI:195250 corn oil affects expression ISO RGD:2018 E RGD:6480464 20230704 CTD MESH:D003314 Corn Oil affects the expression of ACLY mRNA PMID:16360708 10064 Acly ATP citrate lyase gene CHEBI:23924 enzyme inhibitor multiple interactions ISO RGD:10065 E RGD:6480464 20161228 CTD MESH:D004791 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ACLY protein PMID:23301498 10064 Acly ATP citrate lyase gene CHEBI:23994 ethyl methanesulfonate decreases expression ISO RGD:10065 E RGD:6480464 20140708 CTD MESH:D005020 Ethyl Methanesulfonate results in decreased expression of ACLY mRNA PMID:23649840 10064 Acly ATP citrate lyase gene CHEBI:2504 aflatoxin B1 decreases expression EXP E RGD:6480464 20120501 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of ACLY mRNA PMID:19770486 10064 Acly ATP citrate lyase gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:2018 E RGD:6480464 20140311 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of ACLY mRNA PMID:23385219 10064 Acly ATP citrate lyase gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:10065 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of ACLY intron PMID:30157460 10064 Acly ATP citrate lyase gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:10065 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of ACLY exon PMID:30157460 10064 Acly ATP citrate lyase gene CHEBI:2504 aflatoxin B1 multiple interactions ISO RGD:2018 E RGD:6480464 20150414 CTD MESH:D016604 [sulforaphane co-treated with Aflatoxin B1] affects the expression of ACLY mRNA PMID:25450479 10064 Acly ATP citrate lyase gene CHEBI:25255 methyl methanesulfonate decreases expression ISO RGD:10065 E RGD:6480464 20140408 CTD MESH:D008741 Methyl Methanesulfonate results in decreased expression of ACLY mRNA PMID:23649840 10064 Acly ATP citrate lyase gene CHEBI:2564 aldrin increases expression EXP E RGD:6480464 20140107 CTD MESH:D000452 Aldrin results in increased expression of ACLY mRNA PMID:18579281 10064 Acly ATP citrate lyase gene CHEBI:25812 ozone decreases expression EXP E RGD:6480464 20120412 CTD MESH:D010126 Ozone results in decreased expression of ACLY mRNA PMID:16183385 10064 Acly ATP citrate lyase gene CHEBI:25812 ozone decreases expression ISO RGD:2018 E RGD:6480464 20150714 CTD MESH:D010126 Ozone results in decreased expression of ACLY mRNA PMID:25838073 10064 Acly ATP citrate lyase gene CHEBI:25812 ozone multiple interactions EXP E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ACLY mRNA PMID:34911549 10064 Acly ATP citrate lyase gene CHEBI:25812 ozone multiple interactions ISO RGD:10065 E RGD:6480464 20231205 CTD MESH:D010126 [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of ACLY mRNA PMID:32845096 10064 Acly ATP citrate lyase gene CHEBI:2663 amiodarone increases expression ISO RGD:10065 E RGD:6480464 20210706 CTD MESH:D000638 Amiodarone results in increased expression of ACLY mRNA PMID:32535746 10064 Acly ATP citrate lyase gene CHEBI:2663 amiodarone increases expression ISO RGD:2018 E RGD:6480464 20230801 CTD MESH:D000638 Amiodarone results in increased expression of ACLY mRNA PMID:32084307 10064 Acly ATP citrate lyase gene CHEBI:26710 sodium chloride multiple interactions ISO RGD:10065 E RGD:6480464 20250114 CTD MESH:D012965 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ACLY protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ACLY protein PMID:38598786 10064 Acly ATP citrate lyase gene CHEBI:27363 zinc atom increases expression ISO RGD:2018 E RGD:6480464 20130122 CTD MESH:D015032 Zinc deficiency results in increased expression of ACLY mRNA PMID:15671213 10064 Acly ATP citrate lyase gene CHEBI:27385 tetrachloromethane affects expression EXP E RGD:6480464 20200804 CTD MESH:D002251 Carbon Tetrachloride affects the expression of ACLY mRNA PMID:31919559 10064 Acly ATP citrate lyase gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACLY mRNA PMID:17522070 10064 Acly ATP citrate lyase gene CHEBI:27432 alpha-linolenic acid decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D017962 alpha-Linolenic Acid results in decreased expression of ACLY mRNA PMID:14563831 10064 Acly ATP citrate lyase gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D005492 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACLY gene; Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACLY mRNA] PMID:20938992|PMID:22206623 10064 Acly ATP citrate lyase gene CHEBI:27563 arsenic atom multiple interactions EXP E RGD:6480464 20220208 CTD MESH:D001151 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACLY mRNA PMID:32045263 10064 Acly ATP citrate lyase gene CHEBI:27732 caffeine decreases phosphorylation ISO RGD:10065 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine results in decreased phosphorylation of ACLY protein PMID:35688186 10064 Acly ATP citrate lyase gene CHEBI:27732 caffeine increases expression ISO RGD:2018 E RGD:6480464 20190702 CTD MESH:D002110 Caffeine results in increased expression of ACLY mRNA PMID:30776459 10064 Acly ATP citrate lyase gene CHEBI:27744 glyphosate decreases expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of ACLY protein PMID:37208198 10064 Acly ATP citrate lyase gene CHEBI:27856 acetamide decreases expression ISO RGD:2018 E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in decreased expression of ACLY mRNA PMID:31881176 10064 Acly ATP citrate lyase gene CHEBI:27881 resveratrol increases expression ISO RGD:10065 E RGD:6480464 20121218 CTD MESH:C059514 resveratrol results in increased expression of ACLY mRNA PMID:20706672 10064 Acly ATP citrate lyase gene CHEBI:27881 resveratrol multiple interactions ISO RGD:2018 E RGD:6480464 20160822 CTD MESH:C059514 [Dietary Fats co-treated with resveratrol] affects the expression of ACLY mRNA; resveratrol inhibits the reaction [Dietary Fats results in increased expression of ACLY protein] PMID:26055348 10064 Acly ATP citrate lyase gene CHEBI:27902 tetracycline decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D013752 Tetracycline results in decreased expression of ACLY mRNA PMID:17522070 10064 Acly ATP citrate lyase gene CHEBI:27961 1,8-cineole multiple interactions ISO RGD:10065 E RGD:6480464 20240806 CTD MESH:D000077591 [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA PMID:38000518 10064 Acly ATP citrate lyase gene CHEBI:28088 genistein decreases expression ISO RGD:10065 E RGD:6480464 20121113 CTD MESH:D019833 Genistein results in decreased expression of ACLY protein PMID:20884965 10064 Acly ATP citrate lyase gene CHEBI:28088 genistein increases expression ISO RGD:10065 E RGD:6480464 20121218 CTD MESH:D019833 Genistein results in increased expression of ACLY mRNA PMID:20706672 10064 Acly ATP citrate lyase gene CHEBI:28088 genistein multiple interactions ISO RGD:10065 E RGD:6480464 20121113 CTD MESH:D019833 ESR2 promotes the reaction [Genistein results in decreased expression of ACLY protein] PMID:20884965 10064 Acly ATP citrate lyase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20160210 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ACLY mRNA PMID:21570461|PMID:26377647 10064 Acly ATP citrate lyase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20160119 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACLY mRNA PMID:18295293|PMID:26290441|PMID:28213091 10064 Acly ATP citrate lyase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2018 E RGD:6480464 20130122 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACLY mRNA PMID:16054898|PMID:20959002|PMID:21215274|PMID:21724226 10064 Acly ATP citrate lyase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACLY mRNA PMID:21846477 10064 Acly ATP citrate lyase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2018 E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACLY mRNA PMID:34747641 10064 Acly ATP citrate lyase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120918 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACLY mRNA; Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in increased expression of ACLY mRNA] PMID:21846477|PMID:28433925 10064 Acly ATP citrate lyase gene CHEBI:28200 2-chloroethanol increases expression EXP E RGD:6480464 20160822 CTD MESH:D005023 Ethylene Chlorohydrin results in increased expression of ACLY mRNA PMID:26962056 10064 Acly ATP citrate lyase gene CHEBI:28201 rotenone decreases expression ISO RGD:2018 E RGD:6480464 20191112 CTD MESH:D012402 Rotenone results in decreased expression of ACLY mRNA PMID:28374803 10064 Acly ATP citrate lyase gene CHEBI:28201 rotenone increases expression ISO RGD:10065 E RGD:6480464 20210810 CTD MESH:D012402 Rotenone results in increased expression of ACLY mRNA PMID:33512557 10064 Acly ATP citrate lyase gene CHEBI:28201 rotenone increases oxidation ISO RGD:2018 E RGD:6480464 20190910 CTD MESH:D012402 Rotenone results in increased oxidation of ACLY protein PMID:30951809 10064 Acly ATP citrate lyase gene CHEBI:28509 chloroethene increases expression EXP E RGD:6480464 20130514 CTD MESH:D014752 Vinyl Chloride metabolite results in increased expression of ACLY mRNA; Vinyl Chloride results in increased expression of ACLY mRNA PMID:18579281|PMID:26962056 10064 Acly ATP citrate lyase gene CHEBI:28527 rutin decreases activity EXP E RGD:6480464 20120412 CTD MESH:D012431 Rutin results in decreased activity of ACLY protein PMID:17032037 10064 Acly ATP citrate lyase gene CHEBI:28694 copper atom decreases expression EXP E RGD:6480464 20120814 CTD MESH:D003300 Copper results in decreased expression of ACLY mRNA PMID:17205981 10064 Acly ATP citrate lyase gene CHEBI:28694 copper atom multiple interactions ISO RGD:2018 E RGD:6480464 20151013 CTD MESH:D003300 [Copper co-treated with Dietary Sucrose] results in increased expression of ACLY mRNA PMID:26033743 10064 Acly ATP citrate lyase gene CHEBI:28748 doxorubicin increases expression ISO RGD:10065 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in increased expression of ACLY mRNA PMID:29803840 10064 Acly ATP citrate lyase gene CHEBI:28757 fructose increases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D005632 Fructose results in increased expression of ACLY mRNA PMID:1396700 10064 Acly ATP citrate lyase gene CHEBI:28794 coumarin affects expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:C030123 coumarin affects the expression of ACLY mRNA PMID:16963487 10064 Acly ATP citrate lyase gene CHEBI:28984 aluminium atom multiple interactions ISO RGD:10065 E RGD:6480464 20120412 CTD MESH:D000535 Aluminum results in increased expression of and results in increased activity of ACLY protein PMID:17762189 10064 Acly ATP citrate lyase gene CHEBI:29678 sodium arsenite affects expression ISO RGD:10065 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite affects the expression of ACLY mRNA PMID:34032870 10064 Acly ATP citrate lyase gene CHEBI:29678 sodium arsenite decreases expression EXP E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in decreased expression of ACLY mRNA PMID:19822182 10064 Acly ATP citrate lyase gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:10065 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of ACLY mRNA PMID:38568856 10064 Acly ATP citrate lyase gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20220208 CTD MESH:C017947 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACLY mRNA PMID:32045263 10064 Acly ATP citrate lyase gene CHEBI:29699 tunicamycin decreases expression ISO RGD:10065 E RGD:6480464 20190312 CTD MESH:D014415 Tunicamycin results in decreased expression of ACLY mRNA PMID:29453283 10064 Acly ATP citrate lyase gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:10065 E RGD:6480464 20190219 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ACLY exon PMID:30157460 10064 Acly ATP citrate lyase gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ACLY mRNA PMID:22228805 10064 Acly ATP citrate lyase gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:10065 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ACLY 5' UTR PMID:27901495 10064 Acly ATP citrate lyase gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20120918 CTD MESH:D001564 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ACLY mRNA] PMID:22228805 10064 Acly ATP citrate lyase gene CHEBI:29866 arsenite(3-) decreases expression EXP E RGD:6480464 20210504 CTD MESH:C015001 arsenite results in decreased expression of ACLY mRNA PMID:33053406 10064 Acly ATP citrate lyase gene CHEBI:30052 copper(0) decreases expression EXP E RGD:6480464 20120814 CTD MESH:D003300 Copper results in decreased expression of ACLY mRNA PMID:17205981 10064 Acly ATP citrate lyase gene CHEBI:30052 copper(0) multiple interactions ISO RGD:2018 E RGD:6480464 20151013 CTD MESH:D003300 [Copper co-treated with Dietary Sucrose] results in increased expression of ACLY mRNA PMID:26033743 10064 Acly ATP citrate lyase gene CHEBI:30185 zinc(0) increases expression ISO RGD:2018 E RGD:6480464 20130122 CTD MESH:D015032 Zinc deficiency results in increased expression of ACLY mRNA PMID:15671213 10064 Acly ATP citrate lyase gene CHEBI:30563 silicon dioxide affects secretion ISO RGD:10065 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog affects the secretion of ACLY protein PMID:25895662 10064 Acly ATP citrate lyase gene CHEBI:30563 silicon dioxide decreases expression EXP E RGD:6480464 20140715 CTD MESH:D012822 Silicon Dioxide results in decreased expression of ACLY mRNA PMID:23221170 10064 Acly ATP citrate lyase gene CHEBI:30563 silicon dioxide increases activity ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D012822 Silicon Dioxide results in increased activity of ACLY protein PMID:1647683 10064 Acly ATP citrate lyase gene CHEBI:30614 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:10065 E RGD:6480464 20220308 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ACLY mRNA PMID:34454013 10064 Acly ATP citrate lyase gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ACLY mRNA PMID:16483693 10064 Acly ATP citrate lyase gene CHEBI:31739 josamycin affects response to substance ISO RGD:10065 E RGD:6480464 20200609 CTD MESH:D015570 ACLY protein affects the susceptibility to Josamycin PMID:31915244 10064 Acly ATP citrate lyase gene CHEBI:3179 bromobenzene decreases expression ISO RGD:2018 E RGD:6480464 20200915 CTD MESH:C032036 bromobenzene results in decreased expression of ACLY mRNA PMID:32479839 10064 Acly ATP citrate lyase gene CHEBI:32161 sulfadimethoxine increases expression ISO RGD:2018 E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in increased expression of ACLY mRNA PMID:30047161 10064 Acly ATP citrate lyase gene CHEBI:3223 buspirone decreases expression ISO RGD:2018 E RGD:6480464 20160412 CTD MESH:D002065 Buspirone results in decreased expression of ACLY mRNA PMID:24136188 10064 Acly ATP citrate lyase gene CHEBI:32234 titanium dioxide decreases expression EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased expression of ACLY mRNA PMID:35295148 10064 Acly ATP citrate lyase gene CHEBI:32234 titanium dioxide decreases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ACLY gene PMID:35295148 10064 Acly ATP citrate lyase gene CHEBI:32234 titanium dioxide increases expression EXP E RGD:6480464 20140211 CTD MESH:C009495 titanium dioxide results in increased expression of ACLY mRNA PMID:23557971 10064 Acly ATP citrate lyase gene CHEBI:32497 thioacetamide affects expression ISO RGD:2018 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide affects the expression of ACLY mRNA PMID:34492290 10064 Acly ATP citrate lyase gene CHEBI:32509 pirinixic acid decreases expression EXP E RGD:6480464 20140610 CTD MESH:C006253 pirinixic acid results in decreased expression of ACLY mRNA PMID:18445702|PMID:23811191 10064 Acly ATP citrate lyase gene CHEBI:32509 pirinixic acid decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in decreased expression of ACLY mRNA PMID:19162173 10064 Acly ATP citrate lyase gene CHEBI:32888 gamma-hexachlorocyclohexane affects activity ISO RGD:2018 E RGD:6480464 20130122 CTD MESH:D001556 Hexachlorocyclohexane affects the activity of ACLY protein PMID:7535533 10064 Acly ATP citrate lyase gene CHEBI:32888 gamma-hexachlorocyclohexane decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D001556 Hexachlorocyclohexane results in decreased expression of ACLY mRNA PMID:17785943 10064 Acly ATP citrate lyase gene CHEBI:33007 chromium(6+) increases expression ISO RGD:10065 E RGD:6480464 20201006 CTD MESH:C074702 chromium hexavalent ion results in increased expression of ACLY protein PMID:32525551 10064 Acly ATP citrate lyase gene CHEBI:33191 potassium cyanide increases expression EXP E RGD:6480464 20211109 CTD MESH:D011190 Potassium Cyanide results in increased expression of ACLY mRNA PMID:33914522 10064 Acly ATP citrate lyase gene CHEBI:33216 bisphenol A affects expression ISO RGD:10065 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of ACLY mRNA PMID:30903817 10064 Acly ATP citrate lyase gene CHEBI:33216 bisphenol A affects expression ISO RGD:2018 E RGD:6480464 20230606 CTD MESH:C006780 bisphenol A affects the expression of ACLY mRNA PMID:32145629 10064 Acly ATP citrate lyase gene CHEBI:33216 bisphenol A affects methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A affects the methylation of ACLY promoter PMID:27334623 10064 Acly ATP citrate lyase gene CHEBI:33216 bisphenol A decreases expression ISO RGD:10065 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of ACLY protein PMID:37567409 10064 Acly ATP citrate lyase gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2018 E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in decreased expression of ACLY mRNA; bisphenol A results in decreased expression of ACLY protein PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998 10064 Acly ATP citrate lyase gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20120515 CTD MESH:C006780 bisphenol A results in increased expression of ACLY mRNA; bisphenol A results in increased expression of ACLY protein; bisphenol A results in increased expression of ACLY protein modified form PMID:21932408|PMID:37105096 10064 Acly ATP citrate lyase gene CHEBI:33216 bisphenol A increases expression ISO RGD:2018 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of ACLY mRNA PMID:25181051|PMID:27178563 10064 Acly ATP citrate lyase gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20180116 CTD MESH:C006780 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA; [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACLY mRNA PMID:28433925|PMID:35739755 10064 Acly ATP citrate lyase gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:2018 E RGD:6480464 20170516 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of ACLY mRNA PMID:27914987 10064 Acly ATP citrate lyase gene CHEBI:33629 aluminium(0) multiple interactions ISO RGD:10065 E RGD:6480464 20120412 CTD MESH:D000535 Aluminum results in increased expression of and results in increased activity of ACLY protein PMID:17762189 10064 Acly ATP citrate lyase gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP E RGD:6480464 20180116 CTD MESH:C014024 [Tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with Diethylhexyl Phthalate co-treated with bisphenol A] results in decreased expression of ACLY mRNA PMID:28433925 10064 Acly ATP citrate lyase gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:10065 E RGD:6480464 20191112 CTD MESH:C543008 bisphenol S results in increased expression of ACLY mRNA; bisphenol S results in increased expression of ACLY protein PMID:31121516|PMID:34186270 10064 Acly ATP citrate lyase gene CHEBI:34567 benzo[e]pyrene increases methylation ISO RGD:10065 E RGD:6480464 20190219 CTD MESH:C026487 benzo(e)pyrene results in increased methylation of ACLY exon PMID:30157460 10064 Acly ATP citrate lyase gene CHEBI:34575 bisphenol F increases expression EXP E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in increased expression of ACLY mRNA PMID:38685157 10064 Acly ATP citrate lyase gene CHEBI:34575 bisphenol F increases expression ISO RGD:10065 E RGD:6480464 20230307 CTD MESH:C008745 bisphenol F results in increased expression of ACLY protein PMID:34186270 10064 Acly ATP citrate lyase gene CHEBI:34581 Bisphenol B increases expression ISO RGD:10065 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of ACLY protein PMID:34186270 10064 Acly ATP citrate lyase gene CHEBI:34595 Butylbenzyl phthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C027561 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA PMID:35739755 10064 Acly ATP citrate lyase gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in decreased expression of ACLY mRNA PMID:37019170 10064 Acly ATP citrate lyase gene CHEBI:34679 Di-n-octyl phthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C010715 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA PMID:35739755 10064 Acly ATP citrate lyase gene CHEBI:34682 diazinon affects expression ISO RGD:2018 E RGD:6480464 20141014 CTD MESH:D003976 Diazinon affects the expression of ACLY mRNA PMID:22546817 10064 Acly ATP citrate lyase gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:2018 E RGD:6480464 20121113 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ACLY mRNA PMID:17379624 10064 Acly ATP citrate lyase gene CHEBI:34687 dibutyl phthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D003993 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA PMID:35739755 10064 Acly ATP citrate lyase gene CHEBI:34696 dieldrin affects expression ISO RGD:2018 E RGD:6480464 20141014 CTD MESH:D004026 Dieldrin affects the expression of ACLY mRNA PMID:22546817 10064 Acly ATP citrate lyase gene CHEBI:34698 diethyl phthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C007379 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA PMID:35739755 10064 Acly ATP citrate lyase gene CHEBI:34709 Diisodecyl phthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C042080 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA PMID:35739755 10064 Acly ATP citrate lyase gene CHEBI:34718 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:10065 E RGD:6480464 20210406 CTD MESH:D004137 Dinitrochlorobenzene binds to ACLY protein PMID:32991956 10064 Acly ATP citrate lyase gene CHEBI:34768 furfural multiple interactions ISO RGD:10065 E RGD:6480464 20250114 CTD MESH:D005662 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ACLY protein PMID:38598786 10064 Acly ATP citrate lyase gene CHEBI:34887 nickel dichloride affects expression ISO RGD:2018 E RGD:6480464 20141014 CTD MESH:C022838 nickel chloride affects the expression of ACLY mRNA PMID:22546817 10064 Acly ATP citrate lyase gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:10065 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ACLY mRNA PMID:37042841 10064 Acly ATP citrate lyase gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:2018 E RGD:6480464 20200331 CTD MESH:C005445 triphenyl phosphate affects the expression of ACLY mRNA PMID:30589522 10064 Acly ATP citrate lyase gene CHEBI:35455 1-naphthyl isothiocyanate decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D015058 1-Naphthylisothiocyanate results in decreased expression of ACLY mRNA PMID:17522070 10064 Acly ATP citrate lyase gene CHEBI:35455 1-naphthyl isothiocyanate increases expression ISO RGD:2018 E RGD:6480464 20190507 CTD MESH:D015058 1-Naphthylisothiocyanate results in increased expression of ACLY mRNA PMID:30723492 10064 Acly ATP citrate lyase gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:2018 E RGD:6480464 20150825 CTD MESH:D019256 Cadmium Chloride results in decreased expression of ACLY mRNA PMID:25993096 10064 Acly ATP citrate lyase gene CHEBI:35459 diisononyl phthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C012125 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diethyl phthalate co-treated with di-n-octyl phthalate co-treated with diisodecyl phthalate co-treated with diisononyl phthalate] results in increased expression of ACLY mRNA PMID:35739755 10064 Acly ATP citrate lyase gene CHEBI:35549 perfluorooctanoic acid decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of ACLY mRNA PMID:19162173 10064 Acly ATP citrate lyase gene CHEBI:35549 perfluorooctanoic acid multiple interactions EXP E RGD:6480464 20140311 CTD MESH:C023036 Dietary Fats, Unsaturated promotes the reaction [perfluorooctanoic acid results in increased expression of ACLY mRNA] PMID:23626681 10064 Acly ATP citrate lyase gene CHEBI:35559 furan decreases expression ISO RGD:2018 E RGD:6480464 20160119 CTD MESH:C039281 furan results in decreased expression of ACLY mRNA PMID:26194646 10064 Acly ATP citrate lyase gene CHEBI:35591 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D011285 Pregnenolone Carbonitrile results in decreased expression of ACLY mRNA PMID:19162173 10064 Acly ATP citrate lyase gene CHEBI:35591 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:2018 E RGD:6480464 20230606 CTD MESH:D011285 Pregnenolone Carbonitrile results in increased expression of ACLY mRNA PMID:30047161 10064 Acly ATP citrate lyase gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:10065 E RGD:6480464 20120814 CTD MESH:C018021 cobaltous chloride results in decreased expression of ACLY mRNA PMID:19320972|PMID:19376846 10064 Acly ATP citrate lyase gene CHEBI:3639 chlorothalonil decreases expression EXP E RGD:6480464 20210810 CTD MESH:C005806 tetrachloroisophthalonitrile results in decreased expression of ACLY mRNA PMID:33246813 10064 Acly ATP citrate lyase gene CHEBI:3639 chlorothalonil multiple interactions EXP E RGD:6480464 20210810 CTD MESH:C005806 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of ACLY mRNA PMID:33246813 10064 Acly ATP citrate lyase gene CHEBI:36773 camphor multiple interactions ISO RGD:10065 E RGD:6480464 20240806 CTD MESH:D002164 [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA PMID:38000518 10064 Acly ATP citrate lyase gene CHEBI:3750 clofibrate decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D002994 Clofibrate results in decreased expression of ACLY mRNA; Clofibrate results in decreased expression of ACLY protein PMID:16470657|PMID:17522070|PMID:8240402 10064 Acly ATP citrate lyase gene CHEBI:38658 dicrotophos increases expression ISO RGD:10065 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in increased expression of ACLY mRNA PMID:28302478 10064 Acly ATP citrate lyase gene CHEBI:38940 sunitinib increases expression ISO RGD:10065 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in increased expression of ACLY mRNA PMID:31533062 10064 Acly ATP citrate lyase gene CHEBI:3908 coumestrol increases expression ISO RGD:10065 E RGD:6480464 20130409 CTD MESH:D003375 Coumestrol results in increased expression of ACLY mRNA PMID:19167446 10064 Acly ATP citrate lyase gene CHEBI:3908 coumestrol multiple interactions ISO RGD:10065 E RGD:6480464 20130409 CTD MESH:D003375 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA PMID:19167446 10064 Acly ATP citrate lyase gene CHEBI:39285 chloropicrin decreases expression ISO RGD:10065 E RGD:6480464 20151215 CTD MESH:C100187 chloropicrin results in decreased expression of ACLY mRNA PMID:26352163 10064 Acly ATP citrate lyase gene CHEBI:39421 perfluorooctane-1-sulfonic acid decreases expression EXP E RGD:6480464 20120412 CTD MESH:C076994 perfluorooctane sulfonic acid results in decreased expression of ACLY mRNA PMID:21705711 10064 Acly ATP citrate lyase gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ACLY mRNA; [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ACLY mRNA PMID:36331819 10064 Acly ATP citrate lyase gene CHEBI:39483 sodium dichromate decreases expression ISO RGD:2018 E RGD:6480464 20150825 CTD MESH:C016104 sodium bichromate results in decreased expression of ACLY mRNA PMID:25993096 10064 Acly ATP citrate lyase gene CHEBI:3962 curcumin affects expression EXP E RGD:6480464 20161025 CTD MESH:D003474 Curcumin affects the expression of ACLY mRNA PMID:27208389 10064 Acly ATP citrate lyase gene CHEBI:3962 curcumin decreases expression ISO RGD:2018 E RGD:6480464 20161025 CTD MESH:D003474 Curcumin results in decreased expression of ACLY mRNA PMID:27208389 10064 Acly ATP citrate lyase gene CHEBI:39867 valproic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of ACLY mRNA PMID:17292431 10064 Acly ATP citrate lyase gene CHEBI:39867 valproic acid affects expression ISO RGD:10065 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ACLY mRNA PMID:25979313 10064 Acly ATP citrate lyase gene CHEBI:39867 valproic acid increases expression EXP E RGD:6480464 20150127 CTD MESH:D014635 Valproic Acid results in increased expression of ACLY mRNA PMID:24489787 10064 Acly ATP citrate lyase gene CHEBI:39867 valproic acid increases expression ISO RGD:10065 E RGD:6480464 20181016 CTD MESH:D014635 Valproic Acid results in increased expression of ACLY mRNA; Valproic Acid results in increased expression of ACLY protein PMID:30003287 10064 Acly ATP citrate lyase gene CHEBI:39867 valproic acid multiple interactions ISO RGD:10065 E RGD:6480464 20181016 CTD MESH:D014635 NR1H3 protein affects the reaction [Valproic Acid results in increased expression of ACLY mRNA] PMID:30003287 10064 Acly ATP citrate lyase gene CHEBI:40036 amitrole increases expression ISO RGD:2018 E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in increased expression of ACLY mRNA PMID:30047161 10064 Acly ATP citrate lyase gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:10065 E RGD:6480464 20120412 CTD MESH:D016572 Cyclosporine results in decreased expression of ACLY mRNA PMID:20106945 10064 Acly ATP citrate lyase gene CHEBI:41774 tamoxifen affects expression EXP E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen affects the expression of ACLY mRNA PMID:20937368 10064 Acly ATP citrate lyase gene CHEBI:41791 calyculin a increases expression EXP E RGD:6480464 20150127 CTD MESH:C059041 calyculin A results in increased expression of ACLY mRNA PMID:25270620 10064 Acly ATP citrate lyase gene CHEBI:41879 dexamethasone decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D003907 Dexamethasone results in decreased expression of ACLY mRNA PMID:17522070 10064 Acly ATP citrate lyase gene CHEBI:42355 erythromycin A increases expression EXP E RGD:6480464 20161213 CTD MESH:D004917 Erythromycin results in increased expression of ACLY mRNA PMID:27503388 10064 Acly ATP citrate lyase gene CHEBI:42355 erythromycin A multiple interactions EXP E RGD:6480464 20161213 CTD MESH:D004917 [Penicillin G co-treated with Erythromycin] results in increased expression of ACLY mRNA PMID:27503388 10064 Acly ATP citrate lyase gene CHEBI:42758 aldehydo-D-glucose increases expression ISO RGD:10065 E RGD:6480464 20180313 CTD MESH:D005947 Glucose deficiency results in increased expression of ACLY mRNA; Glucose deficiency results in increased expression of ACLY protein PMID:26811028 10064 Acly ATP citrate lyase gene CHEBI:42758 aldehydo-D-glucose increases expression ISO RGD:2018 E RGD:6480464 20140513 CTD MESH:D005947 Glucose results in increased expression of ACLY mRNA PMID:24349266 10064 Acly ATP citrate lyase gene CHEBI:44185 methotrexate decreases expression ISO RGD:2018 E RGD:6480464 20160412 CTD MESH:D008727 Methotrexate results in decreased expression of ACLY mRNA PMID:24136188 10064 Acly ATP citrate lyase gene CHEBI:44445 nimesulide decreases expression ISO RGD:2018 E RGD:6480464 20160412 CTD MESH:C012655 nimesulide results in decreased expression of ACLY mRNA PMID:24136188 10064 Acly ATP citrate lyase gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of ACLY mRNA PMID:17562736 10064 Acly ATP citrate lyase gene CHEBI:46195 paracetamol decreases expression ISO RGD:2018 E RGD:6480464 20120501 CTD MESH:D000082 Acetaminophen results in decreased expression of ACLY mRNA PMID:15084756|PMID:17522070 10064 Acly ATP citrate lyase gene CHEBI:46195 paracetamol increases expression EXP E RGD:6480464 20190910 CTD MESH:D000082 Acetaminophen results in increased expression of ACLY mRNA PMID:29246445 10064 Acly ATP citrate lyase gene CHEBI:46195 paracetamol multiple interactions EXP E RGD:6480464 20150414 CTD MESH:D000082 [CTH gene mutant form results in increased susceptibility to Acetaminophen] which results in increased expression of ACLY protein; PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of ACLY mRNA] PMID:25499718|PMID:29246445 10064 Acly ATP citrate lyase gene CHEBI:47217 arsane multiple interactions EXP E RGD:6480464 20220208 CTD MESH:D001151 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ACLY mRNA PMID:32045263 10064 Acly ATP citrate lyase gene CHEBI:47807 sulforaphane multiple interactions ISO RGD:2018 E RGD:6480464 20150414 CTD MESH:C016766 [sulforaphane co-treated with Aflatoxin B1] affects the expression of ACLY mRNA PMID:25450479 10064 Acly ATP citrate lyase gene CHEBI:4791 endosulfan decreases expression ISO RGD:2018 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of ACLY mRNA PMID:29391264 10064 Acly ATP citrate lyase gene CHEBI:4806 (-)-epigallocatechin 3-gallate increases expression ISO RGD:10065 E RGD:6480464 20121218 CTD MESH:C045651 epigallocatechin gallate results in increased expression of ACLY mRNA PMID:20706672 10064 Acly ATP citrate lyase gene CHEBI:4811 epoxiconazole decreases expression EXP E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in decreased expression of ACLY mRNA PMID:35436446 10064 Acly ATP citrate lyase gene CHEBI:4811 epoxiconazole increases expression ISO RGD:2018 E RGD:6480464 20180515 CTD MESH:C109476 epoxiconazole results in increased expression of ACLY mRNA PMID:29038839 10064 Acly ATP citrate lyase gene CHEBI:4846 erythromycin estolate decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D004918 Erythromycin Estolate results in decreased expression of ACLY mRNA PMID:17522070 10064 Acly ATP citrate lyase gene CHEBI:4903 17alpha-ethynylestradiol decreases expression ISO RGD:2018 E RGD:6480464 20120613 CTD MESH:D004997 Ethinyl Estradiol results in decreased expression of ACLY mRNA PMID:15953391|PMID:17108234 10064 Acly ATP citrate lyase gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20140513 CTD MESH:D004997 [lard co-treated with Cholesterol co-treated with Sucrose co-treated with Ethinyl Estradiol] results in increased expression of ACLY mRNA PMID:24440342 10064 Acly ATP citrate lyase gene CHEBI:49662 indometacin affects expression EXP E RGD:6480464 20120412 CTD MESH:D007213 Indomethacin affects the expression of ACLY mRNA PMID:17546600 10064 Acly ATP citrate lyase gene CHEBI:49662 indometacin increases expression ISO RGD:10065 E RGD:6480464 20210706 CTD MESH:D007213 Indomethacin results in increased expression of ACLY mRNA PMID:32535746 10064 Acly ATP citrate lyase gene CHEBI:5001 fenofibrate increases expression EXP E RGD:6480464 20140715 CTD MESH:D011345 Fenofibrate results in increased expression of ACLY mRNA PMID:23063693 10064 Acly ATP citrate lyase gene CHEBI:5001 fenofibrate multiple interactions EXP E RGD:6480464 20140715 CTD MESH:D011345 PPARA gene mutant form inhibits the reaction [Fenofibrate results in increased expression of ACLY mRNA] PMID:23063693 10064 Acly ATP citrate lyase gene CHEBI:50027 sabinene multiple interactions ISO RGD:10065 E RGD:6480464 20240806 CTD MESH:C035127 [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA PMID:38000518 10064 Acly ATP citrate lyase gene CHEBI:50045 (+)-beta-thujone multiple interactions ISO RGD:10065 E RGD:6480464 20240806 CTD MESH:C005790 [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA PMID:38000518 10064 Acly ATP citrate lyase gene CHEBI:50102 N-methyl-N-nitrosourea increases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D008770 Methylnitrosourea results in increased expression of ACLY mRNA PMID:16525678 10064 Acly ATP citrate lyase gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ACLY mRNA; Nanotubes, Carbon results in decreased expression of ACLY mRNA PMID:25554681|PMID:25620056 10064 Acly ATP citrate lyase gene CHEBI:50692 mifepristone increases expression ISO RGD:10065 E RGD:6480464 20120412 CTD MESH:D015735 Mifepristone results in increased expression of ACLY mRNA PMID:17584828 10064 Acly ATP citrate lyase gene CHEBI:50866 3H-1,2-dithiole-3-thione increases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:C049325 1,2-dithiol-3-thione results in increased expression of ACLY mRNA PMID:19162173 10064 Acly ATP citrate lyase gene CHEBI:5132 flutamide increases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D005485 Flutamide results in increased expression of ACLY mRNA PMID:21525395 10064 Acly ATP citrate lyase gene CHEBI:5759 Honokiol decreases expression ISO RGD:2018 E RGD:6480464 20170228 CTD MESH:C005499 honokiol results in decreased expression of ACLY mRNA PMID:19371623 10064 Acly ATP citrate lyase gene CHEBI:6067 isotretinoin decreases expression ISO RGD:10065 E RGD:6480464 20120412 CTD MESH:D015474 Isotretinoin results in decreased expression of ACLY mRNA PMID:20436886 10064 Acly ATP citrate lyase gene CHEBI:6078 ivermectin decreases expression ISO RGD:10065 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ACLY protein PMID:32959892 10064 Acly ATP citrate lyase gene CHEBI:63634 valdecoxib decreases expression ISO RGD:2018 E RGD:6480464 20170303 CTD MESH:C406224 valdecoxib results in decreased expression of ACLY mRNA PMID:24136188 10064 Acly ATP citrate lyase gene CHEBI:63637 vemurafenib multiple interactions ISO RGD:10065 E RGD:6480464 20190910 CTD MESH:C551177 [BRAF protein affects the susceptibility to Vemurafenib] which affects the expression of ACLY mRNA; trametinib affects the reaction [[BRAF protein affects the susceptibility to Vemurafenib] which affects the expression of ACLY mRNA] PMID:29950559 10064 Acly ATP citrate lyase gene CHEBI:63933 Aroclor 1254 decreases expression EXP E RGD:6480464 20131210 CTD MESH:D020111 Chlorodiphenyl (54% Chlorine) results in decreased expression of ACLY mRNA PMID:23650126 10064 Acly ATP citrate lyase gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200331 CTD MESH:D012970 [Sodium Glutamate co-treated with Trans Fatty Acids] results in increased expression of ACLY mRNA PMID:19001666 10064 Acly ATP citrate lyase gene CHEBI:6469 linalyl acetate multiple interactions ISO RGD:10065 E RGD:6480464 20240806 CTD MESH:C074463 [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA PMID:38000518 10064 Acly ATP citrate lyase gene CHEBI:65585 carnosic acid increases expression EXP E RGD:6480464 20230404 CTD MESH:C018381 salvin results in increased expression of ACLY protein PMID:35926579 10064 Acly ATP citrate lyase gene CHEBI:6801 metformin affects expression ISO RGD:2018 E RGD:6480464 20200114 CTD MESH:D008687 Metformin affects the expression of ACLY mRNA PMID:31324951 10064 Acly ATP citrate lyase gene CHEBI:6801 metformin multiple interactions ISO RGD:10065 E RGD:6480464 20180116 CTD MESH:D008687 [Metformin co-treated with caffeic acid] results in decreased expression of ACLY protein PMID:28576465 10064 Acly ATP citrate lyase gene CHEBI:6820 methapyrilene increases methylation ISO RGD:10065 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in increased methylation of ACLY exon PMID:30157460 10064 Acly ATP citrate lyase gene CHEBI:6923 miconazole increases expression EXP E RGD:6480464 20190910 CTD MESH:D008825 Miconazole results in increased expression of ACLY mRNA PMID:27462272 10064 Acly ATP citrate lyase gene CHEBI:72544 flavonoids increases expression ISO RGD:2018 E RGD:6480464 20170303 CTD MESH:D005419 Flavonoids results in increased expression of ACLY mRNA PMID:18035473 10064 Acly ATP citrate lyase gene CHEBI:72754 bisphenol AF increases expression ISO RGD:10065 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of ACLY protein PMID:34186270 10064 Acly ATP citrate lyase gene CHEBI:73755 1,2-dimethylhydrazine increases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of ACLY mRNA PMID:22206623 10064 Acly ATP citrate lyase gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D019813 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACLY mRNA] PMID:22206623 10064 Acly ATP citrate lyase gene CHEBI:7459 naloxone decreases expression ISO RGD:2018 E RGD:6480464 20120412 CTD MESH:D009270 Naloxone results in decreased expression of ACLY mRNA PMID:17522070 10064 Acly ATP citrate lyase gene CHEBI:7494 nefazodone decreases expression ISO RGD:2018 E RGD:6480464 20160412 CTD MESH:C051752 nefazodone results in decreased expression of ACLY mRNA PMID:24136188 10064 Acly ATP citrate lyase gene CHEBI:75170 zaragozic acid A decreases expression ISO RGD:2018 E RGD:6480464 20180220 CTD MESH:C075117 squalestatin 1 results in decreased expression of ACLY mRNA PMID:27225895 10064 Acly ATP citrate lyase gene CHEBI:75170 zaragozic acid A increases expression EXP E RGD:6480464 20180220 CTD MESH:C075117 squalestatin 1 results in increased expression of ACLY mRNA PMID:27225895 10064 Acly ATP citrate lyase gene CHEBI:75701 sarin decreases expression ISO RGD:10065 E RGD:6480464 20131112 CTD MESH:D012524 Sarin results in decreased expression of ACLY mRNA PMID:19522546 10064 Acly ATP citrate lyase gene CHEBI:75998 trametinib multiple interactions ISO RGD:10065 E RGD:6480464 20190910 CTD MESH:C560077 trametinib affects the reaction [[BRAF protein affects the susceptibility to Vemurafenib] which affects the expression of ACLY mRNA] PMID:29950559 10064 Acly ATP citrate lyase gene CHEBI:7797 Osajin increases expression ISO RGD:10065 E RGD:6480464 20170110 CTD MESH:C485800 osajin results in increased expression of ACLY mRNA PMID:20706672 10064 Acly ATP citrate lyase gene CHEBI:78334 (R)-linalyl acetate multiple interactions ISO RGD:10065 E RGD:6480464 20240806 CTD MESH:C074463 [beta-thujone co-treated with linalyl acetate co-treated with sabinene co-treated with linalool co-treated with Camphor co-treated with myrcene co-treated with Eucalyptol co-treated with caryophyllene co-treated with spathulenol] results in decreased expression of ACLY mRNA PMID:38000518 10064 Acly ATP citrate lyase gene CHEBI:79995 GW 3965 multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C473027 GW 3965 inhibits the reaction [Palmitic Acid results in increased expression of ACLY mRNA] PMID:31421115 10064 Acly ATP citrate lyase gene CHEBI:79997 GW 4064 multiple interactions ISO RGD:10065 E RGD:6480464 20190312 CTD MESH:C412815 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACLY mRNA PMID:30611723 10064 Acly ATP citrate lyase gene CHEBI:8064 phenformin decreases expression ISO RGD:2018 E RGD:6480464 20200114 CTD MESH:D010629 Phenformin results in decreased expression of ACLY mRNA PMID:31324951 10064 Acly ATP citrate lyase gene CHEBI:8069 phenobarbital affects expression EXP E RGD:6480464 20130514 CTD MESH:D010634 Phenobarbital affects the expression of ACLY mRNA PMID:23091169 10064 Acly ATP citrate lyase gene CHEBI:80774 tauroursodeoxycholic acid decreases expression ISO RGD:2018 E RGD:6480464 20141111 CTD MESH:C031655 ursodoxicoltaurine results in decreased expression of ACLY mRNA PMID:15885361 10064 Acly ATP citrate lyase gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:2018 E RGD:6480464 20141111 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ACLY mRNA PMID:21724226|PMID:32109520 10064 Acly ATP citrate lyase gene CHEBI:81508 2,3,4,7,8-Pentachlorodibenzofuran decreases expression ISO RGD:2018 E RGD:6480464 20141111 CTD MESH:C038890 2,3,4,7,8-pentachlorodibenzofuran results in decreased expression of ACLY mRNA PMID:21724226 10064 Acly ATP citrate lyase gene CHEBI:81543 Tributyltin oxide decreases phosphorylation EXP E RGD:6480464 20161213 CTD MESH:C005961 bis(tri-n-butyltin)oxide results in decreased phosphorylation of ACLY protein PMID:22174045 10064 Acly ATP citrate lyase gene CHEBI:81555 Enterolactone multiple interactions ISO RGD:10065 E RGD:6480464 20151103 CTD MESH:C029497 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ACLY mRNA PMID:19167446 10064 Acly ATP citrate lyase gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:2018 E RGD:6480464 20170303 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACLY mRNA PMID:20056577 10064 Acly ATP citrate lyase gene CHEBI:81758 cyproconazole increases expression ISO RGD:2018 E RGD:6480464 20180515 CTD MESH:C093628 cyproconazole results in increased expression of ACLY mRNA PMID:29038839 10064 Acly ATP citrate lyase gene CHEBI:81892 Brodifacoum increases expression ISO RGD:2018 E RGD:6480464 20171114 CTD MESH:C013418 bromfenacoum results in increased expression of ACLY protein PMID:28903499 10064 Acly ATP citrate lyase gene CHEBI:82033 propamocarb decreases expression EXP E RGD:6480464 20190219 CTD MESH:C033205 propamocarb results in decreased expression of ACLY mRNA PMID:29137890 10064 Acly ATP citrate lyase gene CHEBI:83197 picoxystrobin increases expression ISO RGD:10065 E RGD:6480464 20210810 CTD MESH:C556557 picoxystrobin results in increased expression of ACLY mRNA PMID:33512557 10064 Acly ATP citrate lyase gene CHEBI:8329 Pomiferin increases expression ISO RGD:10065 E RGD:6480464 20170110 CTD MESH:C474837 pomiferin results in increased expression of ACLY mRNA PMID:20706672 10064 Acly ATP citrate lyase gene CHEBI:8450 procymidone decreases expression EXP E RGD:6480464 20210810 CTD MESH:C035988 procymidone results in decreased expression of ACLY mRNA PMID:33246813 10064 Acly ATP citrate lyase gene CHEBI:8450 procymidone increases expression EXP E RGD:6480464 20230606 CTD MESH:C035988 procymidone results in increased expression of ACLY mRNA PMID:36764477 10064 Acly ATP citrate lyase gene CHEBI:8450 procymidone multiple interactions EXP E RGD:6480464 20210810 CTD MESH:C035988 [procymidone co-treated with tetrachloroisophthalonitrile] results in decreased expression of ACLY mRNA PMID:33246813 10064 Acly ATP citrate lyase gene CHEBI:8489 propiconazole increases expression ISO RGD:2018 E RGD:6480464 20230606 CTD MESH:C045950 propiconazole results in increased expression of ACLY mRNA PMID:30047161 10064 Acly ATP citrate lyase gene CHEBI:8493 Propiverine affects binding ISO RGD:2018 E RGD:6480464 20180410 CTD MESH:C015586 propiverine binds to ACLY protein PMID:29273565 10064 Acly ATP citrate lyase gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2018 E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in increased expression of ACLY mRNA PMID:30047161 10064 Acly ATP citrate lyase gene CHEBI:8633 puerarin increases expression ISO RGD:10065 E RGD:6480464 20141111 CTD MESH:C033607 puerarin results in increased expression of ACLY mRNA PMID:20706672 10064 Acly ATP citrate lyase gene CHEBI:88046 cylindrospermopsin decreases expression ISO RGD:10065 E RGD:6480464 20250114 CTD MESH:C089595 cylindrospermopsin results in decreased expression of ACLY mRNA PMID:38735451 10064 Acly ATP citrate lyase gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:10065 E RGD:6480464 20240206 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of ACLY protein PMID:37664457 10064 Acly ATP citrate lyase gene CHEBI:9144 silibinin decreases phosphorylation ISO RGD:10065 E RGD:6480464 20191114 CTD MESH:C440975 Silybin results in decreased phosphorylation of ACLY protein PMID:25294820 10064 Acly ATP citrate lyase gene CHEBI:93310 N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide multiple interactions EXP E RGD:6480464 20181016 CTD MESH:C492919 N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Particulate Matter results in increased expression of ACLY protein] PMID:29635361 10064 Acly ATP citrate lyase gene CHEBI:9352 sulindac increases expression ISO RGD:10065 E RGD:6480464 20210706 CTD MESH:D013467 Sulindac results in increased expression of ACLY mRNA PMID:32535746 10064 Acly ATP citrate lyase gene CHEBI:9381 T-2 toxin decreases expression ISO RGD:2018 E RGD:6480464 20151110 CTD MESH:D013605 T-2 Toxin results in decreased expression of ACLY mRNA PMID:26141394 10064 Acly ATP citrate lyase gene CHEBI:9495 thiram decreases expression ISO RGD:10065 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of ACLY mRNA PMID:38568856 10064 Acly ATP citrate lyase gene CHEBI:9516 thapsigargin increases expression EXP E RGD:6480464 20160412 CTD MESH:D019284 Thapsigargin results in increased expression of ACLY protein PMID:24648495 10064 Acly ATP citrate lyase gene CHEBI:9516 thapsigargin increases expression ISO RGD:2018 E RGD:6480464 20221101 CTD MESH:D019284 Thapsigargin results in increased expression of ACLY protein PMID:35544339 10064 Acly ATP citrate lyase gene CHEBI:955 2,6-dimethoxyphenol multiple interactions ISO RGD:10065 E RGD:6480464 20250114 CTD MESH:C010120 [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ACLY protein PMID:38598786 10064 Acly ATP citrate lyase gene CHEBI:9747 Triptolide decreases expression EXP E RGD:6480464 20210706 CTD MESH:C001899 triptolide results in decreased expression of ACLY mRNA PMID:32835833 10064 Acly ATP citrate lyase gene CHEBI:9753 troglitazone decreases expression ISO RGD:10065 E RGD:6480464 20150825 CTD MESH:C057693 troglitazone results in decreased expression of ACLY mRNA PMID:25572481 10066 Aco1 aconitase 1 gene CHEBI:10106 zearalenone decreases expression EXP E RGD:6480464 20230404 CTD MESH:D015025 Zearalenone results in decreased expression of ACO1 protein PMID:36252740 10066 Aco1 aconitase 1 gene CHEBI:1224 2-nitrofluorene increases expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:C019499 2-nitrofluorene results in increased expression of ACO1 mRNA PMID:15890375 10066 Aco1 aconitase 1 gene CHEBI:132267 triptonide decreases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in decreased expression of ACO1 mRNA PMID:33045310 10066 Aco1 aconitase 1 gene CHEBI:132471 (+)-schisandrin B multiple interactions ISO RGD:2019 E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACO1 mRNA] PMID:31150632 10066 Aco1 aconitase 1 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:10067 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in decreased expression of ACO1 mRNA PMID:33167477 10066 Aco1 aconitase 1 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:10067 E RGD:6480464 20140408 CTD MESH:D014212 Tretinoin results in increased expression of ACO1 mRNA PMID:23724009 10066 Aco1 aconitase 1 gene CHEBI:15368 acrolein multiple interactions ISO RGD:10067 E RGD:6480464 20210112 CTD MESH:D000171 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ACO1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ACO1 mRNA PMID:32699268 10066 Aco1 aconitase 1 gene CHEBI:15379 dioxygen multiple interactions ISO RGD:2019 E RGD:6480464 20181016 CTD MESH:D010100 [Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein] PMID:16135072 10066 Aco1 aconitase 1 gene CHEBI:16240 hydrogen peroxide affects expression ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D006861 Hydrogen Peroxide affects the expression of ACO1 mRNA PMID:20044591 10066 Aco1 aconitase 1 gene CHEBI:16240 hydrogen peroxide increases activity EXP E RGD:6480464 20120412 CTD MESH:D006861 Hydrogen Peroxide results in increased activity of ACO1 protein PMID:15664434 10066 Aco1 aconitase 1 gene CHEBI:16243 quercetin increases expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D011794 Quercetin results in increased expression of ACO1 mRNA PMID:17103110 10066 Aco1 aconitase 1 gene CHEBI:16412 lipopolysaccharide increases activity EXP E RGD:6480464 20161228 CTD MESH:D008070 Lipopolysaccharides results in increased activity of ACO1 protein PMID:11054110 10066 Aco1 aconitase 1 gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20161228 CTD MESH:D008070 [Lipopolysaccharides co-treated with IFNG protein] results in increased activity of ACO1 protein PMID:11054110 10066 Aco1 aconitase 1 gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20120412 CTD MESH:D004958 Estradiol affects the expression of ACO1 mRNA PMID:16684588 10066 Aco1 aconitase 1 gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:10067 E RGD:6480464 20121113 CTD MESH:D004958 Estradiol results in decreased expression of ACO1 mRNA PMID:21185374 10066 Aco1 aconitase 1 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:2019 E RGD:6480464 20160705 CTD MESH:D004958 [bisphenol A co-treated with Estradiol] results in decreased expression of ACO1 mRNA PMID:26496021 10066 Aco1 aconitase 1 gene CHEBI:16480 nitric oxide decreases expression EXP E RGD:6480464 20120412 CTD MESH:D009569 Nitric Oxide results in decreased expression of ACO1 mRNA PMID:16886906 10066 Aco1 aconitase 1 gene CHEBI:16480 nitric oxide multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D009569 STAT5A protein affects the reaction [Nitric Oxide results in decreased expression of ACO1 mRNA]; STAT5B protein affects the reaction [Nitric Oxide results in decreased expression of ACO1 mRNA] PMID:16886906 10066 Aco1 aconitase 1 gene CHEBI:16602 trichloroethene decreases expression ISO RGD:2019 E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in decreased expression of ACO1 mRNA PMID:33387578 10066 Aco1 aconitase 1 gene CHEBI:17234 glucose increases expression ISO RGD:10067 E RGD:6480464 20240806 CTD MESH:D005947 Glucose results in increased expression of ACO1 protein PMID:38483099 10066 Aco1 aconitase 1 gene CHEBI:17234 glucose increases expression ISO RGD:2019 E RGD:6480464 20240806 CTD MESH:D005947 Glucose results in increased expression of ACO1 protein PMID:38483099 10066 Aco1 aconitase 1 gene CHEBI:17234 glucose multiple interactions ISO RGD:2019 E RGD:6480464 20181016 CTD MESH:D005947 [Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein] PMID:16135072 10066 Aco1 aconitase 1 gene CHEBI:174045 Fluorocitric acid decreases activity ISO RGD:2019 E RGD:6480464 20210706 CTD MESH:C007744 fluorocitrate results in decreased activity of ACO1 protein PMID:17469137 10066 Aco1 aconitase 1 gene CHEBI:17580 linalool increases expression ISO RGD:10067 E RGD:6480464 20190219 CTD MESH:C018584 linalool results in increased expression of ACO1 mRNA PMID:24752549 10066 Aco1 aconitase 1 gene CHEBI:17634 D-glucose increases expression ISO RGD:10067 E RGD:6480464 20240806 CTD MESH:D005947 Glucose results in increased expression of ACO1 protein PMID:38483099 10066 Aco1 aconitase 1 gene CHEBI:17634 D-glucose increases expression ISO RGD:2019 E RGD:6480464 20240806 CTD MESH:D005947 Glucose results in increased expression of ACO1 protein PMID:38483099 10066 Aco1 aconitase 1 gene CHEBI:17634 D-glucose multiple interactions ISO RGD:2019 E RGD:6480464 20181016 CTD MESH:D005947 [Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein] PMID:16135072 10066 Aco1 aconitase 1 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACO1 mRNA PMID:36331819 10066 Aco1 aconitase 1 gene CHEBI:18248 iron atom affects metabolic processing EXP E RGD:6480464 20120412 CTD MESH:D007501 ACO1 protein affects the metabolism of Iron PMID:17194590 10066 Aco1 aconitase 1 gene CHEBI:18248 iron atom multiple interactions ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D007501 Iron inhibits the reaction [nickel chloride results in increased activity of ACO1 protein]; Iron inhibits the reaction [Nickel results in increased activity of ACO1 protein] PMID:16039939|PMID:16877034 10066 Aco1 aconitase 1 gene CHEBI:18248 iron atom multiple interactions ISO RGD:2019 E RGD:6480464 20120814 CTD MESH:D007501 [Deferoxamine results in decreased abundance of Iron] which results in increased activity of ACO1 protein PMID:15893546 10066 Aco1 aconitase 1 gene CHEBI:18291 manganese atom decreases activity ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D008345 Manganese results in decreased activity of ACO1 protein PMID:17469137 10066 Aco1 aconitase 1 gene CHEBI:18291 manganese atom increases activity ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D008345 Manganese results in increased activity of ACO1 protein PMID:16386771 10066 Aco1 aconitase 1 gene CHEBI:18291 manganese atom increases activity ISO RGD:2019 E RGD:6480464 20120501 CTD MESH:D008345 Manganese results in increased activity of ACO1 protein PMID:16545456|PMID:16568477 10066 Aco1 aconitase 1 gene CHEBI:18291 manganese atom multiple interactions ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D008345 Manganese results in increased stability of [ACO1 protein binds to SLC11A2 mRNA] PMID:16729984 10066 Aco1 aconitase 1 gene CHEBI:18421 superoxide decreases activity EXP E RGD:6480464 20190219 CTD MESH:D013481 Superoxides results in decreased activity of ACO1 protein PMID:28542246 10066 Aco1 aconitase 1 gene CHEBI:18421 superoxide multiple interactions EXP E RGD:6480464 20190219 CTD MESH:D013481 [SOD1 protein results in decreased abundance of Superoxides] which results in increased expression of ACO1 protein PMID:28542246 10066 Aco1 aconitase 1 gene CHEBI:18721 3-chloropropane-1,2-diol affects expression ISO RGD:2019 E RGD:6480464 20170516 CTD MESH:D000517 alpha-Chlorohydrin affects the expression of ACO1 protein PMID:26597043 10066 Aco1 aconitase 1 gene CHEBI:18721 3-chloropropane-1,2-diol decreases expression ISO RGD:2019 E RGD:6480464 20170516 CTD MESH:D000517 alpha-Chlorohydrin analog results in decreased expression of ACO1 protein PMID:26597043 10066 Aco1 aconitase 1 gene CHEBI:18721 3-chloropropane-1,2-diol increases expression ISO RGD:2019 E RGD:6480464 20171010 CTD MESH:D000517 alpha-Chlorohydrin results in increased expression of ACO1 mRNA PMID:28522335 10066 Aco1 aconitase 1 gene CHEBI:188851 Muraglitazar increases expression ISO RGD:2019 E RGD:6480464 20220104 CTD MESH:C500085 muraglitazar results in increased expression of ACO1 mRNA PMID:21515302 10066 Aco1 aconitase 1 gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:10067 E RGD:6480464 20221101 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACO1 mRNA PMID:35301059 10066 Aco1 aconitase 1 gene CHEBI:231505 gallium nitrate increases expression ISO RGD:10067 E RGD:6480464 20240702 CTD MESH:C027235 gallium nitrate results in increased expression of ACO1 mRNA PMID:18586083 10066 Aco1 aconitase 1 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D016604 Aflatoxin B1 results in increased expression of ACO1 mRNA PMID:15890375 10066 Aco1 aconitase 1 gene CHEBI:25812 ozone multiple interactions EXP E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ACO1 mRNA PMID:34911549 10066 Aco1 aconitase 1 gene CHEBI:25812 ozone multiple interactions ISO RGD:10067 E RGD:6480464 20210112 CTD MESH:D010126 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ACO1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ACO1 mRNA; [Air Pollutants results in increased abundance of Ozone] which affects the expression of ACO1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in increased expression of ACO1 mRNA PMID:32699268|PMID:35430440 10066 Aco1 aconitase 1 gene CHEBI:2663 amiodarone affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D000638 Amiodarone affects the expression of ACO1 mRNA PMID:19483382 10066 Aco1 aconitase 1 gene CHEBI:27363 zinc atom decreases activity EXP E RGD:6480464 20130122 CTD MESH:D015032 Zinc deficiency results in decreased activity of ACO1 protein PMID:18073202 10066 Aco1 aconitase 1 gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20200804 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACO1 mRNA PMID:31919559 10066 Aco1 aconitase 1 gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:2019 E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACO1 mRNA PMID:31150632 10066 Aco1 aconitase 1 gene CHEBI:27385 tetrachloromethane multiple interactions ISO RGD:2019 E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACO1 mRNA] PMID:31150632 10066 Aco1 aconitase 1 gene CHEBI:27470 folic acid decreases expression EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of ACO1 mRNA PMID:25629700 10066 Aco1 aconitase 1 gene CHEBI:27504 mitomycin C affects response to substance ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D016685 ACO1 protein affects the susceptibility to Mitomycin PMID:16217747 10066 Aco1 aconitase 1 gene CHEBI:27563 arsenic atom increases activity ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D001151 Arsenic results in increased activity of ACO1 protein PMID:16386771 10066 Aco1 aconitase 1 gene CHEBI:27638 cobalt atom increases activity ISO RGD:10067 E RGD:6480464 20120717 CTD MESH:D003035 Cobalt results in increased activity of ACO1 protein PMID:16386771|PMID:16877034 10066 Aco1 aconitase 1 gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:10067 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased secretion of ACO1 protein PMID:38460933 10066 Aco1 aconitase 1 gene CHEBI:27698 vanadium atom increases activity ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D014639 Vanadium results in increased activity of ACO1 protein PMID:16386771 10066 Aco1 aconitase 1 gene CHEBI:28112 nickel atom decreases expression ISO RGD:10067 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in decreased expression of ACO1 mRNA PMID:25583101 10066 Aco1 aconitase 1 gene CHEBI:28112 nickel atom increases activity ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D009532 Nickel results in increased activity of ACO1 protein PMID:16386771|PMID:16877034 10066 Aco1 aconitase 1 gene CHEBI:28112 nickel atom multiple interactions ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D009532 ferric sulfate inhibits the reaction [Nickel results in increased activity of ACO1 protein]; Iron inhibits the reaction [Nickel results in increased activity of ACO1 protein] PMID:16877034 10066 Aco1 aconitase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ACO1 mRNA PMID:21570461 10066 Aco1 aconitase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases activity EXP E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased activity of ACO1 protein PMID:9443932 10066 Aco1 aconitase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACO1 mRNA; Tetrachlorodibenzodioxin results in decreased expression of ACO1 protein PMID:18163543|PMID:28213091 10066 Aco1 aconitase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACO1 mRNA; Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ACO1 gene] PMID:17942748|PMID:28213091 10066 Aco1 aconitase 1 gene CHEBI:28201 rotenone decreases activity ISO RGD:10067 E RGD:6480464 20130416 CTD MESH:D012402 Rotenone results in decreased activity of ACO1 protein PMID:21570952 10066 Aco1 aconitase 1 gene CHEBI:28201 rotenone increases activity ISO RGD:10067 E RGD:6480464 20130416 CTD MESH:D012402 Rotenone results in increased activity of ACO1 protein PMID:21570952 10066 Aco1 aconitase 1 gene CHEBI:28694 copper atom decreases expression ISO RGD:2019 E RGD:6480464 20120717 CTD MESH:D003300 Copper results in decreased expression of ACO1 mRNA PMID:22465980 10066 Aco1 aconitase 1 gene CHEBI:28694 copper atom increases activity ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D003300 Copper results in increased activity of ACO1 protein PMID:16386771 10066 Aco1 aconitase 1 gene CHEBI:28748 doxorubicin affects activity ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D004317 Doxorubicin affects the activity of ACO1 protein PMID:11731422 10066 Aco1 aconitase 1 gene CHEBI:28748 doxorubicin affects response to substance ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D004317 ACO1 protein affects the susceptibility to Doxorubicin PMID:16217747 10066 Aco1 aconitase 1 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:10067 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of ACO1 mRNA PMID:29803840 10066 Aco1 aconitase 1 gene CHEBI:2877 aspartame multiple interactions EXP E RGD:6480464 20200317 CTD MESH:D001218 [Fats, Unsaturated co-treated with Aspartame] affects the expression of ACO1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACO1 mRNA PMID:23783067 10066 Aco1 aconitase 1 gene CHEBI:28794 coumarin affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:C030123 coumarin affects the expression of ACO1 mRNA PMID:16963487 10066 Aco1 aconitase 1 gene CHEBI:28869 menadione affects activity EXP E RGD:6480464 20120412 CTD MESH:D024483 Vitamin K 3 affects the activity of ACO1 protein PMID:10037708 10066 Aco1 aconitase 1 gene CHEBI:28984 aluminium atom decreases activity ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D000535 Aluminum results in decreased activity of ACO1 protein PMID:10806405 10066 Aco1 aconitase 1 gene CHEBI:29287 gold atom multiple interactions ISO RGD:10067 E RGD:6480464 20171010 CTD MESH:D006046 [Polyethyleneimine binds to Gold] which results in increased expression of ACO1 mRNA PMID:28433809 10066 Aco1 aconitase 1 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:2019 E RGD:6480464 20190507 CTD MESH:C017947 sodium arsenite results in increased expression of ACO1 protein PMID:29459688 10066 Aco1 aconitase 1 gene CHEBI:29865 benzo[a]pyrene decreases methylation EXP E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ACO1 exon; Benzo(a)pyrene results in decreased methylation of ACO1 intron PMID:27901495 10066 Aco1 aconitase 1 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ACO1 mRNA PMID:22228805 10066 Aco1 aconitase 1 gene CHEBI:29865 benzo[a]pyrene multiple interactions ISO RGD:10067 E RGD:6480464 20140812 CTD MESH:D001564 [Soot co-treated with Benzo(a)pyrene] results in increased expression of ACO1 protein PMID:24464499 10066 Aco1 aconitase 1 gene CHEBI:30050 gold(0) multiple interactions ISO RGD:10067 E RGD:6480464 20171010 CTD MESH:D006046 [Polyethyleneimine binds to Gold] which results in increased expression of ACO1 mRNA PMID:28433809 10066 Aco1 aconitase 1 gene CHEBI:30052 copper(0) decreases expression ISO RGD:2019 E RGD:6480464 20120717 CTD MESH:D003300 Copper results in decreased expression of ACO1 mRNA PMID:22465980 10066 Aco1 aconitase 1 gene CHEBI:30052 copper(0) increases activity ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D003300 Copper results in increased activity of ACO1 protein PMID:16386771 10066 Aco1 aconitase 1 gene CHEBI:30185 zinc(0) decreases activity EXP E RGD:6480464 20130122 CTD MESH:D015032 Zinc deficiency results in decreased activity of ACO1 protein PMID:18073202 10066 Aco1 aconitase 1 gene CHEBI:3023 benzbromarone affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D001553 Benzbromarone affects the expression of ACO1 mRNA PMID:19483382 10066 Aco1 aconitase 1 gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:10067 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of ACO1 protein PMID:19364129 10066 Aco1 aconitase 1 gene CHEBI:30621 diarsenic trioxide increases expression ISO RGD:10067 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in increased expression of ACO1 mRNA PMID:20458559 10066 Aco1 aconitase 1 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ACO1 mRNA PMID:16483693 10066 Aco1 aconitase 1 gene CHEBI:31604 ferric ammonium citrate decreases activity EXP E RGD:6480464 20130122 CTD MESH:C013531 ferric ammonium citrate results in decreased activity of ACO1 protein PMID:18073202 10066 Aco1 aconitase 1 gene CHEBI:31604 ferric ammonium citrate increases activity EXP E RGD:6480464 20120412 CTD MESH:C013531 ferric ammonium citrate results in increased activity of ACO1 protein PMID:11054110 10066 Aco1 aconitase 1 gene CHEBI:31638 fulvestrant increases methylation ISO RGD:10067 E RGD:6480464 20220308 CTD MESH:C070081 Fulvestrant results in increased methylation of ACO1 gene PMID:31601247 10066 Aco1 aconitase 1 gene CHEBI:32161 sulfadimethoxine increases expression ISO RGD:2019 E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in increased expression of ACO1 mRNA PMID:30047161 10066 Aco1 aconitase 1 gene CHEBI:32195 Tesaglitazar increases expression ISO RGD:2019 E RGD:6480464 20170303 CTD MESH:C501413 tesaglitazar results in increased expression of ACO1 mRNA PMID:21515302 10066 Aco1 aconitase 1 gene CHEBI:32234 titanium dioxide increases expression EXP E RGD:6480464 20191112 CTD MESH:C009495 titanium dioxide results in increased expression of ACO1 mRNA PMID:29264374 10066 Aco1 aconitase 1 gene CHEBI:32497 thioacetamide affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D013853 Thioacetamide affects the expression of ACO1 mRNA PMID:19483382 10066 Aco1 aconitase 1 gene CHEBI:32497 thioacetamide decreases expression ISO RGD:2019 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of ACO1 mRNA PMID:34492290 10066 Aco1 aconitase 1 gene CHEBI:32506 4,4'-diaminodiphenylmethane increases expression EXP E RGD:6480464 20120412 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in increased expression of ACO1 mRNA PMID:18648102 10066 Aco1 aconitase 1 gene CHEBI:32509 pirinixic acid affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid affects the expression of ACO1 mRNA PMID:19483382 10066 Aco1 aconitase 1 gene CHEBI:32509 pirinixic acid increases expression ISO RGD:2019 E RGD:6480464 20121113 CTD MESH:C006253 pirinixic acid results in increased expression of ACO1 mRNA PMID:15890375|PMID:16940010|PMID:19162173|PMID:22484513 10066 Aco1 aconitase 1 gene CHEBI:32687 piperonyl butoxide increases expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D010882 Piperonyl Butoxide results in increased expression of ACO1 mRNA PMID:15890375 10066 Aco1 aconitase 1 gene CHEBI:32692 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:C016583 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ACO1 mRNA PMID:15890375 10066 Aco1 aconitase 1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:10067 E RGD:6480464 20230307 CTD MESH:C006780 bisphenol A results in decreased expression of ACO1 protein PMID:34186270 10066 Aco1 aconitase 1 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:10067 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of ACO1 gene PMID:31601247 10066 Aco1 aconitase 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:2019 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of ACO1 mRNA PMID:25181051 10066 Aco1 aconitase 1 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:2019 E RGD:6480464 20160705 CTD MESH:C006780 [bisphenol A co-treated with Estradiol] results in decreased expression of ACO1 mRNA PMID:26496021 10066 Aco1 aconitase 1 gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:10067 E RGD:6480464 20220308 CTD MESH:C020806 tetrabromobisphenol A results in decreased expression of ACO1 protein PMID:31675489 10066 Aco1 aconitase 1 gene CHEBI:33629 aluminium(0) decreases activity ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D000535 Aluminum results in decreased activity of ACO1 protein PMID:10806405 10066 Aco1 aconitase 1 gene CHEBI:34031 1,1-dichloroethene decreases expression EXP E RGD:6480464 20170725 CTD MESH:C029297 vinylidene chloride results in decreased expression of ACO1 mRNA PMID:26682919 10066 Aco1 aconitase 1 gene CHEBI:34575 bisphenol F increases expression ISO RGD:10067 E RGD:6480464 20230307 CTD MESH:C008745 bisphenol F results in increased expression of ACO1 protein PMID:34186270 10066 Aco1 aconitase 1 gene CHEBI:34581 Bisphenol B increases expression ISO RGD:10067 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of ACO1 protein PMID:34186270 10066 Aco1 aconitase 1 gene CHEBI:34631 chlorpyrifos increases expression EXP E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of ACO1 mRNA PMID:37019170 10066 Aco1 aconitase 1 gene CHEBI:34648 clofibric acid affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D002995 Clofibric Acid affects the expression of ACO1 mRNA PMID:17602206 10066 Aco1 aconitase 1 gene CHEBI:34682 diazinon increases methylation ISO RGD:10067 E RGD:6480464 20141014 CTD MESH:D003976 Diazinon results in increased methylation of ACO1 gene PMID:22964155 10066 Aco1 aconitase 1 gene CHEBI:34887 nickel dichloride decreases activity ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:C022838 nickel chloride results in decreased activity of ACO1 protein PMID:17018869 10066 Aco1 aconitase 1 gene CHEBI:34887 nickel dichloride increases activity ISO RGD:10067 E RGD:6480464 20120814 CTD MESH:C022838 nickel chloride results in increased activity of ACO1 protein PMID:16039939|PMID:16649251 10066 Aco1 aconitase 1 gene CHEBI:34887 nickel dichloride multiple interactions ISO RGD:10067 E RGD:6480464 20120717 CTD MESH:C022838 [nickel chloride results in increased activity of ACO1 protein] inhibits the reaction [ferrous sulfate results in increased expression of FTL protein]; [nickel chloride results in increased activity of ACO1 protein] which results in increased expression of and results in increased stability of TFRC mRNA; Iron inhibits the reaction [nickel chloride results in increased activity of ACO1 protein] PMID:16039939 10066 Aco1 aconitase 1 gene CHEBI:34905 paraquat decreases activity ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D010269 Paraquat results in decreased activity of ACO1 protein PMID:11520895|PMID:17324120 10066 Aco1 aconitase 1 gene CHEBI:34905 paraquat decreases expression EXP E RGD:6480464 20190219 CTD MESH:D010269 Paraquat results in decreased expression of ACO1 protein PMID:28542246 10066 Aco1 aconitase 1 gene CHEBI:34905 paraquat increases activity EXP E RGD:6480464 20120412 CTD MESH:D010269 Paraquat results in increased activity of ACO1 protein PMID:15664434 10066 Aco1 aconitase 1 gene CHEBI:35033 triphenyl phosphate increases expression ISO RGD:2019 E RGD:6480464 20200331 CTD MESH:C005445 triphenyl phosphate results in increased expression of ACO1 mRNA PMID:30589522 10066 Aco1 aconitase 1 gene CHEBI:35154 manganese(0) decreases activity ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D008345 Manganese results in decreased activity of ACO1 protein PMID:17469137 10066 Aco1 aconitase 1 gene CHEBI:35154 manganese(0) increases activity ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D008345 Manganese results in increased activity of ACO1 protein PMID:16386771 10066 Aco1 aconitase 1 gene CHEBI:35154 manganese(0) increases activity ISO RGD:2019 E RGD:6480464 20120501 CTD MESH:D008345 Manganese results in increased activity of ACO1 protein PMID:16545456|PMID:16568477 10066 Aco1 aconitase 1 gene CHEBI:35154 manganese(0) multiple interactions ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D008345 Manganese results in increased stability of [ACO1 protein binds to SLC11A2 mRNA] PMID:16729984 10066 Aco1 aconitase 1 gene CHEBI:35170 vanadium(0) increases activity ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D014639 Vanadium results in increased activity of ACO1 protein PMID:16386771 10066 Aco1 aconitase 1 gene CHEBI:35456 cadmium dichloride affects localization ISO RGD:2019 E RGD:6480464 20141223 CTD MESH:D019256 Cadmium Chloride affects the localization of ACO1 protein PMID:25106854 10066 Aco1 aconitase 1 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:10067 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in decreased expression of ACO1 mRNA PMID:38568856 10066 Aco1 aconitase 1 gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:10067 E RGD:6480464 20160119 CTD MESH:D019256 Cadmium Chloride results in increased expression of ACO1 mRNA PMID:26472689 10066 Aco1 aconitase 1 gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:10067 E RGD:6480464 20141223 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACO1 mRNA; Cadmium Chloride results in decreased activity of and affects the folding of ACO1 protein PMID:25106854|PMID:35301059 10066 Aco1 aconitase 1 gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:2019 E RGD:6480464 20141223 CTD MESH:D019256 Butylated Hydroxyanisole inhibits the reaction [Cadmium Chloride affects the localization of ACO1 protein]; Cadmium Chloride promotes the reaction [ACO1 protein binds to ACO1 protein]; Cadmium Chloride results in decreased expression of and results in decreased activity of ACO1 protein; KN 93 inhibits the reaction [Cadmium Chloride affects the localization of ACO1 protein] PMID:25106854 10066 Aco1 aconitase 1 gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACO1 mRNA PMID:19162173|PMID:28511854 10066 Aco1 aconitase 1 gene CHEBI:35559 furan increases methylation ISO RGD:2019 E RGD:6480464 20120918 CTD MESH:C039281 furan results in increased methylation of ACO1 gene PMID:22079235 10066 Aco1 aconitase 1 gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:2019 E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in decreased expression of ACO1 mRNA PMID:24386269 10066 Aco1 aconitase 1 gene CHEBI:35807 N-nitrosodimethylamine decreases expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D004128 Dimethylnitrosamine results in decreased expression of ACO1 mRNA PMID:15890375 10066 Aco1 aconitase 1 gene CHEBI:36740 alpha-pinene multiple interactions ISO RGD:10067 E RGD:6480464 20210112 CTD MESH:C005451 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of ACO1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of ACO1 mRNA PMID:32699268 10066 Aco1 aconitase 1 gene CHEBI:37187 lead nitrate decreases expression ISO RGD:10067 E RGD:6480464 20170303 CTD MESH:C017461 lead nitrate results in decreased expression of ACO1 protein PMID:22502979 10066 Aco1 aconitase 1 gene CHEBI:37187 lead nitrate multiple interactions ISO RGD:10067 E RGD:6480464 20170303 CTD MESH:C017461 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [lead nitrate results in decreased expression of ACO1 protein] PMID:22502979 10066 Aco1 aconitase 1 gene CHEBI:3750 clofibrate affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D002994 Clofibrate affects the expression of ACO1 mRNA PMID:19483382 10066 Aco1 aconitase 1 gene CHEBI:3750 clofibrate increases activity ISO RGD:2019 E RGD:6480464 20120613 CTD MESH:D002994 Clofibrate results in increased activity of ACO1 protein PMID:11969379 10066 Aco1 aconitase 1 gene CHEBI:37537 phorbol 13-acetate 12-myristate increases activity EXP E RGD:6480464 20181016 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein PMID:10889193 10066 Aco1 aconitase 1 gene CHEBI:37537 phorbol 13-acetate 12-myristate increases activity ISO RGD:2019 E RGD:6480464 20181016 CTD MESH:D013755 Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein PMID:10889193 10066 Aco1 aconitase 1 gene CHEBI:37537 phorbol 13-acetate 12-myristate multiple interactions EXP E RGD:6480464 20181016 CTD MESH:D013755 Tetradecanoylphorbol Acetate inhibits the reaction [TRH protein results in increased activity of ACO1 protein] PMID:10889193 10066 Aco1 aconitase 1 gene CHEBI:37537 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:2019 E RGD:6480464 20181016 CTD MESH:D013755 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein]; Okadaic Acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein]; pervanadate promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein] PMID:10889193 10066 Aco1 aconitase 1 gene CHEBI:37699 protein kinase inhibitor multiple interactions EXP E RGD:6480464 20181016 CTD MESH:D047428 Protein Kinase Inhibitors inhibits the reaction [TRH protein results in increased activity of ACO1 protein] PMID:10889193 10066 Aco1 aconitase 1 gene CHEBI:37825 p-toluidine increases expression ISO RGD:2019 E RGD:6480464 20170516 CTD MESH:C029370 4-toluidine results in increased expression of ACO1 mRNA PMID:27638505 10066 Aco1 aconitase 1 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ACO1 mRNA PMID:36331819 10066 Aco1 aconitase 1 gene CHEBI:39867 valproic acid affects expression ISO RGD:10067 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ACO1 mRNA PMID:25979313 10066 Aco1 aconitase 1 gene CHEBI:40036 amitrole increases expression ISO RGD:2019 E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in increased expression of ACO1 mRNA PMID:30047161 10066 Aco1 aconitase 1 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D016572 Cyclosporine results in decreased expression of ACO1 mRNA PMID:20106945 10066 Aco1 aconitase 1 gene CHEBI:41879 dexamethasone increases expression ISO RGD:10067 E RGD:6480464 20160705 CTD MESH:D003907 Dexamethasone results in increased expression of ACO1 mRNA PMID:25047013 10066 Aco1 aconitase 1 gene CHEBI:41922 diethylstilbestrol increases expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D004054 Diethylstilbestrol results in increased expression of ACO1 mRNA PMID:15890375 10066 Aco1 aconitase 1 gene CHEBI:42588 4-hydroxyphenyl retinamide decreases expression EXP E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in decreased expression of ACO1 mRNA PMID:28973697 10066 Aco1 aconitase 1 gene CHEBI:42758 aldehydo-D-glucose increases expression ISO RGD:10067 E RGD:6480464 20240806 CTD MESH:D005947 Glucose results in increased expression of ACO1 protein PMID:38483099 10066 Aco1 aconitase 1 gene CHEBI:42758 aldehydo-D-glucose increases expression ISO RGD:2019 E RGD:6480464 20240806 CTD MESH:D005947 Glucose results in increased expression of ACO1 protein PMID:38483099 10066 Aco1 aconitase 1 gene CHEBI:42758 aldehydo-D-glucose multiple interactions ISO RGD:2019 E RGD:6480464 20181016 CTD MESH:D005947 [Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein; Oxygen inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the activity of ACO1 protein] PMID:16135072 10066 Aco1 aconitase 1 gene CHEBI:4356 desferrioxamine B increases activity EXP E RGD:6480464 20130122 CTD MESH:D003676 Deferoxamine results in increased activity of ACO1 protein PMID:11054110|PMID:18073202 10066 Aco1 aconitase 1 gene CHEBI:4356 desferrioxamine B increases activity ISO RGD:10067 E RGD:6480464 20190611 CTD MESH:D003676 Deferoxamine results in increased activity of ACO1 protein PMID:10397746 10066 Aco1 aconitase 1 gene CHEBI:4356 desferrioxamine B increases activity ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D003676 Deferoxamine results in increased activity of ACO1 protein PMID:16568477 10066 Aco1 aconitase 1 gene CHEBI:4356 desferrioxamine B increases expression ISO RGD:2019 E RGD:6480464 20141223 CTD MESH:D003676 Deferoxamine results in increased expression of ACO1 protein PMID:25106854 10066 Aco1 aconitase 1 gene CHEBI:4356 desferrioxamine B multiple interactions ISO RGD:2019 E RGD:6480464 20120814 CTD MESH:D003676 [Deferoxamine results in decreased abundance of Iron] which results in increased activity of ACO1 protein PMID:15893546 10066 Aco1 aconitase 1 gene CHEBI:44445 nimesulide increases expression ISO RGD:2019 E RGD:6480464 20160412 CTD MESH:C012655 nimesulide results in increased expression of ACO1 mRNA PMID:24136188 10066 Aco1 aconitase 1 gene CHEBI:44658 okadaic acid multiple interactions ISO RGD:2019 E RGD:6480464 20181016 CTD MESH:D019319 Okadaic Acid inhibits the reaction [EGF protein results in decreased activity of ACO1 protein]; Okadaic Acid inhibits the reaction [TRH protein results in decreased activity of ACO1 protein]; Okadaic Acid promotes the reaction [Tetradecanoylphorbol Acetate results in increased activity of ACO1 protein] PMID:10889193 10066 Aco1 aconitase 1 gene CHEBI:46024 trichostatin A affects expression ISO RGD:10067 E RGD:6480464 20170613 CTD MESH:C012589 trichostatin A affects the expression of ACO1 mRNA PMID:28542535 10066 Aco1 aconitase 1 gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of ACO1 mRNA PMID:17562736 10066 Aco1 aconitase 1 gene CHEBI:46195 paracetamol decreases expression ISO RGD:10067 E RGD:6480464 20180515 CTD MESH:D000082 Acetaminophen results in decreased expression of ACO1 mRNA PMID:29067470 10066 Aco1 aconitase 1 gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:10067 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased secretion of ACO1 protein PMID:38460933 10066 Aco1 aconitase 1 gene CHEBI:47217 arsane increases activity ISO RGD:10067 E RGD:6480464 20140805 CTD MESH:D001151 Arsenic results in increased activity of ACO1 protein PMID:16386771 10066 Aco1 aconitase 1 gene CHEBI:4791 endosulfan decreases expression ISO RGD:2019 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of ACO1 mRNA PMID:29391264 10066 Aco1 aconitase 1 gene CHEBI:4811 epoxiconazole multiple interactions ISO RGD:2019 E RGD:6480464 20180515 CTD MESH:C109476 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ACO1 mRNA PMID:29038839 10066 Aco1 aconitase 1 gene CHEBI:4886 L-ethionine affects expression ISO RGD:2019 E RGD:6480464 20121106 CTD MESH:D005001 Ethionine affects the expression of ACO1 mRNA PMID:19483382 10066 Aco1 aconitase 1 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACO1 mRNA PMID:17942748 10066 Aco1 aconitase 1 gene CHEBI:4911 etoposide increases expression EXP E RGD:6480464 20150127 CTD MESH:D005047 Etoposide results in increased expression of ACO1 mRNA PMID:25270620 10066 Aco1 aconitase 1 gene CHEBI:49553 copper(II) chloride decreases expression EXP E RGD:6480464 20181016 CTD MESH:C029892 cupric chloride results in decreased expression of ACO1 protein PMID:29617964 10066 Aco1 aconitase 1 gene CHEBI:49662 indometacin decreases expression ISO RGD:2019 E RGD:6480464 20230704 CTD MESH:D007213 Indomethacin results in decreased expression of ACO1 mRNA PMID:36868495 10066 Aco1 aconitase 1 gene CHEBI:49900 arsenous acid decreases expression ISO RGD:10067 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of ACO1 protein PMID:19364129 10066 Aco1 aconitase 1 gene CHEBI:49900 arsenous acid increases expression ISO RGD:10067 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in increased expression of ACO1 mRNA PMID:20458559 10066 Aco1 aconitase 1 gene CHEBI:5001 fenofibrate increases expression ISO RGD:2019 E RGD:6480464 20121113 CTD MESH:D011345 Fenofibrate results in increased expression of ACO1 mRNA PMID:17264098 10066 Aco1 aconitase 1 gene CHEBI:50385 hemin decreases activity ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D006427 Hemin results in decreased activity of ACO1 protein PMID:16568477 10066 Aco1 aconitase 1 gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ACO1 mRNA; Nanotubes, Carbon results in decreased expression of ACO1 mRNA PMID:25620056 10066 Aco1 aconitase 1 gene CHEBI:50673 methimazole increases expression ISO RGD:2019 E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in increased expression of ACO1 mRNA PMID:30047161 10066 Aco1 aconitase 1 gene CHEBI:5132 flutamide decreases expression ISO RGD:2019 E RGD:6480464 20140909 CTD MESH:D005485 Flutamide results in decreased expression of ACO1 mRNA PMID:24793618 10066 Aco1 aconitase 1 gene CHEBI:53001 nickel sulfate decreases expression ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:C029938 nickel sulfate results in decreased expression of ACO1 mRNA PMID:16780908 10066 Aco1 aconitase 1 gene CHEBI:53438 iron(3+) sulfate multiple interactions ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:C024823 ferric sulfate inhibits the reaction [Nickel results in increased activity of ACO1 protein] PMID:16877034 10066 Aco1 aconitase 1 gene CHEBI:6067 isotretinoin decreases expression ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D015474 Isotretinoin results in decreased expression of ACO1 mRNA PMID:20436886 10066 Aco1 aconitase 1 gene CHEBI:6078 ivermectin decreases expression ISO RGD:10067 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ACO1 protein PMID:32959892 10066 Aco1 aconitase 1 gene CHEBI:63041 manganese(II) chloride increases activity ISO RGD:2019 E RGD:6480464 20120814 CTD MESH:C025340 manganese chloride results in increased activity of ACO1 protein PMID:15893546|PMID:16545456|PMID:16568477 10066 Aco1 aconitase 1 gene CHEBI:63634 valdecoxib increases expression ISO RGD:2019 E RGD:6480464 20170303 CTD MESH:C406224 valdecoxib results in increased expression of ACO1 mRNA PMID:24136188 10066 Aco1 aconitase 1 gene CHEBI:63921 2-butoxyethanol increases expression EXP E RGD:6480464 20120412 CTD MESH:C017096 n-butoxyethanol results in increased expression of ACO1 mRNA PMID:19812364 10066 Aco1 aconitase 1 gene CHEBI:6402 leflunomide increases expression ISO RGD:2019 E RGD:6480464 20161213 CTD MESH:C045463 leflunomide results in increased expression of ACO1 mRNA PMID:24136188 10066 Aco1 aconitase 1 gene CHEBI:64090 tert-butyl hydroperoxide increases expression ISO RGD:10067 E RGD:6480464 20120412 CTD MESH:D020122 tert-Butylhydroperoxide results in increased expression of ACO1 mRNA PMID:15336504 10066 Aco1 aconitase 1 gene CHEBI:64243 monosodium L-glutamate multiple interactions EXP E RGD:6480464 20200317 CTD MESH:D012970 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACO1 mRNA; [Fats, Unsaturated co-treated with Sodium Glutamate] affects the expression of ACO1 mRNA PMID:23783067 10066 Aco1 aconitase 1 gene CHEBI:6773 Mesaconitine increases expression ISO RGD:2019 E RGD:6480464 20231031 CTD MESH:C019470 mesaconitine results in increased expression of ACO1 protein PMID:37182599 10066 Aco1 aconitase 1 gene CHEBI:6809 methamphetamine increases expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D008694 Methamphetamine results in increased expression of ACO1 protein PMID:19826936 10066 Aco1 aconitase 1 gene CHEBI:6820 methapyrilene decreases expression ISO RGD:2019 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in decreased expression of ACO1 mRNA PMID:30467583 10066 Aco1 aconitase 1 gene CHEBI:6820 methapyrilene increases expression ISO RGD:10067 E RGD:6480464 20180116 CTD MESH:D008701 Methapyrilene results in increased expression of ACO1 mRNA PMID:28935588 10066 Aco1 aconitase 1 gene CHEBI:6820 methapyrilene increases expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D008701 Methapyrilene results in increased expression of ACO1 mRNA PMID:15890375 10066 Aco1 aconitase 1 gene CHEBI:6923 miconazole increases expression EXP E RGD:6480464 20190910 CTD MESH:D008825 Miconazole results in increased expression of ACO1 mRNA PMID:27462272 10066 Aco1 aconitase 1 gene CHEBI:72564 temozolomide decreases expression ISO RGD:10067 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in decreased expression of ACO1 mRNA PMID:31758290 10066 Aco1 aconitase 1 gene CHEBI:72754 bisphenol AF increases expression ISO RGD:10067 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of ACO1 protein PMID:34186270 10066 Aco1 aconitase 1 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ACO1 mRNA PMID:22206623 10066 Aco1 aconitase 1 gene CHEBI:7494 nefazodone increases expression ISO RGD:2019 E RGD:6480464 20160412 CTD MESH:C051752 nefazodone results in increased expression of ACO1 mRNA PMID:24136188 10066 Aco1 aconitase 1 gene CHEBI:75832 iron(2+) sulfate (anhydrous) multiple interactions ISO RGD:10067 E RGD:6480464 20161213 CTD MESH:C020748 [nickel chloride results in increased activity of ACO1 protein] inhibits the reaction [ferrous sulfate results in increased expression of FTL protein] PMID:16039939 10066 Aco1 aconitase 1 gene CHEBI:76359 butylated hydroxyanisole multiple interactions ISO RGD:2019 E RGD:6480464 20141223 CTD MESH:D002083 Butylated Hydroxyanisole inhibits the reaction [Cadmium Chloride affects the localization of ACO1 protein] PMID:25106854 10066 Aco1 aconitase 1 gene CHEBI:77260 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO RGD:2019 E RGD:6480464 20140805 CTD MESH:D009853 Omeprazole affects the expression of ACO1 mRNA PMID:19483382 10066 Aco1 aconitase 1 gene CHEBI:7772 omeprazole affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D009853 Omeprazole affects the expression of ACO1 mRNA PMID:19483382 10066 Aco1 aconitase 1 gene CHEBI:78741 oxidopamine affects response to substance EXP E RGD:6480464 20181016 CTD MESH:D016627 ACO1 protein affects the susceptibility to Oxidopamine PMID:19913091 10066 Aco1 aconitase 1 gene CHEBI:78741 oxidopamine increases expression EXP E RGD:6480464 20181016 CTD MESH:D016627 Oxidopamine results in increased expression of ACO1 mRNA PMID:19913091 10066 Aco1 aconitase 1 gene CHEBI:78741 oxidopamine multiple interactions EXP E RGD:6480464 20181016 CTD MESH:D016627 [ACO1 protein affects the susceptibility to Oxidopamine] which results in decreased expression of HEPH mRNA; Oxidopamine promotes the reaction [ACO1 protein results in decreased expression of SLC40A1 mRNA] PMID:19913091 10066 Aco1 aconitase 1 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:10067 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to ACO1 gene] PMID:28238834 10066 Aco1 aconitase 1 gene CHEBI:8069 phenobarbital affects expression ISO RGD:10067 E RGD:6480464 20121009 CTD MESH:D010634 Phenobarbital affects the expression of ACO1 mRNA PMID:19159669 10066 Aco1 aconitase 1 gene CHEBI:8113 phlorizin decreases expression EXP E RGD:6480464 20121009 CTD MESH:D010695 Phlorhizin results in decreased expression of ACO1 mRNA PMID:22538082 10066 Aco1 aconitase 1 gene CHEBI:81758 cyproconazole multiple interactions ISO RGD:2019 E RGD:6480464 20180515 CTD MESH:C093628 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA; [cyproconazole co-treated with epoxiconazole] results in increased expression of ACO1 mRNA PMID:29038839 10066 Aco1 aconitase 1 gene CHEBI:82436 decabromodiphenyl ether decreases expression ISO RGD:10067 E RGD:6480464 20220308 CTD MESH:C010902 decabromobiphenyl ether results in decreased expression of ACO1 protein PMID:31675489 10066 Aco1 aconitase 1 gene CHEBI:82664 iron(0) affects metabolic processing EXP E RGD:6480464 20140902 CTD MESH:D007501 ACO1 protein affects the metabolism of Iron PMID:17194590 10066 Aco1 aconitase 1 gene CHEBI:82664 iron(0) multiple interactions ISO RGD:10067 E RGD:6480464 20140902 CTD MESH:D007501 Iron inhibits the reaction [nickel chloride results in increased activity of ACO1 protein]; Iron inhibits the reaction [Nickel results in increased activity of ACO1 protein] PMID:16039939|PMID:16877034 10066 Aco1 aconitase 1 gene CHEBI:82664 iron(0) multiple interactions ISO RGD:2019 E RGD:6480464 20140902 CTD MESH:D007501 [Deferoxamine results in decreased abundance of Iron] which results in increased activity of ACO1 protein PMID:15893546 10066 Aco1 aconitase 1 gene CHEBI:84050 trabectedin increases expression ISO RGD:10067 E RGD:6480464 20230404 CTD MESH:C099150 Trabectedin results in increased expression of ACO1 mRNA; Trabectedin results in increased expression of ACO1 protein PMID:36396105 10066 Aco1 aconitase 1 gene CHEBI:8434 prochloraz multiple interactions ISO RGD:2019 E RGD:6480464 20180515 CTD MESH:C045362 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of ACO1 mRNA PMID:29038839 10066 Aco1 aconitase 1 gene CHEBI:8489 propiconazole increases expression ISO RGD:2019 E RGD:6480464 20230606 CTD MESH:C045950 propiconazole results in increased expression of ACO1 mRNA PMID:30047161 10066 Aco1 aconitase 1 gene CHEBI:8502 6-propyl-2-thiouracil affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:D011441 Propylthiouracil affects the expression of ACO1 mRNA PMID:19483382 10066 Aco1 aconitase 1 gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2019 E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in increased expression of ACO1 mRNA PMID:30047161 10066 Aco1 aconitase 1 gene CHEBI:91460 KN-93 multiple interactions ISO RGD:2019 E RGD:6480464 20160503 CTD MESH:C072105 KN 93 inhibits the reaction [Cadmium Chloride affects the localization of ACO1 protein] PMID:25106854 10066 Aco1 aconitase 1 gene CHEBI:9195 Soman decreases expression ISO RGD:2019 E RGD:6480464 20141111 CTD MESH:D012999 Soman results in decreased expression of ACO1 mRNA PMID:19281266 10066 Aco1 aconitase 1 gene CHEBI:920 2,4-dinitrotoluene affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of ACO1 mRNA PMID:21346803 10066 Aco1 aconitase 1 gene CHEBI:9495 thiram decreases expression ISO RGD:10067 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of ACO1 mRNA PMID:38568856 10066 Aco1 aconitase 1 gene CHEBI:9516 thapsigargin increases expression ISO RGD:2019 E RGD:6480464 20221101 CTD MESH:D019284 Thapsigargin results in increased expression of ACO1 protein PMID:35544339 10066 Aco1 aconitase 1 gene CHEBI:957 2,6-dinitrotoluene affects expression ISO RGD:2019 E RGD:6480464 20120412 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of ACO1 mRNA PMID:21346803 10066 Aco1 aconitase 1 gene CHEBI:9753 troglitazone increases expression ISO RGD:2019 E RGD:6480464 20120918 CTD MESH:C057693 troglitazone results in increased expression of ACO1 mRNA PMID:21515302 10066 Aco1 aconitase 1 gene CHEBI:9986 vinclozolin increases methylation ISO RGD:2019 E RGD:6480464 20201215 CTD MESH:C025643 vinclozolin results in increased methylation of ACO1 gene PMID:31079544 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression ISO RGD:10069 E RGD:6480464 20211207 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of ACP1 mRNA PMID:25812627 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:10069 E RGD:6480464 20120501 CTD MESH:D014212 Tretinoin results in decreased expression of ACP1 mRNA PMID:21934132|PMID:33167477 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:15743 butanal decreases expression ISO RGD:10069 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in decreased expression of ACP1 mRNA PMID:26079696 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:16602 trichloroethene increases expression EXP E RGD:6480464 20120412 CTD MESH:D014241 Trichloroethylene results in increased expression of ACP1 mRNA PMID:19448997 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:17440 4-nitrophenyl phosphate increases hydrolysis ISO RGD:10069 E RGD:6480464 20161115 CTD MESH:C008644 ACP1 protein results in increased hydrolysis of nitrophenylphosphate PMID:24287560 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:17440 4-nitrophenyl phosphate multiple interactions ISO RGD:10069 E RGD:6480464 20161115 CTD MESH:C008644 Benzoic Acid analog inhibits the reaction [ACP1 protein results in increased hydrolysis of nitrophenylphosphate]; Thiazolidines analog inhibits the reaction [ACP1 protein results in increased hydrolysis of nitrophenylphosphate] PMID:24287560 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:17688 (S)-nicotine decreases expression EXP E RGD:6480464 20161213 CTD MESH:D009538 Nicotine results in decreased expression of ACP1 mRNA PMID:17997037 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:178012 FR900359 increases phosphorylation ISO RGD:10069 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in increased phosphorylation of ACP1 protein PMID:37730182 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:18723 nicotine decreases expression EXP E RGD:6480464 20161213 CTD MESH:D009538 Nicotine results in decreased expression of ACP1 mRNA PMID:17997037 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:22977 cadmium atom increases expression ISO RGD:2020 E RGD:6480464 20130618 CTD MESH:D002104 Cadmium results in increased expression of ACP1 mRNA PMID:17327700 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:10069 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in increased expression of ACP1 mRNA PMID:27153756 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:25812 ozone multiple interactions ISO RGD:10069 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of ACP1 mRNA PMID:35430440 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:2654 aminoglutethimide decreases expression ISO RGD:10069 E RGD:6480464 20150825 CTD MESH:D000616 Aminoglutethimide results in decreased expression of ACP1 protein PMID:26102013 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:26710 sodium chloride multiple interactions ISO RGD:10069 E RGD:6480464 20250114 CTD MESH:D012965 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ACP1 protein; [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ACP1 protein PMID:38598786 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:27375 vincaleukoblastine affects response to substance ISO RGD:10069 E RGD:6480464 20120412 CTD MESH:D014747 ACP1 protein affects the susceptibility to Vinblastine PMID:16217747 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:27470 folic acid decreases expression EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of ACP1 mRNA PMID:25629700 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:27568 selenium atom decreases expression ISO RGD:10069 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in decreased expression of ACP1 mRNA PMID:19244175 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:10069 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased secretion of ACP1 protein PMID:38460933 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:27881 resveratrol increases expression EXP E RGD:6480464 20160822 CTD MESH:C059514 resveratrol results in increased expression of ACP1 protein PMID:25505154 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:27889 lead(0) affects splicing ISO RGD:10069 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the splicing of ACP1 mRNA PMID:28903495 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:28112 nickel atom increases expression ISO RGD:10069 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in increased expression of ACP1 mRNA PMID:24768652|PMID:25583101 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2020 E RGD:6480464 20200609 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACP1 mRNA PMID:32109520 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2020 E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACP1 mRNA PMID:34747641 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP1 mRNA PMID:17942748 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:10069 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of ACP1 protein PMID:33212167 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:10069 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of ACP1 mRNA PMID:30851411 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:28741 sodium fluoride decreases expression EXP E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in decreased expression of ACP1 protein PMID:28918527 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:28748 doxorubicin affects response to substance ISO RGD:10069 E RGD:6480464 20120412 CTD MESH:D004317 ACP1 protein affects the susceptibility to Doxorubicin PMID:16217747 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:29287 gold atom decreases expression ISO RGD:10069 E RGD:6480464 20150414 CTD MESH:D006046 Gold results in decreased expression of ACP1 mRNA PMID:25523186 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:10069 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ACP1 promoter PMID:27901495 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20120515 CTD MESH:D001564 Benzo(a)pyrene promotes the reaction [AHR protein binds to ACP1 promoter] PMID:19654925 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:10069 E RGD:6480464 20220405 CTD MESH:C015001 arsenite promotes the reaction [G3BP1 protein binds to ACP1 mRNA]; arsenite promotes the reaction [G3BP1 protein binds to ACP1 protein] PMID:32406909 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:30050 gold(0) decreases expression ISO RGD:10069 E RGD:6480464 20150414 CTD MESH:D006046 Gold results in decreased expression of ACP1 mRNA PMID:25523186 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:301 (-)-alpha-phellandrene decreases expression ISO RGD:10069 E RGD:6480464 20220208 CTD MESH:C005403 alpha phellandrene results in decreased expression of ACP1 mRNA PMID:25075043 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:30746 benzoic acid decreases activity ISO RGD:10069 E RGD:6480464 20161213 CTD MESH:D019817 Benzoic Acid analog results in decreased activity of ACP1 protein PMID:24287560 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:30746 benzoic acid multiple interactions ISO RGD:10069 E RGD:6480464 20161213 CTD MESH:D019817 Benzoic Acid analog inhibits the reaction [ACP1 protein results in increased hydrolysis of nitrophenylphosphate] PMID:24287560 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2020 E RGD:6480464 20130618 CTD MESH:D000643 Ammonium Chloride affects the expression of ACP1 mRNA PMID:16483693 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:31746 kainic acid decreases expression EXP E RGD:6480464 20120412 CTD MESH:D007608 Kainic Acid results in decreased expression of ACP1 mRNA PMID:17997037 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:31941 oxaliplatin decreases expression ISO RGD:2020 E RGD:6480464 20161213 CTD MESH:C030110 oxaliplatin results in decreased expression of ACP1 mRNA PMID:25729387 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:31941 oxaliplatin multiple interactions ISO RGD:2020 E RGD:6480464 20161213 CTD MESH:C030110 [oxaliplatin co-treated with Topotecan] results in decreased expression of ACP1 mRNA PMID:25729387 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:32234 titanium dioxide increases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in increased methylation of ACP1 promoter alternative form PMID:35295148 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:32506 4,4'-diaminodiphenylmethane increases expression EXP E RGD:6480464 20120412 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in increased expression of ACP1 mRNA PMID:18648102 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:33216 bisphenol A decreases expression ISO RGD:10069 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased expression of ACP1 protein PMID:31675489 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of ACP1 mRNA PMID:33221593 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:33216 bisphenol A increases expression ISO RGD:10069 E RGD:6480464 20230307 CTD MESH:C006780 bisphenol A results in increased expression of ACP1 protein PMID:34186270|PMID:37567409 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:33216 bisphenol A increases expression ISO RGD:2020 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of ACP1 mRNA PMID:25181051|PMID:32145629|PMID:34947998 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:33216 bisphenol A increases methylation ISO RGD:10069 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in increased methylation of ACP1 gene PMID:31601247 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:33217 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:10069 E RGD:6480464 20220308 CTD MESH:C020806 tetrabromobisphenol A results in increased expression of ACP1 protein PMID:31675489 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:33234 vitamin E decreases expression ISO RGD:10069 E RGD:6480464 20161228 CTD MESH:D024502 Vitamin E results in decreased expression of ACP1 mRNA PMID:19244175 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:34687 dibutyl phthalate decreases expression EXP E RGD:6480464 20121113 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ACP1 mRNA PMID:17361019|PMID:21266533 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:34718 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:10069 E RGD:6480464 20210406 CTD MESH:D004137 Dinitrochlorobenzene binds to ACP1 protein PMID:32991956 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:34761 fenthion increases expression EXP E RGD:6480464 20220607 CTD MESH:D005284 Fenthion results in increased expression of ACP1 mRNA PMID:34813904 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:34768 furfural multiple interactions ISO RGD:10069 E RGD:6480464 20250114 CTD MESH:D005662 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of ACP1 protein PMID:38598786 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:2020 E RGD:6480464 20130618 CTD MESH:D019256 Cadmium Chloride results in increased expression of ACP1 mRNA PMID:17327700 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:35549 perfluorooctanoic acid decreases expression ISO RGD:10069 E RGD:6480464 20121009 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of ACP1 protein PMID:22609092 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:35549 perfluorooctanoic acid increases expression EXP E RGD:6480464 20240206 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACP1 protein PMID:37422089 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:10069 E RGD:6480464 20211207 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACP1 mRNA PMID:25812627 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:35622 thiazolidines decreases activity ISO RGD:10069 E RGD:6480464 20170303 CTD MESH:D053778 Thiazolidines analog results in decreased activity of ACP1 protein PMID:24287560 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:35622 thiazolidines multiple interactions ISO RGD:10069 E RGD:6480464 20170303 CTD MESH:D053778 Thiazolidines analog inhibits the reaction [ACP1 protein results in increased hydrolysis of nitrophenylphosphate] PMID:24287560 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:10069 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of ACP1 mRNA PMID:24449571 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:36904 elemental selenium decreases expression ISO RGD:10069 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in decreased expression of ACP1 mRNA PMID:19244175 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20120515 CTD MESH:D002994 Clofibrate results in decreased expression of ACP1 mRNA PMID:17585979 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:3750 clofibrate multiple interactions EXP E RGD:6480464 20120515 CTD MESH:D002994 [Clofibrate co-treated with Acetaminophen] affects the expression of ACP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACP1 mRNA] PMID:17585979 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:38658 dicrotophos decreases expression ISO RGD:10069 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in decreased expression of ACP1 mRNA PMID:28302478 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:38940 sunitinib increases expression ISO RGD:10069 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in increased expression of ACP1 mRNA PMID:31533062 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:39285 chloropicrin decreases expression ISO RGD:10069 E RGD:6480464 20151215 CTD MESH:C100187 chloropicrin results in decreased expression of ACP1 mRNA PMID:26352163|PMID:28476498 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression ISO RGD:10069 E RGD:6480464 20211207 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of ACP1 mRNA PMID:25812627 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:39867 valproic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of ACP1 mRNA PMID:17963808 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:39867 valproic acid affects expression ISO RGD:10069 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ACP1 mRNA PMID:25979313 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:39867 valproic acid decreases methylation ISO RGD:10069 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of ACP1 gene PMID:29154799 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:41774 tamoxifen affects expression EXP E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen affects the expression of ACP1 mRNA PMID:17555576 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:42588 4-hydroxyphenyl retinamide decreases expression EXP E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in decreased expression of ACP1 mRNA PMID:28973697 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:45716 vorinostat increases expression ISO RGD:10069 E RGD:6480464 20161213 CTD MESH:C111237 vorinostat results in increased expression of ACP1 protein PMID:20543569 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:46195 paracetamol multiple interactions EXP E RGD:6480464 20120515 CTD MESH:D000082 [Clofibrate co-treated with Acetaminophen] affects the expression of ACP1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACP1 mRNA] PMID:17585979 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:10069 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased secretion of ACP1 protein PMID:38460933 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ACP1 mRNA PMID:17555576 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP1 mRNA PMID:17942748 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:50035 alpha-phellandrene decreases expression ISO RGD:10069 E RGD:6480464 20220208 CTD MESH:C005403 alpha phellandrene results in decreased expression of ACP1 mRNA PMID:25075043 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20200714 CTD MESH:D037742 Nanotubes, Carbon results in decreased expression of ACP1 mRNA PMID:31978390 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:50594 carbon nanotube increases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of ACP1 mRNA; Nanotubes, Carbon results in increased expression of ACP1 mRNA PMID:25554681 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:5063 fipronil increases expression ISO RGD:2020 E RGD:6480464 20140408 CTD MESH:C082360 fipronil results in increased expression of ACP1 mRNA PMID:23962444 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:5132 flutamide increases expression ISO RGD:2020 E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in increased expression of ACP1 mRNA PMID:24136188 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:6078 ivermectin decreases expression ISO RGD:10069 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ACP1 protein PMID:32959892 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:63632 topotecan decreases expression ISO RGD:2020 E RGD:6480464 20160315 CTD MESH:D019772 Topotecan results in decreased expression of ACP1 mRNA PMID:25729387 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:63632 topotecan multiple interactions ISO RGD:2020 E RGD:6480464 20160315 CTD MESH:D019772 [oxaliplatin co-treated with Topotecan] results in decreased expression of ACP1 mRNA PMID:25729387 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:63921 2-butoxyethanol increases expression EXP E RGD:6480464 20120412 CTD MESH:C017096 n-butoxyethanol results in increased expression of ACP1 mRNA PMID:19812364 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:63933 Aroclor 1254 decreases expression EXP E RGD:6480464 20131210 CTD MESH:D020111 Chlorodiphenyl (54% Chlorine) results in decreased expression of ACP1 mRNA PMID:23650126 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:73755 1,2-dimethylhydrazine decreases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ACP1 mRNA PMID:22206623 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:7494 nefazodone increases expression ISO RGD:2020 E RGD:6480464 20160412 CTD MESH:C051752 nefazodone results in increased expression of ACP1 mRNA PMID:24136188 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:78320 2-hydroxypropanoic acid decreases expression ISO RGD:10069 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of ACP1 mRNA PMID:30851411 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:78870 sodium nitrite increases activity ISO RGD:10069 E RGD:6480464 20151215 CTD MESH:D012977 Sodium Nitrite results in increased activity of ACP1 protein PMID:26231821 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:2020 E RGD:6480464 20200609 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ACP1 mRNA PMID:32109520 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:81584 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:10069 E RGD:6480464 20220308 CTD MESH:C511295 2,2',4,4'-tetrabromodiphenyl ether results in increased expression of ACP1 protein PMID:31675489 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:82436 decabromodiphenyl ether increases expression ISO RGD:10069 E RGD:6480464 20220308 CTD MESH:C010902 decabromobiphenyl ether results in increased expression of ACP1 protein PMID:31675489 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:84069 pentanal decreases expression ISO RGD:10069 E RGD:6480464 20150825 CTD MESH:C046012 pentanal results in decreased expression of ACP1 mRNA PMID:26079696 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:90633 perfluorododecanoic acid increases expression ISO RGD:2020 E RGD:6480464 20170303 CTD MESH:C522391 perfluorododecanoic acid results in increased expression of ACP1 protein PMID:19854247 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:10069 E RGD:6480464 20240206 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ACP1 protein PMID:37664457 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:920 2,4-dinitrotoluene affects expression ISO RGD:2020 E RGD:6480464 20130618 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of ACP1 mRNA PMID:21346803 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:9422 tebufenpyrad decreases expression ISO RGD:10069 E RGD:6480464 20210810 CTD MESH:C429623 4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of ACP1 mRNA PMID:33512557 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:955 2,6-dimethoxyphenol multiple interactions ISO RGD:10069 E RGD:6480464 20250114 CTD MESH:C010120 [Sodium Chloride co-treated with pyrogallol 1,3-dimethyl ether] results in decreased expression of and affects the localization of ACP1 protein PMID:38598786 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:957 2,6-dinitrotoluene affects expression ISO RGD:2020 E RGD:6480464 20130618 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of ACP1 mRNA PMID:21346803 10068 Acp1 acid phosphatase 1, soluble gene CHEBI:9986 vinclozolin increases expression ISO RGD:2020 E RGD:6480464 20150825 CTD MESH:C025643 vinclozolin results in increased expression of ACP1 mRNA PMID:23034163 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:133152 2-bromohexadecanoic acid multiple interactions ISO RGD:10071 E RGD:6480464 20240702 CTD MESH:C022776 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACP2 protein] PMID:38195004 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression EXP E RGD:6480464 20120918 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ACP2 mRNA PMID:20188158 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:10071 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in increased expression of ACP2 mRNA PMID:33167477 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:15443 inulin multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D007444 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACP2 mRNA PMID:36331819 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:16170 mercury(0) decreases expression ISO RGD:10071 E RGD:6480464 20120412 CTD MESH:D008628 Mercury results in decreased expression of ACP2 mRNA PMID:17547211 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:16236 ethanol affects splicing EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the splicing of ACP2 mRNA PMID:30319688 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:16482 naphthalene affects expression ISO RGD:10071 E RGD:6480464 20180515 CTD MESH:C031721 naphthalene affects the expression of ACP2 protein PMID:28803881 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:16482 naphthalene multiple interactions ISO RGD:10071 E RGD:6480464 20180515 CTD MESH:C031721 [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein PMID:28803881 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:10071 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of ACP2 mRNA PMID:37042841 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:17642 pentachlorophenol decreases expression EXP E RGD:6480464 20140311 CTD MESH:D010416 Pentachlorophenol results in decreased expression of ACP2 mRNA PMID:23892564 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:17833 gentamycin decreases expression ISO RGD:2021 E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in decreased expression of ACP2 mRNA PMID:33387578 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:10071 E RGD:6480464 20240702 CTD MESH:D002104 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACP2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACP2 protein PMID:38195004 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:10071 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of ACP2 mRNA PMID:27153756 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:25195 mercury atom decreases expression ISO RGD:10071 E RGD:6480464 20120412 CTD MESH:D008628 Mercury results in decreased expression of ACP2 mRNA PMID:17547211 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACP2 mRNA] PMID:22206623 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:2761 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate decreases expression ISO RGD:10071 E RGD:6480464 20120412 CTD MESH:D000966 Antimony Potassium Tartrate results in decreased expression of ACP2 mRNA PMID:17547211 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:28073 chromium atom decreases expression ISO RGD:10071 E RGD:6480464 20120412 CTD MESH:D002857 Chromium results in decreased expression of ACP2 mRNA PMID:17547211 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ACP2 mRNA PMID:21570461 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20120501 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACP2 mRNA PMID:19770486 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2021 E RGD:6480464 20130122 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACP2 mRNA PMID:16054898|PMID:18178546|PMID:18796159|PMID:20959002|PMID:22342509|PMID:32109520 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:28619 acrylamide decreases expression ISO RGD:2021 E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in decreased expression of ACP2 mRNA PMID:28959563 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:28748 doxorubicin decreases expression ISO RGD:10071 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of ACP2 mRNA PMID:29803840 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:28851 phenanthrene affects expression ISO RGD:10071 E RGD:6480464 20180515 CTD MESH:C031181 phenanthrene affects the expression of ACP2 protein PMID:28803881 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:28851 phenanthrene multiple interactions ISO RGD:10071 E RGD:6480464 20180515 CTD MESH:C031181 [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein PMID:28803881 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ACP2 mRNA PMID:22228805 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:30304 antimony(0) decreases expression ISO RGD:10071 E RGD:6480464 20120412 CTD MESH:D000965 Antimony results in decreased expression of ACP2 mRNA PMID:17547211 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:30812 iron dichloride decreases expression ISO RGD:10071 E RGD:6480464 20231003 CTD MESH:C029451 ferrous chloride results in decreased expression of ACP2 mRNA PMID:35984750 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2021 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ACP2 mRNA PMID:16483693 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:32161 sulfadimethoxine increases expression ISO RGD:2021 E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in increased expression of ACP2 mRNA PMID:30047161 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:32234 titanium dioxide decreases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ACP2 promoter alternative form PMID:35295148 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:32497 thioacetamide decreases expression ISO RGD:2021 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of ACP2 mRNA PMID:34492290 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:32506 4,4'-diaminodiphenylmethane increases expression EXP E RGD:6480464 20120412 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in increased expression of ACP2 mRNA PMID:18648102 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:32509 pirinixic acid increases expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in increased expression of ACP2 mRNA PMID:18301758 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:33216 bisphenol A affects expression ISO RGD:10071 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of ACP2 mRNA PMID:30903817 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:33216 bisphenol A affects expression ISO RGD:2021 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of ACP2 mRNA PMID:25181051 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2021 E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in decreased expression of ACP2 mRNA PMID:30816183|PMID:32528016|PMID:34947998 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:33216 bisphenol A increases expression ISO RGD:10071 E RGD:6480464 20230307 CTD MESH:C006780 bisphenol A results in increased expression of ACP2 protein PMID:34186270|PMID:37567409 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:3387 carbamazepine affects expression ISO RGD:10071 E RGD:6480464 20151013 CTD MESH:D002220 Carbamazepine affects the expression of ACP2 mRNA PMID:25979313 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:2021 E RGD:6480464 20130122 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ACP2 mRNA PMID:20959002 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:10071 E RGD:6480464 20230307 CTD MESH:C543008 bisphenol S results in increased expression of ACP2 protein PMID:34186270 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:34581 Bisphenol B increases expression ISO RGD:10071 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of ACP2 protein PMID:34186270 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:34631 chlorpyrifos increases expression EXP E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of ACP2 mRNA PMID:37019170 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:10071 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ACP2 mRNA PMID:37042841 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:35298 anthracene affects expression ISO RGD:10071 E RGD:6480464 20180515 CTD MESH:C034020 anthracene affects the expression of ACP2 protein PMID:28803881 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:35298 anthracene multiple interactions ISO RGD:10071 E RGD:6480464 20180515 CTD MESH:C034020 [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein PMID:28803881 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:10071 E RGD:6480464 20240702 CTD MESH:D019256 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACP2 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ACP2 protein PMID:38195004 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:2021 E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in decreased expression of ACP2 mRNA PMID:24386269 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:35807 N-nitrosodimethylamine decreases expression ISO RGD:10071 E RGD:6480464 20120412 CTD MESH:D004128 Dimethylnitrosamine results in decreased expression of ACP2 mRNA PMID:17547211 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:10071 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of ACP2 mRNA PMID:24449571 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:3764 clotrimazole increases expression ISO RGD:2021 E RGD:6480464 20230606 CTD MESH:D003022 Clotrimazole results in increased expression of ACP2 mRNA PMID:30047161 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:37825 p-toluidine decreases expression ISO RGD:2021 E RGD:6480464 20170516 CTD MESH:C029370 4-toluidine results in decreased expression of ACP2 mRNA PMID:27638505 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:38922 dibenzofurans increases expression EXP E RGD:6480464 20230704 CTD MESH:D000072318 Dibenzofurans results in increased expression of ACP2 mRNA PMID:34254344 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:39106 pyrene affects expression ISO RGD:10071 E RGD:6480464 20180515 CTD MESH:C030984 pyrene affects the expression of ACP2 protein PMID:28803881 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:39106 pyrene multiple interactions ISO RGD:10071 E RGD:6480464 20180515 CTD MESH:C030984 [naphthalene co-treated with anthracene co-treated with phenanthrene co-treated with pyrene] affects the expression of ACP2 protein PMID:28803881 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ACP2 mRNA PMID:36331819 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:40036 amitrole increases expression ISO RGD:2021 E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in increased expression of ACP2 mRNA PMID:30047161 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:10071 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of ACP2 mRNA PMID:20106945|PMID:25562108 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of ACP2 mRNA PMID:17562736 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:46195 paracetamol decreases expression ISO RGD:2021 E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in decreased expression of ACP2 mRNA PMID:33387578 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:4811 epoxiconazole decreases expression EXP E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in decreased expression of ACP2 mRNA PMID:35436446 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:4811 epoxiconazole increases expression EXP E RGD:6480464 20141111 CTD MESH:C109476 epoxiconazole results in increased expression of ACP2 mRNA PMID:22334560 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:50594 carbon nanotube increases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of ACP2 mRNA; Nanotubes, Carbon results in increased expression of ACP2 mRNA PMID:25554681 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:5063 fipronil increases expression ISO RGD:2021 E RGD:6480464 20211109 CTD MESH:C082360 fipronil results in increased expression of ACP2 mRNA PMID:34044035 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:5132 flutamide decreases expression ISO RGD:2021 E RGD:6480464 20140909 CTD MESH:D005485 Flutamide results in decreased expression of ACP2 mRNA PMID:24793618 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:53444 potassium dichromate decreases expression ISO RGD:10071 E RGD:6480464 20120412 CTD MESH:D011192 Potassium Dichromate results in decreased expression of ACP2 mRNA PMID:17547211 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:6078 ivermectin decreases expression ISO RGD:10071 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ACP2 protein PMID:32959892 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:63933 Aroclor 1254 increases expression ISO RGD:2021 E RGD:6480464 20120412 CTD MESH:D020111 Chlorodiphenyl (54% Chlorine) results in increased expression of ACP2 mRNA PMID:18178546 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:6402 leflunomide increases expression ISO RGD:2021 E RGD:6480464 20161213 CTD MESH:C045463 leflunomide results in increased expression of ACP2 mRNA PMID:24136188 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:641 N-methyl-4-phenylpyridinium affects expression ISO RGD:10071 E RGD:6480464 20130611 CTD MESH:D015655 1-Methyl-4-phenylpyridinium affects the expression of ACP2 mRNA PMID:12710931 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:64215 2,3-dimethoxynaphthalene-1,4-dione decreases expression ISO RGD:10071 E RGD:6480464 20120412 CTD MESH:C063002 2,3-dimethoxy-1,4-naphthoquinone results in decreased expression of ACP2 mRNA PMID:17547211 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:69808 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO RGD:10071 E RGD:6480464 20170303 CTD MESH:C495626 14-deoxy-11,12-didehydroandrographolide results in decreased expression of ACP2 mRNA PMID:22101062 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:72564 temozolomide increases expression ISO RGD:10071 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in increased expression of ACP2 mRNA PMID:31758290 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:72754 bisphenol AF increases expression ISO RGD:10071 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of ACP2 protein PMID:34186270 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:73755 1,2-dimethylhydrazine increases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of ACP2 mRNA PMID:22206623 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D019813 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ACP2 mRNA] PMID:22206623 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:7494 nefazodone decreases expression ISO RGD:2021 E RGD:6480464 20160412 CTD MESH:C051752 nefazodone results in decreased expression of ACP2 mRNA PMID:24136188 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:8069 phenobarbital affects expression EXP E RGD:6480464 20130514 CTD MESH:D010634 Phenobarbital affects the expression of ACP2 mRNA PMID:23091169 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:81758 cyproconazole increases expression EXP E RGD:6480464 20141111 CTD MESH:C093628 cyproconazole results in increased expression of ACP2 mRNA PMID:22334560 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:8489 propiconazole increases expression EXP E RGD:6480464 20120918 CTD MESH:C045950 propiconazole results in increased expression of ACP2 mRNA PMID:21278054|PMID:22334560 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2021 E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in increased expression of ACP2 mRNA PMID:30047161 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:10071 E RGD:6480464 20240206 CTD MESH:C459179 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ACP2 protein PMID:37664457 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:9195 Soman decreases expression ISO RGD:2021 E RGD:6480464 20141111 CTD MESH:D012999 Soman results in decreased expression of ACP2 mRNA PMID:19281266 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:9352 sulindac increases expression ISO RGD:10071 E RGD:6480464 20120412 CTD MESH:D013467 Sulindac results in increased expression of ACP2 mRNA PMID:11906190 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:9495 thiram decreases expression ISO RGD:10071 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of ACP2 mRNA PMID:38568856 10070 Acp2 acid phosphatase 2, lysosomal gene CHEBI:957 2,6-dinitrotoluene affects expression ISO RGD:2021 E RGD:6480464 20120412 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of ACP2 mRNA PMID:21346803 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:10073 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of ACP5 mRNA PMID:38218311 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:116509 diuron increases expression ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D004237 Diuron results in increased expression of ACP5 mRNA PMID:21551480 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:132082 entinostat increases expression ISO RGD:10073 E RGD:6480464 20161228 CTD MESH:C118739 entinostat results in increased expression of ACP5 mRNA PMID:26272509 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:132082 entinostat multiple interactions ISO RGD:10073 E RGD:6480464 20161228 CTD MESH:C118739 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA PMID:27188386 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:133663 thymol sulfate(1-) multiple interactions EXP E RGD:6480464 20181016 CTD MESH:D013943 Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] PMID:30048646 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:136004 linsidomine increases oxidation ISO RGD:2022 E RGD:6480464 20180220 CTD MESH:C002385 linsidomine results in increased oxidation of ACP5 protein PMID:28086193 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression EXP E RGD:6480464 20160210 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ACP5 mRNA PMID:26251327 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases methylation EXP E RGD:6480464 20160210 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of ACP5 promoter PMID:26251327 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:15367 all-trans-retinoic acid increases expression EXP E RGD:6480464 20120412 CTD MESH:D014212 Tretinoin results in increased expression of ACP5 mRNA PMID:16604517 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:15367 all-trans-retinoic acid multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D014212 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACP5 mRNA PMID:36189433 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:15379 dioxygen multiple interactions ISO RGD:2022 E RGD:6480464 20220510 CTD MESH:D010100 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ACP5 mRNA PMID:33729688 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:16171 NMN zwitterion multiple interactions ISO RGD:2022 E RGD:6480464 20190219 CTD MESH:D009537 Nicotinamide Mononucleotide inhibits the reaction [Aluminum Chloride results in increased expression of ACP5 protein] PMID:30292833 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20140408 CTD MESH:D000431 Ethanol results in increased expression of ACP5 mRNA PMID:22892342 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20140408 CTD MESH:D000431 Vitamin D inhibits the reaction [Ethanol results in increased expression of ACP5 mRNA] PMID:22892342 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:16412 lipopolysaccharide increases expression EXP E RGD:6480464 20161228 CTD MESH:D008070 Lipopolysaccharides results in increased expression of ACP5 mRNA; Lipopolysaccharides results in increased expression of ACP5 protein PMID:22067001|PMID:30048646|PMID:39111524 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:16412 lipopolysaccharide increases expression ISO RGD:2022 E RGD:6480464 20241203 CTD MESH:D008070 Lipopolysaccharides results in increased expression of ACP5 protein PMID:39111524 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:16412 lipopolysaccharide multiple interactions EXP E RGD:6480464 20161228 CTD MESH:D008070 CSF1R affects the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; ganoderic acid A inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein] PMID:22067001|PMID:30048646|PMID:39111524 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:2022 E RGD:6480464 20241203 CTD MESH:D008070 ganoderic acid A inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein] PMID:39111524 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D004958 Estradiol results in decreased expression of ACP5 protein PMID:15917159 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:10073 E RGD:6480464 20190611 CTD MESH:D004958 [Estradiol co-treated with TGFB1 protein] results in decreased expression of ACP5 mRNA PMID:30165855 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:10073 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of ACP5 mRNA PMID:37042841 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:168262 Ganoderic acid A multiple interactions EXP E RGD:6480464 20241203 CTD MESH:C515005 ganoderic acid A inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein] PMID:39111524 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:168262 Ganoderic acid A multiple interactions ISO RGD:2022 E RGD:6480464 20241203 CTD MESH:C515005 ganoderic acid A inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein] PMID:39111524 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:17158 methylglyoxal increases expression EXP E RGD:6480464 20190910 CTD MESH:D011765 Pyruvaldehyde results in increased expression of ACP5 mRNA PMID:31103701 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:17158 methylglyoxal increases expression ISO RGD:2022 E RGD:6480464 20190910 CTD MESH:D011765 Pyruvaldehyde results in increased expression of ACP5 mRNA; Pyruvaldehyde results in increased expression of ACP5 protein PMID:31103701 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:17158 methylglyoxal multiple interactions EXP E RGD:6480464 20190219 CTD MESH:D011765 [TNFSF11 protein co-treated with Pyruvaldehyde] affects the activity of ACP5 protein; [TNFSF11 protein co-treated with Pyruvaldehyde] results in decreased activity of ACP5 protein; bergenin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in decreased activity of ACP5 protein]; MAPK8 protein affects the reaction [Pyruvaldehyde results in increased expression of ACP5 mRNA] PMID:30217477|PMID:31103701|PMID:31369791 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:17243 mono(2-ethylhexyl) phthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C016599 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of ACP5 mRNA PMID:36189433 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:17347 testosterone increases expression ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in increased expression of ACP5 mRNA PMID:15917159 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:17823 calcitriol decreases expression ISO RGD:10073 E RGD:6480464 20120814 CTD MESH:D002117 Calcitriol results in decreased expression of ACP5 protein PMID:21985997 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:17833 gentamycin increases expression ISO RGD:2022 E RGD:6480464 20161228 CTD MESH:D005839 Gentamicins results in increased expression of ACP5 mRNA PMID:22061828 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:17963 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression EXP E RGD:6480464 20190312 CTD MESH:D015632 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of ACP5 mRNA PMID:30529163 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:18088 formononetin multiple interactions EXP E RGD:6480464 20221206 CTD MESH:C007768 formononetin inhibits the reaction [Streptozocin results in increased activity of ACP5 protein]; formononetin inhibits the reaction [Streptozocin results in increased expression of ACP5 mRNA] PMID:35315182 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:201431 Cyclosporin H multiple interactions EXP E RGD:6480464 20231219 CTD MESH:C050025 cyclosporin H inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] PMID:15207740 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:22977 cadmium atom increases expression ISO RGD:2022 E RGD:6480464 20140211 CTD MESH:D002104 Cadmium results in increased expression of ACP5 protein alternative form PMID:23954550 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20200609 CTD MESH:D002104 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]; 2-aminoethoxydiphenyl borate affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACP5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACP5 protein; [Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 mRNA; [Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein; KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]; STO 609 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein]; W 7 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein] PMID:31793751|PMID:32522522|PMID:37325564 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:10073 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of ACP5 mRNA PMID:19549813 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:10073 E RGD:6480464 20161025 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of ACP5 mRNA PMID:27153756 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:10073 E RGD:6480464 20120918 CTD MESH:D016604 Aflatoxin B1 results in increased expression of ACP5 mRNA PMID:21641981 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:2567 alendronic acid multiple interactions ISO RGD:2022 E RGD:6480464 20170207 CTD MESH:D019386 Alendronate inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]; Alendronate inhibits the reaction [modafinil results in increased expression of ACP5 mRNA] PMID:27387537|PMID:29649498 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:25812 ozone multiple interactions EXP E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ACP5 mRNA PMID:34911549 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27214 uranium atom increases expression ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D014501 Uranium results in increased expression of ACP5 protein PMID:16436523 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27214 uranium atom increases secretion ISO RGD:2022 E RGD:6480464 20180828 CTD MESH:D014501 Uranium results in increased secretion of ACP5 protein PMID:29477364 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27214 uranium atom multiple interactions ISO RGD:2022 E RGD:6480464 20180828 CTD MESH:D014501 GHRL protein inhibits the reaction [Uranium results in increased secretion of ACP5 protein] PMID:29477364 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27300 vitamin D multiple interactions EXP E RGD:6480464 20170303 CTD MESH:D014807 Vitamin D inhibits the reaction [Ethanol results in increased expression of ACP5 mRNA] PMID:22892342 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27363 zinc atom decreases activity ISO RGD:2022 E RGD:6480464 20130212 CTD MESH:D015032 Zinc deficiency results in decreased activity of ACP5 protein PMID:21893222 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27363 zinc atom decreases expression ISO RGD:2022 E RGD:6480464 20130212 CTD MESH:D015032 Zinc deficiency results in decreased expression of ACP5 mRNA PMID:21893222 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20200804 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACP5 mRNA PMID:31919559 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27607 thymol multiple interactions EXP E RGD:6480464 20181016 CTD MESH:D013943 Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 mRNA]; Thymol inhibits the reaction [Lipopolysaccharides results in increased expression of ACP5 protein]; Thymol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] PMID:30048646 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:10073 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased expression of ACP5 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of ACP5 protein PMID:38460933 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27856 acetamide increases expression ISO RGD:2022 E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of ACP5 mRNA PMID:31881176 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27881 resveratrol multiple interactions ISO RGD:10073 E RGD:6480464 20120412 CTD MESH:C059514 resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased activity of ACP5 protein] PMID:16267019 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27899 cisplatin increases expression ISO RGD:10073 E RGD:6480464 20180220 CTD MESH:D002945 Cisplatin results in increased expression of ACP5 mRNA PMID:27594783 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27899 cisplatin multiple interactions ISO RGD:10073 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in increased expression of ACP5 mRNA PMID:27392435 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:27998 tungsten multiple interactions EXP E RGD:6480464 20210209 CTD MESH:D014414 Tungsten promotes the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] PMID:33146397 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28073 chromium atom decreases activity ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D002857 Chromium results in decreased activity of ACP5 protein PMID:16866188 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28088 genistein decreases expression ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D019833 Genistein results in decreased expression of ACP5 mRNA PMID:12075121 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28088 genistein multiple interactions EXP E RGD:6480464 20130122 CTD MESH:D019833 [Zinc Sulfate co-treated with Genistein co-treated with CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ACP5 mRNA PMID:17295206 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2022 E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ACP5 mRNA PMID:34747641 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2022 E RGD:6480464 20200609 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACP5 mRNA PMID:32109520 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20120515 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACP5 mRNA PMID:17035482|PMID:21041162 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2022 E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACP5 mRNA PMID:33387578 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP5 mRNA; Tetrachlorodibenzodioxin results in increased expression of and results in increased secretion of ACP5 protein PMID:17942748|PMID:29673856 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28177 theophylline increases expression ISO RGD:2022 E RGD:6480464 20160607 CTD MESH:D013806 Theophylline results in increased expression of ACP5 mRNA; Theophylline results in increased expression of ACP5 protein PMID:26851681 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28179 benzamide multiple interactions EXP E RGD:6480464 20181113 CTD MESH:C037689 benzamide analog inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of ACP5 mRNA] PMID:29935282 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28201 rotenone increases expression ISO RGD:2022 E RGD:6480464 20191112 CTD MESH:D012402 Rotenone results in increased expression of ACP5 mRNA PMID:28374803 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28201 rotenone multiple interactions ISO RGD:10073 E RGD:6480464 20130416 CTD MESH:D012402 Rotenone inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] PMID:19900598 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:10073 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of ACP5 mRNA PMID:33212167 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28358 rac-lactic acid decreases expression ISO RGD:10073 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of ACP5 mRNA PMID:30851411 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28618 1,4-dichlorobenzene increases expression EXP E RGD:6480464 20171114 CTD MESH:C018511 4-dichlorobenzene results in increased expression of ACP5 mRNA PMID:26975756 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28741 sodium fluoride decreases expression EXP E RGD:6480464 20180410 CTD MESH:D012969 Sodium Fluoride results in decreased expression of ACP5 protein PMID:29127033 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28741 sodium fluoride increases expression EXP E RGD:6480464 20180410 CTD MESH:D012969 Sodium Fluoride results in increased expression of ACP5 mRNA PMID:29127033|PMID:32156525 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28741 sodium fluoride multiple interactions EXP E RGD:6480464 20180410 CTD MESH:D012969 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Sodium Fluoride results in increased expression of ACP5 mRNA]; [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Sodium Fluoride] affects the expression of ACP5 protein; Sodium Fluoride promotes the reaction [TNFSF11 protein results in increased expression of ACP5 protein] PMID:29127033|PMID:32156525 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28748 doxorubicin decreases expression ISO RGD:10073 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of ACP5 mRNA PMID:29803840 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28819 naringin decreases expression EXP E RGD:6480464 20150512 CTD MESH:C005274 naringin results in decreased expression of ACP5 mRNA PMID:24376342 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:28819 naringin multiple interactions EXP E RGD:6480464 20150512 CTD MESH:C005274 naringin inhibits the reaction [[TNFSF11 protein co-treated with CSF1R protein] results in increased expression of ACP5 mRNA]; naringin inhibits the reaction [Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein] PMID:21835177|PMID:24376342 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:2942 azadirachtin A decreases expression EXP E RGD:6480464 20201215 CTD MESH:C010329 azadirachtin results in decreased expression of ACP5 mRNA PMID:31225646 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:2942 azadirachtin A multiple interactions EXP E RGD:6480464 20201215 CTD MESH:C010329 azadirachtin inhibits the reaction [Estrogens deficiency results in increased expression of ACP5 mRNA] PMID:31225646 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:29678 sodium arsenite multiple interactions EXP E RGD:6480464 20190409 CTD MESH:C017947 [NFE2L2 protein affects the susceptibility to sodium arsenite] which affects the expression of ACP5 protein PMID:30742845 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:10073 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ACP5 5' UTR; Benzo(a)pyrene affects the methylation of ACP5 promoter PMID:27901495 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:2022 E RGD:6480464 20120613 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ACP5 mRNA PMID:21839799 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:29865 benzo[a]pyrene increases activity EXP E RGD:6480464 20221004 CTD MESH:D001564 Benzo(a)pyrene results in increased activity of ACP5 protein PMID:35777681 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:10073 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ACP5 mRNA PMID:20064835|PMID:22316170 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:3001 beclomethasone decreases activity ISO RGD:10073 E RGD:6480464 20131210 CTD MESH:D001507 Beclomethasone results in decreased activity of ACP5 protein PMID:8429434 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:30185 zinc(0) decreases activity ISO RGD:2022 E RGD:6480464 20130212 CTD MESH:D015032 Zinc deficiency results in decreased activity of ACP5 protein PMID:21893222 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:30185 zinc(0) decreases expression ISO RGD:2022 E RGD:6480464 20130212 CTD MESH:D015032 Zinc deficiency results in decreased expression of ACP5 mRNA PMID:21893222 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:30187 aluminium oxide decreases expression ISO RGD:10073 E RGD:6480464 20120412 CTD MESH:D000537 Aluminum Oxide results in decreased expression of ACP5 mRNA PMID:15585240 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:30563 silicon dioxide increases expression EXP E RGD:6480464 20200310 CTD MESH:D012822 Silicon Dioxide results in increased expression of ACP5 mRNA PMID:29341224 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:30563 silicon dioxide increases expression ISO RGD:10073 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in increased expression of ACP5 mRNA PMID:23806026|PMID:25895662 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:30812 iron dichloride decreases expression ISO RGD:10073 E RGD:6480464 20231003 CTD MESH:C029451 ferrous chloride results in decreased expression of ACP5 mRNA PMID:35984750 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:30812 iron dichloride multiple interactions ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:C029451 ferrous chloride inhibits the reaction [Dithionite results in decreased activity of ACP5 protein] PMID:6886379 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:31604 ferric ammonium citrate increases expression ISO RGD:2022 E RGD:6480464 20230404 CTD MESH:C013531 ferric ammonium citrate results in increased expression of ACP5 protein PMID:36087815 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:31604 ferric ammonium citrate multiple interactions ISO RGD:2022 E RGD:6480464 20230404 CTD MESH:C013531 Silybin inhibits the reaction [ferric ammonium citrate results in increased expression of ACP5 protein] PMID:36087815 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:31801 Maxacalcitol decreases expression ISO RGD:10073 E RGD:6480464 20141111 CTD MESH:C051883 maxacalcitol results in decreased expression of ACP5; maxacalcitol results in decreased expression of ACP5 protein PMID:11576942|PMID:8840326 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:31859 modafinil increases expression ISO RGD:2022 E RGD:6480464 20180828 CTD MESH:C048833 modafinil results in increased expression of ACP5 mRNA; modafinil results in increased expression of ACP5 protein PMID:29649498 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:31859 modafinil multiple interactions ISO RGD:2022 E RGD:6480464 20180828 CTD MESH:C048833 Alendronate inhibits the reaction [modafinil results in increased expression of ACP5 mRNA] PMID:29649498 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:31941 oxaliplatin increases expression ISO RGD:2022 E RGD:6480464 20161213 CTD MESH:C030110 oxaliplatin results in increased expression of ACP5 mRNA PMID:25729387 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:31941 oxaliplatin multiple interactions ISO RGD:2022 E RGD:6480464 20161213 CTD MESH:C030110 [oxaliplatin co-treated with Topotecan] results in increased expression of ACP5 mRNA PMID:25729387 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:32161 sulfadimethoxine increases expression ISO RGD:2022 E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in increased expression of ACP5 mRNA PMID:30047161 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:32234 titanium dioxide decreases expression EXP E RGD:6480464 20140211 CTD MESH:C009495 titanium dioxide results in decreased expression of ACP5 mRNA PMID:23557971|PMID:35295148 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:32497 thioacetamide increases expression ISO RGD:2022 E RGD:6480464 20140408 CTD MESH:D013853 Thioacetamide results in increased expression of ACP5 mRNA PMID:23411599 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:32497 thioacetamide multiple interactions ISO RGD:2022 E RGD:6480464 20180116 CTD MESH:D013853 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ACP5 mRNA PMID:28943392 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:32506 4,4'-diaminodiphenylmethane increases expression ISO RGD:2022 E RGD:6480464 20160315 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in increased expression of ACP5 mRNA PMID:25380136 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2022 E RGD:6480464 20230606 CTD MESH:C006780 bisphenol A results in decreased expression of ACP5 mRNA PMID:32145629 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of ACP5 mRNA PMID:32156529|PMID:33221593|PMID:34585602|PMID:38701888 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:33216 bisphenol A increases expression ISO RGD:2022 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of ACP5 mRNA PMID:25181051 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:33216 bisphenol A increases methylation ISO RGD:2022 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of ACP5 gene PMID:28505145 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:34039 1,2,4-trimethylbenzene decreases expression ISO RGD:2022 E RGD:6480464 20120918 CTD MESH:C010313 pseudocumene results in decreased expression of ACP5 protein PMID:17337753 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:34372 4,4'-sulfonyldiphenol decreases methylation EXP E RGD:6480464 20220208 CTD MESH:C543008 bisphenol S results in decreased methylation of ACP5 promoter PMID:33297965 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:34631 chlorpyrifos increases expression EXP E RGD:6480464 20210706 CTD MESH:D004390 Chlorpyrifos results in increased expression of ACP5 mRNA PMID:32715474 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:34786 Heptachlor epoxide increases expression EXP E RGD:6480464 20150127 CTD MESH:D006534 Heptachlor Epoxide results in increased expression of ACP5 mRNA PMID:25270620 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:34873 N-nitrosodiethylamine increases expression ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D004052 Diethylnitrosamine results in increased expression of ACP5 mRNA PMID:19638242 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:34873 N-nitrosodiethylamine multiple interactions ISO RGD:2022 E RGD:6480464 20180116 CTD MESH:D004052 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ACP5 mRNA PMID:28943392 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:35064 alpha-Zearalanol increases expression ISO RGD:2022 E RGD:6480464 20240430 CTD MESH:D015029 Zeranol results in increased expression of ACP5 mRNA PMID:35163327 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:35176 zinc sulfate multiple interactions EXP E RGD:6480464 20130122 CTD MESH:D019287 [Cryptoxanthins co-treated with Zinc Sulfate] results in decreased expression of ACP5 mRNA; [CSF1 protein co-treated with TNFSF11 protein co-treated with Cryptoxanthins co-treated with Zinc Sulfate] results in decreased expression of ACP5 mRNA; [Zinc Sulfate co-treated with Genistein co-treated with CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ACP5 mRNA PMID:17295206|PMID:18636177 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:35455 1-naphthyl isothiocyanate increases expression ISO RGD:2022 E RGD:6480464 20160315 CTD MESH:D015058 1-Naphthylisothiocyanate results in increased expression of ACP5 mRNA PMID:25380136 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:10073 E RGD:6480464 20241001 CTD MESH:D019256 Cadmium Chloride results in decreased expression of ACP5 mRNA PMID:38382870 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:2022 E RGD:6480464 20150825 CTD MESH:D019256 Cadmium Chloride results in decreased expression of ACP5 mRNA PMID:25993096 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20120717 CTD MESH:D019256 [Cadmium Chloride co-treated with TNFSF11] results in increased activity of ACP5 protein; [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACP5 mRNA; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACP5 protein PMID:21723911|PMID:31793751|PMID:37325564 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:35559 furan increases expression ISO RGD:2022 E RGD:6480464 20150414 CTD MESH:C039281 furan results in increased expression of ACP5 mRNA PMID:25539665 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:35807 N-nitrosodimethylamine increases expression ISO RGD:2022 E RGD:6480464 20160315 CTD MESH:D004128 Dimethylnitrosamine results in increased expression of ACP5 mRNA PMID:25380136 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:3647 chlorpromazine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D002746 Chlorpromazine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] PMID:21869564 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:3720 cisapride multiple interactions EXP E RGD:6480464 20190910 CTD MESH:D020117 Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] PMID:31150804 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20120515 CTD MESH:D002994 Clofibrate results in decreased expression of ACP5 mRNA PMID:17585979 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:38397 perfluorononanoic acid affects expression ISO RGD:10073 E RGD:6480464 20241203 CTD MESH:C101816 perfluoro-n-nonanoic acid affects the expression of ACP5 protein PMID:38537583 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:39481 chloroprene decreases expression ISO RGD:2022 E RGD:6480464 20130514 CTD MESH:D002737 Chloroprene results in decreased expression of ACP5 mRNA PMID:23125180 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:39483 sodium dichromate increases expression ISO RGD:2022 E RGD:6480464 20121009 CTD MESH:C016104 sodium bichromate results in increased expression of ACP5 mRNA PMID:22561333 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:39867 valproic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of ACP5 mRNA PMID:17292431 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:39867 valproic acid decreases expression ISO RGD:10073 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased expression of ACP5 mRNA PMID:29154799 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:39867 valproic acid increases expression ISO RGD:10073 E RGD:6480464 20160119 CTD MESH:D014635 Valproic Acid results in increased expression of ACP5 mRNA PMID:23179753|PMID:26272509 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:39867 valproic acid multiple interactions ISO RGD:10073 E RGD:6480464 20161025 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA PMID:27188386 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:40036 amitrole increases expression ISO RGD:2022 E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in increased expression of ACP5 mRNA PMID:30047161 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:10073 E RGD:6480464 20170516 CTD MESH:D016572 Cyclosporine results in decreased expression of ACP5 mRNA PMID:27989131 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:4031 cyclosporin A multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D016572 Cyclosporine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] PMID:15207740 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:41879 dexamethasone increases activity ISO RGD:2022 E RGD:6480464 20170207 CTD MESH:D003907 Dexamethasone results in increased activity of ACP5 protein PMID:27387537|PMID:28363435 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:41879 dexamethasone increases expression EXP E RGD:6480464 20120515 CTD MESH:D003907 Dexamethasone results in increased expression of ACP5 mRNA PMID:21041162 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:10073 E RGD:6480464 20120412 CTD MESH:D003907 [Thalidomide co-treated with Dexamethasone] results in decreased expression of ACP5 protein PMID:16079895 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:2022 E RGD:6480464 20170207 CTD MESH:D003907 Alendronate inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]; caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein]; ginsenoside Rg3 inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein] PMID:27387537|PMID:28363435 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:41922 diethylstilbestrol increases expression EXP E RGD:6480464 20120515 CTD MESH:D004054 Diethylstilbestrol results in increased expression of ACP5 mRNA PMID:21041162 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:42160 dithionite(2-) decreases activity ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D004227 Dithionite results in decreased activity of ACP5 protein PMID:6886379 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:42160 dithionite(2-) multiple interactions ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D004227 ferrous chloride inhibits the reaction [Dithionite results in decreased activity of ACP5 protein] PMID:6886379 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:42588 4-hydroxyphenyl retinamide decreases expression EXP E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in decreased expression of ACP5 mRNA PMID:28973697 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:42588 4-hydroxyphenyl retinamide multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D017313 Fenretinide inhibits the reaction [TNF protein results in increased expression of ACP5 protein] PMID:16230421 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:4356 desferrioxamine B decreases activity EXP E RGD:6480464 20191008 CTD MESH:D003676 Deferoxamine results in decreased activity of ACP5 protein PMID:31238089 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:4356 desferrioxamine B multiple interactions EXP E RGD:6480464 20191008 CTD MESH:D003676 Deferoxamine inhibits the reaction [TF protein results in increased activity of ACP5 protein]; TF protein inhibits the reaction [Deferoxamine results in decreased activity of ACP5 protein] PMID:31238089 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of ACP5 mRNA PMID:17562736 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:4629 diosgenin multiple interactions EXP E RGD:6480464 20130702 CTD MESH:D004144 Diosgenin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] PMID:16331273 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:4630 diosmetin multiple interactions EXP E RGD:6480464 20230404 CTD MESH:C039602 diosmetin inhibits the reaction [RANK Ligand affects the expression of ACP5 mRNA] PMID:36563736 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:10073 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased expression of ACP5 mRNA; [Dactinomycin co-treated with nutlin 3] results in increased secretion of ACP5 protein PMID:38460933 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:4775 ellagic acid multiple interactions EXP E RGD:6480464 20210309 CTD MESH:D004610 Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; Ellagic Acid inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] PMID:32971123 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20190312 CTD MESH:C016766 sulforaphane results in increased expression of ACP5 mRNA PMID:30529165 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:479072 2-aminopurine multiple interactions EXP E RGD:6480464 20190702 CTD MESH:D015075 2-Aminopurine inhibits the reaction [[TNF protein co-treated with TNFSF11 protein] results in increased expression of ACP5 protein] PMID:25739386 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:48107 nitric acid increases expression ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D017942 Nitric Acid results in increased expression of ACP5 protein PMID:16436523 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:4903 17alpha-ethynylestradiol affects expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol affects the expression of ACP5 mRNA PMID:17555576 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ACP5 mRNA PMID:17942748 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACP5 mRNA PMID:17942748 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:49662 indometacin decreases expression ISO RGD:2022 E RGD:6480464 20150825 CTD MESH:D007213 Indomethacin results in decreased expression of ACP5 mRNA PMID:25972201 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:50131 5-aza-2'-deoxycytidine affects expression ISO RGD:10073 E RGD:6480464 20191114 CTD MESH:C014347 Decitabine affects the expression of ACP5 mRNA PMID:17145863 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ACP5 mRNA; Nanotubes, Carbon results in decreased expression of ACP5 mRNA PMID:25620056 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:50594 carbon nanotube increases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of ACP5 mRNA; Nanotubes, Carbon results in increased expression of ACP5 mRNA PMID:25554681 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:50673 methimazole increases expression ISO RGD:2022 E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in increased expression of ACP5 mRNA PMID:30047161 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:5118 fluoxetine multiple interactions EXP E RGD:6480464 20120613 CTD MESH:D005473 Fluoxetine inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] PMID:15312242 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:53205 poly(methyl methacrylate) macromolecule multiple interactions EXP E RGD:6480464 20150512 CTD MESH:D019904 naringin inhibits the reaction [Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein]; Polymethyl Methacrylate analog results in increased expression of and results in increased activity of ACP5 protein PMID:24376342 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:53227 poly(ethylene) decreases expression ISO RGD:10073 E RGD:6480464 20120412 CTD MESH:D020959 Polyethylene results in decreased expression of ACP5 mRNA PMID:15585240 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:53444 potassium dichromate decreases activity ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D011192 Potassium Dichromate results in decreased activity of ACP5 protein PMID:16866188 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:5557 guanethidine affects expression ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D006145 Guanethidine affects the expression of ACP5 protein PMID:14527964 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:5557 guanethidine increases expression ISO RGD:2022 E RGD:6480464 20120412 CTD MESH:D006145 Guanethidine results in increased expression of ACP5 mRNA PMID:14527964 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:6078 ivermectin decreases expression ISO RGD:10073 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ACP5 protein PMID:32959892 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:61057 tacrolimus hydrate multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D016559 Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] PMID:15207740 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:61076 belinostat decreases expression ISO RGD:10073 E RGD:6480464 20170303 CTD MESH:C487081 belinostat results in decreased expression of ACP5 mRNA PMID:27188386 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:63041 manganese(II) chloride increases expression ISO RGD:2022 E RGD:6480464 20120717 CTD MESH:C025340 manganese chloride results in increased expression of ACP5 mRNA PMID:22281203|PMID:28801915 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:63041 manganese(II) chloride increases methylation ISO RGD:2022 E RGD:6480464 20190219 CTD MESH:C025340 manganese chloride results in increased methylation of ACP5 gene PMID:28801915 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:63623 succimer multiple interactions EXP E RGD:6480464 20120918 CTD MESH:D004113 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACP5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACP5 mRNA PMID:21641980|PMID:26378955 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:63632 topotecan increases expression ISO RGD:2022 E RGD:6480464 20160315 CTD MESH:D019772 Topotecan results in increased expression of ACP5 mRNA PMID:25729387 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:63632 topotecan multiple interactions ISO RGD:2022 E RGD:6480464 20160315 CTD MESH:D019772 [oxaliplatin co-treated with Topotecan] results in increased expression of ACP5 mRNA PMID:25729387 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:641 N-methyl-4-phenylpyridinium decreases expression ISO RGD:2022 E RGD:6480464 20130611 CTD MESH:D015655 1-Methyl-4-phenylpyridinium results in decreased expression of ACP5 mRNA PMID:16026605 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:6682 mangiferin multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C013592 mangiferin inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] PMID:20683903 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:6698 (-)-matairesinol decreases activity EXP E RGD:6480464 20230404 CTD MESH:C068935 matairesinol results in decreased activity of ACP5 protein PMID:24444335 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:67991 (20S)-ginsenoside Rg3 multiple interactions ISO RGD:2022 E RGD:6480464 20170207 CTD MESH:C097367 ginsenoside Rg3 inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein] PMID:27387537 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:6925 microcystin-LR increases expression ISO RGD:2022 E RGD:6480464 20231031 CTD MESH:C057862 cyanoginosin LR results in increased expression of ACP5 protein PMID:37467923 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:69499 Bergenin multiple interactions EXP E RGD:6480464 20191210 CTD MESH:C006741 bergenin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in decreased activity of ACP5 protein] PMID:31369791 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:7005 morusin decreases expression EXP E RGD:6480464 20240702 CTD MESH:C057451 morusin results in decreased expression of ACP5 mRNA PMID:38522564 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:7553 niclosamide multiple interactions EXP E RGD:6480464 20191114 CTD MESH:D009534 Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of ACP5 mRNA] PMID:28824321 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:7553 niclosamide multiple interactions ISO RGD:10073 E RGD:6480464 20191114 CTD MESH:D009534 Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] PMID:26792726 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:7590 nitrofen increases expression ISO RGD:2022 E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in increased expression of ACP5 mRNA PMID:33484710 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:78320 2-hydroxypropanoic acid decreases expression ISO RGD:10073 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in decreased expression of ACP5 mRNA PMID:30851411 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:10073 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA PMID:27188386 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:79068 crocin-1 multiple interactions EXP E RGD:6480464 20190312 CTD MESH:C029036 crocin promotes the reaction [pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein]] PMID:30580027 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:79516 Nonylphenol decreases expression ISO RGD:2022 E RGD:6480464 20240903 CTD MESH:C025256 nonylphenol results in decreased expression of ACP5 protein PMID:34219512 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:8062 phenethyl caffeate multiple interactions ISO RGD:2022 E RGD:6480464 20170613 CTD MESH:C055494 caffeic acid phenethyl ester inhibits the reaction [Dexamethasone results in increased activity of ACP5 protein] PMID:28363435 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:80852 Morroniside decreases expression EXP E RGD:6480464 20221004 CTD MESH:C488401 morroniside results in decreased expression of ACP5 mRNA PMID:34638983 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression EXP E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of ACP5 mRNA PMID:38648751 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:8489 propiconazole increases expression ISO RGD:2022 E RGD:6480464 20230606 CTD MESH:C045950 propiconazole results in increased expression of ACP5 mRNA PMID:30047161 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2022 E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in increased expression of ACP5 mRNA PMID:30047161 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:9053 sclareol decreases expression EXP E RGD:6480464 20210706 CTD MESH:C070760 sclareol results in decreased expression of ACP5 mRNA; sclareol results in decreased expression of ACP5 protein PMID:33423118 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:9053 sclareol multiple interactions EXP E RGD:6480464 20210706 CTD MESH:C070760 sclareol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]; sclareol inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] PMID:33423118 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:90695 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP E RGD:6480464 20190312 CTD MESH:C432165 crocin promotes the reaction [pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein]]; pyrazolanthrone inhibits the reaction [TNFSF11 protein results in increased activity of ACP5 protein] PMID:30580027 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:91108 SB 431542 multiple interactions EXP E RGD:6480464 20180410 CTD MESH:C459179 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Sodium Fluoride results in increased expression of ACP5 mRNA]; [4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with Sodium Fluoride] affects the expression of ACP5 protein PMID:29127033 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:10073 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACP5 mRNA PMID:27188386 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:9144 silibinin multiple interactions ISO RGD:2022 E RGD:6480464 20230404 CTD MESH:C440975 Silybin inhibits the reaction [ferric ammonium citrate results in increased expression of ACP5 protein] PMID:36087815 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:91460 KN-93 multiple interactions EXP E RGD:6480464 20200915 CTD MESH:C072105 KN 93 affects the reaction [[Cadmium co-treated with TNFSF11 protein co-treated with CSF1R protein] affects the expression of ACP5 protein] PMID:32522522 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:9195 Soman increases expression ISO RGD:2022 E RGD:6480464 20141111 CTD MESH:D012999 Soman results in increased expression of ACP5 mRNA PMID:19281266 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:9271 stevioside decreases secretion ISO RGD:2022 E RGD:6480464 20180703 CTD MESH:C012043 stevioside results in decreased secretion of ACP5 protein PMID:21089163 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:9288 streptozocin increases activity EXP E RGD:6480464 20221206 CTD MESH:D013311 Streptozocin results in increased activity of ACP5 protein PMID:35315182 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:9288 streptozocin increases expression EXP E RGD:6480464 20221206 CTD MESH:D013311 Streptozocin results in increased expression of ACP5 mRNA PMID:35315182 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:9288 streptozocin multiple interactions EXP E RGD:6480464 20221206 CTD MESH:D013311 formononetin inhibits the reaction [Streptozocin results in increased activity of ACP5 protein]; formononetin inhibits the reaction [Streptozocin results in increased expression of ACP5 mRNA] PMID:35315182 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:9434 telmisartan decreases activity ISO RGD:2022 E RGD:329956421|PMID:33364953 20230720 RGD MESH:C084178 telmisartan decreases enzyme activity of Trap, Acp5 in serum of rats with periodontal disease 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:95129 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide multiple interactions EXP E RGD:6480464 20190910 CTD MESH:D020117 Cisapride inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA] PMID:31150804 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:9513 thalidomide multiple interactions ISO RGD:10073 E RGD:6480464 20120412 CTD MESH:D013792 [Thalidomide co-treated with Dexamethasone] results in decreased expression of ACP5 protein PMID:16079895 10072 Acp5 acid phosphatase 5, tartrate resistant gene CHEBI:9944 venlafaxine hydrochloride decreases expression ISO RGD:10073 E RGD:6480464 20170303 CTD MESH:D000069470 Venlafaxine Hydrochloride results in decreased expression of ACP5 mRNA PMID:16341940 10076 Acr acrosin prepropeptide gene CHEBI:15743 butanal increases expression ISO RGD:736688 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in increased expression of ACR mRNA PMID:26079696 10076 Acr acrosin prepropeptide gene CHEBI:164200 triclosan increases expression ISO RGD:736688 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in increased expression of ACR mRNA PMID:30510588 10076 Acr acrosin prepropeptide gene CHEBI:17347 testosterone decreases expression ISO RGD:736688 E RGD:6480464 20211109 CTD MESH:D013739 Testosterone results in decreased expression of ACR mRNA PMID:33359661 10076 Acr acrosin prepropeptide gene CHEBI:27470 folic acid decreases expression EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of ACR mRNA PMID:25629700 10076 Acr acrosin prepropeptide gene CHEBI:27744 glyphosate increases methylation ISO RGD:2024 E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased methylation of ACR gene PMID:31011160 10076 Acr acrosin prepropeptide gene CHEBI:27881 resveratrol multiple interactions ISO RGD:736688 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in decreased expression of ACR mRNA PMID:23557933 10076 Acr acrosin prepropeptide gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACR mRNA PMID:17942748 10076 Acr acrosin prepropeptide gene CHEBI:28741 sodium fluoride increases expression EXP E RGD:6480464 20180116 CTD MESH:D012969 Sodium Fluoride results in increased expression of ACR protein PMID:28918527 10076 Acr acrosin prepropeptide gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:736688 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ACR promoter PMID:27901495 10076 Acr acrosin prepropeptide gene CHEBI:32234 titanium dioxide decreases expression EXP E RGD:6480464 20191112 CTD MESH:C009495 titanium dioxide results in decreased expression of ACR mRNA PMID:29264374 10076 Acr acrosin prepropeptide gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2024 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of ACR mRNA PMID:25181051 10076 Acr acrosin prepropeptide gene CHEBI:33216 bisphenol A increases expression ISO RGD:2024 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of ACR mRNA PMID:34947998 10076 Acr acrosin prepropeptide gene CHEBI:39421 perfluorooctane-1-sulfonic acid decreases expression EXP E RGD:6480464 20230606 CTD MESH:C076994 perfluorooctane sulfonic acid results in decreased expression of ACR mRNA PMID:36321694 10076 Acr acrosin prepropeptide gene CHEBI:39867 valproic acid increases methylation ISO RGD:736688 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of ACR gene PMID:29154799 10076 Acr acrosin prepropeptide gene CHEBI:46195 paracetamol decreases expression ISO RGD:736688 E RGD:6480464 20121009 CTD MESH:D000082 Acetaminophen results in decreased expression of ACR mRNA PMID:22230336 10076 Acr acrosin prepropeptide gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACR mRNA PMID:17942748 10076 Acr acrosin prepropeptide gene CHEBI:6121 ketamine increases expression ISO RGD:2024 E RGD:6480464 20121218 CTD MESH:D007649 Ketamine results in increased expression of ACR mRNA PMID:20080153 10076 Acr acrosin prepropeptide gene CHEBI:63041 manganese(II) chloride increases expression ISO RGD:2024 E RGD:6480464 20190219 CTD MESH:C025340 manganese chloride results in increased expression of ACR mRNA PMID:28801915 10076 Acr acrosin prepropeptide gene CHEBI:64243 monosodium L-glutamate increases expression ISO RGD:2024 E RGD:6480464 20200331 CTD MESH:D012970 Sodium Glutamate results in increased expression of ACR mRNA PMID:20928830 10076 Acr acrosin prepropeptide gene CHEBI:72544 flavonoids decreases expression ISO RGD:2024 E RGD:6480464 20170303 CTD MESH:D005419 Flavonoids results in decreased expression of ACR mRNA PMID:18035473 10076 Acr acrosin prepropeptide gene CHEBI:8502 6-propyl-2-thiouracil decreases expression ISO RGD:2024 E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in decreased expression of ACR mRNA PMID:24780913 10076 Acr acrosin prepropeptide gene CHEBI:9986 vinclozolin decreases expression EXP E RGD:6480464 20141111 CTD MESH:C025643 vinclozolin results in decreased expression of ACR mRNA PMID:18940246 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:113532 thymoquinone multiple interactions ISO RGD:2027 E RGD:6480464 20240806 CTD MESH:C003466 thymoquinone inhibits the reaction [Thioacetamide results in increased expression of ACTG2 mRNA] PMID:38504479 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:116509 diuron decreases expression ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:D004237 Diuron results in decreased expression of ACTG2 mRNA PMID:21551480 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:116509 diuron increases expression ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:D004237 Diuron results in increased expression of ACTG2 mRNA PMID:21551480 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:144804 nickel subsulfide affects expression ISO RGD:2027 E RGD:6480464 20191008 CTD MESH:C017557 nickel subsulfide affects the expression of ACTG2 mRNA PMID:24952340 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:D014212 Tretinoin results in decreased expression of ACTG2 protein PMID:16043492 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:737318 E RGD:6480464 20121218 CTD MESH:D014212 Tretinoin results in increased expression of ACTG2 mRNA PMID:15894607 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:15367 all-trans-retinoic acid multiple interactions EXP E RGD:6480464 20191112 CTD MESH:D014212 [bisphenol A co-treated with Tretinoin] results in decreased expression of ACTG2 mRNA; [bisphenol F co-treated with Tretinoin] results in decreased expression of ACTG2 mRNA; [bisphenol S co-treated with Tretinoin] results in decreased expression of ACTG2 mRNA PMID:30951980 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:15367 all-trans-retinoic acid multiple interactions ISO RGD:737318 E RGD:6480464 20121218 CTD MESH:D014212 [Tretinoin co-treated with arsenic trioxide] results in increased expression of ACTG2 mRNA PMID:15894607 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:15379 dioxygen increases expression ISO RGD:2027 E RGD:6480464 20140408 CTD MESH:D010100 Oxygen results in increased expression of ACTG2 mRNA PMID:22911455 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:15743 butanal increases expression ISO RGD:737318 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in increased expression of ACTG2 mRNA PMID:26079696 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16130 DDT increases expression ISO RGD:2027 E RGD:6480464 20191112 CTD MESH:D003634 DDT results in increased expression of ACTG2 mRNA PMID:30207508 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16236 ethanol increases expression ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:D000431 Ethanol results in increased expression of ACTG2 protein PMID:16043492 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16236 ethanol multiple interactions ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:D000431 Vitamin A results in decreased expression of [Ethanol results in increased expression of ACTG2 protein] PMID:16043492 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16240 hydrogen peroxide decreases expression ISO RGD:2027 E RGD:6480464 20130514 CTD MESH:D006861 Hydrogen Peroxide results in decreased expression of ACTG2 protein PMID:23178681 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16240 hydrogen peroxide multiple interactions ISO RGD:2027 E RGD:6480464 20130514 CTD MESH:D006861 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ACTG2 protein] PMID:23178681 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16336 hyaluronic acid decreases expression ISO RGD:2027 E RGD:6480464 20130514 CTD MESH:D006820 Hyaluronic Acid analog results in decreased expression of ACTG2 protein PMID:23178681 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16336 hyaluronic acid multiple interactions ISO RGD:2027 E RGD:6480464 20130514 CTD MESH:D006820 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ACTG2 protein] PMID:23178681 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:737318 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACTG2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ACTG2 mRNA PMID:35811015 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:737318 E RGD:6480464 20160705 CTD MESH:D004958 Estradiol results in decreased expression of ACTG2 mRNA PMID:25878060 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:2027 E RGD:6480464 20230606 CTD MESH:D004958 Estradiol results in increased expression of ACTG2 mRNA PMID:32145629 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:2027 E RGD:6480464 20160705 CTD MESH:D004958 [bisphenol A co-treated with Estradiol] results in decreased expression of ACTG2 mRNA PMID:26496021 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16602 trichloroethene increases expression ISO RGD:2027 E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of ACTG2 mRNA PMID:33387578 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:16827 corticosterone increases expression ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:D003345 Corticosterone results in increased expression of ACTG2 mRNA PMID:15755911 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:17026 progesterone affects expression EXP E RGD:6480464 20120412 CTD MESH:D011374 Progesterone affects the expression of ACTG2 mRNA PMID:17251523 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:17026 progesterone increases expression ISO RGD:737318 E RGD:6480464 20130723 CTD MESH:D011374 Progesterone results in increased expression of ACTG2 mRNA PMID:20864642 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:17336 all-trans-retinol decreases expression ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:D014801 Vitamin A results in decreased expression of ACTG2 protein PMID:16043492 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:17336 all-trans-retinol multiple interactions ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:D014801 Vitamin A results in decreased expression of [Ethanol results in increased expression of ACTG2 protein] PMID:16043492 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:17347 testosterone increases expression ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:D013739 Testosterone results in increased expression of ACTG2 mRNA PMID:21592394 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:17347 testosterone multiple interactions ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:D013739 [Testosterone co-treated with Calcitriol] results in increased expression of ACTG2 mRNA PMID:21592394 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:17747 bis(2-ethylhexyl) phthalate increases expression ISO RGD:737318 E RGD:6480464 20190910 CTD MESH:D004051 Diethylhexyl Phthalate results in increased expression of ACTG2 mRNA PMID:31163220 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:17747 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:2027 E RGD:6480464 20130514 CTD MESH:D004051 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ACTG2 promoter PMID:23359474 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:17823 calcitriol increases expression ISO RGD:737318 E RGD:6480464 20160412 CTD MESH:D002117 Calcitriol results in increased expression of ACTG2 mRNA PMID:21592394|PMID:26485663 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:17823 calcitriol multiple interactions ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:D002117 [Testosterone co-treated with Calcitriol] results in increased expression of ACTG2 mRNA PMID:21592394 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:2208 purine-6-thiol decreases expression ISO RGD:2027 E RGD:6480464 20130514 CTD MESH:D015122 Mercaptopurine results in decreased expression of ACTG2 mRNA PMID:23358152 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:22977 cadmium atom increases expression ISO RGD:737318 E RGD:6480464 20140513 CTD MESH:D002104 Cadmium results in increased expression of ACTG2 mRNA PMID:24376830 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACTG2 mRNA PMID:37325564 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:737318 E RGD:6480464 20221101 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACTG2 mRNA PMID:35301059 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:232796 cadmium acetate decreases expression ISO RGD:737318 E RGD:6480464 20250107 CTD MESH:C028031 cadmium acetate results in decreased expression of ACTG2 mRNA PMID:18155341 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:23414 copper(II) sulfate increases expression ISO RGD:737318 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in increased expression of ACTG2 mRNA PMID:19549813 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:254496 7,12-dimethyltetraphene increases expression ISO RGD:2027 E RGD:6480464 20161025 CTD MESH:D015127 9,10-Dimethyl-1,2-benzanthracene results in increased expression of ACTG2 mRNA PMID:19480007 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20120412 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACTG2 mRNA PMID:17484886 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ACTG2 mRNA PMID:22206623 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:27684 phenylmercury acetate increases expression ISO RGD:737318 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in increased expression of ACTG2 mRNA PMID:26272509 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:737318 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTG2 mRNA PMID:27188386 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:27744 glyphosate affects expression EXP E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate affects the expression of ACTG2 protein PMID:20045496 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:27856 acetamide increases expression ISO RGD:2027 E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of ACTG2 mRNA PMID:31881176 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:27958 cocaine decreases expression ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:D003042 Cocaine results in decreased expression of ACTG2 mRNA PMID:20948987 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:28088 genistein decreases expression ISO RGD:737318 E RGD:6480464 20140715 CTD MESH:D019833 Genistein results in decreased expression of ACTG2 mRNA PMID:22228119 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:28112 nickel atom decreases expression ISO RGD:737318 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in decreased expression of ACTG2 mRNA PMID:25583101 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2027 E RGD:6480464 20200609 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACTG2 mRNA PMID:32109520|PMID:34747641 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACTG2 mRNA PMID:17942748 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:28216 methylmercury chloride decreases expression ISO RGD:737318 E RGD:6480464 20220308 CTD MESH:C004925 methylmercuric chloride results in decreased expression of ACTG2 mRNA PMID:34089799 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:28694 copper atom decreases expression ISO RGD:2027 E RGD:6480464 20190409 CTD MESH:D003300 Copper results in decreased expression of ACTG2 mRNA PMID:30556269 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:28741 sodium fluoride decreases expression EXP E RGD:6480464 20170516 CTD MESH:D012969 Sodium Fluoride results in decreased expression of ACTG2 protein PMID:27548804 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:737318 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ACTG2 5' UTR; Benzo(a)pyrene affects the methylation of ACTG2 promoter PMID:27901495 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20120412 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ACTG2 mRNA PMID:20713471 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:2027 E RGD:6480464 20120613 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ACTG2 mRNA PMID:21839799 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ACTG2 mRNA PMID:22228805 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:29866 arsenite(3-) increases expression EXP E RGD:6480464 20130910 CTD MESH:C015001 arsenite results in increased expression of ACTG2 mRNA PMID:18296743 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:29866 arsenite(3-) multiple interactions EXP E RGD:6480464 20130910 CTD MESH:C015001 Dietary Fats promotes the reaction [arsenite results in increased expression of ACTG2 mRNA] PMID:18296743 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:30052 copper(0) decreases expression ISO RGD:2027 E RGD:6480464 20190409 CTD MESH:D003300 Copper results in decreased expression of ACTG2 mRNA PMID:30556269 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:30512 silver atom decreases expression ISO RGD:737318 E RGD:6480464 20150310 CTD MESH:D012834 Silver analog results in decreased expression of ACTG2 mRNA PMID:24974767 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:2027 E RGD:6480464 20140715 CTD MESH:D012822 Silicon Dioxide results in decreased expression of ACTG2 mRNA PMID:22431001 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:737318 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of ACTG2 mRNA PMID:25895662 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:30621 diarsenic trioxide increases expression ISO RGD:737318 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in increased expression of ACTG2 mRNA PMID:15894607 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:30621 diarsenic trioxide multiple interactions ISO RGD:737318 E RGD:6480464 20191114 CTD MESH:C006632 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ACTG2 mRNA PMID:15894607 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:2027 E RGD:6480464 20181113 CTD MESH:C009495 titanium dioxide results in decreased expression of ACTG2 mRNA PMID:30012374 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:32497 thioacetamide increases expression ISO RGD:2027 E RGD:6480464 20240806 CTD MESH:D013853 Thioacetamide results in increased expression of ACTG2 mRNA PMID:38504479 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:32497 thioacetamide multiple interactions ISO RGD:2027 E RGD:6480464 20240806 CTD MESH:D013853 Silymarin inhibits the reaction [Thioacetamide results in increased expression of ACTG2 mRNA]; thymoquinone inhibits the reaction [Thioacetamide results in increased expression of ACTG2 mRNA] PMID:38504479 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:32509 pirinixic acid multiple interactions ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ACTG2 mRNA PMID:19710929 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:33007 chromium(6+) multiple interactions ISO RGD:737318 E RGD:6480464 20240702 CTD MESH:C074702 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ACTG2 mRNA PMID:38479592 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:33098 2-nitrotoluene decreases expression ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:C029955 2-nitrotoluene results in decreased expression of ACTG2 mRNA PMID:16460773 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:33216 bisphenol A affects expression ISO RGD:2027 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of ACTG2 mRNA PMID:25181051 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in decreased expression of ACTG2 mRNA PMID:37105096 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:33216 bisphenol A decreases expression ISO RGD:737318 E RGD:6480464 20180515 CTD MESH:C006780 bisphenol A results in decreased expression of ACTG2 mRNA PMID:29275510 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A results in increased expression of ACTG2 mRNA PMID:30951980 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:33216 bisphenol A increases expression ISO RGD:2027 E RGD:6480464 20140812 CTD MESH:C006780 bisphenol A results in increased expression of ACTG2 mRNA PMID:24134786|PMID:32145629 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:33216 bisphenol A increases methylation ISO RGD:2027 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of ACTG2 gene PMID:28505145 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20191112 CTD MESH:C006780 [bisphenol A co-treated with Tretinoin] results in decreased expression of ACTG2 mRNA PMID:30951980 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:2027 E RGD:6480464 20130514 CTD MESH:C006780 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ACTG2 promoter; [bisphenol A co-treated with Estradiol] results in decreased expression of ACTG2 mRNA PMID:23359474|PMID:26496021 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:3387 carbamazepine affects expression ISO RGD:737318 E RGD:6480464 20151013 CTD MESH:D002220 Carbamazepine affects the expression of ACTG2 mRNA PMID:25979313 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:737318 E RGD:6480464 20230801 CTD MESH:C009407 2,5,2',5'-tetrachlorobiphenyl analog results in decreased expression of ACTG2 mRNA PMID:36804509 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:3423 carmustine decreases expression ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:D002330 Carmustine results in decreased expression of ACTG2 mRNA PMID:15980968 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:2027 E RGD:6480464 20200609 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ACTG2 mRNA PMID:32119087 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression EXP E RGD:6480464 20191112 CTD MESH:C543008 bisphenol S results in increased expression of ACTG2 mRNA PMID:30951980 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions EXP E RGD:6480464 20191112 CTD MESH:C543008 [bisphenol S co-treated with Tretinoin] results in decreased expression of ACTG2 mRNA PMID:30951980 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34575 bisphenol F decreases expression EXP E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of ACTG2 mRNA PMID:38685157 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34575 bisphenol F increases expression EXP E RGD:6480464 20191112 CTD MESH:C008745 bisphenol F results in increased expression of ACTG2 mRNA PMID:30951980 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34575 bisphenol F multiple interactions EXP E RGD:6480464 20191112 CTD MESH:C008745 [bisphenol F co-treated with Tretinoin] results in decreased expression of ACTG2 mRNA PMID:30951980 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34687 dibutyl phthalate increases expression EXP E RGD:6480464 20121113 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of ACTG2 mRNA PMID:17361019|PMID:21266533 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34687 dibutyl phthalate increases expression ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of ACTG2 mRNA PMID:21266533 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34687 dibutyl phthalate multiple interactions ISO RGD:2027 E RGD:6480464 20130514 CTD MESH:D003993 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of ACTG2 promoter PMID:23359474 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D015056 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTG2 mRNA PMID:16054899 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34873 N-nitrosodiethylamine decreases expression ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:D004052 Diethylnitrosamine results in decreased expression of ACTG2 mRNA PMID:21527772 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:34905 paraquat increases expression ISO RGD:2027 E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in increased expression of ACTG2 mRNA PMID:32680482 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:2027 E RGD:6480464 20120717 CTD MESH:D019256 Cadmium Chloride results in increased expression of ACTG2 mRNA PMID:21297351 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACTG2 mRNA PMID:37325564 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:737318 E RGD:6480464 20221101 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACTG2 mRNA PMID:35301059 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:39867 valproic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of ACTG2 mRNA PMID:17292431 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:39867 valproic acid affects expression ISO RGD:737318 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ACTG2 mRNA PMID:25979313 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:39867 valproic acid decreases expression ISO RGD:737318 E RGD:6480464 20140909 CTD MESH:D014635 Valproic Acid results in decreased expression of ACTG2 mRNA PMID:23179753|PMID:24935251|PMID:29154799 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:40036 amitrole increases expression ISO RGD:2027 E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in increased expression of ACTG2 mRNA PMID:30047161 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:4031 cyclosporin A increases expression ISO RGD:737318 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in increased expression of ACTG2 mRNA PMID:25562108 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:40953 doramapimod increases expression ISO RGD:2027 E RGD:6480464 20170228 CTD MESH:C452139 doramapimod results in increased expression of ACTG2 mRNA PMID:24303162 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:41879 dexamethasone increases expression EXP E RGD:6480464 20140408 CTD MESH:D003907 Dexamethasone results in increased expression of ACTG2 mRNA PMID:22733784 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D003907 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTG2 mRNA PMID:16054899 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:41922 diethylstilbestrol increases expression ISO RGD:2027 E RGD:6480464 20120918 CTD MESH:D004054 Diethylstilbestrol results in increased expression of ACTG2 mRNA PMID:21658437 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:41922 diethylstilbestrol increases expression ISO RGD:737318 E RGD:6480464 20230704 CTD MESH:D004054 Diethylstilbestrol results in increased expression of ACTG2 mRNA PMID:36621641 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of ACTG2 mRNA PMID:17562736 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:46345 5-fluorouracil decreases expression ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:D005472 Fluorouracil results in decreased expression of ACTG2 mRNA PMID:16709241 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:46557 zoledronic acid decreases expression ISO RGD:737318 E RGD:6480464 20161213 CTD MESH:C088658 zoledronic acid results in decreased expression of ACTG2 mRNA PMID:24714768 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:737318 E RGD:6480464 20221101 CTD MESH:C039961 S-(1,2-dichlorovinyl)cysteine results in decreased expression of ACTG2 mRNA PMID:35811015 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:737318 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ACTG2 mRNA; [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ACTG2 mRNA PMID:35811015 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:46680 serpentine asbestos decreases expression ISO RGD:737318 E RGD:6480464 20180828 CTD MESH:D017632 Asbestos, Serpentine results in decreased expression of ACTG2 mRNA PMID:29523930 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:47807 sulforaphane increases expression EXP E RGD:6480464 20190312 CTD MESH:C016766 sulforaphane results in increased expression of ACTG2 mRNA PMID:30529165 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ACTG2 mRNA PMID:17942748 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:2027 E RGD:6480464 20120515 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ACTG2 mRNA PMID:12655037|PMID:15576828 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ACTG2 mRNA PMID:17942748 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:49639 mercury dibromide multiple interactions ISO RGD:737318 E RGD:6480464 20161025 CTD MESH:C042720 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTG2 mRNA PMID:27188386 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:49900 arsenous acid increases expression ISO RGD:737318 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in increased expression of ACTG2 mRNA PMID:15894607 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:49900 arsenous acid multiple interactions ISO RGD:737318 E RGD:6480464 20191114 CTD MESH:C032793 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ACTG2 mRNA PMID:15894607 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:50594 carbon nanotube affects expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon affects the expression of ACTG2 mRNA PMID:25554681 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ACTG2 mRNA PMID:25620056 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:50594 carbon nanotube increases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of ACTG2 mRNA PMID:25554681 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:5063 fipronil increases expression ISO RGD:2027 E RGD:6480464 20211109 CTD MESH:C082360 fipronil results in increased expression of ACTG2 mRNA PMID:34044035 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:50648 9-cis-retinoic acid decreases expression ISO RGD:2027 E RGD:6480464 20191114 CTD MESH:C103303 Alitretinoin results in decreased expression of ACTG2 protein PMID:16043492 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:50667 mercaptopurine decreases expression ISO RGD:2027 E RGD:6480464 20130514 CTD MESH:D015122 Mercaptopurine results in decreased expression of ACTG2 mRNA PMID:23358152 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:50673 methimazole increases expression ISO RGD:2027 E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in increased expression of ACTG2 mRNA PMID:30047161 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:50729 mitoxantrone affects response to substance ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:D008942 ACTG2 protein affects the susceptibility to Mitoxantrone PMID:16217747 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:50924 sorafenib decreases expression ISO RGD:2027 E RGD:6480464 20170303 CTD MESH:C471405 sorafenib results in decreased expression of ACTG2 mRNA PMID:19338580 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:53001 nickel sulfate increases expression ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:C029938 nickel sulfate results in increased expression of ACTG2 mRNA PMID:16780908 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:5643 Heliotrine decreases expression ISO RGD:2027 E RGD:6480464 20211109 CTD MESH:C010178 heliotrine results in decreased expression of ACTG2 mRNA PMID:34185104 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:6121 ketamine decreases expression ISO RGD:2027 E RGD:6480464 20121218 CTD MESH:D007649 Ketamine results in decreased expression of ACTG2 mRNA PMID:20080153 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:63623 succimer multiple interactions ISO RGD:737318 E RGD:6480464 20151215 CTD MESH:D004113 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACTG2 mRNA PMID:26378955 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:63632 topotecan affects response to substance ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:D019772 ACTG2 protein affects the susceptibility to Topotecan PMID:16217747 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:6402 leflunomide increases expression ISO RGD:737318 E RGD:6480464 20180410 CTD MESH:C045463 leflunomide results in increased expression of ACTG2 mRNA PMID:28988120 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:64090 tert-butyl hydroperoxide increases expression ISO RGD:737318 E RGD:6480464 20120412 CTD MESH:D020122 tert-Butylhydroperoxide results in increased expression of ACTG2 mRNA PMID:15336504 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:64206 bromochloroacetic acid decreases expression ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:C099813 bromochloroacetic acid results in decreased expression of ACTG2 mRNA PMID:16460773 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:64317 isoprenaline increases expression EXP E RGD:6480464 20121113 CTD MESH:D007545 Isoproterenol results in increased expression of ACTG2 mRNA PMID:21335049 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:6541 losartan decreases expression ISO RGD:2027 E RGD:6480464 20120412 CTD MESH:D019808 Losartan results in decreased expression of ACTG2 mRNA PMID:15100363 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:71957 XL147 multiple interactions EXP E RGD:6480464 20180220 CTD MESH:C581157 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ACTG2 mRNA PMID:27935865 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:72564 temozolomide increases expression ISO RGD:737318 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in increased expression of ACTG2 mRNA PMID:31758290 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:73755 1,2-dimethylhydrazine increases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of ACTG2 mRNA PMID:22206623 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ACTG2 mRNA PMID:22206623 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:2027 E RGD:6480464 20180220 CTD MESH:D019813 [APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of ACTG2 mRNA PMID:27840820 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:7590 nitrofen decreases expression ISO RGD:2027 E RGD:6480464 20190312 CTD MESH:C007350 nitrofen results in decreased expression of ACTG2 mRNA PMID:26720608|PMID:33484710 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:76290 PhIP decreases expression ISO RGD:2027 E RGD:6480464 20140107 CTD MESH:C049584 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of ACTG2 mRNA PMID:15059925|PMID:29877212 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:77012 methylseleninic acid increases expression ISO RGD:737318 E RGD:6480464 20140304 CTD MESH:C008493 methylselenic acid results in increased expression of ACTG2 mRNA PMID:18548127 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:737318 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTG2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTG2 mRNA PMID:27188386 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:2027 E RGD:6480464 20200609 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ACTG2 mRNA PMID:32109520 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP E RGD:6480464 20181113 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether results in decreased expression of ACTG2 protein PMID:18550172 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP E RGD:6480464 20181113 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether results in increased expression of ACTG2 protein PMID:18550172 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:8228 pioglitazone multiple interactions EXP E RGD:6480464 20180220 CTD MESH:C060836 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ACTG2 mRNA PMID:27935865 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:8502 6-propyl-2-thiouracil decreases expression ISO RGD:2027 E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in decreased expression of ACTG2 mRNA PMID:24780913 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2027 E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in increased expression of ACTG2 mRNA PMID:30047161 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:88522 Monobutylphthalate decreases expression EXP E RGD:6480464 20240430 CTD MESH:C028577 monobutyl phthalate results in decreased expression of ACTG2 mRNA PMID:35278568 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:9107 senecionine decreases expression ISO RGD:2027 E RGD:6480464 20211109 CTD MESH:C009237 senecionine results in decreased expression of ACTG2 mRNA PMID:34185104 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:737318 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTG2 mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ACTG2 mRNA PMID:27188386 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:9141 silver(0) decreases expression ISO RGD:737318 E RGD:6480464 20150310 CTD MESH:D012834 Silver analog results in decreased expression of ACTG2 mRNA PMID:24974767 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:94796 3,7-dihydropurine-6-thione decreases expression ISO RGD:2027 E RGD:6480464 20170307 CTD MESH:D015122 Mercaptopurine results in decreased expression of ACTG2 mRNA PMID:23358152 10077 Actg2 actin, gamma 2, smooth muscle, enteric gene CHEBI:9665 triadimefon decreases expression ISO RGD:737318 E RGD:6480464 20160210 CTD MESH:C032910 triadimefon results in decreased expression of ACTG2 mRNA PMID:26705709 10078 Acvr2b activin receptor IIB gene CHEBI:132082 entinostat decreases expression ISO RGD:737613 E RGD:6480464 20161228 CTD MESH:C118739 entinostat results in decreased expression of ACVR2B mRNA PMID:27188386 10078 Acvr2b activin receptor IIB gene CHEBI:132267 triptonide increases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of ACVR2B mRNA PMID:33045310 10078 Acvr2b activin receptor IIB gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression EXP E RGD:6480464 20240206 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of ACVR2B mRNA PMID:37995155 10078 Acvr2b activin receptor IIB gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACVR2B gene PMID:20938992 10078 Acvr2b activin receptor IIB gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:737613 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in decreased expression of ACVR2B mRNA PMID:33167477 10078 Acvr2b activin receptor IIB gene CHEBI:15743 butanal decreases expression ISO RGD:737613 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in decreased expression of ACVR2B mRNA PMID:26079696 10078 Acvr2b activin receptor IIB gene CHEBI:15948 lycopene decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:C015329 Lycopene results in decreased expression of SCGB2A2 mRNA PMID:15084515 10078 Acvr2b activin receptor IIB gene CHEBI:16469 17beta-estradiol decreases expression EXP E RGD:6480464 20120412 CTD MESH:D004958 Estradiol results in decreased expression of ACVR2B mRNA PMID:14994273 10078 Acvr2b activin receptor IIB gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:737613 E RGD:6480464 20120412 CTD MESH:D004958 Estradiol results in decreased expression of ACVR2B mRNA PMID:14994273 10078 Acvr2b activin receptor IIB gene CHEBI:165219 PCB138 multiple interactions EXP E RGD:6480464 20201208 CTD MESH:C029790 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACVR2B mRNA PMID:25510870 10078 Acvr2b activin receptor IIB gene CHEBI:16643 L-methionine multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACVR2B gene PMID:20938992 10078 Acvr2b activin receptor IIB gene CHEBI:16842 formaldehyde increases expression ISO RGD:737613 E RGD:6480464 20140408 CTD MESH:D005557 Formaldehyde results in increased expression of ACVR2B mRNA PMID:23649840 10078 Acvr2b activin receptor IIB gene CHEBI:17026 progesterone affects expression EXP E RGD:6480464 20120412 CTD MESH:D011374 Progesterone affects the expression of ACVR2B mRNA PMID:17251523 10078 Acvr2b activin receptor IIB gene CHEBI:17578 toluene decreases expression ISO RGD:737613 E RGD:6480464 20200609 CTD MESH:D014050 Toluene results in decreased expression of ACVR2B mRNA PMID:26717081 10078 Acvr2b activin receptor IIB gene CHEBI:17578 toluene increases methylation ISO RGD:737613 E RGD:6480464 20200609 CTD MESH:D014050 Toluene results in increased methylation of ACVR2B gene PMID:26717081 10078 Acvr2b activin receptor IIB gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of SCGB2A2 mRNA PMID:20420898 10078 Acvr2b activin receptor IIB gene CHEBI:17833 gentamycin decreases expression ISO RGD:2028 E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in decreased expression of ACVR2B mRNA PMID:33387578 10078 Acvr2b activin receptor IIB gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACVR2B mRNA PMID:37325564 10078 Acvr2b activin receptor IIB gene CHEBI:25255 methyl methanesulfonate increases expression ISO RGD:737613 E RGD:6480464 20140408 CTD MESH:D008741 Methyl Methanesulfonate results in increased expression of ACVR2B mRNA PMID:23649840 10078 Acvr2b activin receptor IIB gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D005492 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ACVR2B gene PMID:20938992 10078 Acvr2b activin receptor IIB gene CHEBI:27496 simazine decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D012839 Simazine results in decreased expression of SCGB2A2 mRNA PMID:15519604 10078 Acvr2b activin receptor IIB gene CHEBI:27563 arsenic atom affects expression ISO RGD:737613 E RGD:6480464 20140610 CTD MESH:D001151 Arsenic affects the expression of ACVR2B protein PMID:24675094 10078 Acvr2b activin receptor IIB gene CHEBI:27684 phenylmercury acetate decreases expression ISO RGD:737613 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in decreased expression of ACVR2B mRNA PMID:26272509 10078 Acvr2b activin receptor IIB gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:737613 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACVR2B mRNA PMID:27188386 10078 Acvr2b activin receptor IIB gene CHEBI:27744 glyphosate decreases expression ISO RGD:737613 E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in decreased expression of ACVR2B mRNA PMID:31295307 10078 Acvr2b activin receptor IIB gene CHEBI:27744 glyphosate increases expression ISO RGD:737613 E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased expression of ACVR2B mRNA PMID:31295307 10078 Acvr2b activin receptor IIB gene CHEBI:27899 cisplatin increases expression ISO RGD:737613 E RGD:6480464 20180220 CTD MESH:D002945 Cisplatin results in increased expression of ACVR2B mRNA PMID:27594783 10078 Acvr2b activin receptor IIB gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ACVR2B mRNA PMID:21570461 10078 Acvr2b activin receptor IIB gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of SCGB2A2 protein PMID:11099645 10078 Acvr2b activin receptor IIB gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2028 E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACVR2B mRNA PMID:33387578 10078 Acvr2b activin receptor IIB gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737613 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACVR2B mRNA PMID:12377990 10078 Acvr2b activin receptor IIB gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:737613 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of ACVR2B mRNA PMID:33212167 10078 Acvr2b activin receptor IIB gene CHEBI:28619 acrylamide decreases expression ISO RGD:2028 E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in decreased expression of ACVR2B mRNA; Acrylamide results in decreased expression of SCGB2A2 mRNA PMID:28959563 10078 Acvr2b activin receptor IIB gene CHEBI:28748 doxorubicin decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D004317 Doxorubicin results in decreased expression of SCGB2A2 protein PMID:18440303 10078 Acvr2b activin receptor IIB gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2028 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ACVR2B mRNA; Ammonium Chloride affects the expression of SCGB2A2 mRNA PMID:16483693 10078 Acvr2b activin receptor IIB gene CHEBI:31638 fulvestrant multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C070081 fulvestrant inhibits the reaction [bisphenol A results in decreased expression of ACVR2B mRNA] PMID:14994273 10078 Acvr2b activin receptor IIB gene CHEBI:32095 retinyl acetate increases expression EXP E RGD:6480464 20120412 CTD MESH:C009166 retinol acetate results in increased expression of ACVR2B mRNA PMID:16772331 10078 Acvr2b activin receptor IIB gene CHEBI:32234 titanium dioxide decreases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ACVR2B gene PMID:35295148 10078 Acvr2b activin receptor IIB gene CHEBI:32506 4,4'-diaminodiphenylmethane decreases expression EXP E RGD:6480464 20120412 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in decreased expression of ACVR2B mRNA PMID:18648102 10078 Acvr2b activin receptor IIB gene CHEBI:33216 bisphenol A affects expression ISO RGD:2028 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of ACVR2B mRNA PMID:25181051 10078 Acvr2b activin receptor IIB gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20120412 CTD MESH:C006780 bisphenol A results in decreased expression of ACVR2B mRNA PMID:14994273 10078 Acvr2b activin receptor IIB gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2028 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of ACVR2B mRNA; bisphenol A results in decreased expression of SCGB2A2 mRNA PMID:25181051|PMID:34947998 10078 Acvr2b activin receptor IIB gene CHEBI:33216 bisphenol A decreases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in decreased methylation of ACVR2B promoter PMID:27312807 10078 Acvr2b activin receptor IIB gene CHEBI:33216 bisphenol A increases expression ISO RGD:2028 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased expression of ACVR2B mRNA PMID:29097150 10078 Acvr2b activin receptor IIB gene CHEBI:33216 bisphenol A increases methylation ISO RGD:2028 E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of ACVR2B gene PMID:28505145 10078 Acvr2b activin receptor IIB gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C006780 fulvestrant inhibits the reaction [bisphenol A results in decreased expression of ACVR2B mRNA] PMID:14994273 10078 Acvr2b activin receptor IIB gene CHEBI:33234 vitamin E decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D024502 Vitamin E results in decreased expression of SCGB2A2 mRNA PMID:15084515 10078 Acvr2b activin receptor IIB gene CHEBI:3387 carbamazepine affects expression ISO RGD:737613 E RGD:6480464 20140715 CTD MESH:D002220 Carbamazepine affects the expression of ACVR2B mRNA PMID:24752500 10078 Acvr2b activin receptor IIB gene CHEBI:34202 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP E RGD:6480464 20150414 CTD MESH:C014024 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACVR2B mRNA PMID:25510870 10078 Acvr2b activin receptor IIB gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20150414 CTD MESH:C009407 [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of ACVR2B mRNA PMID:25510870 10078 Acvr2b activin receptor IIB gene CHEBI:34575 bisphenol F decreases expression EXP E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in decreased expression of ACVR2B mRNA PMID:38685157 10078 Acvr2b activin receptor IIB gene CHEBI:34873 N-nitrosodiethylamine multiple interactions ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D004052 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of SCGB2A2 protein PMID:20935162 10078 Acvr2b activin receptor IIB gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:737613 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ACVR2B mRNA PMID:37042841 10078 Acvr2b activin receptor IIB gene CHEBI:35299 dibenz[a,h]anthracene increases expression EXP E RGD:6480464 20160119 CTD MESH:C026486 1,2,5,6-dibenzanthracene results in increased expression of ACVR2B mRNA PMID:26377693 10078 Acvr2b activin receptor IIB gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACVR2B mRNA PMID:37325564 10078 Acvr2b activin receptor IIB gene CHEBI:35572 phorone affects expression ISO RGD:2028 E RGD:6480464 20120501 CTD MESH:C018637 phorone affects the expression of ACVR2B mRNA PMID:18198479 10078 Acvr2b activin receptor IIB gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:737613 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of ACVR2B mRNA PMID:24449571 10078 Acvr2b activin receptor IIB gene CHEBI:38508 methiocarb decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D008714 Methiocarb results in decreased expression of SCGB2A2 mRNA PMID:15519604 10078 Acvr2b activin receptor IIB gene CHEBI:38940 sunitinib increases expression ISO RGD:737613 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in increased expression of ACVR2B mRNA PMID:31533062 10078 Acvr2b activin receptor IIB gene CHEBI:39867 valproic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of ACVR2B mRNA PMID:17963808 10078 Acvr2b activin receptor IIB gene CHEBI:39867 valproic acid affects expression ISO RGD:737613 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ACVR2B mRNA PMID:25979313 10078 Acvr2b activin receptor IIB gene CHEBI:39867 valproic acid decreases expression ISO RGD:737613 E RGD:6480464 20140513 CTD MESH:D014635 Valproic Acid results in decreased expression of ACVR2B mRNA PMID:23179753|PMID:28001369 10078 Acvr2b activin receptor IIB gene CHEBI:4031 cyclosporin A increases expression ISO RGD:737613 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in increased expression of ACVR2B mRNA PMID:25562108 10078 Acvr2b activin receptor IIB gene CHEBI:41774 tamoxifen decreases expression EXP E RGD:6480464 20141223 CTD MESH:D013629 Tamoxifen results in decreased expression of ACVR2B mRNA PMID:25123088 10078 Acvr2b activin receptor IIB gene CHEBI:45716 vorinostat decreases expression ISO RGD:737613 E RGD:6480464 20161213 CTD MESH:C111237 vorinostat results in decreased expression of ACVR2B mRNA PMID:27188386 10078 Acvr2b activin receptor IIB gene CHEBI:47217 arsane affects expression ISO RGD:737613 E RGD:6480464 20140805 CTD MESH:D001151 Arsenic affects the expression of ACVR2B protein PMID:24675094 10078 Acvr2b activin receptor IIB gene CHEBI:47381 diclofenac affects expression ISO RGD:737613 E RGD:6480464 20140715 CTD MESH:D004008 Diclofenac affects the expression of ACVR2B mRNA PMID:24752500 10078 Acvr2b activin receptor IIB gene CHEBI:4791 endosulfan increases expression ISO RGD:2028 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in increased expression of ACVR2B mRNA PMID:29391264 10078 Acvr2b activin receptor IIB gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:2028 E RGD:6480464 20180116 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ACVR2B mRNA PMID:29097150 10078 Acvr2b activin receptor IIB gene CHEBI:4998 fenarimol decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:C033789 fenarimol results in decreased expression of SCGB2A2 mRNA PMID:15590119 10078 Acvr2b activin receptor IIB gene CHEBI:50131 5-aza-2'-deoxycytidine increases expression EXP E RGD:6480464 20191114 CTD MESH:C014347 Decitabine results in increased expression of ACVR2B mRNA PMID:27915011 10078 Acvr2b activin receptor IIB gene CHEBI:50292 cadmium sulfate increases expression EXP E RGD:6480464 20120717 CTD MESH:C037123 cadmium sulfate results in increased expression of ACVR2B mRNA PMID:19274763 10078 Acvr2b activin receptor IIB gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ACVR2B mRNA; Nanotubes, Carbon results in decreased expression of ACVR2B mRNA PMID:25554681 10078 Acvr2b activin receptor IIB gene CHEBI:50859 bexarotene increases expression ISO RGD:2028 E RGD:6480464 20170303 CTD MESH:C095105 bexarotene results in increased expression of ACVR2B mRNA PMID:16648578 10078 Acvr2b activin receptor IIB gene CHEBI:5132 flutamide affects expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D005485 Flutamide affects the expression of SCGB2A2 mRNA PMID:15519604 10078 Acvr2b activin receptor IIB gene CHEBI:5132 flutamide decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D005485 Flutamide results in decreased expression of SCGB2A2 mRNA PMID:15590119 10078 Acvr2b activin receptor IIB gene CHEBI:5132 flutamide multiple interactions ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D005485 Flutamide inhibits the reaction [Testosterone Propionate results in increased expression of SCGB2A2 mRNA] PMID:11376863|PMID:12377983 10078 Acvr2b activin receptor IIB gene CHEBI:641 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:737613 E RGD:6480464 20130611 CTD MESH:D015655 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of ACVR2B mRNA] PMID:12710931 10078 Acvr2b activin receptor IIB gene CHEBI:64243 monosodium L-glutamate increases expression ISO RGD:2028 E RGD:6480464 20200331 CTD MESH:D012970 Sodium Glutamate results in increased expression of ACVR2B mRNA PMID:20928830 10078 Acvr2b activin receptor IIB gene CHEBI:65329 LY294002 multiple interactions ISO RGD:737613 E RGD:6480464 20130611 CTD MESH:C085911 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [1-Methyl-4-phenylpyridinium affects the expression of ACVR2B mRNA] PMID:12710931 10078 Acvr2b activin receptor IIB gene CHEBI:77006 17beta-estradiol 3-benzoate affects expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:C074283 estradiol 3-benzoate affects the expression of SCGB2A2 mRNA PMID:15925091 10078 Acvr2b activin receptor IIB gene CHEBI:77006 17beta-estradiol 3-benzoate decreases expression EXP E RGD:6480464 20140204 CTD MESH:C074283 estradiol 3-benzoate results in decreased expression of ACVR2B mRNA PMID:14994273 10078 Acvr2b activin receptor IIB gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:737613 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACVR2B mRNA PMID:27188386 10078 Acvr2b activin receptor IIB gene CHEBI:8069 phenobarbital multiple interactions ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D010634 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of SCGB2A2 protein PMID:20935162 10078 Acvr2b activin receptor IIB gene CHEBI:81351 Activin A decreases expression ISO RGD:737613 E RGD:153350163|PMID:25659497 20220913 RGD Activin A decreases expression of ACVR2B mRNA in trophoblast cells 10078 Acvr2b activin receptor IIB gene CHEBI:8434 prochloraz decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:C045362 prochloraz results in decreased expression of SCGB2A2 mRNA PMID:15519604|PMID:16375936 10078 Acvr2b activin receptor IIB gene CHEBI:8434 prochloraz multiple interactions ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:C045362 prochloraz inhibits the reaction [Testosterone Propionate results in increased expression of SCGB2A2 mRNA] PMID:12377983 10078 Acvr2b activin receptor IIB gene CHEBI:8450 procymidone decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:C035988 procymidone results in decreased expression of SCGB2A2 mRNA PMID:15590119 10078 Acvr2b activin receptor IIB gene CHEBI:8489 propiconazole decreases expression EXP E RGD:6480464 20120412 CTD MESH:C045950 propiconazole results in decreased expression of ACVR2B mRNA PMID:21278054 10078 Acvr2b activin receptor IIB gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2028 E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of ACVR2B mRNA PMID:24780913 10078 Acvr2b activin receptor IIB gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:737613 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACVR2B mRNA PMID:27188386 10078 Acvr2b activin receptor IIB gene CHEBI:9464 testosterone enanthate affects expression ISO RGD:737613 E RGD:6480464 20161213 CTD MESH:C004648 testosterone enanthate affects the expression of ACVR2B mRNA PMID:17440010 10078 Acvr2b activin receptor IIB gene CHEBI:9466 Testosterone propionate increases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D043343 Testosterone Propionate results in increased expression of SCGB2A2 mRNA PMID:11376863|PMID:12377983 10078 Acvr2b activin receptor IIB gene CHEBI:9466 Testosterone propionate multiple interactions ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:D043343 Flutamide inhibits the reaction [Testosterone Propionate results in increased expression of SCGB2A2 mRNA]; prochloraz inhibits the reaction [Testosterone Propionate results in increased expression of SCGB2A2 mRNA]; vinclozolin inhibits the reaction [Testosterone Propionate results in increased expression of SCGB2A2 mRNA] PMID:11376863|PMID:12377983 10078 Acvr2b activin receptor IIB gene CHEBI:9753 troglitazone decreases expression EXP E RGD:6480464 20180220 CTD MESH:C057693 troglitazone results in decreased expression of ACVR2B mRNA PMID:28973697 10078 Acvr2b activin receptor IIB gene CHEBI:9986 vinclozolin decreases expression ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:C025643 vinclozolin results in decreased expression of SCGB2A2 mRNA PMID:15590119 10078 Acvr2b activin receptor IIB gene CHEBI:9986 vinclozolin multiple interactions ISO RGD:2028 E RGD:6480464 20250128 CTD MESH:C025643 vinclozolin inhibits the reaction [Testosterone Propionate results in increased expression of SCGB2A2 mRNA] PMID:11376863 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:132082 entinostat increases expression ISO RGD:737253 E RGD:6480464 20161228 CTD MESH:C118739 entinostat results in increased expression of ACVRL1 mRNA PMID:27188386 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:132267 triptonide increases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of ACVRL1 mRNA PMID:33045310 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression ISO RGD:737253 E RGD:6480464 20211207 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of ACVRL1 mRNA PMID:25812627 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression EXP E RGD:6480464 20120918 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ACVRL1 mRNA PMID:20188158 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:15367 all-trans-retinoic acid decreases expression ISO RGD:737253 E RGD:6480464 20120515 CTD MESH:D014212 Tretinoin results in decreased expression of ACVRL1 mRNA PMID:15498508 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:15367 all-trans-retinoic acid multiple interactions EXP E RGD:6480464 20240402 CTD MESH:D014212 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ACVRL1 mRNA PMID:36189433 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:15379 dioxygen multiple interactions ISO RGD:737253 E RGD:6480464 20161025 CTD MESH:D010100 Oxygen affects the reaction [AHR protein results in decreased expression of ACVRL1 mRNA] PMID:27103661 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:15930 atrazine increases expression ISO RGD:737253 E RGD:6480464 20141014 CTD MESH:D001280 Atrazine results in increased expression of ACVRL1 mRNA PMID:22378314 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:16598 DDE multiple interactions ISO RGD:737253 E RGD:6480464 20120412 CTD MESH:D003633 [Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of ACVRL1 mRNA PMID:19422813 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:16716 benzene increases expression EXP E RGD:6480464 20120412 CTD MESH:D001554 Benzene results in increased expression of ACVRL1 mRNA PMID:12928149 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:17153 propanal increases expression ISO RGD:737253 E RGD:6480464 20150825 CTD MESH:C005556 propionaldehyde results in increased expression of ACVRL1 mRNA PMID:26079696 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:17243 mono(2-ethylhexyl) phthalate multiple interactions EXP E RGD:6480464 20240402 CTD MESH:C016599 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of ACVRL1 mRNA PMID:36189433 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:17578 toluene increases expression ISO RGD:2029 E RGD:6480464 20140408 CTD MESH:D014050 Toluene results in increased expression of ACVRL1 mRNA PMID:22967744 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:18145 (R,R,R)-alpha-tocopherol increases expression ISO RGD:2029 E RGD:6480464 20120412 CTD MESH:D024502 alpha-Tocopherol results in increased expression of ACVRL1 mRNA PMID:16908007 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:181914 Aflatoxin B2 alpha increases methylation ISO RGD:737253 E RGD:6480464 20211109 CTD MESH:C029753 aflatoxin B2 results in increased methylation of ACVRL1 intron PMID:30157460 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:18258 3,3',5-triiodo-L-thyronine increases expression EXP E RGD:6480464 20141223 CTD MESH:D014284 Triiodothyronine results in increased expression of ACVRL1 mRNA PMID:25172293 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:18305 hydroquinone O-beta-D-glucopyranoside decreases expression ISO RGD:737253 E RGD:6480464 20120412 CTD MESH:D001104 Arbutin results in decreased expression of ACVRL1 mRNA PMID:17103032 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:737253 E RGD:6480464 20221101 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACVRL1 mRNA PMID:35301059 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:2564 aldrin multiple interactions ISO RGD:737253 E RGD:6480464 20140107 CTD MESH:D000452 [Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of ACVRL1 mRNA PMID:19422813 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:25812 ozone multiple interactions EXP E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ACVRL1 mRNA; [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ACVRL1 mRNA PMID:34911549 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:27841 DDD multiple interactions ISO RGD:737253 E RGD:6480464 20120412 CTD MESH:D003632 [Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of ACVRL1 mRNA PMID:19422813 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:27856 acetamide increases expression ISO RGD:2029 E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of ACVRL1 mRNA PMID:31881176 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:28112 nickel atom decreases expression EXP E RGD:6480464 20120717 CTD MESH:D009532 Nickel results in decreased expression of ACVRL1 mRNA PMID:12540486 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2029 E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ACVRL1 mRNA PMID:34747641 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2029 E RGD:6480464 20200609 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACVRL1 mRNA PMID:32109520 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:737253 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ACVRL1 promoter PMID:27901495 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ACVRL1 mRNA PMID:22228805 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:2029 E RGD:6480464 20140715 CTD MESH:D012822 Silicon Dioxide results in decreased expression of ACVRL1 mRNA PMID:22431001 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:737253 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of ACVRL1 mRNA PMID:25895662 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:30614 benzo[a]pyrene diol epoxide I increases expression ISO RGD:737253 E RGD:6480464 20140805 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ACVRL1 mRNA PMID:20382639 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:737253 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of ACVRL1 mRNA PMID:18231732 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2029 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ACVRL1 mRNA PMID:16483693 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:31767 lead diacetate increases expression EXP E RGD:6480464 20130416 CTD MESH:C008261 lead acetate results in increased expression of ACVRL1 mRNA PMID:22609695 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:31941 oxaliplatin multiple interactions ISO RGD:2029 E RGD:6480464 20161213 CTD MESH:C030110 [oxaliplatin co-treated with Topotecan] results in increased expression of ACVRL1 mRNA PMID:25729387 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:32181 tamibarotene decreases expression ISO RGD:737253 E RGD:6480464 20120515 CTD MESH:C061133 tamibarotene results in decreased expression of ACVRL1 mRNA PMID:15498508 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:32234 titanium dioxide decreases expression EXP E RGD:6480464 20140211 CTD MESH:C009495 titanium dioxide results in decreased expression of ACVRL1 mRNA PMID:23557971 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:32506 4,4'-diaminodiphenylmethane decreases expression EXP E RGD:6480464 20120412 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in decreased expression of ACVRL1 mRNA PMID:18648102 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2029 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of ACVRL1 mRNA PMID:25181051|PMID:30816183|PMID:32528016 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A results in increased expression of ACVRL1 mRNA PMID:30951980|PMID:32156529 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:737253 E RGD:6480464 20231205 CTD MESH:C006780 bisphenol A results in increased expression of ACVRL1 mRNA PMID:36232920 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:737253 E RGD:6480464 20180116 CTD MESH:C006780 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ACVRL1 mRNA PMID:28628672 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:34206 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:737253 E RGD:6480464 20230801 CTD MESH:C009407 2,5,2',5'-tetrachlorobiphenyl analog results in increased expression of ACVRL1 mRNA PMID:36804509 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:34211 2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene multiple interactions ISO RGD:737253 E RGD:6480464 20141111 CTD MESH:C054919 [Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of ACVRL1 mRNA PMID:19422813 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:34372 4,4'-sulfonyldiphenol affects methylation EXP E RGD:6480464 20230207 CTD MESH:C543008 bisphenol S affects the methylation of ACVRL1 gene PMID:31683443 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression EXP E RGD:6480464 20191112 CTD MESH:C543008 bisphenol S results in increased expression of ACVRL1 mRNA PMID:30951980 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:34569 Benzo[k]fluoranthene increases expression EXP E RGD:6480464 20160119 CTD MESH:C022921 benzo(k)fluoranthene results in increased expression of ACVRL1 mRNA PMID:26377693 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:34575 bisphenol F increases expression EXP E RGD:6480464 20191112 CTD MESH:C008745 bisphenol F results in increased expression of ACVRL1 mRNA PMID:30951980 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:34631 chlorpyrifos increases expression EXP E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of ACVRL1 mRNA PMID:37019170 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:34696 dieldrin multiple interactions ISO RGD:737253 E RGD:6480464 20120412 CTD MESH:D004026 [Dichlorodiphenyldichloroethane co-treated with Dichlorodiphenyl Dichloroethylene co-treated with 2,2-(2-chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene co-treated with Aldrin co-treated with Dieldrin] results in increased expression of ACVRL1 mRNA PMID:19422813 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737253 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ACVRL1 mRNA PMID:28628672 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:34873 N-nitrosodiethylamine multiple interactions ISO RGD:2029 E RGD:6480464 20120412 CTD MESH:D004052 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACVRL1 mRNA PMID:18164116 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:35064 alpha-Zearalanol multiple interactions ISO RGD:2029 E RGD:6480464 20240430 CTD MESH:D015029 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ACVRL1 mRNA PMID:35163327 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:737253 E RGD:6480464 20221101 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ACVRL1 mRNA PMID:35301059 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:35549 perfluorooctanoic acid decreases expression ISO RGD:737253 E RGD:6480464 20211207 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of ACVRL1 mRNA PMID:25812627 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:35549 perfluorooctanoic acid multiple interactions ISO RGD:2029 E RGD:6480464 20240430 CTD MESH:C023036 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ACVRL1 mRNA PMID:35163327 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:35559 furan increases expression ISO RGD:2029 E RGD:6480464 20170516 CTD MESH:C039281 furan results in increased expression of ACVRL1 mRNA PMID:27387713 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:737253 E RGD:6480464 20120814 CTD MESH:C018021 cobaltous chloride results in decreased expression of ACVRL1 mRNA PMID:19320972 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:3750 clofibrate multiple interactions EXP E RGD:6480464 20120515 CTD MESH:D002994 [Clofibrate co-treated with Acetaminophen] affects the expression of ACVRL1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACVRL1 mRNA] PMID:17585979 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:38397 perfluorononanoic acid decreases expression ISO RGD:737253 E RGD:6480464 20220111 CTD MESH:C101816 perfluoro-n-nonanoic acid results in decreased expression of ACVRL1 mRNA PMID:25812627 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:39421 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:737253 E RGD:6480464 20211207 CTD MESH:C076994 perfluorooctane sulfonic acid results in decreased expression of ACVRL1 mRNA PMID:25812627 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:39867 valproic acid increases methylation ISO RGD:737253 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of ACVRL1 gene PMID:29154799 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:41879 dexamethasone increases expression ISO RGD:737253 E RGD:6480464 20160705 CTD MESH:D003907 Dexamethasone results in increased expression of ACVRL1 mRNA PMID:25047013 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:737253 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ACVRL1 mRNA PMID:28628672 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:43572 kojic acid decreases expression ISO RGD:737253 E RGD:6480464 20120412 CTD MESH:C011890 kojic acid results in decreased expression of ACVRL1 mRNA PMID:16595896 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:46195 paracetamol multiple interactions EXP E RGD:6480464 20120515 CTD MESH:D000082 [Clofibrate co-treated with Acetaminophen] affects the expression of ACVRL1 mRNA; PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of ACVRL1 mRNA] PMID:17585979 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:4784 enalapril decreases expression ISO RGD:2029 E RGD:6480464 20120515 CTD MESH:D004656 Enalapril results in decreased expression of ACVRL1 protein PMID:12883979 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:4791 endosulfan decreases expression ISO RGD:2029 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of ACVRL1 mRNA PMID:29391264 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:49662 indometacin multiple interactions ISO RGD:737253 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ACVRL1 mRNA PMID:28628672 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:49900 arsenous acid decreases expression ISO RGD:737253 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of ACVRL1 mRNA PMID:18231732 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ACVRL1 mRNA; Nanotubes, Carbon results in decreased expression of ACVRL1 mRNA PMID:25554681 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:63041 manganese(II) chloride increases expression ISO RGD:2029 E RGD:6480464 20190219 CTD MESH:C025340 manganese chloride results in increased expression of ACVRL1 mRNA PMID:28801915 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:63632 topotecan multiple interactions ISO RGD:2029 E RGD:6480464 20160315 CTD MESH:D019772 [oxaliplatin co-treated with Topotecan] results in increased expression of ACVRL1 mRNA PMID:25729387 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:6437 levetiracetam decreases expression ISO RGD:2029 E RGD:6480464 20181113 CTD MESH:D000077287 Levetiracetam results in decreased expression of ACVRL1 mRNA PMID:20345932 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:6809 methamphetamine decreases methylation EXP E RGD:6480464 20151215 CTD MESH:D008694 Methamphetamine results in decreased methylation of ACVRL1 promoter PMID:26307267 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:73755 1,2-dimethylhydrazine increases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of ACVRL1 mRNA PMID:22206623 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:7590 nitrofen increases expression ISO RGD:2029 E RGD:6480464 20170613 CTD MESH:C007350 nitrofen results in increased expression of ACVRL1 mRNA; nitrofen results in increased expression of ACVRL1 protein PMID:26540443 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:77013 beta-naphthoflavone decreases expression ISO RGD:737253 E RGD:6480464 20210406 CTD MESH:D019324 beta-Naphthoflavone results in decreased expression of ACVRL1 mRNA PMID:32858204 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:77013 beta-naphthoflavone multiple interactions ISO RGD:2029 E RGD:6480464 20140204 CTD MESH:D019324 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ACVRL1 mRNA PMID:18164116 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:737253 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to ACVRL1 gene] PMID:28238834 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:8772 raloxifene increases expression ISO RGD:737253 E RGD:6480464 20161213 CTD MESH:D020849 Raloxifene Hydrochloride results in increased expression of ACVRL1 mRNA; Raloxifene Hydrochloride results in increased expression of ACVRL1 protein PMID:20135064 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:88522 Monobutylphthalate increases expression EXP E RGD:6480464 20240430 CTD MESH:C028577 monobutyl phthalate results in increased expression of ACVRL1 mRNA PMID:35278568 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:9753 troglitazone increases expression EXP E RGD:6480464 20120501 CTD MESH:C057693 troglitazone results in increased expression of ACVRL1 mRNA PMID:17569031 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:9763 trovafloxacin increases expression EXP E RGD:6480464 20221101 CTD MESH:C080163 trovafloxacin results in increased expression of ACVRL1 mRNA PMID:35537566 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:9986 vinclozolin affects expression ISO RGD:2029 E RGD:6480464 20141111 CTD MESH:C025643 vinclozolin affects the expression of ACVRL1 mRNA PMID:19015723 10079 Acvrl1 activin A receptor, type II-like 1 gene CHEBI:9986 vinclozolin increases expression ISO RGD:2029 E RGD:6480464 20141111 CTD MESH:C025643 vinclozolin results in increased expression of ACVRL1 mRNA PMID:22570695 10080 Acy1 aminoacylase 1 gene CHEBI:10429 beta-lapachone increases expression ISO RGD:1351880 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in increased expression of ACY1 mRNA PMID:38218311 10080 Acy1 aminoacylase 1 gene CHEBI:132267 triptonide increases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of ACY1 mRNA PMID:33045310 10080 Acy1 aminoacylase 1 gene CHEBI:132471 (+)-schisandrin B multiple interactions ISO RGD:2030 E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACY1 mRNA] PMID:31150632 10080 Acy1 aminoacylase 1 gene CHEBI:16240 hydrogen peroxide increases expression ISO RGD:1351880 E RGD:6480464 20220607 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of ACY1 protein PMID:34581912 10080 Acy1 aminoacylase 1 gene CHEBI:16243 quercetin decreases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D011794 Quercetin results in decreased expression of ACY1 mRNA PMID:21632981 10080 Acy1 aminoacylase 1 gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:2030 E RGD:6480464 20230606 CTD MESH:D004958 Estradiol results in decreased expression of ACY1 mRNA PMID:32145629 10080 Acy1 aminoacylase 1 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:2030 E RGD:6480464 20230606 CTD MESH:D004958 Estradiol results in increased expression of ACY1 protein PMID:32145629 10080 Acy1 aminoacylase 1 gene CHEBI:16469 17beta-estradiol multiple interactions EXP E RGD:6480464 20180320 CTD MESH:D004958 [Estradiol co-treated with Progesterone] results in increased expression of ACY1 mRNA PMID:19693291 10080 Acy1 aminoacylase 1 gene CHEBI:17026 progesterone multiple interactions EXP E RGD:6480464 20180320 CTD MESH:D011374 [Estradiol co-treated with Progesterone] results in increased expression of ACY1 mRNA PMID:19693291 10080 Acy1 aminoacylase 1 gene CHEBI:17347 testosterone decreases expression EXP E RGD:6480464 20180320 CTD MESH:D013739 Testosterone results in decreased expression of ACY1 mRNA PMID:19693291 10080 Acy1 aminoacylase 1 gene CHEBI:17833 gentamycin decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D005839 Gentamicins results in decreased expression of ACY1 mRNA; Gentamicins results in decreased expression of ACY1 protein PMID:21081137|PMID:22061828 10080 Acy1 aminoacylase 1 gene CHEBI:17967 urethane decreases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D014520 Urethane results in decreased expression of ACY1 mRNA PMID:28818685 10080 Acy1 aminoacylase 1 gene CHEBI:18721 3-chloropropane-1,2-diol decreases expression ISO RGD:2030 E RGD:6480464 20220705 CTD MESH:D000517 alpha-Chlorohydrin results in decreased expression of ACY1 protein PMID:34915118 10080 Acy1 aminoacylase 1 gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:1351880 E RGD:6480464 20221101 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACY1 mRNA PMID:35301059 10080 Acy1 aminoacylase 1 gene CHEBI:2504 aflatoxin B1 affects expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D016604 Aflatoxin B1 affects the expression of ACY1 protein PMID:20106945 10080 Acy1 aminoacylase 1 gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20200804 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACY1 mRNA PMID:31919559 10080 Acy1 aminoacylase 1 gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:2030 E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ACY1 mRNA PMID:31150632 10080 Acy1 aminoacylase 1 gene CHEBI:27385 tetrachloromethane multiple interactions ISO RGD:2030 E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ACY1 mRNA] PMID:31150632 10080 Acy1 aminoacylase 1 gene CHEBI:27568 selenium atom increases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D012643 Selenium results in increased expression of ACY1 mRNA PMID:19244175 10080 Acy1 aminoacylase 1 gene CHEBI:27744 glyphosate multiple interactions ISO RGD:2030 E RGD:6480464 20240206 CTD MESH:C010974 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACY1 mRNA PMID:33854195 10080 Acy1 aminoacylase 1 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in increased expression of ACY1 mRNA PMID:27392435 10080 Acy1 aminoacylase 1 gene CHEBI:28001 vancomycin increases expression EXP E RGD:6480464 20180320 CTD MESH:D014640 Vancomycin results in increased expression of ACY1 mRNA PMID:18930951 10080 Acy1 aminoacylase 1 gene CHEBI:28088 genistein increases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D019833 Genistein results in increased expression of ACY1 protein PMID:20884965 10080 Acy1 aminoacylase 1 gene CHEBI:28088 genistein multiple interactions ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D019833 ESR2 promotes the reaction [Genistein results in increased expression of ACY1 protein] PMID:20884965 10080 Acy1 aminoacylase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20180320 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ACY1 mRNA PMID:21570461 10080 Acy1 aminoacylase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACY1 mRNA PMID:12377990 10080 Acy1 aminoacylase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ACY1 mRNA PMID:21215274|PMID:32109520 10080 Acy1 aminoacylase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20180320 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACY1 mRNA PMID:23994337 10080 Acy1 aminoacylase 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ACY1 mRNA PMID:11489354 10080 Acy1 aminoacylase 1 gene CHEBI:28619 acrylamide increases expression ISO RGD:2030 E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in increased expression of ACY1 mRNA PMID:28959563 10080 Acy1 aminoacylase 1 gene CHEBI:28694 copper atom affects binding ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D003300 ACY1 protein binds to Copper PMID:15359738 10080 Acy1 aminoacylase 1 gene CHEBI:28694 copper atom decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D003300 Copper results in decreased expression of ACY1 mRNA PMID:22465980 10080 Acy1 aminoacylase 1 gene CHEBI:29699 tunicamycin increases expression ISO RGD:1351880 E RGD:6480464 20190312 CTD MESH:D014415 Tunicamycin results in increased expression of ACY1 mRNA PMID:29453283 10080 Acy1 aminoacylase 1 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20180320 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ACY1 mRNA PMID:22228805 10080 Acy1 aminoacylase 1 gene CHEBI:30052 copper(0) affects binding ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D003300 ACY1 protein binds to Copper PMID:15359738 10080 Acy1 aminoacylase 1 gene CHEBI:30052 copper(0) decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D003300 Copper results in decreased expression of ACY1 mRNA PMID:22465980 10080 Acy1 aminoacylase 1 gene CHEBI:30621 diarsenic trioxide decreases expression ISO RGD:1351880 E RGD:6480464 20191114 CTD MESH:C006632 Arsenic Trioxide results in decreased expression of ACY1 protein PMID:19364129 10080 Acy1 aminoacylase 1 gene CHEBI:32161 sulfadimethoxine increases expression ISO RGD:2030 E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in increased expression of ACY1 mRNA PMID:30047161 10080 Acy1 aminoacylase 1 gene CHEBI:3223 buspirone decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D002065 Buspirone results in decreased expression of ACY1 mRNA PMID:24136188 10080 Acy1 aminoacylase 1 gene CHEBI:32497 thioacetamide decreases expression ISO RGD:2030 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of ACY1 mRNA PMID:34492290 10080 Acy1 aminoacylase 1 gene CHEBI:32506 4,4'-diaminodiphenylmethane decreases expression EXP E RGD:6480464 20180320 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in decreased expression of ACY1 mRNA PMID:18648102 10080 Acy1 aminoacylase 1 gene CHEBI:32509 pirinixic acid decreases expression EXP E RGD:6480464 20180320 CTD MESH:C006253 pirinixic acid results in decreased expression of ACY1 mRNA PMID:23811191 10080 Acy1 aminoacylase 1 gene CHEBI:32509 pirinixic acid multiple interactions EXP E RGD:6480464 20180320 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ACY1 mRNA PMID:19710929 10080 Acy1 aminoacylase 1 gene CHEBI:33128 C60 fullerene increases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:C069837 fullerene C60 results in increased expression of ACY1 mRNA PMID:19167457 10080 Acy1 aminoacylase 1 gene CHEBI:33216 bisphenol A affects expression ISO RGD:1351880 E RGD:6480464 20191112 CTD MESH:C006780 bisphenol A affects the expression of ACY1 mRNA PMID:30903817 10080 Acy1 aminoacylase 1 gene CHEBI:33216 bisphenol A increases expression EXP E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of ACY1 mRNA PMID:33221593 10080 Acy1 aminoacylase 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:1351880 E RGD:6480464 20240206 CTD MESH:C006780 bisphenol A results in increased expression of ACY1 protein PMID:37567409 10080 Acy1 aminoacylase 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:2030 E RGD:6480464 20230606 CTD MESH:C006780 bisphenol A results in increased expression of ACY1 protein PMID:32145629 10080 Acy1 aminoacylase 1 gene CHEBI:33216 bisphenol A multiple interactions EXP E RGD:6480464 20230207 CTD MESH:C006780 [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of ACY1 protein PMID:35999755 10080 Acy1 aminoacylase 1 gene CHEBI:34031 1,1-dichloroethene decreases expression EXP E RGD:6480464 20180320 CTD MESH:C029297 vinylidene chloride results in decreased expression of ACY1 mRNA PMID:26682919 10080 Acy1 aminoacylase 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of ACY1 mRNA PMID:20959002 10080 Acy1 aminoacylase 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression EXP E RGD:6480464 20180320 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ACY1 mRNA PMID:23994337 10080 Acy1 aminoacylase 1 gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:1351880 E RGD:6480464 20230307 CTD MESH:C543008 bisphenol S results in increased expression of ACY1 protein PMID:34186270 10080 Acy1 aminoacylase 1 gene CHEBI:34575 bisphenol F increases expression ISO RGD:1351880 E RGD:6480464 20230307 CTD MESH:C008745 bisphenol F results in increased expression of ACY1 protein PMID:34186270 10080 Acy1 aminoacylase 1 gene CHEBI:34581 Bisphenol B increases expression ISO RGD:1351880 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of ACY1 protein PMID:34186270 10080 Acy1 aminoacylase 1 gene CHEBI:34631 chlorpyrifos increases expression EXP E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of ACY1 mRNA PMID:37019170 10080 Acy1 aminoacylase 1 gene CHEBI:34631 chlorpyrifos multiple interactions ISO RGD:2030 E RGD:6480464 20210706 CTD MESH:D004390 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACY1 mRNA PMID:33854195 10080 Acy1 aminoacylase 1 gene CHEBI:34674 dextran sulfate multiple interactions EXP E RGD:6480464 20230207 CTD MESH:D016264 [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of ACY1 protein PMID:35999755 10080 Acy1 aminoacylase 1 gene CHEBI:34687 dibutyl phthalate decreases expression EXP E RGD:6480464 20180320 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ACY1 mRNA PMID:17361019|PMID:21266533 10080 Acy1 aminoacylase 1 gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ACY1 mRNA PMID:21266533 10080 Acy1 aminoacylase 1 gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:1351880 E RGD:6480464 20221101 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACY1 mRNA PMID:35301059 10080 Acy1 aminoacylase 1 gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ACY1 protein PMID:22609092 10080 Acy1 aminoacylase 1 gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:C018021 cobaltous chloride results in decreased expression of ACY1 mRNA PMID:19376846 10080 Acy1 aminoacylase 1 gene CHEBI:36904 elemental selenium increases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D012643 Selenium results in increased expression of ACY1 mRNA PMID:19244175 10080 Acy1 aminoacylase 1 gene CHEBI:3750 clofibrate decreases expression EXP E RGD:6480464 20180320 CTD MESH:D002994 Clofibrate results in decreased expression of ACY1 mRNA PMID:17585979 10080 Acy1 aminoacylase 1 gene CHEBI:39501 2,2,2-tetramine multiple interactions ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D014266 Trientine inhibits the reaction [Streptozocin results in decreased expression of ACY1 protein] PMID:19634143 10080 Acy1 aminoacylase 1 gene CHEBI:39867 valproic acid affects expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D014635 Valproic Acid affects the expression of ACY1 mRNA PMID:25979313 10080 Acy1 aminoacylase 1 gene CHEBI:39867 valproic acid decreases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D014635 Valproic Acid results in decreased expression of ACY1 mRNA PMID:24935251 10080 Acy1 aminoacylase 1 gene CHEBI:40036 amitrole increases expression ISO RGD:2030 E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in increased expression of ACY1 mRNA PMID:30047161 10080 Acy1 aminoacylase 1 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D016572 Cyclosporine results in decreased expression of ACY1 mRNA PMID:20106945|PMID:21163907|PMID:25562108 10080 Acy1 aminoacylase 1 gene CHEBI:40909 azoxystrobin multiple interactions ISO RGD:2030 E RGD:6480464 20210706 CTD MESH:C087670 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACY1 mRNA PMID:33854195 10080 Acy1 aminoacylase 1 gene CHEBI:45979 thiabendazole multiple interactions ISO RGD:2030 E RGD:6480464 20210706 CTD MESH:D013827 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACY1 mRNA PMID:33854195 10080 Acy1 aminoacylase 1 gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20180320 CTD MESH:D000082 Acetaminophen affects the expression of ACY1 mRNA PMID:17562736 10080 Acy1 aminoacylase 1 gene CHEBI:46345 5-fluorouracil multiple interactions ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D005472 TP53 protein affects the reaction [Fluorouracil results in decreased expression of ACY1 mRNA] PMID:15016801 10080 Acy1 aminoacylase 1 gene CHEBI:4811 epoxiconazole decreases expression EXP E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in decreased expression of ACY1 mRNA PMID:35436446 10080 Acy1 aminoacylase 1 gene CHEBI:48981 quinolin-8-ol decreases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D015125 Oxyquinoline results in decreased expression of ACY1 mRNA PMID:21632981 10080 Acy1 aminoacylase 1 gene CHEBI:49662 indometacin decreases expression ISO RGD:2030 E RGD:6480464 20230704 CTD MESH:D007213 Indomethacin results in decreased expression of ACY1 mRNA PMID:36868495 10080 Acy1 aminoacylase 1 gene CHEBI:49900 arsenous acid decreases expression ISO RGD:1351880 E RGD:6480464 20191114 CTD MESH:C032793 Arsenic Trioxide results in decreased expression of ACY1 protein PMID:19364129 10080 Acy1 aminoacylase 1 gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20180320 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ACY1 mRNA; Nanotubes, Carbon results in decreased expression of ACY1 mRNA PMID:25620056 10080 Acy1 aminoacylase 1 gene CHEBI:50594 carbon nanotube increases expression EXP E RGD:6480464 20180320 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of ACY1 mRNA; Nanotubes, Carbon results in increased expression of ACY1 mRNA PMID:25554681 10080 Acy1 aminoacylase 1 gene CHEBI:5062 finasteride increases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D018120 Finasteride results in increased expression of ACY1 mRNA PMID:24136188 10080 Acy1 aminoacylase 1 gene CHEBI:50673 methimazole increases expression ISO RGD:2030 E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in increased expression of ACY1 mRNA PMID:30047161 10080 Acy1 aminoacylase 1 gene CHEBI:5132 flutamide increases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D005485 Flutamide results in increased expression of ACY1 mRNA PMID:24136188 10080 Acy1 aminoacylase 1 gene CHEBI:5870 imidacloprid multiple interactions ISO RGD:2030 E RGD:6480464 20210706 CTD MESH:C082359 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACY1 mRNA PMID:33854195 10080 Acy1 aminoacylase 1 gene CHEBI:6067 isotretinoin decreases expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D015474 Isotretinoin results in decreased expression of ACY1 mRNA PMID:20436886 10080 Acy1 aminoacylase 1 gene CHEBI:6078 ivermectin decreases expression ISO RGD:1351880 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ACY1 protein PMID:32959892 10080 Acy1 aminoacylase 1 gene CHEBI:63598 levofloxacin decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D064704 Levofloxacin results in decreased expression of ACY1 mRNA PMID:24136188 10080 Acy1 aminoacylase 1 gene CHEBI:63623 succimer multiple interactions EXP E RGD:6480464 20180320 CTD MESH:D004113 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACY1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACY1 mRNA PMID:21641980|PMID:26378955 10080 Acy1 aminoacylase 1 gene CHEBI:72754 bisphenol AF increases expression ISO RGD:1351880 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of ACY1 protein PMID:34186270 10080 Acy1 aminoacylase 1 gene CHEBI:73755 1,2-dimethylhydrazine increases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of ACY1 mRNA PMID:22206623 10080 Acy1 aminoacylase 1 gene CHEBI:76326 N-nitrosomorpholine decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:C002741 N-nitrosomorpholine results in decreased expression of ACY1 protein PMID:19716841 10080 Acy1 aminoacylase 1 gene CHEBI:77013 beta-naphthoflavone increases expression EXP E RGD:6480464 20180320 CTD MESH:D019324 beta-Naphthoflavone results in increased expression of ACY1 mRNA PMID:23994337 10080 Acy1 aminoacylase 1 gene CHEBI:7719 ochratoxin A increases expression ISO RGD:2030 E RGD:6480464 20200609 CTD MESH:C025589 ochratoxin A results in increased expression of ACY1 protein PMID:31369848 10080 Acy1 aminoacylase 1 gene CHEBI:8069 phenobarbital affects expression ISO RGD:1351880 E RGD:6480464 20180320 CTD MESH:D010634 Phenobarbital affects the expression of ACY1 mRNA PMID:19159669 10080 Acy1 aminoacylase 1 gene CHEBI:8069 phenobarbital increases expression ISO RGD:1351880 E RGD:6480464 20230502 CTD MESH:D010634 Phenobarbital results in increased expression of ACY1 protein PMID:35881160 10080 Acy1 aminoacylase 1 gene CHEBI:8489 propiconazole decreases expression EXP E RGD:6480464 20180320 CTD MESH:C045950 propiconazole results in decreased expression of ACY1 mRNA PMID:21278054 10080 Acy1 aminoacylase 1 gene CHEBI:8489 propiconazole increases expression ISO RGD:2030 E RGD:6480464 20230606 CTD MESH:C045950 propiconazole results in increased expression of ACY1 mRNA PMID:30047161 10080 Acy1 aminoacylase 1 gene CHEBI:8502 6-propyl-2-thiouracil decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D011441 Propylthiouracil results in decreased expression of ACY1 mRNA PMID:24780913 10080 Acy1 aminoacylase 1 gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2030 E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in increased expression of ACY1 mRNA PMID:30047161 10080 Acy1 aminoacylase 1 gene CHEBI:90633 perfluorododecanoic acid decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:C522391 perfluorododecanoic acid results in decreased expression of ACY1 protein PMID:26168851 10080 Acy1 aminoacylase 1 gene CHEBI:920 2,4-dinitrotoluene affects expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of ACY1 mRNA PMID:21346803 10080 Acy1 aminoacylase 1 gene CHEBI:9288 streptozocin decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D013311 Streptozocin results in decreased expression of ACY1 protein PMID:19634143 10080 Acy1 aminoacylase 1 gene CHEBI:9288 streptozocin multiple interactions ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D013311 Trientine inhibits the reaction [Streptozocin results in decreased expression of ACY1 protein] PMID:19634143 10080 Acy1 aminoacylase 1 gene CHEBI:9352 sulindac increases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:D013467 Sulindac results in increased expression of ACY1 mRNA PMID:24136188 10080 Acy1 aminoacylase 1 gene CHEBI:957 2,6-dinitrotoluene affects expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of ACY1 mRNA PMID:21346803 10080 Acy1 aminoacylase 1 gene CHEBI:9763 trovafloxacin decreases expression ISO RGD:2030 E RGD:6480464 20180320 CTD MESH:C080163 trovafloxacin results in decreased expression of ACY1 mRNA PMID:24136188 10081 Ada adenosine deaminase gene CHEBI:10110 zidovudine increases expression ISO RGD:736149 E RGD:6480464 20120412 CTD MESH:D015215 Zidovudine results in increased expression of ADA protein PMID:2261134 10081 Ada adenosine deaminase gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:736149 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of ADA mRNA PMID:38218311 10081 Ada adenosine deaminase gene CHEBI:113532 thymoquinone multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C003466 thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased activity of ADA protein] PMID:36193556 10081 Ada adenosine deaminase gene CHEBI:116509 diuron decreases expression ISO RGD:736149 E RGD:6480464 20230905 CTD MESH:D004237 Diuron results in decreased expression of ADA mRNA PMID:35967413 10081 Ada adenosine deaminase gene CHEBI:132082 entinostat increases expression ISO RGD:736149 E RGD:6480464 20161228 CTD MESH:C118739 entinostat results in increased expression of ADA mRNA PMID:27188386 10081 Ada adenosine deaminase gene CHEBI:132448 perfluorohexanesulfonic acid decreases expression ISO RGD:736149 E RGD:6480464 20211207 CTD MESH:C471071 perfluorohexanesulfonic acid results in decreased expression of ADA mRNA PMID:25812627 10081 Ada adenosine deaminase gene CHEBI:135014 erdosteine multiple interactions ISO RGD:2031 E RGD:6480464 20170307 CTD MESH:C048498 erdosteine inhibits the reaction [Doxorubicin results in increased activity of ADA protein] PMID:12965118 10081 Ada adenosine deaminase gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:736149 E RGD:6480464 20121218 CTD MESH:D014212 Tretinoin results in increased expression of ADA mRNA PMID:15498508|PMID:15894607|PMID:33167477 10081 Ada adenosine deaminase gene CHEBI:15379 dioxygen multiple interactions EXP E RGD:6480464 20190312 CTD MESH:D010100 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ADA mRNA PMID:30529165 10081 Ada adenosine deaminase gene CHEBI:15930 atrazine increases expression ISO RGD:736149 E RGD:6480464 20141014 CTD MESH:D001280 Atrazine results in increased expression of ADA mRNA PMID:22378314 10081 Ada adenosine deaminase gene CHEBI:16136 hydrogen sulfide increases expression EXP E RGD:6480464 20200519 CTD MESH:D006862 Hydrogen Sulfide results in increased expression of ADA mRNA PMID:31843631 10081 Ada adenosine deaminase gene CHEBI:16243 quercetin decreases activity EXP E RGD:6480464 20161213 CTD MESH:D011794 Quercetin results in decreased activity of ADA protein PMID:7853360 10081 Ada adenosine deaminase gene CHEBI:16243 quercetin decreases activity ISO RGD:2031 E RGD:6480464 20161213 CTD MESH:D011794 Quercetin results in decreased activity of ADA protein PMID:25064450 10081 Ada adenosine deaminase gene CHEBI:16243 quercetin increases expression ISO RGD:736149 E RGD:6480464 20121009 CTD MESH:D011794 Quercetin results in increased expression of ADA mRNA PMID:21632981 10081 Ada adenosine deaminase gene CHEBI:16243 quercetin multiple interactions EXP E RGD:6480464 20161213 CTD MESH:D011794 [Quercetin co-treated with Tetrachlorodibenzodioxin] results in decreased activity of ADA protein; Quercetin inhibits the reaction [Benzo(a)pyrene results in increased activity of ADA protein]; Tetrachlorodibenzodioxin inhibits the reaction [Quercetin results in decreased activity of ADA protein] PMID:18057710|PMID:7853360 10081 Ada adenosine deaminase gene CHEBI:16243 quercetin multiple interactions ISO RGD:2031 E RGD:6480464 20161213 CTD MESH:D011794 Quercetin inhibits the reaction [Cadmium Chloride results in increased activity of ADA protein] PMID:25064450 10081 Ada adenosine deaminase gene CHEBI:16335 adenosine decreases metabolic processing ISO RGD:736149 E RGD:6480464 20120412 CTD MESH:D000241 ADA alternative form results in decreased metabolism of Adenosine PMID:16221767 10081 Ada adenosine deaminase gene CHEBI:16335 adenosine increases metabolic processing ISO RGD:736149 E RGD:6480464 20120412 CTD MESH:D000241 ADA protein results in increased metabolism of Adenosine PMID:16221767 10081 Ada adenosine deaminase gene CHEBI:16412 lipopolysaccharide increases expression ISO RGD:736149 E RGD:6480464 20221101 CTD MESH:D008070 Lipopolysaccharides results in increased expression of ADA mRNA PMID:35811015 10081 Ada adenosine deaminase gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:736149 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ADA mRNA PMID:35811015 10081 Ada adenosine deaminase gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:2031 E RGD:6480464 20230606 CTD MESH:D004958 Estradiol results in decreased expression of ADA mRNA PMID:32145629 10081 Ada adenosine deaminase gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:736149 E RGD:6480464 20130723 CTD MESH:D004958 [Estradiol co-treated with Progesterone] results in increased expression of ADA mRNA PMID:20660070 10081 Ada adenosine deaminase gene CHEBI:16482 naphthalene increases expression EXP E RGD:6480464 20121009 CTD MESH:C031721 naphthalene results in increased expression of ADA mRNA PMID:18978301 10081 Ada adenosine deaminase gene CHEBI:16494 lipoic acid multiple interactions ISO RGD:2031 E RGD:6480464 20201006 CTD MESH:D008063 [Thioctic Acid co-treated with Valproic Acid] results in decreased activity of ADA protein PMID:32662911 10081 Ada adenosine deaminase gene CHEBI:16598 DDE increases expression ISO RGD:736149 E RGD:6480464 20240702 CTD MESH:D003633 Dichlorodiphenyl Dichloroethylene results in increased expression of ADA mRNA PMID:38568856 10081 Ada adenosine deaminase gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:736149 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of ADA mRNA PMID:37042841 10081 Ada adenosine deaminase gene CHEBI:16716 benzene decreases activity ISO RGD:2031 E RGD:6480464 20130611 CTD MESH:D001554 Benzene results in decreased activity of ADA protein PMID:17562280 10081 Ada adenosine deaminase gene CHEBI:17026 progesterone multiple interactions ISO RGD:736149 E RGD:6480464 20130723 CTD MESH:D011374 [Estradiol co-treated with Progesterone] results in increased expression of ADA mRNA PMID:20660070 10081 Ada adenosine deaminase gene CHEBI:17059 2-methylcholine affects expression ISO RGD:736149 E RGD:6480464 20121113 CTD MESH:C044887 beta-methylcholine affects the expression of ADA mRNA PMID:21179406 10081 Ada adenosine deaminase gene CHEBI:175936 8-Epidiosbulbin E acetate increases expression EXP E RGD:6480464 20210706 CTD MESH:C534602 8-epidiosbulbin E acetate results in increased expression of ADA mRNA PMID:31626840 10081 Ada adenosine deaminase gene CHEBI:17596 inosine decreases abundance ISO RGD:736149 E RGD:6480464 20120412 CTD MESH:D007288 ADA alternative form results in decreased abundance of Inosine PMID:16221767 10081 Ada adenosine deaminase gene CHEBI:17596 inosine increases abundance ISO RGD:736149 E RGD:6480464 20120412 CTD MESH:D007288 ADA protein results in increased abundance of Inosine PMID:16221767 10081 Ada adenosine deaminase gene CHEBI:17688 (S)-nicotine increases activity ISO RGD:2031 E RGD:6480464 20200331 CTD MESH:D009538 Nicotine results in increased activity of ADA protein PMID:31857090 10081 Ada adenosine deaminase gene CHEBI:17688 (S)-nicotine multiple interactions ISO RGD:2031 E RGD:6480464 20200331 CTD MESH:D009538 Sodium Acetate inhibits the reaction [Nicotine results in increased activity of ADA protein] PMID:31857090 10081 Ada adenosine deaminase gene CHEBI:17754 glycerol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D005990 [ADA protein co-treated with Norepinephrine] results in increased secretion of Glycerol PMID:17428236 10081 Ada adenosine deaminase gene CHEBI:177802 Cuprizon increases expression ISO RGD:2031 E RGD:6480464 20210907 CTD MESH:D003471 Cuprizone results in increased expression of ADA mRNA PMID:26577399 10081 Ada adenosine deaminase gene CHEBI:18050 L-glutamine multiple interactions ISO RGD:2031 E RGD:6480464 20191210 CTD MESH:D005973 Glutamine inhibits the reaction [Fructose results in increased activity of ADA protein] PMID:31233715 10081 Ada adenosine deaminase gene CHEBI:18357 (R)-noradrenaline decreases response to substance ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:D009638 ADA protein results in decreased susceptibility to Norepinephrine PMID:7949234 10081 Ada adenosine deaminase gene CHEBI:18357 (R)-noradrenaline multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D009638 [ADA protein co-treated with Norepinephrine] results in increased secretion of Glycerol PMID:17428236 10081 Ada adenosine deaminase gene CHEBI:18357 (R)-noradrenaline multiple interactions ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:D009638 Propranolol promotes the reaction [ADA protein results in decreased susceptibility to Norepinephrine] PMID:7949234 10081 Ada adenosine deaminase gene CHEBI:18421 superoxide multiple interactions ISO RGD:736149 E RGD:6480464 20120412 CTD MESH:D013481 ADA protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Superoxides] PMID:10947063 10081 Ada adenosine deaminase gene CHEBI:18723 nicotine increases activity ISO RGD:2031 E RGD:6480464 20200331 CTD MESH:D009538 Nicotine results in increased activity of ADA protein PMID:31857090 10081 Ada adenosine deaminase gene CHEBI:18723 nicotine multiple interactions ISO RGD:2031 E RGD:6480464 20200331 CTD MESH:D009538 Sodium Acetate inhibits the reaction [Nicotine results in increased activity of ADA protein] PMID:31857090 10081 Ada adenosine deaminase gene CHEBI:23994 ethyl methanesulfonate increases expression ISO RGD:736149 E RGD:6480464 20140708 CTD MESH:D005020 Ethyl Methanesulfonate results in increased expression of ADA mRNA PMID:23649840 10081 Ada adenosine deaminase gene CHEBI:27086 tributylstannane increases expression EXP E RGD:6480464 20200804 CTD MESH:C011559 tributyltin results in increased expression of ADA mRNA PMID:31939706 10081 Ada adenosine deaminase gene CHEBI:27363 zinc atom multiple interactions ISO RGD:2031 E RGD:6480464 20210406 CTD MESH:D015032 [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Streptozocin results in increased activity of ADA protein] PMID:32864810 10081 Ada adenosine deaminase gene CHEBI:27385 tetrachloromethane increases activity ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:D002251 Carbon Tetrachloride results in increased activity of ADA protein PMID:19900420 10081 Ada adenosine deaminase gene CHEBI:27385 tetrachloromethane increases expression EXP E RGD:6480464 20200804 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of ADA mRNA PMID:31919559 10081 Ada adenosine deaminase gene CHEBI:27470 folic acid increases expression EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid deficiency results in increased expression of ADA protein PMID:25384423 10081 Ada adenosine deaminase gene CHEBI:27684 phenylmercury acetate decreases expression ISO RGD:736149 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in decreased expression of ADA mRNA PMID:26272509 10081 Ada adenosine deaminase gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:736149 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA PMID:27188386 10081 Ada adenosine deaminase gene CHEBI:27732 caffeine increases activity ISO RGD:2031 E RGD:6480464 20240430 CTD MESH:D002110 Caffeine results in increased activity of ADA protein PMID:37865952 10081 Ada adenosine deaminase gene CHEBI:27732 caffeine increases expression ISO RGD:2031 E RGD:6480464 20161025 CTD MESH:D002110 Caffeine results in increased expression of ADA protein PMID:6149265 10081 Ada adenosine deaminase gene CHEBI:27732 caffeine multiple interactions ISO RGD:2031 E RGD:6480464 20240430 CTD MESH:D002110 [potassium bromate co-treated with Caffeine] results in increased activity of ADA protein; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of ADA protein]; naringin inhibits the reaction [Caffeine results in increased activity of ADA protein] PMID:37865952 10081 Ada adenosine deaminase gene CHEBI:27856 acetamide increases expression ISO RGD:2031 E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of ADA mRNA PMID:31881176 10081 Ada adenosine deaminase gene CHEBI:27881 resveratrol multiple interactions ISO RGD:736149 E RGD:6480464 20220510 CTD MESH:C059514 [Plant Extracts co-treated with Resveratrol] results in increased expression of ADA mRNA PMID:23557933 10081 Ada adenosine deaminase gene CHEBI:27899 cisplatin affects expression ISO RGD:736149 E RGD:6480464 20140513 CTD MESH:D002945 Cisplatin affects the expression of ADA mRNA PMID:23300844 10081 Ada adenosine deaminase gene CHEBI:27899 cisplatin increases expression ISO RGD:736149 E RGD:6480464 20170516 CTD MESH:D002945 Cisplatin results in increased expression of ADA mRNA PMID:27392435 10081 Ada adenosine deaminase gene CHEBI:27899 cisplatin multiple interactions ISO RGD:736149 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in increased expression of ADA mRNA PMID:27392435 10081 Ada adenosine deaminase gene CHEBI:28088 genistein decreases activity EXP E RGD:6480464 20161213 CTD MESH:D019833 Genistein results in decreased activity of ADA protein PMID:7853360 10081 Ada adenosine deaminase gene CHEBI:28088 genistein multiple interactions EXP E RGD:6480464 20161213 CTD MESH:D019833 Tetrachlorodibenzodioxin inhibits the reaction [Genistein results in decreased activity of ADA protein] PMID:7853360 10081 Ada adenosine deaminase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ADA mRNA PMID:21570461 10081 Ada adenosine deaminase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2031 E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ADA mRNA PMID:34747641 10081 Ada adenosine deaminase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases activity EXP E RGD:6480464 20161213 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased activity of ADA protein PMID:7853360 10081 Ada adenosine deaminase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736149 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ADA mRNA PMID:19901195 10081 Ada adenosine deaminase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ADA mRNA PMID:19933214 10081 Ada adenosine deaminase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2031 E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ADA mRNA PMID:33387578 10081 Ada adenosine deaminase gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Quercetin co-treated with Tetrachlorodibenzodioxin] results in decreased activity of ADA protein; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADA mRNA; [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of ADA mRNA; Tetrachlorodibenzodioxin inhibits the reaction [Genistein results in decreased activity of ADA protein]; Tetrachlorodibenzodioxin inhibits the reaction [Neomycin results in decreased activity of ADA protein]; Tetrachlorodibenzodioxin inhibits the reaction [Quercetin results in decreased activity of ADA protein] PMID:17942748|PMID:25975270|PMID:7853360 10081 Ada adenosine deaminase gene CHEBI:28201 rotenone increases expression ISO RGD:736149 E RGD:6480464 20181016 CTD MESH:D012402 Rotenone results in increased expression of ADA mRNA PMID:29955902 10081 Ada adenosine deaminase gene CHEBI:28358 rac-lactic acid increases expression ISO RGD:736149 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of ADA mRNA PMID:30851411 10081 Ada adenosine deaminase gene CHEBI:28619 acrylamide decreases expression ISO RGD:736149 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of ADA mRNA PMID:32763439 10081 Ada adenosine deaminase gene CHEBI:28694 copper atom decreases expression ISO RGD:2031 E RGD:6480464 20190409 CTD MESH:D003300 Copper results in decreased expression of ADA mRNA PMID:30556269 10081 Ada adenosine deaminase gene CHEBI:28748 doxorubicin decreases expression ISO RGD:736149 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of ADA mRNA PMID:29803840 10081 Ada adenosine deaminase gene CHEBI:28748 doxorubicin increases activity ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:D004317 Doxorubicin results in increased activity of ADA protein PMID:12965118 10081 Ada adenosine deaminase gene CHEBI:28748 doxorubicin multiple interactions ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:D004317 erdosteine inhibits the reaction [Doxorubicin results in increased activity of ADA protein] PMID:12965118 10081 Ada adenosine deaminase gene CHEBI:28757 fructose increases activity ISO RGD:2031 E RGD:6480464 20191210 CTD MESH:D005632 Fructose results in increased activity of ADA protein PMID:31233715 10081 Ada adenosine deaminase gene CHEBI:28757 fructose multiple interactions ISO RGD:2031 E RGD:6480464 20191210 CTD MESH:D005632 Glutamine inhibits the reaction [Fructose results in increased activity of ADA protein] PMID:31233715 10081 Ada adenosine deaminase gene CHEBI:28819 naringin multiple interactions ISO RGD:2031 E RGD:6480464 20201006 CTD MESH:C005274 naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ADA protein]; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of ADA protein]; naringin inhibits the reaction [bisphenol A results in increased activity of ADA protein]; naringin inhibits the reaction [Caffeine results in increased activity of ADA protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of ADA protein]; naringin inhibits the reaction [potassium bromate results in increased activity of ADA protein] PMID:32172062|PMID:32428650|PMID:32810514|PMID:37865952 10081 Ada adenosine deaminase gene CHEBI:28940 calciol decreases expression EXP E RGD:6480464 20120412 CTD MESH:D002762 Cholecalciferol results in decreased expression of ADA mRNA PMID:16508948 10081 Ada adenosine deaminase gene CHEBI:29678 sodium arsenite affects expression ISO RGD:736149 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite affects the expression of ADA mRNA PMID:20816728 10081 Ada adenosine deaminase gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:736149 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of ADA mRNA PMID:38568856 10081 Ada adenosine deaminase gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20120613 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ADA mRNA PMID:21569818 10081 Ada adenosine deaminase gene CHEBI:29865 benzo[a]pyrene increases activity EXP E RGD:6480464 20161213 CTD MESH:D001564 Benzo(a)pyrene results in increased activity of ADA protein PMID:18057710|PMID:36193556 10081 Ada adenosine deaminase gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:736149 E RGD:6480464 20121009 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ADA mRNA PMID:20106945|PMID:21632981|PMID:22316170 10081 Ada adenosine deaminase gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20161213 CTD MESH:D001564 Quercetin inhibits the reaction [Benzo(a)pyrene results in increased activity of ADA protein]; thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased activity of ADA protein] PMID:18057710|PMID:36193556 10081 Ada adenosine deaminase gene CHEBI:30052 copper(0) decreases expression ISO RGD:2031 E RGD:6480464 20190409 CTD MESH:D003300 Copper results in decreased expression of ADA mRNA PMID:30556269 10081 Ada adenosine deaminase gene CHEBI:30185 zinc(0) multiple interactions ISO RGD:2031 E RGD:6480464 20210406 CTD MESH:D015032 [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Streptozocin results in increased activity of ADA protein] PMID:32864810 10081 Ada adenosine deaminase gene CHEBI:3020 benzalkonium chloride increases expression EXP E RGD:6480464 20190219 CTD MESH:D001548 Benzalkonium Compounds results in increased expression of ADA mRNA PMID:30171875 10081 Ada adenosine deaminase gene CHEBI:30314 (R)-lipoic acid multiple interactions ISO RGD:2031 E RGD:6480464 20201006 CTD MESH:D008063 [Thioctic Acid co-treated with Valproic Acid] results in decreased activity of ADA protein PMID:32662911 10081 Ada adenosine deaminase gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ADA mRNA PMID:16483693 10081 Ada adenosine deaminase gene CHEBI:31638 fulvestrant decreases methylation ISO RGD:736149 E RGD:6480464 20220308 CTD MESH:C070081 Fulvestrant results in decreased methylation of ADA gene PMID:31601247 10081 Ada adenosine deaminase gene CHEBI:31941 oxaliplatin decreases expression ISO RGD:736149 E RGD:6480464 20161213 CTD MESH:C030110 oxaliplatin results in decreased expression of ADA mRNA PMID:17762391 10081 Ada adenosine deaminase gene CHEBI:31941 oxaliplatin increases expression ISO RGD:2031 E RGD:6480464 20161213 CTD MESH:C030110 oxaliplatin results in increased expression of ADA mRNA PMID:25729387 10081 Ada adenosine deaminase gene CHEBI:31941 oxaliplatin multiple interactions ISO RGD:2031 E RGD:6480464 20161213 CTD MESH:C030110 [oxaliplatin co-treated with Topotecan] results in increased expression of ADA mRNA PMID:25729387 10081 Ada adenosine deaminase gene CHEBI:32138 sodium acetate trihydrate multiple interactions ISO RGD:2031 E RGD:6480464 20200331 CTD MESH:D019346 Sodium Acetate inhibits the reaction [Nicotine results in increased activity of ADA protein] PMID:31857090 10081 Ada adenosine deaminase gene CHEBI:32161 sulfadimethoxine increases expression ISO RGD:2031 E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in increased expression of ADA mRNA PMID:30047161 10081 Ada adenosine deaminase gene CHEBI:32181 tamibarotene increases expression ISO RGD:736149 E RGD:6480464 20120515 CTD MESH:C061133 tamibarotene results in increased expression of ADA mRNA PMID:15498508 10081 Ada adenosine deaminase gene CHEBI:32234 titanium dioxide decreases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ADA gene PMID:35295148 10081 Ada adenosine deaminase gene CHEBI:32497 thioacetamide increases expression ISO RGD:2031 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in increased expression of ADA mRNA PMID:34492290 10081 Ada adenosine deaminase gene CHEBI:32506 4,4'-diaminodiphenylmethane decreases expression ISO RGD:2031 E RGD:6480464 20160315 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in decreased expression of ADA mRNA PMID:25380136 10081 Ada adenosine deaminase gene CHEBI:32509 pirinixic acid decreases expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in decreased expression of ADA mRNA PMID:17426115 10081 Ada adenosine deaminase gene CHEBI:33070 indole-3-butyric acid decreases activity ISO RGD:2031 E RGD:6480464 20121113 CTD MESH:C014612 indolebutyric acid results in decreased activity of ADA protein PMID:19442822 10081 Ada adenosine deaminase gene CHEBI:33216 bisphenol A affects expression ISO RGD:2031 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of ADA mRNA PMID:25181051 10081 Ada adenosine deaminase gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2031 E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in decreased expression of ADA mRNA PMID:30816183|PMID:32528016|PMID:34947998 10081 Ada adenosine deaminase gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:736149 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of ADA gene PMID:31601247 10081 Ada adenosine deaminase gene CHEBI:33216 bisphenol A increases activity ISO RGD:2031 E RGD:6480464 20201006 CTD MESH:C006780 bisphenol A results in increased activity of ADA protein PMID:32172062|PMID:32428650|PMID:32810514 10081 Ada adenosine deaminase gene CHEBI:33216 bisphenol A increases expression ISO RGD:2031 E RGD:6480464 20230606 CTD MESH:C006780 bisphenol A results in increased expression of ADA mRNA PMID:32145629 10081 Ada adenosine deaminase gene CHEBI:33216 bisphenol A increases methylation EXP E RGD:6480464 20180116 CTD MESH:C006780 bisphenol A results in increased methylation of ADA promoter PMID:27312807 10081 Ada adenosine deaminase gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:2031 E RGD:6480464 20201006 CTD MESH:C006780 [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ADA protein; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ADA protein]; naringin inhibits the reaction [bisphenol A results in increased activity of ADA protein] PMID:32172062|PMID:32428650|PMID:32810514 10081 Ada adenosine deaminase gene CHEBI:34372 4,4'-sulfonyldiphenol increases expression ISO RGD:736149 E RGD:6480464 20230307 CTD MESH:C543008 bisphenol S results in increased expression of ADA protein PMID:34186270 10081 Ada adenosine deaminase gene CHEBI:34565 benzo[b]fluoranthene increases expression EXP E RGD:6480464 20160119 CTD MESH:C006703 benzo(b)fluoranthene results in increased expression of ADA mRNA PMID:26377693 10081 Ada adenosine deaminase gene CHEBI:34575 bisphenol F multiple interactions ISO RGD:736149 E RGD:6480464 20180116 CTD MESH:C008745 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADA mRNA PMID:28628672 10081 Ada adenosine deaminase gene CHEBI:34674 dextran sulfate increases expression EXP E RGD:6480464 20200609 CTD MESH:D016264 Dextran Sulfate results in increased expression of ADA protein PMID:32272095 10081 Ada adenosine deaminase gene CHEBI:34674 dextran sulfate multiple interactions EXP E RGD:6480464 20200609 CTD MESH:D016264 Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ADA protein] PMID:32272095 10081 Ada adenosine deaminase gene CHEBI:34687 dibutyl phthalate decreases expression EXP E RGD:6480464 20121113 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ADA mRNA PMID:17361019|PMID:21266533 10081 Ada adenosine deaminase gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ADA mRNA PMID:21266533 10081 Ada adenosine deaminase gene CHEBI:34687 dibutyl phthalate increases expression ISO RGD:2031 E RGD:6480464 20150127 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of ADA mRNA PMID:24893172 10081 Ada adenosine deaminase gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736149 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADA mRNA PMID:28628672 10081 Ada adenosine deaminase gene CHEBI:34905 paraquat increases expression EXP E RGD:6480464 20210209 CTD MESH:D010269 Paraquat results in increased expression of ADA mRNA PMID:21463325 10081 Ada adenosine deaminase gene CHEBI:35038 tris(2-butoxyethyl) phosphate affects expression ISO RGD:736149 E RGD:6480464 20180515 CTD MESH:C013320 tris(2-butoxyethyl) phosphate affects the expression of ADA mRNA PMID:29024780 10081 Ada adenosine deaminase gene CHEBI:35064 alpha-Zearalanol multiple interactions ISO RGD:2031 E RGD:6480464 20240430 CTD MESH:D015029 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADA mRNA PMID:35163327 10081 Ada adenosine deaminase gene CHEBI:35176 zinc sulfate multiple interactions ISO RGD:2031 E RGD:6480464 20210406 CTD MESH:D019287 [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Streptozocin results in increased activity of ADA protein] PMID:32864810 10081 Ada adenosine deaminase gene CHEBI:35455 1-naphthyl isothiocyanate decreases expression ISO RGD:2031 E RGD:6480464 20160315 CTD MESH:D015058 1-Naphthylisothiocyanate results in decreased expression of ADA mRNA PMID:25380136 10081 Ada adenosine deaminase gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:736149 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in decreased expression of ADA mRNA PMID:38568856 10081 Ada adenosine deaminase gene CHEBI:35456 cadmium dichloride increases activity ISO RGD:2031 E RGD:6480464 20161213 CTD MESH:D019256 Cadmium Chloride results in increased activity of ADA protein PMID:25064450 10081 Ada adenosine deaminase gene CHEBI:35456 cadmium dichloride increases methylation ISO RGD:2031 E RGD:6480464 20120717 CTD MESH:D019256 Cadmium Chloride results in increased methylation of ADA promoter PMID:22457795 10081 Ada adenosine deaminase gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:2031 E RGD:6480464 20161213 CTD MESH:D019256 Quercetin inhibits the reaction [Cadmium Chloride results in increased activity of ADA protein] PMID:25064450 10081 Ada adenosine deaminase gene CHEBI:35549 perfluorooctanoic acid decreases expression ISO RGD:736149 E RGD:6480464 20211207 CTD MESH:C023036 perfluorooctanoic acid results in decreased expression of ADA mRNA PMID:25812627 10081 Ada adenosine deaminase gene CHEBI:35549 perfluorooctanoic acid multiple interactions ISO RGD:2031 E RGD:6480464 20240430 CTD MESH:C023036 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADA mRNA PMID:35163327 10081 Ada adenosine deaminase gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:736149 E RGD:6480464 20120814 CTD MESH:C018021 cobaltous chloride results in decreased expression of ADA mRNA PMID:19320972 10081 Ada adenosine deaminase gene CHEBI:35696 cobalt dichloride increases expression ISO RGD:2031 E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in increased expression of ADA mRNA PMID:24386269 10081 Ada adenosine deaminase gene CHEBI:35696 cobalt dichloride increases expression ISO RGD:736149 E RGD:6480464 20151215 CTD MESH:C018021 cobaltous chloride results in increased expression of ADA mRNA PMID:19376846 10081 Ada adenosine deaminase gene CHEBI:35807 N-nitrosodimethylamine decreases expression ISO RGD:2031 E RGD:6480464 20160315 CTD MESH:D004128 Dimethylnitrosamine results in decreased expression of ADA mRNA PMID:25380136 10081 Ada adenosine deaminase gene CHEBI:38211 potassium bromate increases activity ISO RGD:2031 E RGD:6480464 20240430 CTD MESH:C019536 potassium bromate results in increased activity of ADA protein PMID:37865952 10081 Ada adenosine deaminase gene CHEBI:38211 potassium bromate multiple interactions ISO RGD:2031 E RGD:6480464 20240430 CTD MESH:C019536 [potassium bromate co-treated with Caffeine] results in increased activity of ADA protein; Haloperidol inhibits the reaction [potassium bromate results in increased activity of ADA protein]; naringin inhibits the reaction [[potassium bromate co-treated with Caffeine] results in increased activity of ADA protein]; naringin inhibits the reaction [potassium bromate results in increased activity of ADA protein] PMID:37865952 10081 Ada adenosine deaminase gene CHEBI:38397 perfluorononanoic acid decreases expression ISO RGD:736149 E RGD:6480464 20220111 CTD MESH:C101816 perfluoro-n-nonanoic acid results in decreased expression of ADA mRNA PMID:25812627 10081 Ada adenosine deaminase gene CHEBI:3892 corticotropin increases activity ISO RGD:736149 E RGD:6480464 20120412 CTD MESH:D000324 Adrenocorticotropic Hormone results in increased activity of ADA protein PMID:8868375 10081 Ada adenosine deaminase gene CHEBI:38940 sunitinib decreases expression ISO RGD:736149 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in decreased expression of ADA mRNA PMID:31533062 10081 Ada adenosine deaminase gene CHEBI:39421 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:736149 E RGD:6480464 20211207 CTD MESH:C076994 perfluorooctane sulfonic acid results in decreased expression of ADA mRNA PMID:25812627 10081 Ada adenosine deaminase gene CHEBI:39481 chloroprene decreases expression ISO RGD:2031 E RGD:6480464 20130514 CTD MESH:D002737 Chloroprene results in decreased expression of ADA mRNA PMID:23125180 10081 Ada adenosine deaminase gene CHEBI:39867 valproic acid affects expression ISO RGD:736149 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ADA mRNA PMID:25979313 10081 Ada adenosine deaminase gene CHEBI:39867 valproic acid decreases expression ISO RGD:736149 E RGD:6480464 20160119 CTD MESH:D014635 Valproic Acid results in decreased expression of ADA mRNA PMID:23179753|PMID:26272509|PMID:28001369 10081 Ada adenosine deaminase gene CHEBI:39867 valproic acid increases activity ISO RGD:2031 E RGD:6480464 20220308 CTD MESH:D014635 Valproic Acid results in increased activity of ADA protein PMID:34309959 10081 Ada adenosine deaminase gene CHEBI:39867 valproic acid increases expression ISO RGD:2031 E RGD:6480464 20180828 CTD MESH:D014635 Valproic Acid results in increased expression of ADA mRNA PMID:29427782 10081 Ada adenosine deaminase gene CHEBI:39867 valproic acid multiple interactions ISO RGD:2031 E RGD:6480464 20201006 CTD MESH:D014635 [Thioctic Acid co-treated with Valproic Acid] results in decreased activity of ADA protein; Vitamin B 6 inhibits the reaction [Valproic Acid results in increased activity of ADA protein] PMID:32662911|PMID:34309959 10081 Ada adenosine deaminase gene CHEBI:39867 valproic acid multiple interactions ISO RGD:736149 E RGD:6480464 20161025 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA PMID:27188386 10081 Ada adenosine deaminase gene CHEBI:40036 amitrole increases expression ISO RGD:2031 E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in increased expression of ADA mRNA PMID:30047161 10081 Ada adenosine deaminase gene CHEBI:4031 cyclosporin A increases expression ISO RGD:736149 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in increased expression of ADA mRNA PMID:25562108 10081 Ada adenosine deaminase gene CHEBI:41774 tamoxifen affects expression EXP E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen affects the expression of ADA mRNA PMID:17555576 10081 Ada adenosine deaminase gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:736149 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADA mRNA PMID:28628672 10081 Ada adenosine deaminase gene CHEBI:42588 4-hydroxyphenyl retinamide increases expression EXP E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in increased expression of ADA mRNA PMID:28973697 10081 Ada adenosine deaminase gene CHEBI:44185 methotrexate increases activity ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:D008727 Methotrexate results in increased activity of ADA protein PMID:16325979 10081 Ada adenosine deaminase gene CHEBI:44185 methotrexate multiple interactions ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:D008727 caffeic acid phenethyl ester inhibits the reaction [Methotrexate results in increased activity of ADA protein] PMID:16325979 10081 Ada adenosine deaminase gene CHEBI:44616 afimoxifene decreases expression ISO RGD:736149 E RGD:6480464 20120412 CTD MESH:C016601 afimoxifene results in decreased expression of ADA mRNA PMID:19901195 10081 Ada adenosine deaminase gene CHEBI:45716 vorinostat decreases expression ISO RGD:736149 E RGD:6480464 20161213 CTD MESH:C111237 vorinostat results in decreased expression of ADA protein PMID:20543569 10081 Ada adenosine deaminase gene CHEBI:46024 trichostatin A decreases expression ISO RGD:736149 E RGD:6480464 20160119 CTD MESH:C012589 trichostatin A results in decreased expression of ADA mRNA PMID:26272509 10081 Ada adenosine deaminase gene CHEBI:46024 trichostatin A multiple interactions ISO RGD:736149 E RGD:6480464 20161025 CTD MESH:C012589 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA PMID:27188386 10081 Ada adenosine deaminase gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of ADA mRNA PMID:17562736 10081 Ada adenosine deaminase gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20120515 CTD MESH:D000082 Acetaminophen results in decreased expression of ADA mRNA PMID:17585979 10081 Ada adenosine deaminase gene CHEBI:46195 paracetamol decreases expression ISO RGD:736149 E RGD:6480464 20180515 CTD MESH:D000082 Acetaminophen results in decreased expression of ADA mRNA PMID:29067470 10081 Ada adenosine deaminase gene CHEBI:46195 paracetamol increases expression ISO RGD:2031 E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in increased expression of ADA mRNA PMID:33387578 10081 Ada adenosine deaminase gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:736149 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of ADA mRNA PMID:35811015 10081 Ada adenosine deaminase gene CHEBI:47807 sulforaphane decreases expression ISO RGD:736149 E RGD:6480464 20200609 CTD MESH:C016766 sulforaphane results in decreased expression of ADA mRNA PMID:31838189 10081 Ada adenosine deaminase gene CHEBI:4791 endosulfan increases expression ISO RGD:2031 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in increased expression of ADA mRNA PMID:29391264 10081 Ada adenosine deaminase gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ADA mRNA PMID:17555576|PMID:17942748 10081 Ada adenosine deaminase gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ADA mRNA PMID:17557909 10081 Ada adenosine deaminase gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADA mRNA PMID:17942748 10081 Ada adenosine deaminase gene CHEBI:49553 copper(II) chloride decreases expression ISO RGD:736149 E RGD:6480464 20240702 CTD MESH:C029892 cupric chloride results in decreased expression of ADA mRNA PMID:38568856 10081 Ada adenosine deaminase gene CHEBI:49662 indometacin multiple interactions ISO RGD:736149 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADA mRNA PMID:28628672 10081 Ada adenosine deaminase gene CHEBI:50131 5-aza-2'-deoxycytidine affects expression ISO RGD:736149 E RGD:6480464 20191114 CTD MESH:C014347 Decitabine affects the expression of ADA mRNA PMID:23300844 10081 Ada adenosine deaminase gene CHEBI:50594 carbon nanotube increases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in increased expression of ADA mRNA; Nanotubes, Carbon results in increased expression of ADA mRNA PMID:25554681|PMID:25620056 10081 Ada adenosine deaminase gene CHEBI:5063 fipronil increases expression ISO RGD:2031 E RGD:6480464 20140408 CTD MESH:C082360 fipronil results in increased expression of ADA mRNA PMID:23962444 10081 Ada adenosine deaminase gene CHEBI:50673 methimazole increases expression ISO RGD:2031 E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in increased expression of ADA mRNA PMID:30047161 10081 Ada adenosine deaminase gene CHEBI:50845 doxycycline multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004318 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of ADA mRNA] PMID:18089841 10081 Ada adenosine deaminase gene CHEBI:5132 flutamide increases expression ISO RGD:2031 E RGD:6480464 20140909 CTD MESH:D005485 Flutamide results in increased expression of ADA mRNA PMID:24793618 10081 Ada adenosine deaminase gene CHEBI:51687 chrysene increases expression EXP E RGD:6480464 20160119 CTD MESH:C031180 chrysene results in increased expression of ADA mRNA PMID:26377693 10081 Ada adenosine deaminase gene CHEBI:53001 nickel sulfate increases expression ISO RGD:736149 E RGD:6480464 20160705 CTD MESH:C029938 nickel sulfate results in increased expression of ADA mRNA PMID:22714537 10081 Ada adenosine deaminase gene CHEBI:53050 trimellitic anhydride increases expression EXP E RGD:6480464 20120501 CTD MESH:C015559 trimellitic anhydride results in increased expression of ADA mRNA PMID:19042947 10081 Ada adenosine deaminase gene CHEBI:53070 2,4-dinitrobenzenesulfonic acid increases expression ISO RGD:2031 E RGD:6480464 20120501 CTD MESH:C001073 2,4-dinitrobenzenesulfonic acid results in increased expression of ADA mRNA PMID:20860664 10081 Ada adenosine deaminase gene CHEBI:53490 N-formyl-L-methionyl-L-leucyl-L-phenylalanine multiple interactions ISO RGD:736149 E RGD:6480464 20120412 CTD MESH:D009240 ADA protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Superoxides] PMID:10947063 10081 Ada adenosine deaminase gene CHEBI:5613 haloperidol multiple interactions ISO RGD:2031 E RGD:6480464 20240430 CTD MESH:D006220 Haloperidol inhibits the reaction [potassium bromate results in increased activity of ADA protein] PMID:37865952 10081 Ada adenosine deaminase gene CHEBI:61076 belinostat decreases expression ISO RGD:736149 E RGD:6480464 20170303 CTD MESH:C487081 belinostat results in decreased expression of ADA mRNA PMID:26272509|PMID:27188386 10081 Ada adenosine deaminase gene CHEBI:61076 belinostat multiple interactions ISO RGD:736149 E RGD:6480464 20170303 CTD MESH:C487081 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA PMID:27188386 10081 Ada adenosine deaminase gene CHEBI:62947 ammonium acetate increases activity ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:C018824 ammonium acetate results in increased activity of ADA protein PMID:19900420 10081 Ada adenosine deaminase gene CHEBI:63632 topotecan multiple interactions ISO RGD:2031 E RGD:6480464 20160315 CTD MESH:D019772 [oxaliplatin co-treated with Topotecan] results in increased expression of ADA mRNA PMID:25729387 10081 Ada adenosine deaminase gene CHEBI:64210 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO RGD:736149 E RGD:6480464 20120412 CTD MESH:C068073 Am 580 results in increased expression of ADA mRNA PMID:16982809 10081 Ada adenosine deaminase gene CHEBI:64317 isoprenaline increases expression EXP E RGD:6480464 20120613 CTD MESH:D007545 Isoproterenol results in increased expression of ADA mRNA PMID:18089841|PMID:20003209 10081 Ada adenosine deaminase gene CHEBI:64317 isoprenaline multiple interactions EXP E RGD:6480464 20120515 CTD MESH:D007545 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of ADA mRNA] PMID:18089841 10081 Ada adenosine deaminase gene CHEBI:72564 temozolomide decreases expression ISO RGD:736149 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in decreased expression of ADA mRNA PMID:31758290 10081 Ada adenosine deaminase gene CHEBI:73755 1,2-dimethylhydrazine increases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of ADA mRNA PMID:22206623 10081 Ada adenosine deaminase gene CHEBI:7507 neomycin decreases activity EXP E RGD:6480464 20161213 CTD MESH:D009355 Neomycin results in decreased activity of ADA protein PMID:7853360 10081 Ada adenosine deaminase gene CHEBI:7507 neomycin multiple interactions EXP E RGD:6480464 20161213 CTD MESH:D009355 Tetrachlorodibenzodioxin inhibits the reaction [Neomycin results in decreased activity of ADA protein] PMID:7853360 10081 Ada adenosine deaminase gene CHEBI:75249 potassium chromate decreases expression ISO RGD:736149 E RGD:6480464 20160705 CTD MESH:C027373 potassium chromate(VI) results in decreased expression of ADA mRNA PMID:22714537 10081 Ada adenosine deaminase gene CHEBI:7549 N(gamma)-nitro-L-arginine methyl ester increases activity ISO RGD:2031 E RGD:6480464 20201006 CTD MESH:D019331 NG-Nitroarginine Methyl Ester results in increased activity of ADA protein PMID:32172062|PMID:32428650|PMID:32810514 10081 Ada adenosine deaminase gene CHEBI:7549 N(gamma)-nitro-L-arginine methyl ester multiple interactions ISO RGD:2031 E RGD:6480464 20201006 CTD MESH:D019331 [NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ADA protein; naringin inhibits the reaction [[NG-Nitroarginine Methyl Ester co-treated with bisphenol A] results in increased activity of ADA protein]; naringin inhibits the reaction [NG-Nitroarginine Methyl Ester results in increased activity of ADA protein] PMID:32172062|PMID:32428650|PMID:32810514 10081 Ada adenosine deaminase gene CHEBI:78320 2-hydroxypropanoic acid increases expression ISO RGD:736149 E RGD:6480464 20190910 CTD MESH:D019344 Lactic Acid results in increased expression of ADA mRNA PMID:30851411 10081 Ada adenosine deaminase gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:736149 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA PMID:27188386 10081 Ada adenosine deaminase gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:736149 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to ADA gene] PMID:28238834 10081 Ada adenosine deaminase gene CHEBI:8062 phenethyl caffeate multiple interactions ISO RGD:2031 E RGD:6480464 20130903 CTD MESH:C055494 caffeic acid phenethyl ester inhibits the reaction [Methotrexate results in increased activity of ADA protein] PMID:16325979 10081 Ada adenosine deaminase gene CHEBI:80630 irinotecan affects expression ISO RGD:2031 E RGD:6480464 20181113 CTD MESH:D000077146 Irinotecan affects the expression of ADA mRNA PMID:20097248 10081 Ada adenosine deaminase gene CHEBI:8069 phenobarbital affects expression EXP E RGD:6480464 20130514 CTD MESH:D010634 Phenobarbital affects the expression of ADA mRNA PMID:23091169 10081 Ada adenosine deaminase gene CHEBI:8069 phenobarbital decreases expression EXP E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in decreased expression of ADA mRNA PMID:19482888 10081 Ada adenosine deaminase gene CHEBI:8069 phenobarbital multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D010634 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ADA mRNA] PMID:19482888 10081 Ada adenosine deaminase gene CHEBI:8489 propiconazole increases expression ISO RGD:2031 E RGD:6480464 20230606 CTD MESH:C045950 propiconazole results in increased expression of ADA mRNA PMID:30047161 10081 Ada adenosine deaminase gene CHEBI:8499 propranolol multiple interactions ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:D011433 Propranolol promotes the reaction [ADA protein results in decreased susceptibility to Norepinephrine] PMID:7949234 10081 Ada adenosine deaminase gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2031 E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of ADA mRNA PMID:24780913|PMID:30047161 10081 Ada adenosine deaminase gene CHEBI:85990 panobinostat decreases expression ISO RGD:736149 E RGD:6480464 20161228 CTD MESH:C496932 panobinostat results in decreased expression of ADA mRNA PMID:26272509 10081 Ada adenosine deaminase gene CHEBI:85990 panobinostat multiple interactions ISO RGD:736149 E RGD:6480464 20161228 CTD MESH:C496932 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA PMID:27188386 10081 Ada adenosine deaminase gene CHEBI:8922 Rutecarpine decreases expression ISO RGD:736149 E RGD:6480464 20250114 CTD MESH:C028632 rutecarpine results in decreased expression of ADA mRNA PMID:34955744 10081 Ada adenosine deaminase gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:736149 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA; [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA; [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADA mRNA PMID:27188386 10081 Ada adenosine deaminase gene CHEBI:920 2,4-dinitrotoluene affects expression ISO RGD:2031 E RGD:6480464 20120412 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of ADA mRNA PMID:21346803 10081 Ada adenosine deaminase gene CHEBI:9288 streptozocin increases activity ISO RGD:2031 E RGD:6480464 20210406 CTD MESH:D013311 Streptozocin results in increased activity of ADA protein PMID:32864810 10081 Ada adenosine deaminase gene CHEBI:9288 streptozocin multiple interactions ISO RGD:2031 E RGD:6480464 20210406 CTD MESH:D013311 [Zinc Sulfate results in increased abundance of Zinc] inhibits the reaction [Streptozocin results in increased activity of ADA protein] PMID:32864810 10081 Ada adenosine deaminase gene CHEBI:9747 Triptolide increases expression ISO RGD:2031 E RGD:6480464 20200915 CTD MESH:C001899 triptolide results in increased expression of ADA protein PMID:32519852 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:132098 methoxyacetic acid decreases expression ISO RGD:2033 E RGD:6480464 20160607 CTD MESH:C013598 methoxyacetic acid results in decreased expression of ADARB1 mRNA PMID:20864626 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:132267 triptonide decreases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in decreased expression of ADARB1 mRNA PMID:33045310 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:137392 chlormequat chloride decreases expression ISO RGD:2033 E RGD:6480464 20220705 CTD MESH:D002716 Chlormequat results in decreased expression of ADARB1 protein PMID:34958886 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:144441 triacsin C decreases expression ISO RGD:732582 E RGD:6480464 20190903 CTD MESH:C034613 triacsin C results in decreased expression of ADARB1 mRNA PMID:16704987 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:732582 E RGD:6480464 20120501 CTD MESH:D014212 Tretinoin results in increased expression of ADARB1 mRNA PMID:21934132 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:15843 arachidonic acid decreases expression ISO RGD:732582 E RGD:6480464 20161213 CTD MESH:D016718 Arachidonic Acid results in decreased expression of ADARB1 mRNA PMID:16704987 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:16164 pyrogallol decreases expression EXP E RGD:6480464 20121218 CTD MESH:D011748 Pyrogallol results in decreased expression of ADARB1 mRNA PMID:20362636 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:16236 ethanol affects splicing EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the splicing of ADARB1 mRNA PMID:30319688 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:17059 2-methylcholine affects expression ISO RGD:732582 E RGD:6480464 20121113 CTD MESH:C044887 beta-methylcholine affects the expression of ADARB1 mRNA PMID:21179406 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:177802 Cuprizon decreases expression ISO RGD:2033 E RGD:6480464 20210907 CTD MESH:D003471 Cuprizone results in decreased expression of ADARB1 mRNA PMID:26577399 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:178012 FR900359 increases phosphorylation ISO RGD:732582 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in increased phosphorylation of ADARB1 protein PMID:37730182 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:17833 gentamycin decreases expression ISO RGD:2033 E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in decreased expression of ADARB1 mRNA PMID:33387578 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:181914 Aflatoxin B2 alpha affects methylation ISO RGD:732582 E RGD:6480464 20211109 CTD MESH:C029753 aflatoxin B2 affects the methylation of ADARB1 intron PMID:30157460 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ADARB1 mRNA PMID:36331819 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:732582 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of ADARB1 mRNA PMID:19549813 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:2504 aflatoxin B1 decreases expression ISO RGD:732582 E RGD:6480464 20121009 CTD MESH:D016604 Aflatoxin B1 results in decreased expression of ADARB1 mRNA PMID:22100608 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:732582 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of ADARB1 intron PMID:30157460 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:2533 alachlor increases expression ISO RGD:2033 E RGD:6480464 20120412 CTD MESH:C000188 alachlor results in increased expression of ADARB1 mRNA PMID:12419858 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:25812 ozone multiple interactions EXP E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADARB1 mRNA PMID:34911549 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:27086 tributylstannane multiple interactions ISO RGD:2033 E RGD:6480464 20191112 CTD MESH:C011559 [bisphenol A co-treated with tributyltin] results in decreased expression of ADARB1 mRNA PMID:31129395 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:27385 tetrachloromethane increases expression EXP E RGD:6480464 20120412 CTD MESH:D002251 Carbon Tetrachloride results in increased expression of ADARB1 mRNA PMID:17484886 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005492 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADARB1 mRNA PMID:22206623 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:27732 caffeine decreases expression ISO RGD:2033 E RGD:6480464 20120412 CTD MESH:D002110 Caffeine results in decreased expression of ADARB1 mRNA PMID:20864626 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:27744 glyphosate increases methylation ISO RGD:2033 E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased methylation of ADARB1 gene PMID:31011160 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:28088 genistein increases expression ISO RGD:732582 E RGD:6480464 20140715 CTD MESH:D019833 Genistein results in increased expression of ADARB1 mRNA PMID:22228119 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20140909 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ADARB1 mRNA PMID:21570461|PMID:24680724 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2033 E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ADARB1 mRNA PMID:34747641 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP E RGD:6480464 20120814 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ADARB1 mRNA PMID:16962184|PMID:19933214 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2033 E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ADARB1 mRNA PMID:33387578 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2033 E RGD:6480464 20200609 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ADARB1 mRNA PMID:32109520 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADARB1 mRNA PMID:17942748 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:28216 methylmercury chloride decreases expression ISO RGD:2033 E RGD:6480464 20120412 CTD MESH:C004925 methylmercuric chloride results in decreased expression of ADARB1 mRNA PMID:20864626 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:732582 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of ADARB1 mRNA PMID:33212167 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:28694 copper atom multiple interactions ISO RGD:732582 E RGD:6480464 20150512 CTD MESH:D003300 [Disulfiram binds to Copper] which results in increased expression of ADARB1 mRNA PMID:24690739 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:28940 calciol increases expression EXP E RGD:6480464 20120412 CTD MESH:D002762 Cholecalciferol results in increased expression of ADARB1 mRNA PMID:16508948 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:29678 sodium arsenite increases expression ISO RGD:732582 E RGD:6480464 20161228 CTD MESH:C017947 sodium arsenite results in increased expression of ADARB1 mRNA PMID:22714537 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:732582 E RGD:6480464 20190219 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ADARB1 intron; Benzo(a)pyrene affects the methylation of ADARB1 promoter PMID:27901495|PMID:30157460 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:732582 E RGD:6480464 20120412 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ADARB1 mRNA PMID:20064835 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ADARB1 mRNA PMID:22228805 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:732582 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ADARB1 3' UTR; Benzo(a)pyrene results in increased methylation of ADARB1 5' UTR PMID:27901495 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:29866 arsenite(3-) increases methylation ISO RGD:732582 E RGD:6480464 20140610 CTD MESH:C015001 arsenite results in increased methylation of ADARB1 promoter PMID:23974009 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:732582 E RGD:6480464 20150512 CTD MESH:D003300 [Disulfiram binds to Copper] which results in increased expression of ADARB1 mRNA PMID:24690739 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:30614 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:732582 E RGD:6480464 20140805 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADARB1 mRNA PMID:19150397 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:31073 2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline multiple interactions ISO RGD:2033 E RGD:6480464 20190409 CTD MESH:C062865 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline promotes the reaction [perfluorooctane sulfonic acid results in increased expression of ADARB1 mRNA] PMID:30508566 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2033 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ADARB1 mRNA PMID:16483693 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:31941 oxaliplatin multiple interactions ISO RGD:2033 E RGD:6480464 20161213 CTD MESH:C030110 [oxaliplatin co-treated with Topotecan] results in increased expression of ADARB1 mRNA PMID:25729387 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:32161 sulfadimethoxine increases expression ISO RGD:2033 E RGD:6480464 20230606 CTD MESH:D013412 Sulfadimethoxine results in increased expression of ADARB1 mRNA PMID:30047161 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:32509 pirinixic acid decreases expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in decreased expression of ADARB1 mRNA PMID:20813756 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:33007 chromium(6+) affects expression ISO RGD:732582 E RGD:6480464 20190507 CTD MESH:C074702 chromium hexavalent ion affects the expression of ADARB1 mRNA PMID:30690063 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:33128 C60 fullerene decreases expression ISO RGD:2033 E RGD:6480464 20120717 CTD MESH:C069837 fullerene C60 results in decreased expression of ADARB1 mRNA PMID:19167457 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:732582 E RGD:6480464 20130122 CTD MESH:C006780 bisphenol A results in decreased expression of ADARB1 mRNA PMID:22576693|PMID:29275510|PMID:33670352 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:2033 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of ADARB1 mRNA PMID:25181051 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:732582 E RGD:6480464 20231205 CTD MESH:C006780 bisphenol A results in increased expression of ADARB1 mRNA PMID:36232920 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:33216 bisphenol A increases methylation ISO RGD:732582 E RGD:6480464 20130122 CTD MESH:C006780 bisphenol A results in increased methylation of ADARB1 gene PMID:22576693 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:2033 E RGD:6480464 20191112 CTD MESH:C006780 [bisphenol A co-treated with tributyltin] results in decreased expression of ADARB1 mRNA PMID:31129395 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:33234 vitamin E decreases expression ISO RGD:732582 E RGD:6480464 20161228 CTD MESH:D024502 Vitamin E results in decreased expression of ADARB1 mRNA PMID:19244175 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:34567 benzo[e]pyrene increases methylation ISO RGD:732582 E RGD:6480464 20190219 CTD MESH:C026487 benzo(e)pyrene results in increased methylation of ADARB1 intron PMID:30157460 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:34575 bisphenol F increases expression EXP E RGD:6480464 20241105 CTD MESH:C008745 bisphenol F results in increased expression of ADARB1 mRNA PMID:38685157 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:34687 dibutyl phthalate increases expression EXP E RGD:6480464 20121113 CTD MESH:D003993 Dibutyl Phthalate results in increased expression of ADARB1 mRNA PMID:17361019 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:34905 paraquat decreases expression ISO RGD:2033 E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in decreased expression of ADARB1 mRNA PMID:32680482 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:34911 permethrin multiple interactions ISO RGD:2033 E RGD:6480464 20210810 CTD MESH:D026023 [Permethrin co-treated with DEET] results in increased methylation of ADARB1 gene PMID:33148267 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:732582 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ADARB1 mRNA PMID:37042841 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:35064 alpha-Zearalanol multiple interactions ISO RGD:2033 E RGD:6480464 20240430 CTD MESH:D015029 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADARB1 mRNA PMID:35163327 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:35549 perfluorooctanoic acid increases expression ISO RGD:2033 E RGD:6480464 20120412 CTD MESH:C023036 perfluorooctanoic acid results in increased expression of ADARB1 mRNA PMID:19162173 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:35549 perfluorooctanoic acid multiple interactions ISO RGD:2033 E RGD:6480464 20240430 CTD MESH:C023036 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of ADARB1 mRNA PMID:35163327 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:35591 pregnenolone 16alpha-carbonitrile increases expression EXP E RGD:6480464 20171114 CTD MESH:D011285 Pregnenolone Carbonitrile results in increased expression of ADARB1 mRNA PMID:28903501 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:35696 cobalt dichloride decreases expression ISO RGD:732582 E RGD:6480464 20120814 CTD MESH:C018021 cobaltous chloride results in decreased expression of ADARB1 mRNA PMID:19320972 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:732582 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of ADARB1 mRNA PMID:24449571 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:38940 sunitinib increases expression ISO RGD:732582 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in increased expression of ADARB1 mRNA PMID:31533062 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:39421 perfluorooctane-1-sulfonic acid increases expression ISO RGD:2033 E RGD:6480464 20190409 CTD MESH:C076994 perfluorooctane sulfonic acid results in increased expression of ADARB1 mRNA PMID:30508566 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ADARB1 mRNA PMID:36331819 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:2033 E RGD:6480464 20190409 CTD MESH:C076994 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline promotes the reaction [perfluorooctane sulfonic acid results in increased expression of ADARB1 mRNA] PMID:30508566 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:39481 chloroprene increases expression ISO RGD:2033 E RGD:6480464 20130514 CTD MESH:D002737 Chloroprene results in increased expression of ADARB1 mRNA PMID:23125180 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:39867 valproic acid affects expression ISO RGD:732582 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ADARB1 mRNA PMID:25979313 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:39867 valproic acid increases expression ISO RGD:732582 E RGD:6480464 20140909 CTD MESH:D014635 Valproic Acid results in increased expression of ADARB1 mRNA PMID:24935251|PMID:28001369 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:39867 valproic acid increases methylation ISO RGD:732582 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of ADARB1 gene PMID:29154799 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:40036 amitrole increases expression ISO RGD:2033 E RGD:6480464 20230606 CTD MESH:D000640 Amitrole results in increased expression of ADARB1 mRNA PMID:30047161 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:41879 dexamethasone increases expression EXP E RGD:6480464 20140408 CTD MESH:D003907 Dexamethasone results in increased expression of ADARB1 mRNA PMID:22733784 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:46024 trichostatin A affects expression ISO RGD:732582 E RGD:6480464 20170613 CTD MESH:C012589 trichostatin A affects the expression of ADARB1 mRNA PMID:28542535 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:46024 trichostatin A decreases expression ISO RGD:732582 E RGD:6480464 20161025 CTD MESH:C012589 trichostatin A results in decreased expression of ADARB1 mRNA PMID:27188386 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:46195 paracetamol increases expression ISO RGD:2033 E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in increased expression of ADARB1 mRNA PMID:33387578 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:46195 paracetamol increases expression ISO RGD:732582 E RGD:6480464 20121009 CTD MESH:D000082 Acetaminophen results in increased expression of ADARB1 mRNA PMID:22230336|PMID:29067470 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:4659 disulfiram multiple interactions ISO RGD:732582 E RGD:6480464 20150512 CTD MESH:D004221 [Disulfiram binds to Copper] which results in increased expression of ADARB1 mRNA PMID:24690739 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:4806 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732582 E RGD:6480464 20121009 CTD MESH:C045651 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ADARB1 mRNA PMID:22079256 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:4811 epoxiconazole decreases expression EXP E RGD:6480464 20220906 CTD MESH:C109476 epoxiconazole results in decreased expression of ADARB1 mRNA PMID:35436446 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADARB1 mRNA PMID:17942748 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:5014 fenvalerate decreases expression ISO RGD:2033 E RGD:6480464 20201103 CTD MESH:C017690 fenvalerate results in decreased expression of ADARB1 mRNA PMID:30307764 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:50594 carbon nanotube affects expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon affects the expression of ADARB1 mRNA PMID:25554681 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ADARB1 mRNA PMID:25554681 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:50673 methimazole increases expression ISO RGD:2033 E RGD:6480464 20230606 CTD MESH:D008713 Methimazole results in increased expression of ADARB1 mRNA PMID:30047161 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:50729 mitoxantrone affects response to substance ISO RGD:732582 E RGD:6480464 20120412 CTD MESH:D008942 ADARB1 protein affects the susceptibility to Mitoxantrone PMID:16217747 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:5118 fluoxetine increases expression EXP E RGD:6480464 20120613 CTD MESH:D005473 Fluoxetine results in increased expression of ADARB1 mRNA; Fluoxetine results in increased expression of ADARB1 protein PMID:21320410 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:5118 fluoxetine multiple interactions EXP E RGD:6480464 20120613 CTD MESH:D005473 ADARB1 protein inhibits the reaction [Fluoxetine inhibits the reaction [Excitatory Amino Acid Agents results in increased phosphorylation of MAPK1 protein]]; ADARB1 protein inhibits the reaction [Fluoxetine inhibits the reaction [Excitatory Amino Acid Agents results in increased phosphorylation of MAPK3 protein]]; ADARB1 protein promotes the reaction [Fluoxetine results in increased expression of GRIK2 mRNA]; ADARB1 protein promotes the reaction [Fluoxetine results in increased expression of GRIK2 protein]; HTR2B protein promotes the reaction [Fluoxetine results in increased expression of ADARB1 mRNA]; HTR2B protein promotes the reaction [Fluoxetine results in increased expression of ADARB1 protein] PMID:21320410 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:53050 trimellitic anhydride increases expression EXP E RGD:6480464 20120501 CTD MESH:C015559 trimellitic anhydride results in increased expression of ADARB1 mRNA PMID:19042947 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:53070 2,4-dinitrobenzenesulfonic acid increases expression EXP E RGD:6480464 20190910 CTD MESH:C001073 2,4-dinitrobenzenesulfonic acid results in increased expression of ADARB1 mRNA PMID:30116771 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:63632 topotecan multiple interactions ISO RGD:2033 E RGD:6480464 20160315 CTD MESH:D019772 [oxaliplatin co-treated with Topotecan] results in increased expression of ADARB1 mRNA PMID:25729387 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:6820 methapyrilene increases methylation ISO RGD:732582 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in increased methylation of ADARB1 intron PMID:30157460 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:7071 N,N-diethyl-m-toluamide multiple interactions ISO RGD:2033 E RGD:6480464 20210810 CTD MESH:D003671 [Permethrin co-treated with DEET] results in increased methylation of ADARB1 gene PMID:33148267 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:73755 1,2-dimethylhydrazine increases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of ADARB1 mRNA PMID:22206623 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D019813 [1,2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of ADARB1 mRNA PMID:22206623 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions ISO RGD:2033 E RGD:6480464 20180220 CTD MESH:D019813 [APC protein affects the susceptibility to 1,2-Dimethylhydrazine] which results in increased expression of ADARB1 mRNA PMID:27840820 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:75249 potassium chromate decreases expression ISO RGD:732582 E RGD:6480464 20130903 CTD MESH:C027373 potassium chromate(VI) results in decreased expression of ADARB1 mRNA PMID:22079256 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:75249 potassium chromate increases expression ISO RGD:732582 E RGD:6480464 20160705 CTD MESH:C027373 potassium chromate(VI) results in increased expression of ADARB1 mRNA PMID:22714537 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:75249 potassium chromate multiple interactions ISO RGD:732582 E RGD:6480464 20130903 CTD MESH:C027373 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ADARB1 mRNA PMID:22079256 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:7590 nitrofen decreases expression ISO RGD:2033 E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in decreased expression of ADARB1 mRNA PMID:33484710 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:732582 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to ADARB1 gene] PMID:28238834 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:81508 2,3,4,7,8-Pentachlorodibenzofuran decreases expression ISO RGD:2033 E RGD:6480464 20141111 CTD MESH:C038890 2,3,4,7,8-pentachlorodibenzofuran results in decreased expression of ADARB1 mRNA PMID:21724226 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:82436 decabromodiphenyl ether decreases expression ISO RGD:2033 E RGD:6480464 20141111 CTD MESH:C010902 decabromobiphenyl ether results in decreased expression of ADARB1 mRNA PMID:23640034 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:84070 sodium arsenate decreases expression EXP E RGD:6480464 20170303 CTD MESH:C009277 sodium arsenate results in decreased expression of ADARB1 mRNA PMID:21795629 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:8502 6-propyl-2-thiouracil decreases expression ISO RGD:2033 E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in decreased expression of ADARB1 mRNA PMID:24780913 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2033 E RGD:6480464 20230606 CTD MESH:D011441 Propylthiouracil results in increased expression of ADARB1 mRNA PMID:30047161 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:88522 Monobutylphthalate decreases expression ISO RGD:2033 E RGD:6480464 20151103 CTD MESH:C028577 monobutyl phthalate results in decreased expression of ADARB1 mRNA PMID:20864626 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:957 2,6-dinitrotoluene affects expression ISO RGD:2033 E RGD:6480464 20120412 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of ADARB1 mRNA PMID:21346803 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:9665 triadimefon increases expression ISO RGD:2033 E RGD:6480464 20230606 CTD MESH:C032910 triadimefon results in increased expression of ADARB1 mRNA PMID:30047161 10082 Adarb1 adenosine deaminase, RNA-specific, B1 gene CHEBI:9753 troglitazone decreases expression ISO RGD:732582 E RGD:6480464 20120501 CTD MESH:C057693 troglitazone results in decreased expression of ADARB1 mRNA PMID:19140230 10083 Adcy6 adenylate cyclase 6 gene CHEBI:116509 diuron decreases expression ISO RGD:2035 E RGD:6480464 20120412 CTD MESH:D004237 Diuron results in decreased expression of ADCY6 mRNA PMID:21551480 10083 Adcy6 adenylate cyclase 6 gene CHEBI:132471 (+)-schisandrin B multiple interactions ISO RGD:2035 E RGD:6480464 20190910 CTD MESH:C015499 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADCY6 mRNA] PMID:31150632 10083 Adcy6 adenylate cyclase 6 gene CHEBI:133152 2-bromohexadecanoic acid multiple interactions ISO RGD:735837 E RGD:6480464 20240702 CTD MESH:C022776 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ADCY6 protein] PMID:38195004 10083 Adcy6 adenylate cyclase 6 gene CHEBI:1367 3,3',4,4'-tetrachlorobiphenyl multiple interactions EXP E RGD:6480464 20121009 CTD MESH:C028451 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of ADCY6 mRNA] PMID:19467301 10083 Adcy6 adenylate cyclase 6 gene CHEBI:16236 ethanol decreases expression ISO RGD:2035 E RGD:6480464 20120412 CTD MESH:D000431 Ethanol results in decreased expression of ADCY6 mRNA PMID:20655511 10083 Adcy6 adenylate cyclase 6 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol results in increased expression of ADCY6 mRNA PMID:30319688 10083 Adcy6 adenylate cyclase 6 gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the expression of and affects the splicing of ADCY6 mRNA PMID:30319688 10083 Adcy6 adenylate cyclase 6 gene CHEBI:164200 triclosan increases expression ISO RGD:2035 E RGD:6480464 20190219 CTD MESH:D014260 Triclosan results in increased expression of ADCY6 mRNA PMID:30447264 10083 Adcy6 adenylate cyclase 6 gene CHEBI:16469 17beta-estradiol affects expression EXP E RGD:6480464 20120412 CTD MESH:D004958 Estradiol affects the expression of ADCY6 mRNA PMID:15598610 10083 Adcy6 adenylate cyclase 6 gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:735837 E RGD:6480464 20160412 CTD MESH:D004958 Estradiol results in decreased expression of ADCY6 mRNA PMID:24758408 10083 Adcy6 adenylate cyclase 6 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:735837 E RGD:6480464 20160412 CTD MESH:D004958 EGF protein promotes the reaction [Estradiol results in decreased expression of ADCY6 mRNA] PMID:24758408 10083 Adcy6 adenylate cyclase 6 gene CHEBI:16548 chlordecone increases expression EXP E RGD:6480464 20210810 CTD MESH:D007631 Chlordecone results in increased expression of ADCY6 mRNA PMID:33711761 10083 Adcy6 adenylate cyclase 6 gene CHEBI:167808 Nor-9-carboxy-delta9-THC multiple interactions ISO RGD:735837 E RGD:6480464 20210406 CTD MESH:C016780 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of ADCY6 gene PMID:30521419 10083 Adcy6 adenylate cyclase 6 gene CHEBI:17059 2-methylcholine affects expression ISO RGD:735837 E RGD:6480464 20121113 CTD MESH:C044887 beta-methylcholine affects the expression of ADCY6 mRNA PMID:21179406 10083 Adcy6 adenylate cyclase 6 gene CHEBI:17303 morphine affects expression ISO RGD:2035 E RGD:6480464 20120412 CTD MESH:D009020 Morphine affects the expression of ADCY6 mRNA PMID:15829634 10083 Adcy6 adenylate cyclase 6 gene CHEBI:178012 FR900359 increases phosphorylation ISO RGD:735837 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in increased phosphorylation of ADCY6 protein PMID:37730182 10083 Adcy6 adenylate cyclase 6 gene CHEBI:18246 (1->4)-beta-D-glucan multiple interactions EXP E RGD:6480464 20230502 CTD MESH:D002482 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ADCY6 mRNA PMID:36331819 10083 Adcy6 adenylate cyclase 6 gene CHEBI:22977 cadmium atom multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D002104 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ADCY6 mRNA PMID:37325564 10083 Adcy6 adenylate cyclase 6 gene CHEBI:22977 cadmium atom multiple interactions ISO RGD:735837 E RGD:6480464 20240702 CTD MESH:D002104 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ADCY6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ADCY6 protein PMID:38195004 10083 Adcy6 adenylate cyclase 6 gene CHEBI:232612 Azoxymethane multiple interactions EXP E RGD:6480464 20241203 CTD MESH:D001397 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADCY6 mRNA PMID:29950665 10083 Adcy6 adenylate cyclase 6 gene CHEBI:23414 copper(II) sulfate increases expression ISO RGD:735837 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in increased expression of ADCY6 mRNA PMID:19549813 10083 Adcy6 adenylate cyclase 6 gene CHEBI:2504 aflatoxin B1 increases expression EXP E RGD:6480464 20120501 CTD MESH:D016604 Aflatoxin B1 results in increased expression of ADCY6 mRNA PMID:19770486 10083 Adcy6 adenylate cyclase 6 gene CHEBI:25434 bis(2-chloroethyl) sulfide decreases expression EXP E RGD:6480464 20120412 CTD MESH:D009151 Mustard Gas results in decreased expression of ADCY6 mRNA PMID:15674843 10083 Adcy6 adenylate cyclase 6 gene CHEBI:2679 amphetamine decreases expression ISO RGD:2035 E RGD:6480464 20191114 CTD MESH:D000661 Amphetamine results in decreased expression of ADCY6 mRNA PMID:30779732 10083 Adcy6 adenylate cyclase 6 gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:2035 E RGD:6480464 20190910 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ADCY6 mRNA PMID:31150632 10083 Adcy6 adenylate cyclase 6 gene CHEBI:27385 tetrachloromethane multiple interactions ISO RGD:2035 E RGD:6480464 20190910 CTD MESH:D002251 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ADCY6 mRNA] PMID:31150632 10083 Adcy6 adenylate cyclase 6 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ADCY6 mRNA] PMID:22206623 10083 Adcy6 adenylate cyclase 6 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:735837 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of ADCY6 gene PMID:25304211 10083 Adcy6 adenylate cyclase 6 gene CHEBI:27568 selenium atom increases expression ISO RGD:735837 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in increased expression of ADCY6 mRNA PMID:19244175 10083 Adcy6 adenylate cyclase 6 gene CHEBI:27744 glyphosate multiple interactions ISO RGD:2035 E RGD:6480464 20240206 CTD MESH:C010974 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ADCY6 mRNA PMID:33854195 10083 Adcy6 adenylate cyclase 6 gene CHEBI:28017 starch multiple interactions ISO RGD:2035 E RGD:6480464 20170516 CTD MESH:D013213 Starch analog inhibits the reaction [Rapeseed Oil metabolite results in decreased expression of ADCY6 mRNA] PMID:27363782 10083 Adcy6 adenylate cyclase 6 gene CHEBI:28112 nickel atom decreases expression ISO RGD:735837 E RGD:6480464 20151110 CTD MESH:D009532 Nickel results in decreased expression of ADCY6 mRNA PMID:24768652|PMID:25583101 10083 Adcy6 adenylate cyclase 6 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ADCY6 mRNA PMID:21570461 10083 Adcy6 adenylate cyclase 6 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2035 E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ADCY6 mRNA PMID:18796159|PMID:34747641 10083 Adcy6 adenylate cyclase 6 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735837 E RGD:6480464 20180828 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ADCY6 mRNA PMID:29704546 10083 Adcy6 adenylate cyclase 6 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin affects the methylation of ADCY6 intron] which results in increased expression of ADCY6 mRNA; [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADCY6 mRNA PMID:17942748|PMID:33017471 10083 Adcy6 adenylate cyclase 6 gene CHEBI:2825 aristolochic acid A increases expression ISO RGD:735837 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in increased expression of ADCY6 mRNA PMID:33212167 10083 Adcy6 adenylate cyclase 6 gene CHEBI:28619 acrylamide decreases expression ISO RGD:2035 E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in decreased expression of ADCY6 mRNA PMID:28959563 10083 Adcy6 adenylate cyclase 6 gene CHEBI:28619 acrylamide decreases expression ISO RGD:735837 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of ADCY6 mRNA PMID:32763439 10083 Adcy6 adenylate cyclase 6 gene CHEBI:28694 copper atom increases expression ISO RGD:2035 E RGD:6480464 20190409 CTD MESH:D003300 Copper results in increased expression of ADCY6 mRNA PMID:30556269 10083 Adcy6 adenylate cyclase 6 gene CHEBI:28694 copper atom multiple interactions ISO RGD:735837 E RGD:6480464 20201215 CTD MESH:D003300 [Chelating Agents binds to Copper] which results in increased expression of ADCY6 mRNA PMID:31162603 10083 Adcy6 adenylate cyclase 6 gene CHEBI:29073 L-ascorbic acid decreases expression ISO RGD:735837 E RGD:6480464 20120501 CTD MESH:D001205 Ascorbic Acid results in decreased expression of ADCY6 mRNA PMID:17303424 10083 Adcy6 adenylate cyclase 6 gene CHEBI:29365 phosgene affects expression EXP E RGD:6480464 20120515 CTD MESH:D010705 Phosgene affects the expression of ADCY6 mRNA PMID:16300373 10083 Adcy6 adenylate cyclase 6 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:735837 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ADCY6 5' UTR PMID:27901495 10083 Adcy6 adenylate cyclase 6 gene CHEBI:29865 benzo[a]pyrene decreases methylation EXP E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ADCY6 5' UTR; Benzo(a)pyrene results in decreased methylation of ADCY6 exon; Benzo(a)pyrene results in decreased methylation of ADCY6 intron PMID:27901495 10083 Adcy6 adenylate cyclase 6 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:735837 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ADCY6 promoter PMID:27901495 10083 Adcy6 adenylate cyclase 6 gene CHEBI:30052 copper(0) increases expression ISO RGD:2035 E RGD:6480464 20190409 CTD MESH:D003300 Copper results in increased expression of ADCY6 mRNA PMID:30556269 10083 Adcy6 adenylate cyclase 6 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:735837 E RGD:6480464 20201215 CTD MESH:D003300 [Chelating Agents binds to Copper] which results in increased expression of ADCY6 mRNA PMID:31162603 10083 Adcy6 adenylate cyclase 6 gene CHEBI:30563 silicon dioxide increases expression ISO RGD:735837 E RGD:6480464 20161115 CTD MESH:D012822 Silicon Dioxide results in increased expression of ADCY6 mRNA PMID:25351596 10083 Adcy6 adenylate cyclase 6 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2035 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ADCY6 mRNA PMID:16483693 10083 Adcy6 adenylate cyclase 6 gene CHEBI:31429 colforsin daropate hydrochloride affects response to substance EXP E RGD:6480464 20141111 CTD MESH:D005576 ADCY6 protein affects the susceptibility to Colforsin PMID:12393090 10083 Adcy6 adenylate cyclase 6 gene CHEBI:3223 buspirone increases expression ISO RGD:2035 E RGD:6480464 20160412 CTD MESH:D002065 Buspirone results in increased expression of ADCY6 mRNA PMID:24136188 10083 Adcy6 adenylate cyclase 6 gene CHEBI:32234 titanium dioxide decreases expression EXP E RGD:6480464 20140211 CTD MESH:C009495 titanium dioxide results in decreased expression of ADCY6 mRNA PMID:23557971 10083 Adcy6 adenylate cyclase 6 gene CHEBI:32234 titanium dioxide multiple interactions EXP E RGD:6480464 20190702 CTD MESH:C009495 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADCY6 mRNA PMID:29950665 10083 Adcy6 adenylate cyclase 6 gene CHEBI:32509 pirinixic acid increases expression EXP E RGD:6480464 20140610 CTD MESH:C006253 pirinixic acid results in increased expression of ADCY6 mRNA PMID:18301758|PMID:23811191 10083 Adcy6 adenylate cyclase 6 gene CHEBI:32509 pirinixic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ADCY6 mRNA PMID:19710929 10083 Adcy6 adenylate cyclase 6 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20160705 CTD MESH:C006780 bisphenol A results in decreased expression of ADCY6 mRNA PMID:26063408|PMID:38074096 10083 Adcy6 adenylate cyclase 6 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:735837 E RGD:6480464 20231205 CTD MESH:C006780 bisphenol A results in decreased expression of ADCY6 mRNA PMID:36232920 10083 Adcy6 adenylate cyclase 6 gene CHEBI:33216 bisphenol A increases expression ISO RGD:2035 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of ADCY6 mRNA PMID:25181051 10083 Adcy6 adenylate cyclase 6 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:735837 E RGD:6480464 20180116 CTD MESH:C006780 [[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects the expression of ADCY6 protein; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADCY6 mRNA PMID:28628672|PMID:33376534 10083 Adcy6 adenylate cyclase 6 gene CHEBI:33234 vitamin E increases expression ISO RGD:735837 E RGD:6480464 20161228 CTD MESH:D024502 Vitamin E results in increased expression of ADCY6 mRNA PMID:19244175 10083 Adcy6 adenylate cyclase 6 gene CHEBI:3387 carbamazepine affects expression ISO RGD:735837 E RGD:6480464 20140715 CTD MESH:D002220 Carbamazepine affects the expression of ADCY6 mRNA PMID:24752500 10083 Adcy6 adenylate cyclase 6 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases methylation EXP E RGD:6480464 20220208 CTD MESH:C543008 bisphenol S results in decreased methylation of ADCY6 exon PMID:33297965 10083 Adcy6 adenylate cyclase 6 gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions ISO RGD:735837 E RGD:6480464 20180116 CTD MESH:C543008 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADCY6 mRNA PMID:28628672 10083 Adcy6 adenylate cyclase 6 gene CHEBI:34575 bisphenol F multiple interactions ISO RGD:735837 E RGD:6480464 20180116 CTD MESH:C008745 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADCY6 mRNA PMID:28628672 10083 Adcy6 adenylate cyclase 6 gene CHEBI:34631 chlorpyrifos multiple interactions ISO RGD:2035 E RGD:6480464 20210706 CTD MESH:D004390 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ADCY6 mRNA PMID:33854195 10083 Adcy6 adenylate cyclase 6 gene CHEBI:34674 dextran sulfate multiple interactions EXP E RGD:6480464 20190702 CTD MESH:D016264 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADCY6 mRNA PMID:29950665 10083 Adcy6 adenylate cyclase 6 gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:2035 E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ADCY6 mRNA PMID:21266533 10083 Adcy6 adenylate cyclase 6 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP E RGD:6480464 20180515 CTD MESH:D015056 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of ADCY6 mRNA PMID:29288687 10083 Adcy6 adenylate cyclase 6 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:735837 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADCY6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADCY6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADCY6 mRNA PMID:28628672 10083 Adcy6 adenylate cyclase 6 gene CHEBI:34905 paraquat increases expression ISO RGD:2035 E RGD:6480464 20130514 CTD MESH:D010269 Paraquat results in increased expression of ADCY6 mRNA PMID:18198484 10083 Adcy6 adenylate cyclase 6 gene CHEBI:35456 cadmium dichloride multiple interactions EXP E RGD:6480464 20231205 CTD MESH:D019256 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ADCY6 mRNA PMID:37325564 10083 Adcy6 adenylate cyclase 6 gene CHEBI:35456 cadmium dichloride multiple interactions ISO RGD:735837 E RGD:6480464 20240702 CTD MESH:D019256 2-bromopalmitate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ADCY6 protein]; [Cadmium Chloride results in increased abundance of Cadmium] which results in increased palmitoylation of ADCY6 protein PMID:38195004 10083 Adcy6 adenylate cyclase 6 gene CHEBI:35559 furan increases methylation ISO RGD:2035 E RGD:6480464 20120918 CTD MESH:C039281 furan results in increased methylation of ADCY6 gene PMID:22079235 10083 Adcy6 adenylate cyclase 6 gene CHEBI:36904 elemental selenium increases expression ISO RGD:735837 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in increased expression of ADCY6 mRNA PMID:19244175 10083 Adcy6 adenylate cyclase 6 gene CHEBI:38940 sunitinib increases expression ISO RGD:735837 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in increased expression of ADCY6 mRNA PMID:31533062 10083 Adcy6 adenylate cyclase 6 gene CHEBI:39421 perfluorooctane-1-sulfonic acid multiple interactions EXP E RGD:6480464 20230502 CTD MESH:C076994 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ADCY6 mRNA PMID:36331819 10083 Adcy6 adenylate cyclase 6 gene CHEBI:39867 valproic acid decreases expression ISO RGD:735837 E RGD:6480464 20140513 CTD MESH:D014635 Valproic Acid results in decreased expression of ADCY6 mRNA PMID:23179753|PMID:28001369 10083 Adcy6 adenylate cyclase 6 gene CHEBI:39867 valproic acid increases methylation ISO RGD:735837 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of ADCY6 gene PMID:29154799 10083 Adcy6 adenylate cyclase 6 gene CHEBI:40909 azoxystrobin multiple interactions ISO RGD:2035 E RGD:6480464 20210706 CTD MESH:C087670 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ADCY6 mRNA PMID:33854195 10083 Adcy6 adenylate cyclase 6 gene CHEBI:41774 tamoxifen affects expression EXP E RGD:6480464 20120412 CTD MESH:D013629 Tamoxifen affects the expression of ADCY6 mRNA PMID:17555576 10083 Adcy6 adenylate cyclase 6 gene CHEBI:41879 dexamethasone multiple interactions EXP E RGD:6480464 20180515 CTD MESH:D003907 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of ADCY6 mRNA PMID:29288687 10083 Adcy6 adenylate cyclase 6 gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:735837 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADCY6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADCY6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADCY6 mRNA PMID:28628672 10083 Adcy6 adenylate cyclase 6 gene CHEBI:41922 diethylstilbestrol decreases expression EXP E RGD:6480464 20120412 CTD MESH:D004054 Diethylstilbestrol results in decreased expression of ADCY6 mRNA PMID:15171707 10083 Adcy6 adenylate cyclase 6 gene CHEBI:41922 diethylstilbestrol decreases expression ISO RGD:2035 E RGD:6480464 20230606 CTD MESH:D004054 Diethylstilbestrol results in decreased expression of ADCY6 mRNA PMID:37077353 10083 Adcy6 adenylate cyclase 6 gene CHEBI:45863 paclitaxel decreases expression ISO RGD:735837 E RGD:6480464 20161213 CTD MESH:D017239 Paclitaxel results in decreased expression of ADCY6 mRNA PMID:15000894 10083 Adcy6 adenylate cyclase 6 gene CHEBI:45979 thiabendazole multiple interactions ISO RGD:2035 E RGD:6480464 20210706 CTD MESH:D013827 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ADCY6 mRNA PMID:33854195 10083 Adcy6 adenylate cyclase 6 gene CHEBI:4670 dobutamine affects response to substance EXP E RGD:6480464 20120412 CTD MESH:D004280 ADCY6 protein affects the susceptibility to Dobutamine PMID:12393090 10083 Adcy6 adenylate cyclase 6 gene CHEBI:47217 arsane affects methylation ISO RGD:735837 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of ADCY6 gene PMID:25304211 10083 Adcy6 adenylate cyclase 6 gene CHEBI:47381 diclofenac affects expression ISO RGD:735837 E RGD:6480464 20140715 CTD MESH:D004008 Diclofenac affects the expression of ADCY6 mRNA PMID:24752500 10083 Adcy6 adenylate cyclase 6 gene CHEBI:47519 ketoconazole decreases expression ISO RGD:2035 E RGD:6480464 20230606 CTD MESH:D007654 Ketoconazole results in decreased expression of ADCY6 mRNA PMID:37077353 10083 Adcy6 adenylate cyclase 6 gene CHEBI:4791 endosulfan decreases expression ISO RGD:2035 E RGD:6480464 20201103 CTD MESH:D004726 Endosulfan results in decreased expression of ADCY6 mRNA PMID:31464424 10083 Adcy6 adenylate cyclase 6 gene CHEBI:4903 17alpha-ethynylestradiol affects expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol affects the expression of ADCY6 mRNA PMID:17555576 10083 Adcy6 adenylate cyclase 6 gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ADCY6 mRNA PMID:17942748 10083 Adcy6 adenylate cyclase 6 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADCY6 mRNA PMID:17942748 10083 Adcy6 adenylate cyclase 6 gene CHEBI:49662 indometacin decreases expression ISO RGD:2035 E RGD:6480464 20120412 CTD MESH:D007213 Indomethacin results in decreased expression of ADCY6 protein PMID:15579502 10083 Adcy6 adenylate cyclase 6 gene CHEBI:49662 indometacin multiple interactions ISO RGD:735837 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ADCY6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ADCY6 mRNA; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of ADCY6 mRNA PMID:28628672 10083 Adcy6 adenylate cyclase 6 gene CHEBI:50859 bexarotene decreases expression ISO RGD:2035 E RGD:6480464 20170303 CTD MESH:C095105 bexarotene results in decreased expression of ADCY6 mRNA PMID:16648578 10083 Adcy6 adenylate cyclase 6 gene CHEBI:5132 flutamide decreases expression ISO RGD:2035 E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in decreased expression of ADCY6 mRNA PMID:24136188 10083 Adcy6 adenylate cyclase 6 gene CHEBI:53076 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression EXP E RGD:6480464 20120412 CTD MESH:D010081 Oxazolone results in decreased expression of ADCY6 mRNA PMID:11379042 10083 Adcy6 adenylate cyclase 6 gene CHEBI:53556 toluene 2,4-diisocyanate increases expression EXP E RGD:6480464 20120412 CTD MESH:D014051 Toluene 2,4-Diisocyanate results in increased expression of ADCY6 mRNA PMID:11379042 10083 Adcy6 adenylate cyclase 6 gene CHEBI:5870 imidacloprid multiple interactions ISO RGD:2035 E RGD:6480464 20210706 CTD MESH:C082359 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ADCY6 mRNA PMID:33854195 10083 Adcy6 adenylate cyclase 6 gene CHEBI:63041 manganese(II) chloride increases expression ISO RGD:2035 E RGD:6480464 20190219 CTD MESH:C025340 manganese chloride results in increased expression of ADCY6 mRNA PMID:28801915 10083 Adcy6 adenylate cyclase 6 gene CHEBI:63921 2-butoxyethanol increases expression EXP E RGD:6480464 20120412 CTD MESH:C017096 n-butoxyethanol results in increased expression of ADCY6 mRNA PMID:19812364 10083 Adcy6 adenylate cyclase 6 gene CHEBI:6402 leflunomide decreases expression ISO RGD:735837 E RGD:6480464 20180410 CTD MESH:C045463 leflunomide results in decreased expression of ADCY6 mRNA PMID:28988120 10083 Adcy6 adenylate cyclase 6 gene CHEBI:64317 isoprenaline affects response to substance EXP E RGD:6480464 20120515 CTD MESH:D007545 ADCY6 protein affects the susceptibility to Isoproterenol PMID:12393090 10083 Adcy6 adenylate cyclase 6 gene CHEBI:6451 Licarin A multiple interactions EXP E RGD:6480464 20180515 CTD MESH:C432503 [licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of ADCY6 mRNA PMID:29288687 10083 Adcy6 adenylate cyclase 6 gene CHEBI:6809 methamphetamine increases expression EXP E RGD:6480464 20151215 CTD MESH:D008694 Methamphetamine results in increased expression of ADCY6 mRNA PMID:26307267|PMID:36914120 10083 Adcy6 adenylate cyclase 6 gene CHEBI:72544 flavonoids increases expression ISO RGD:2035 E RGD:6480464 20170303 CTD MESH:D005419 Flavonoids results in increased expression of ADCY6 mRNA PMID:18035473 10083 Adcy6 adenylate cyclase 6 gene CHEBI:72564 temozolomide increases expression ISO RGD:735837 E RGD:6480464 20210706 CTD MESH:C047246 Temozolomide results in increased expression of ADCY6 mRNA PMID:31758290 10083 Adcy6 adenylate cyclase 6 gene CHEBI:73755 1,2-dimethylhydrazine multiple interactions EXP E RGD:6480464 20200804 CTD MESH:D019813 Folic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of ADCY6 mRNA] PMID:22206623 10083 Adcy6 adenylate cyclase 6 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:735837 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to ADCY6 gene] PMID:28238834 10083 Adcy6 adenylate cyclase 6 gene CHEBI:8069 phenobarbital decreases expression EXP E RGD:6480464 20121113 CTD MESH:D010634 Phenobarbital results in decreased expression of ADCY6 mRNA PMID:21335049 10083 Adcy6 adenylate cyclase 6 gene CHEBI:8069 phenobarbital increases expression EXP E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital results in increased expression of ADCY6 mRNA PMID:19482888 10083 Adcy6 adenylate cyclase 6 gene CHEBI:8069 phenobarbital multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D010634 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ADCY6 mRNA] PMID:19482888 10083 Adcy6 adenylate cyclase 6 gene CHEBI:82019 folpet decreases expression EXP E RGD:6480464 20201103 CTD MESH:C005020 folpet results in decreased expression of ADCY6 mRNA PMID:31558096 10083 Adcy6 adenylate cyclase 6 gene CHEBI:8489 propiconazole decreases expression EXP E RGD:6480464 20120412 CTD MESH:C045950 propiconazole results in decreased expression of ADCY6 mRNA PMID:21278054 10083 Adcy6 adenylate cyclase 6 gene CHEBI:920 2,4-dinitrotoluene affects expression ISO RGD:2035 E RGD:6480464 20120412 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of ADCY6 mRNA PMID:21346803 10083 Adcy6 adenylate cyclase 6 gene CHEBI:9464 testosterone enanthate decreases expression ISO RGD:2035 E RGD:6480464 20161213 CTD MESH:C004648 testosterone enanthate results in decreased expression of ADCY6 mRNA PMID:25603467 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:104872 rolipram multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D020889 Rolipram promotes the reaction [ADCYAP1 protein affects the secretion of Acids] PMID:20388963 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:132082 entinostat decreases expression ISO RGD:732730 E RGD:6480464 20161228 CTD MESH:C118739 entinostat results in decreased expression of ADCYAP1 mRNA PMID:27188386 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:15422 ATP increases secretion ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D000255 ADCYAP1 protein results in increased secretion of Adenosine Triphosphate PMID:18563302 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:15551 prostaglandin E2 multiple interactions ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D015232 Dinoprostone inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine] PMID:11164953 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:15571 hydrazine decreases expression EXP E RGD:6480464 20120412 CTD MESH:C029424 hydrazine results in decreased expression of ADCYAP1 mRNA PMID:15282401 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:15930 atrazine multiple interactions ISO RGD:732730 E RGD:6480464 20120412 CTD MESH:D001280 [Atrazine co-treated with Arsenates] results in increased expression of ADCYAP1 mRNA PMID:18585445 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:16236 ethanol decreases expression ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D000431 Ethanol results in decreased expression of ADCYAP1 mRNA PMID:20655511 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:16236 ethanol multiple interactions ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D000431 N-methyl-N-(6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-ylmethyl)aminomethylcarboxylic acid inhibits the reaction [Ethanol results in decreased expression of ADCYAP1 mRNA] PMID:20655511 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:164200 triclosan increases expression ISO RGD:732730 E RGD:6480464 20190507 CTD MESH:D014260 Triclosan results in increased expression of ADCYAP1 mRNA PMID:30510588 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:17026 progesterone increases abundance ISO RGD:732730 E RGD:6480464 20130723 CTD MESH:D011374 ADCYAP1 protein results in increased abundance of Progesterone PMID:19926922 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:17489 3',5'-cyclic AMP multiple interactions ISO RGD:732730 E RGD:6480464 20120412 CTD MESH:D000242 [ADCYAP1 protein binds to VIPR2 protein] which results in increased abundance of Cyclic AMP PMID:7733904 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:177802 Cuprizon decreases expression ISO RGD:2037 E RGD:6480464 20210907 CTD MESH:D003471 Cuprizone results in decreased expression of ADCYAP1 mRNA PMID:26577399 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:18295 histamine increases secretion ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D006632 ADCYAP1 protein results in increased secretion of Histamine PMID:11164953 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:18295 histamine multiple interactions ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D006632 Dinoprostone inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; Galanin inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; IL1B protein inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; Misoprostol inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; SST protein inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine]; TNF protein inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine] PMID:11164953 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:211249 Ampullosporin multiple interactions ISO RGD:2037 E RGD:6480464 20240806 CTD MESH:C109004 [ampullosporin co-treated with Ketamine] results in decreased expression of ADCYAP1 mRNA PMID:16635253 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:22984 calcium atom affects abundance ISO RGD:2037 E RGD:6480464 20130416 CTD MESH:D002118 ADCYAP1 protein affects the abundance of Calcium PMID:21039959 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:22984 calcium atom increases abundance ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D002118 ADCYAP1 protein results in increased abundance of Calcium PMID:18198219 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:22984 calcium atom multiple interactions ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D002118 Calcium affects the reaction [ADCYAP1 protein results in increased expression of SELENOT mRNA]; SELENOT protein affects the reaction [ADCYAP1 protein results in increased abundance of Calcium] PMID:18198219 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:232612 Azoxymethane multiple interactions EXP E RGD:6480464 20241203 CTD MESH:D001397 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCYAP1 mRNA PMID:29950665 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:23704 diepoxybutane decreases expression ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:C007366 diepoxybutane results in decreased expression of ADCYAP1 mRNA PMID:12242682 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:732730 E RGD:6480464 20121009 CTD MESH:D016604 Aflatoxin B1 results in increased expression of ADCYAP1 mRNA PMID:22100608 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:2567 alendronic acid affects expression ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D019386 Alendronate affects the expression of ADCYAP1 mRNA PMID:16079270 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:27470 folic acid decreases expression EXP E RGD:6480464 20200804 CTD MESH:D005492 Folic Acid results in decreased expression of ADCYAP1 mRNA PMID:25629700 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:27563 arsenic atom affects methylation ISO RGD:732730 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of ADCYAP1 gene PMID:25304211 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:27889 lead(0) affects expression ISO RGD:732730 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the expression of ADCYAP1 mRNA PMID:28903495 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:27958 cocaine increases expression EXP E RGD:6480464 20180828 CTD MESH:D003042 Cocaine results in increased expression of ADCYAP1 mRNA PMID:29673861 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:27958 cocaine multiple interactions EXP E RGD:6480464 20180828 CTD MESH:D003042 ADCYAP1 protein modified form affects the reaction [Cocaine results in increased cleavage of CASP3 protein]; ADCYAP1 protein modified form affects the reaction [Cocaine results in increased expression of BAX protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide affects the reaction [IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1 mRNA]]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Cocaine results in increased expression of ADCYAP1 mRNA]; IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1 mRNA]; TNF protein affects the reaction [Cocaine results in increased expression of ADCYAP1 mRNA] PMID:29673861 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of ADCYAP1 mRNA PMID:19465110 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:28201 rotenone decreases expression ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D012402 Rotenone results in decreased expression of ADCYAP1 mRNA PMID:19013527 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:28201 rotenone multiple interactions ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D012402 ADCYAP1 protein modified form inhibits the reaction [Rotenone results in increased activity of CASP3 protein] PMID:16004991 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:28619 acrylamide decreases expression ISO RGD:732730 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of ADCYAP1 mRNA PMID:32763439 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:28694 copper atom increases expression ISO RGD:2037 E RGD:6480464 20151013 CTD MESH:D003300 Copper deficiency results in increased expression of ADCYAP1 mRNA PMID:26033743 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:28694 copper atom multiple interactions ISO RGD:2037 E RGD:6480464 20151013 CTD MESH:D003300 [Copper co-treated with Dietary Sucrose] results in increased expression of ADCYAP1 mRNA PMID:26033743 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:29320 calcium(0) affects abundance ISO RGD:2037 E RGD:6480464 20130416 CTD MESH:D002118 ADCYAP1 protein affects the abundance of Calcium PMID:21039959 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:29320 calcium(0) increases abundance ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D002118 ADCYAP1 protein results in increased abundance of Calcium PMID:18198219 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:29320 calcium(0) multiple interactions ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D002118 Calcium affects the reaction [ADCYAP1 protein results in increased expression of SELENOT mRNA]; SELENOT protein affects the reaction [ADCYAP1 protein results in increased abundance of Calcium] PMID:18198219 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:732730 E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in decreased expression of ADCYAP1 mRNA PMID:29301061 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:732730 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ADCYAP1 3' UTR; Benzo(a)pyrene affects the methylation of ADCYAP1 5' UTR PMID:27901495 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:732730 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ADCYAP1 mRNA PMID:27901495 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:732730 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ADCYAP1 promoter PMID:27901495 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:29866 arsenite(3-) increases methylation ISO RGD:732730 E RGD:6480464 20140610 CTD MESH:C015001 arsenite results in increased methylation of ADCYAP1 promoter PMID:23974009 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:30052 copper(0) increases expression ISO RGD:2037 E RGD:6480464 20151013 CTD MESH:D003300 Copper deficiency results in increased expression of ADCYAP1 mRNA PMID:26033743 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:2037 E RGD:6480464 20151013 CTD MESH:D003300 [Copper co-treated with Dietary Sucrose] results in increased expression of ADCYAP1 mRNA PMID:26033743 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ADCYAP1 mRNA PMID:16483693 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:31767 lead diacetate decreases expression EXP E RGD:6480464 20150825 CTD MESH:C008261 lead acetate results in decreased expression of ADCYAP1 mRNA PMID:22613225 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:32234 titanium dioxide multiple interactions EXP E RGD:6480464 20190702 CTD MESH:C009495 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCYAP1 mRNA PMID:29950665 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:32509 pirinixic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid affects the expression of ADCYAP1 mRNA PMID:19136022 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:32509 pirinixic acid decreases expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in decreased expression of ADCYAP1 mRNA PMID:17950772 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:32509 pirinixic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C006253 NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of ADCYAP1 mRNA] PMID:17950772 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230117 CTD MESH:C006780 bisphenol A results in decreased expression of ADCYAP1 mRNA PMID:35479511 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2037 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of ADCYAP1 mRNA PMID:25181051 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:2037 E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in increased expression of ADCYAP1 mRNA PMID:30816183|PMID:32528016 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:3423 carmustine decreases expression ISO RGD:732730 E RGD:6480464 20120412 CTD MESH:D002330 Carmustine results in decreased expression of ADCYAP1 mRNA PMID:15980968 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:34372 4,4'-sulfonyldiphenol increases methylation ISO RGD:732730 E RGD:6480464 20220308 CTD MESH:C543008 bisphenol S results in increased methylation of ADCYAP1 gene PMID:31601247 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:34631 chlorpyrifos increases expression ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D004390 Chlorpyrifos results in increased expression of ADCYAP1 mRNA PMID:17452286 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:34674 dextran sulfate multiple interactions EXP E RGD:6480464 20190702 CTD MESH:D016264 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCYAP1 mRNA PMID:29950665 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:34682 diazinon increases expression ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D003976 Diazinon results in increased expression of ADCYAP1 mRNA PMID:17452286 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D015056 1-Methyl-3-isobutylxanthine promotes the reaction [ADCYAP1 protein affects the secretion of Acids] PMID:20388963 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:34887 nickel dichloride decreases activity EXP E RGD:6480464 20151110 CTD MESH:C022838 nickel chloride results in decreased activity of ADCYAP1 protein PMID:22009744 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:34887 nickel dichloride multiple interactions ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:C022838 nickel chloride inhibits the reaction [ADCYAP1 protein results in increased expression of SELENOT mRNA] PMID:18198219 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:34905 paraquat decreases response to substance EXP E RGD:6480464 20140408 CTD MESH:D010269 ADCYAP1 protein results in decreased susceptibility to Paraquat PMID:23500093 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:35456 cadmium dichloride decreases expression EXP E RGD:6480464 20120501 CTD MESH:D019256 Cadmium Chloride results in decreased expression of ADCYAP1 mRNA PMID:18974090 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:35456 cadmium dichloride increases methylation ISO RGD:2037 E RGD:6480464 20120717 CTD MESH:D019256 Cadmium Chloride results in increased methylation of ADCYAP1 promoter PMID:22457795 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:35559 furan decreases expression ISO RGD:2037 E RGD:6480464 20150414 CTD MESH:C039281 furan results in decreased expression of ADCYAP1 mRNA PMID:25539665 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:35559 furan increases expression ISO RGD:2037 E RGD:6480464 20150414 CTD MESH:C039281 furan results in increased expression of ADCYAP1 mRNA PMID:25539665 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:3750 clofibrate increases expression EXP E RGD:6480464 20120515 CTD MESH:D002994 Clofibrate results in increased expression of ADCYAP1 mRNA PMID:17585979 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:38626 pyridaben increases expression EXP E RGD:6480464 20121113 CTD MESH:C428725 pyridaben results in increased expression of ADCYAP1 mRNA PMID:22563483 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:39867 valproic acid affects expression ISO RGD:732730 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ADCYAP1 mRNA PMID:25979313 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:39867 valproic acid decreases expression ISO RGD:732730 E RGD:6480464 20161025 CTD MESH:D014635 Valproic Acid results in decreased expression of ADCYAP1 mRNA PMID:27188386 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:39867 valproic acid increases expression ISO RGD:732730 E RGD:6480464 20140513 CTD MESH:D014635 Valproic Acid results in increased expression of ADCYAP1 mRNA PMID:24383497 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:4027 cyclophosphamide affects expression ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D003520 Cyclophosphamide affects the expression of ADCYAP1 mRNA PMID:18563302 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:4027 cyclophosphamide increases expression ISO RGD:2037 E RGD:6480464 20120501 CTD MESH:D003520 Cyclophosphamide results in increased expression of ADCYAP1 protein PMID:10754506|PMID:9776515 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:4031 cyclosporin A decreases methylation ISO RGD:732730 E RGD:6480464 20170516 CTD MESH:D016572 Cyclosporine results in decreased methylation of ADCYAP1 promoter PMID:27989131 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:44185 methotrexate affects expression EXP E RGD:6480464 20120412 CTD MESH:D008727 Methotrexate affects the expression of ADCYAP1 mRNA PMID:18502557 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:45716 vorinostat decreases expression ISO RGD:732730 E RGD:6480464 20161213 CTD MESH:C111237 vorinostat results in decreased expression of ADCYAP1 mRNA PMID:27188386 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:45716 vorinostat increases expression ISO RGD:732730 E RGD:6480464 20161213 CTD MESH:C111237 vorinostat results in increased expression of ADCYAP1 mRNA PMID:26272509 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:45716 vorinostat multiple interactions ISO RGD:732730 E RGD:6480464 20161213 CTD MESH:C111237 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1 mRNA PMID:27188386 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:46195 paracetamol affects expression EXP E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen affects the expression of ADCYAP1 mRNA PMID:17562736 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:47217 arsane affects methylation ISO RGD:732730 E RGD:6480464 20150310 CTD MESH:D001151 Arsenic affects the methylation of ADCYAP1 gene PMID:25304211 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:47495 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:2037 E RGD:6480464 20160405 CTD MESH:C063509 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [ADCYAP1 protein results in increased expression of SELENOT mRNA] PMID:18198219 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:4903 17alpha-ethynylestradiol affects expression ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol affects the expression of ADCYAP1 mRNA PMID:16079270 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:4903 17alpha-ethynylestradiol increases expression ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ADCYAP1 mRNA PMID:17108234 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:4975 famotidine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D015738 Famotidine inhibits the reaction [ADCYAP1 protein affects the secretion of Acids] PMID:20388963 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:50131 5-aza-2'-deoxycytidine increases expression ISO RGD:732730 E RGD:6480464 20201006 CTD MESH:C014347 Decitabine results in increased expression of ADCYAP1 mRNA PMID:27901495 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:61076 belinostat increases expression ISO RGD:732730 E RGD:6480464 20170303 CTD MESH:C487081 belinostat results in increased expression of ADCYAP1 mRNA PMID:26272509 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:61076 belinostat multiple interactions ISO RGD:732730 E RGD:6480464 20170303 CTD MESH:C487081 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1 mRNA PMID:27188386 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:6121 ketamine decreases expression ISO RGD:2037 E RGD:6480464 20121218 CTD MESH:D007649 Ketamine results in decreased expression of ADCYAP1 mRNA PMID:20080153 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:6121 ketamine multiple interactions ISO RGD:2037 E RGD:6480464 20240806 CTD MESH:D007649 [ampullosporin co-treated with Ketamine] results in decreased expression of ADCYAP1 mRNA PMID:16635253 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:63610 misoprostol multiple interactions ISO RGD:2037 E RGD:6480464 20120412 CTD MESH:D016595 Misoprostol inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine] PMID:11164953 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:641 N-methyl-4-phenylpyridinium multiple interactions ISO RGD:732730 E RGD:6480464 20130611 CTD MESH:D015655 ADCYAP1 protein inhibits the reaction [SNCA protein results in increased susceptibility to 1-Methyl-4-phenylpyridinium] PMID:15888489 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:64629 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine increases response to substance EXP E RGD:6480464 20140408 CTD MESH:C015952 ADCYAP1 gene mutant form results in increased susceptibility to 4-iodo-2,5-dimethoxyphenylisopropylamine PMID:24586556 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:64629 2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine multiple interactions EXP E RGD:6480464 20140408 CTD MESH:C015952 ADCYAP1 gene mutant form promotes the reaction [4-iodo-2,5-dimethoxyphenylisopropylamine results in increased expression of FOS protein] PMID:24586556 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:7034 Muscarine multiple interactions EXP E RGD:6480464 20220405 CTD MESH:D009116 ADCYAP1 protein promotes the reaction [Muscarine affects the localization of TRPC1 protein]; ADCYAP1 protein promotes the reaction [Muscarine affects the localization of TRPC4 protein] PMID:32001221 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:75455 2-palmitoylglycerol increases expression ISO RGD:732730 E RGD:6480464 20240109 CTD MESH:C114956 2-palmitoylglycerol results in increased expression of ADCYAP1 mRNA PMID:37199045 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:732730 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1 mRNA PMID:27188386 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:79994 CGP 52608 multiple interactions ISO RGD:732730 E RGD:6480464 20220607 CTD MESH:C092451 CGP 52608 promotes the reaction [RORA protein binds to ADCYAP1 gene] PMID:28238834 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:80161 Galanin multiple interactions ISO RGD:2037 E RGD:6480464 20170303 CTD MESH:D019004 Galanin inhibits the reaction [ADCYAP1 protein results in increased secretion of Histamine] PMID:11164953 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:8069 phenobarbital affects expression EXP E RGD:6480464 20120412 CTD MESH:D010634 Phenobarbital affects the expression of ADCYAP1 mRNA PMID:19136022 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:81506 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:2037 E RGD:6480464 20200609 CTD MESH:C014211 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of ADCYAP1 mRNA PMID:32109520 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:85990 panobinostat increases expression ISO RGD:732730 E RGD:6480464 20161228 CTD MESH:C496932 panobinostat results in increased expression of ADCYAP1 mRNA PMID:26272509 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:85990 panobinostat multiple interactions ISO RGD:732730 E RGD:6480464 20161228 CTD MESH:C496932 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1 mRNA PMID:27188386 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:8772 raloxifene affects expression ISO RGD:2037 E RGD:6480464 20161213 CTD MESH:D020849 Raloxifene Hydrochloride affects the expression of ADCYAP1 mRNA PMID:16079270 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:732730 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1 mRNA PMID:27188386 10084 Adcyap1 adenylate cyclase activating polypeptide 1 gene CHEBI:9466 Testosterone propionate increases expression ISO RGD:2037 E RGD:6480464 20141111 CTD MESH:D043343 Testosterone Propionate results in increased expression of ADCYAP1 mRNA PMID:19427307 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:132082 entinostat increases expression ISO RGD:736792 E RGD:6480464 20161228 CTD MESH:C118739 entinostat results in increased expression of ADCYAP1R1 mRNA PMID:26272509 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:132082 entinostat multiple interactions ISO RGD:736792 E RGD:6480464 20161228 CTD MESH:C118739 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1R1 mRNA PMID:27188386 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:15379 dioxygen multiple interactions ISO RGD:2038 E RGD:6480464 20220510 CTD MESH:D010100 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ADCYAP1R1 mRNA PMID:33729688 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:15930 atrazine affects methylation ISO RGD:2038 E RGD:6480464 20230905 CTD MESH:D001280 Atrazine affects the methylation of ADCYAP1R1 gene PMID:35440735 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:16236 ethanol affects splicing EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the splicing of ADCYAP1R1 mRNA PMID:30319688 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:16236 ethanol decreases expression ISO RGD:2038 E RGD:6480464 20120412 CTD MESH:D000431 Ethanol results in decreased expression of ADCYAP1R1 mRNA PMID:20655511 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol results in increased expression of ADCYAP1R1 mRNA PMID:30319688 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:16330 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:736792 E RGD:6480464 20120412 CTD MESH:D013196 Dihydrotestosterone results in increased expression of ADCYAP1R1 mRNA PMID:17254854 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:17026 progesterone multiple interactions ISO RGD:736792 E RGD:6480464 20130723 CTD MESH:D011374 ADCYAP1R1 protein promotes the reaction [LHB protein results in increased abundance of Progesterone] PMID:19926922 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:17747 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:736792 E RGD:6480464 20190910 CTD MESH:D004051 Diethylhexyl Phthalate results in decreased expression of ADCYAP1R1 mRNA PMID:31163220 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:232612 Azoxymethane multiple interactions EXP E RGD:6480464 20241203 CTD MESH:D001397 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADCYAP1R1 mRNA PMID:29950665 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:24631 hydrazines multiple interactions ISO RGD:736792 E RGD:6480464 20170207 CTD MESH:D006834 Hydrazines binds to and results in decreased activity of ADCYAP1R1 protein PMID:25069645 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:25812 ozone increases expression ISO RGD:2038 E RGD:6480464 20221004 CTD MESH:D010126 Ozone results in increased expression of ADCYAP1R1 mRNA PMID:35737395 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:27086 tributylstannane multiple interactions ISO RGD:2038 E RGD:6480464 20191112 CTD MESH:C011559 [bisphenol A co-treated with tributyltin] results in decreased expression of ADCYAP1R1 mRNA PMID:31129395 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:27666 actinomycin D multiple interactions ISO RGD:736792 E RGD:6480464 20240806 CTD MESH:D003609 [Dactinomycin co-treated with nutlin 3] results in increased expression of ADCYAP1R1 mRNA PMID:38460933 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:27856 acetamide increases expression ISO RGD:2038 E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in increased expression of ADCYAP1R1 mRNA PMID:31881176 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:27889 lead(0) affects splicing ISO RGD:736792 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the splicing of ADCYAP1R1 mRNA PMID:28903495 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:27958 cocaine increases expression EXP E RGD:6480464 20180828 CTD MESH:D003042 Cocaine results in increased expression of ADCYAP1R1 mRNA PMID:29673861 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:27958 cocaine multiple interactions EXP E RGD:6480464 20180828 CTD MESH:D003042 alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide affects the reaction [IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA]]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA]; IL6 protein affects the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA]; TNF protein affects the reaction [Cocaine results in increased expression of ADCYAP1R1 mRNA] PMID:29673861 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2038 E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ADCYAP1R1 mRNA PMID:21215274|PMID:32109520 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:28216 methylmercury chloride decreases expression ISO RGD:736792 E RGD:6480464 20170516 CTD MESH:C004925 methylmercuric chloride results in decreased expression of ADCYAP1R1 mRNA PMID:28001369 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:28420 p-chloromercuribenzoic acid decreases expression ISO RGD:736792 E RGD:6480464 20160119 CTD MESH:D020245 p-Chloromercuribenzoic Acid results in decreased expression of ADCYAP1R1 mRNA PMID:26272509 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:28420 p-chloromercuribenzoic acid multiple interactions ISO RGD:736792 E RGD:6480464 20161025 CTD MESH:D020245 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADCYAP1R1 mRNA PMID:27188386 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:28619 acrylamide decreases expression ISO RGD:736792 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of ADCYAP1R1 mRNA PMID:32763439 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:29678 sodium arsenite affects methylation ISO RGD:736792 E RGD:6480464 20171114 CTD MESH:C017947 sodium arsenite affects the methylation of ADCYAP1R1 gene PMID:28589171 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:2038 E RGD:6480464 20230207 CTD MESH:C017947 sodium arsenite results in decreased expression of ADCYAP1R1 mRNA PMID:35314868 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:29678 sodium arsenite increases expression EXP E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in increased expression of ADCYAP1R1 mRNA PMID:37682722 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:736792 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ADCYAP1R1 5' UTR; Benzo(a)pyrene affects the methylation of ADCYAP1R1 promoter PMID:27901495 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ADCYAP1R1 mRNA PMID:22228805 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:29865 benzo[a]pyrene increases mutagenesis ISO RGD:736792 E RGD:6480464 20160315 CTD MESH:D001564 Benzo(a)pyrene results in increased mutagenesis of ADCYAP1R1 gene PMID:25435355 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20120918 CTD MESH:D001564 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ADCYAP1R1 mRNA] PMID:22228805 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:30966 glycidol decreases expression ISO RGD:2038 E RGD:6480464 20150127 CTD MESH:C004312 glycidol results in decreased expression of ADCYAP1R1 mRNA PMID:24915197 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:31823 mercury dichloride increases expression ISO RGD:2038 E RGD:6480464 20200915 CTD MESH:D008627 Mercuric Chloride results in increased expression of ADCYAP1R1 mRNA PMID:32599119 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:32234 titanium dioxide decreases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ADCYAP1R1 promoter PMID:35295148 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:32234 titanium dioxide multiple interactions EXP E RGD:6480464 20190702 CTD MESH:C009495 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADCYAP1R1 mRNA PMID:29950665 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:32506 4,4'-diaminodiphenylmethane increases expression EXP E RGD:6480464 20120412 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in increased expression of ADCYAP1R1 mRNA PMID:18648102 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:32509 pirinixic acid decreases expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in decreased expression of ADCYAP1R1 mRNA PMID:17950772 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:32509 pirinixic acid decreases expression ISO RGD:2038 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in decreased expression of ADCYAP1R1 mRNA PMID:19162173 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:32509 pirinixic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C006253 NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of ADCYAP1R1 mRNA] PMID:17950772 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2038 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of ADCYAP1R1 mRNA PMID:25181051 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:2038 E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in increased expression of ADCYAP1R1 mRNA PMID:30816183|PMID:32528016 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:33216 bisphenol A increases methylation ISO RGD:736792 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in increased methylation of ADCYAP1R1 gene PMID:31601247 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:2038 E RGD:6480464 20191112 CTD MESH:C006780 [bisphenol A co-treated with tributyltin] results in decreased expression of ADCYAP1R1 mRNA PMID:31129395 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:2038 E RGD:6480464 20200609 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ADCYAP1R1 mRNA PMID:32119087 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:34565 benzo[b]fluoranthene increases expression EXP E RGD:6480464 20160119 CTD MESH:C006703 benzo(b)fluoranthene results in increased expression of ADCYAP1R1 mRNA PMID:26377693 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:34567 benzo[e]pyrene increases methylation ISO RGD:736792 E RGD:6480464 20190219 CTD MESH:C026487 benzo(e)pyrene results in increased methylation of ADCYAP1R1 intron PMID:30157460 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:34631 chlorpyrifos increases expression EXP E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of ADCYAP1R1 mRNA PMID:37019170 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:34674 dextran sulfate multiple interactions EXP E RGD:6480464 20190702 CTD MESH:D016264 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADCYAP1R1 mRNA PMID:29950665 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:34687 dibutyl phthalate decreases expression EXP E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ADCYAP1R1 mRNA PMID:21266533 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:34905 paraquat increases expression ISO RGD:2038 E RGD:6480464 20210907 CTD MESH:D010269 Paraquat results in increased expression of ADCYAP1R1 mRNA PMID:32680482 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:35064 alpha-Zearalanol multiple interactions ISO RGD:2038 E RGD:6480464 20240430 CTD MESH:D015029 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADCYAP1R1 mRNA PMID:35163327 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:35549 perfluorooctanoic acid multiple interactions ISO RGD:2038 E RGD:6480464 20240430 CTD MESH:C023036 [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ADCYAP1R1 mRNA PMID:35163327 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:35559 furan decreases expression ISO RGD:2038 E RGD:6480464 20150414 CTD MESH:C039281 furan results in decreased expression of ADCYAP1R1 mRNA PMID:25539665 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:736792 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of ADCYAP1R1 mRNA PMID:24449571 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:39478 buta-1,3-diene decreases expression EXP E RGD:6480464 20180703 CTD MESH:C031763 1,3-butadiene results in decreased expression of ADCYAP1R1 mRNA PMID:29038090 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:736792 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of ADCYAP1R1 gene PMID:29154799 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:39867 valproic acid increases expression ISO RGD:736792 E RGD:6480464 20161025 CTD MESH:D014635 Valproic Acid results in increased expression of ADCYAP1R1 mRNA PMID:23179753|PMID:24935251|PMID:27188386 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:4027 cyclophosphamide affects expression ISO RGD:2038 E RGD:6480464 20120412 CTD MESH:D003520 Cyclophosphamide affects the expression of ADCYAP1R1 mRNA PMID:18563302 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:42588 4-hydroxyphenyl retinamide decreases expression EXP E RGD:6480464 20180220 CTD MESH:D017313 Fenretinide results in decreased expression of ADCYAP1R1 mRNA PMID:28973697 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:45716 vorinostat increases expression ISO RGD:736792 E RGD:6480464 20161213 CTD MESH:C111237 vorinostat results in increased expression of ADCYAP1R1 mRNA PMID:26272509 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:45716 vorinostat multiple interactions ISO RGD:736792 E RGD:6480464 20161213 CTD MESH:C111237 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1R1 mRNA PMID:27188386 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:45980 tacrine increases expression ISO RGD:2038 E RGD:6480464 20120412 CTD MESH:D013619 Tacrine results in increased expression of ADCYAP1R1 mRNA PMID:12832660 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:46024 trichostatin A increases expression ISO RGD:736792 E RGD:6480464 20140909 CTD MESH:C012589 trichostatin A results in increased expression of ADCYAP1R1 mRNA PMID:24935251 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:46680 serpentine asbestos decreases methylation ISO RGD:736792 E RGD:6480464 20180828 CTD MESH:D017632 Asbestos, Serpentine results in decreased methylation of ADCYAP1R1 5' UTR PMID:29523930 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:46742 Nutlin-3 multiple interactions ISO RGD:736792 E RGD:6480464 20240806 CTD MESH:C482205 [Dactinomycin co-treated with nutlin 3] results in increased expression of ADCYAP1R1 mRNA PMID:38460933 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:4953 exemestane increases expression ISO RGD:736792 E RGD:6480464 20120412 CTD MESH:C056516 exemestane results in increased expression of ADCYAP1R1 mRNA PMID:17254854 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:49639 mercury dibromide decreases expression ISO RGD:736792 E RGD:6480464 20160119 CTD MESH:C042720 mercuric bromide results in decreased expression of ADCYAP1R1 mRNA PMID:26272509 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:49639 mercury dibromide multiple interactions ISO RGD:736792 E RGD:6480464 20161025 CTD MESH:C042720 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADCYAP1R1 mRNA PMID:27188386 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:5014 fenvalerate increases expression ISO RGD:2038 E RGD:6480464 20201103 CTD MESH:C017690 fenvalerate results in increased expression of ADCYAP1R1 mRNA PMID:30307764 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:5613 haloperidol affects expression ISO RGD:736792 E RGD:6480464 20180220 CTD MESH:D006220 Haloperidol affects the expression of ADCYAP1R1 mRNA PMID:27900577 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:6820 methapyrilene increases methylation ISO RGD:736792 E RGD:6480464 20190219 CTD MESH:D008701 Methapyrilene results in increased methylation of ADCYAP1R1 intron PMID:30157460 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:71957 XL147 multiple interactions EXP E RGD:6480464 20180220 CTD MESH:C581157 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADCYAP1R1 mRNA PMID:27935865 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:72544 flavonoids decreases expression ISO RGD:2038 E RGD:6480464 20170303 CTD MESH:D005419 Flavonoids results in decreased expression of ADCYAP1R1 mRNA PMID:18035473 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:73755 1,2-dimethylhydrazine increases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of ADCYAP1R1 mRNA PMID:22206623 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:7735 olanzapine affects expression ISO RGD:736792 E RGD:6480464 20180220 CTD MESH:C076029 olanzapine affects the expression of ADCYAP1R1 mRNA PMID:27900577 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:736792 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1R1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADCYAP1R1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADCYAP1R1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1R1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1R1 mRNA PMID:27188386 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:81582 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression EXP E RGD:6480464 20240903 CTD MESH:C477694 2,2',4,4',5-brominated diphenyl ether affects the expression of ADCYAP1R1 mRNA PMID:38648751 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:8228 pioglitazone multiple interactions EXP E RGD:6480464 20180220 CTD MESH:C060836 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ADCYAP1R1 mRNA PMID:27935865 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:85990 panobinostat increases expression ISO RGD:736792 E RGD:6480464 20161228 CTD MESH:C496932 panobinostat results in increased expression of ADCYAP1R1 mRNA PMID:26272509 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:85990 panobinostat multiple interactions ISO RGD:736792 E RGD:6480464 20161228 CTD MESH:C496932 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1R1 mRNA PMID:27188386 10085 Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:736792 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1R1 mRNA; [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADCYAP1R1 mRNA; [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADCYAP1R1 mRNA; [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1R1 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCYAP1R1 mRNA PMID:27188386 10086 Add1 adducin 1 gene CHEBI:10429 beta-lapachone decreases expression ISO RGD:733925 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in decreased expression of ADD1 mRNA PMID:38218311 10086 Add1 adducin 1 gene CHEBI:132267 triptonide affects expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide affects the expression of ADD1 mRNA PMID:33045310 10086 Add1 adducin 1 gene CHEBI:1391 3,4-methylenedioxymethamphetamine decreases expression EXP E RGD:6480464 20160210 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ADD1 mRNA PMID:26251327 10086 Add1 adducin 1 gene CHEBI:15367 all-trans-retinoic acid increases expression EXP E RGD:6480464 20120412 CTD MESH:D014212 Tretinoin results in increased expression of ADD1 mRNA PMID:16604517 10086 Add1 adducin 1 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:733925 E RGD:6480464 20220208 CTD MESH:D014212 Tretinoin results in increased expression of ADD1 mRNA PMID:33167477 10086 Add1 adducin 1 gene CHEBI:15368 acrolein multiple interactions ISO RGD:733925 E RGD:6480464 20210112 CTD MESH:D000171 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ADD1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of ADD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ADD1 mRNA PMID:32699268|PMID:32845096 10086 Add1 adducin 1 gene CHEBI:15756 hexadecanoic acid increases phosphorylation ISO RGD:733925 E RGD:6480464 20190702 CTD MESH:D019308 Palmitic Acid results in increased phosphorylation of ADD1 protein PMID:28073184 10086 Add1 adducin 1 gene CHEBI:15948 lycopene decreases expression ISO RGD:733925 E RGD:6480464 20120412 CTD MESH:C015329 lycopene results in decreased expression of ADD1 mRNA PMID:16886892 10086 Add1 adducin 1 gene CHEBI:16164 pyrogallol increases expression EXP E RGD:6480464 20121218 CTD MESH:D011748 Pyrogallol results in increased expression of ADD1 mRNA PMID:20362636 10086 Add1 adducin 1 gene CHEBI:16236 ethanol multiple interactions EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol affects the expression of and affects the splicing of ADD1 mRNA PMID:30319688 10086 Add1 adducin 1 gene CHEBI:16243 quercetin increases phosphorylation ISO RGD:733925 E RGD:6480464 20221004 CTD MESH:D011794 Quercetin results in increased phosphorylation of ADD1 protein PMID:35688186 10086 Add1 adducin 1 gene CHEBI:166473 Dibutyl phosphate affects expression ISO RGD:733925 E RGD:6480464 20240604 CTD MESH:C065087 di-n-butylphosphoric acid affects the expression of ADD1 mRNA PMID:37042841 10086 Add1 adducin 1 gene CHEBI:17347 testosterone increases expression EXP E RGD:6480464 20211109 CTD MESH:D013739 Testosterone deficiency results in increased expression of ADD1 mRNA PMID:33848595 10086 Add1 adducin 1 gene CHEBI:178012 FR900359 affects phosphorylation ISO RGD:733925 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 affects the phosphorylation of ADD1 protein PMID:37730182 10086 Add1 adducin 1 gene CHEBI:17833 gentamycin decreases expression ISO RGD:2041 E RGD:6480464 20161228 CTD MESH:D005839 Gentamicins results in decreased expression of ADD1 mRNA PMID:22061828 10086 Add1 adducin 1 gene CHEBI:181914 Aflatoxin B2 alpha increases methylation ISO RGD:733925 E RGD:6480464 20211109 CTD MESH:C029753 aflatoxin B2 results in increased methylation of ADD1 polyA tail PMID:30157460 10086 Add1 adducin 1 gene CHEBI:18407 hydrogen cyanide decreases expression EXP E RGD:6480464 20211109 CTD MESH:D006856 Hydrogen Cyanide results in decreased expression of ADD1 mRNA PMID:33914522 10086 Add1 adducin 1 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:733925 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of ADD1 mRNA PMID:19549813 10086 Add1 adducin 1 gene CHEBI:23924 enzyme inhibitor multiple interactions ISO RGD:733925 E RGD:6480464 20161228 CTD MESH:D004791 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ADD1 protein PMID:23301498 10086 Add1 adducin 1 gene CHEBI:2504 aflatoxin B1 decreases methylation ISO RGD:733925 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in decreased methylation of ADD1 intron PMID:30157460 10086 Add1 adducin 1 gene CHEBI:25812 ozone multiple interactions ISO RGD:733925 E RGD:6480464 20210112 CTD MESH:D010126 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ADD1 mRNA; [Acrolein co-treated with methacrylaldehyde co-treated with Ozone] results in increased oxidation of ADD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ADD1 mRNA; [Volatile Organic Compounds co-treated with Ozone] results in decreased expression of and results in increased oxidation of ADD1 mRNA PMID:32699268|PMID:32845096 10086 Add1 adducin 1 gene CHEBI:2663 amiodarone affects expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:D000638 Amiodarone affects the expression of ADD1 mRNA PMID:19483382 10086 Add1 adducin 1 gene CHEBI:27568 selenium atom increases expression ISO RGD:733925 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in increased expression of ADD1 mRNA PMID:19244175 10086 Add1 adducin 1 gene CHEBI:27732 caffeine affects phosphorylation ISO RGD:733925 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine affects the phosphorylation of ADD1 protein PMID:35688186 10086 Add1 adducin 1 gene CHEBI:27744 glyphosate increases methylation ISO RGD:2041 E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased methylation of ADD1 gene PMID:31011160 10086 Add1 adducin 1 gene CHEBI:27889 lead(0) affects splicing ISO RGD:733925 E RGD:6480464 20171114 CTD MESH:D007854 Lead affects the splicing of ADD1 mRNA PMID:28903495 10086 Add1 adducin 1 gene CHEBI:27889 lead(0) decreases expression ISO RGD:733925 E RGD:6480464 20120412 CTD MESH:D007854 Lead results in decreased expression of ADD1 mRNA PMID:19921347 10086 Add1 adducin 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ADD1 mRNA PMID:21570461 10086 Add1 adducin 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2041 E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ADD1 mRNA PMID:21215274|PMID:34747641 10086 Add1 adducin 1 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20210209 CTD MESH:D013749 [Tetrachlorodibenzodioxin affects the methylation of ADD1 enhancer] which results in decreased expression of ADD1 mRNA PMID:33017471 10086 Add1 adducin 1 gene CHEBI:28794 coumarin increases phosphorylation ISO RGD:733925 E RGD:6480464 20221004 CTD MESH:C030123 coumarin results in increased phosphorylation of ADD1 protein PMID:35688186 10086 Add1 adducin 1 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:2041 E RGD:6480464 20190507 CTD MESH:C017947 sodium arsenite results in decreased expression of ADD1 protein PMID:29459688 10086 Add1 adducin 1 gene CHEBI:29865 benzo[a]pyrene decreases methylation ISO RGD:733925 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in decreased methylation of ADD1 promoter PMID:27901495 10086 Add1 adducin 1 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120501 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ADD1 mRNA PMID:19770486 10086 Add1 adducin 1 gene CHEBI:3023 benzbromarone affects expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:D001553 Benzbromarone affects the expression of ADD1 mRNA PMID:19483382 10086 Add1 adducin 1 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ADD1 mRNA PMID:16483693 10086 Add1 adducin 1 gene CHEBI:32234 titanium dioxide decreases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ADD1 gene PMID:35295148 10086 Add1 adducin 1 gene CHEBI:32497 thioacetamide affects expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:D013853 Thioacetamide affects the expression of ADD1 mRNA PMID:19483382 10086 Add1 adducin 1 gene CHEBI:32497 thioacetamide decreases expression ISO RGD:2041 E RGD:6480464 20220405 CTD MESH:D013853 Thioacetamide results in decreased expression of ADD1 mRNA PMID:34492290 10086 Add1 adducin 1 gene CHEBI:32509 pirinixic acid affects expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid affects the expression of ADD1 mRNA PMID:19483382 10086 Add1 adducin 1 gene CHEBI:32509 pirinixic acid decreases expression EXP E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in decreased expression of ADD1 mRNA PMID:17426115 10086 Add1 adducin 1 gene CHEBI:32509 pirinixic acid increases expression EXP E RGD:6480464 20140610 CTD MESH:C006253 pirinixic acid results in increased expression of ADD1 mRNA PMID:23811191 10086 Add1 adducin 1 gene CHEBI:32509 pirinixic acid increases expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:C006253 pirinixic acid results in increased expression of ADD1 mRNA PMID:19162173 10086 Add1 adducin 1 gene CHEBI:33128 C60 fullerene decreases expression ISO RGD:2041 E RGD:6480464 20120717 CTD MESH:C069837 fullerene C60 results in decreased expression of ADD1 mRNA PMID:19167457 10086 Add1 adducin 1 gene CHEBI:33191 potassium cyanide increases expression EXP E RGD:6480464 20211109 CTD MESH:D011190 Potassium Cyanide results in increased expression of ADD1 mRNA PMID:33914522 10086 Add1 adducin 1 gene CHEBI:33216 bisphenol A affects expression ISO RGD:2041 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A affects the expression of ADD1 mRNA PMID:25181051 10086 Add1 adducin 1 gene CHEBI:33216 bisphenol A increases expression ISO RGD:733925 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in increased expression of ADD1 mRNA; bisphenol A results in increased expression of ADD1 protein PMID:33670352|PMID:37567409 10086 Add1 adducin 1 gene CHEBI:33234 vitamin E increases expression ISO RGD:733925 E RGD:6480464 20161228 CTD MESH:D024502 Vitamin E results in increased expression of ADD1 mRNA PMID:19244175 10086 Add1 adducin 1 gene CHEBI:34572 allethrin multiple interactions ISO RGD:2041 E RGD:6480464 20230905 CTD MESH:D000487 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADD1 protein PMID:34896426 10086 Add1 adducin 1 gene CHEBI:34575 bisphenol F increases expression ISO RGD:733925 E RGD:6480464 20230307 CTD MESH:C008745 bisphenol F results in increased expression of ADD1 protein PMID:34186270 10086 Add1 adducin 1 gene CHEBI:34581 Bisphenol B increases expression ISO RGD:733925 E RGD:6480464 20230307 CTD MESH:C492482 bisphenol B results in increased expression of ADD1 protein PMID:34186270 10086 Add1 adducin 1 gene CHEBI:34631 chlorpyrifos increases expression EXP E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in increased expression of ADD1 mRNA PMID:37019170 10086 Add1 adducin 1 gene CHEBI:35591 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:D011285 Pregnenolone Carbonitrile results in increased expression of ADD1 mRNA PMID:19162173 10086 Add1 adducin 1 gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:733925 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of ADD1 mRNA PMID:24449571 10086 Add1 adducin 1 gene CHEBI:36740 alpha-pinene multiple interactions ISO RGD:733925 E RGD:6480464 20210112 CTD MESH:C005451 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of ADD1 mRNA; [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of ADD1 mRNA PMID:32699268 10086 Add1 adducin 1 gene CHEBI:36904 elemental selenium increases expression ISO RGD:733925 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in increased expression of ADD1 mRNA PMID:19244175 10086 Add1 adducin 1 gene CHEBI:3750 clofibrate affects expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:D002994 Clofibrate affects the expression of ADD1 mRNA PMID:19483382 10086 Add1 adducin 1 gene CHEBI:38658 dicrotophos increases expression ISO RGD:733925 E RGD:6480464 20170725 CTD MESH:C000944 dicrotophos results in increased expression of ADD1 mRNA PMID:28302478 10086 Add1 adducin 1 gene CHEBI:39098 pyrethrins decreases expression ISO RGD:2041 E RGD:6480464 20230905 CTD MESH:D011722 Pyrethrins results in decreased expression of ADD1 protein PMID:34896426 10086 Add1 adducin 1 gene CHEBI:39867 valproic acid affects expression ISO RGD:733925 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ADD1 mRNA PMID:25979313 10086 Add1 adducin 1 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:733925 E RGD:6480464 20120412 CTD MESH:D016572 Cyclosporine results in decreased expression of ADD1 mRNA PMID:20106945 10086 Add1 adducin 1 gene CHEBI:4035 cyhalothrin multiple interactions ISO RGD:2041 E RGD:6480464 20230905 CTD MESH:C037304 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADD1 protein PMID:34896426 10086 Add1 adducin 1 gene CHEBI:4042 cypermethrin multiple interactions ISO RGD:2041 E RGD:6480464 20230905 CTD MESH:C017160 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADD1 protein PMID:34896426 10086 Add1 adducin 1 gene CHEBI:44185 methotrexate increases expression ISO RGD:733925 E RGD:6480464 20151110 CTD MESH:D008727 Methotrexate results in increased expression of ADD1 mRNA PMID:24449571 10086 Add1 adducin 1 gene CHEBI:44445 nimesulide increases expression ISO RGD:2041 E RGD:6480464 20160412 CTD MESH:C012655 nimesulide results in increased expression of ADD1 mRNA PMID:24136188 10086 Add1 adducin 1 gene CHEBI:46195 paracetamol decreases expression EXP E RGD:6480464 20120412 CTD MESH:D000082 Acetaminophen results in decreased expression of ADD1 mRNA PMID:11264010 10086 Add1 adducin 1 gene CHEBI:46195 paracetamol increases expression ISO RGD:733925 E RGD:6480464 20121009 CTD MESH:D000082 Acetaminophen results in increased expression of ADD1 mRNA PMID:22230336 10086 Add1 adducin 1 gene CHEBI:46661 asbestos affects expression ISO RGD:733925 E RGD:6480464 20120412 CTD MESH:D001194 Asbestos affects the expression of ADD1 mRNA PMID:17297452 10086 Add1 adducin 1 gene CHEBI:4791 endosulfan decreases expression ISO RGD:2041 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of ADD1 mRNA PMID:29391264 10086 Add1 adducin 1 gene CHEBI:48843 disodium selenite increases expression ISO RGD:733925 E RGD:6480464 20120412 CTD MESH:D018038 Sodium Selenite results in increased expression of ADD1 mRNA PMID:18175754 10086 Add1 adducin 1 gene CHEBI:4886 L-ethionine affects expression ISO RGD:2041 E RGD:6480464 20121106 CTD MESH:D005001 Ethionine affects the expression of ADD1 mRNA PMID:19483382 10086 Add1 adducin 1 gene CHEBI:49747 methylmercury(1+) increases expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:C030957 methylmercury II results in increased expression of ADD1 mRNA PMID:17905399 10086 Add1 adducin 1 gene CHEBI:5014 fenvalerate increases expression ISO RGD:2041 E RGD:6480464 20201103 CTD MESH:C017690 fenvalerate results in increased expression of ADD1 mRNA PMID:30307764 10086 Add1 adducin 1 gene CHEBI:5014 fenvalerate multiple interactions ISO RGD:2041 E RGD:6480464 20230905 CTD MESH:C017690 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADD1 protein PMID:34896426 10086 Add1 adducin 1 gene CHEBI:5062 finasteride increases expression ISO RGD:2041 E RGD:6480464 20160412 CTD MESH:D018120 Finasteride results in increased expression of ADD1 mRNA PMID:24136188 10086 Add1 adducin 1 gene CHEBI:5132 flutamide increases expression ISO RGD:2041 E RGD:6480464 20160412 CTD MESH:D005485 Flutamide results in increased expression of ADD1 mRNA PMID:24136188 10086 Add1 adducin 1 gene CHEBI:6078 ivermectin decreases expression ISO RGD:733925 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ADD1 protein PMID:32959892 10086 Add1 adducin 1 gene CHEBI:72754 bisphenol AF increases expression ISO RGD:733925 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of ADD1 protein PMID:34186270 10086 Add1 adducin 1 gene CHEBI:73755 1,2-dimethylhydrazine increases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in increased expression of ADD1 mRNA PMID:22206623 10086 Add1 adducin 1 gene CHEBI:7494 nefazodone increases expression ISO RGD:2041 E RGD:6480464 20160412 CTD MESH:C051752 nefazodone results in increased expression of ADD1 mRNA PMID:24136188 10086 Add1 adducin 1 gene CHEBI:75701 sarin decreases expression ISO RGD:733925 E RGD:6480464 20131112 CTD MESH:D012524 Sarin results in decreased expression of ADD1 mRNA PMID:19522546 10086 Add1 adducin 1 gene CHEBI:77260 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression ISO RGD:2041 E RGD:6480464 20140805 CTD MESH:D009853 Omeprazole affects the expression of ADD1 mRNA PMID:19483382 10086 Add1 adducin 1 gene CHEBI:7772 omeprazole affects expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:D009853 Omeprazole affects the expression of ADD1 mRNA PMID:19483382 10086 Add1 adducin 1 gene CHEBI:81892 Brodifacoum decreases expression ISO RGD:2041 E RGD:6480464 20171114 CTD MESH:C013418 bromfenacoum results in decreased expression of ADD1 protein PMID:28903499 10086 Add1 adducin 1 gene CHEBI:8489 propiconazole decreases expression EXP E RGD:6480464 20120412 CTD MESH:C045950 propiconazole results in decreased expression of ADD1 mRNA PMID:19363144|PMID:21278054 10086 Add1 adducin 1 gene CHEBI:8502 6-propyl-2-thiouracil affects expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:D011441 Propylthiouracil affects the expression of ADD1 mRNA PMID:19483382 10086 Add1 adducin 1 gene CHEBI:9352 sulindac increases expression ISO RGD:2041 E RGD:6480464 20160412 CTD MESH:D013467 Sulindac results in increased expression of ADD1 mRNA PMID:24136188 10086 Add1 adducin 1 gene CHEBI:957 2,6-dinitrotoluene affects expression ISO RGD:2041 E RGD:6480464 20120412 CTD MESH:C023514 2,6-dinitrotoluene affects the expression of ADD1 mRNA PMID:21346803 10086 Add1 adducin 1 gene CHEBI:9986 vinclozolin affects expression ISO RGD:2041 E RGD:6480464 20141111 CTD MESH:C025643 vinclozolin affects the expression of ADD1 mRNA PMID:19015723 10087 Add2 adducin 2 gene CHEBI:132267 triptonide increases expression EXP E RGD:6480464 20210406 CTD MESH:C084079 triptonide results in increased expression of ADD2 mRNA PMID:33045310 10087 Add2 adducin 2 gene CHEBI:136608 Theaflavin 3,3'-digallate affects expression ISO RGD:736575 E RGD:6480464 20240402 CTD MESH:C585473 theaflavin-3,3'-digallate affects the expression of ADD2 mRNA PMID:34925699 10087 Add2 adducin 2 gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases expression EXP E RGD:6480464 20120918 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ADD2 mRNA PMID:20188158 10087 Add2 adducin 2 gene CHEBI:15743 butanal increases expression ISO RGD:736575 E RGD:6480464 20150825 CTD MESH:C018475 butyraldehyde results in increased expression of ADD2 mRNA PMID:26079696 10087 Add2 adducin 2 gene CHEBI:15930 atrazine affects methylation ISO RGD:2042 E RGD:6480464 20230905 CTD MESH:D001280 Atrazine affects the methylation of ADD2 gene PMID:35440735 10087 Add2 adducin 2 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:2042 E RGD:6480464 20230606 CTD MESH:D004958 Estradiol results in increased expression of ADD2 mRNA PMID:32145629 10087 Add2 adducin 2 gene CHEBI:16469 17beta-estradiol multiple interactions ISO RGD:736575 E RGD:6480464 20190611 CTD MESH:D004958 [Estradiol co-treated with TGFB1 protein] results in increased expression of ADD2 mRNA PMID:30165855 10087 Add2 adducin 2 gene CHEBI:16573 carbonyl sulfide decreases expression ISO RGD:2042 E RGD:6480464 20121009 CTD MESH:C010063 carbonyl sulfide results in decreased expression of ADD2 mRNA PMID:19395590 10087 Add2 adducin 2 gene CHEBI:16602 trichloroethene increases expression ISO RGD:2042 E RGD:6480464 20211207 CTD MESH:D014241 Trichloroethylene results in increased expression of ADD2 mRNA PMID:33387578 10087 Add2 adducin 2 gene CHEBI:17578 toluene decreases expression ISO RGD:736575 E RGD:6480464 20200609 CTD MESH:D014050 Toluene results in decreased expression of ADD2 mRNA PMID:26717081 10087 Add2 adducin 2 gene CHEBI:17578 toluene increases methylation ISO RGD:736575 E RGD:6480464 20200609 CTD MESH:D014050 Toluene results in increased methylation of ADD2 gene PMID:26717081 10087 Add2 adducin 2 gene CHEBI:178012 FR900359 decreases phosphorylation ISO RGD:736575 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 results in decreased phosphorylation of ADD2 protein PMID:37730182 10087 Add2 adducin 2 gene CHEBI:181914 Aflatoxin B2 alpha increases methylation ISO RGD:736575 E RGD:6480464 20211109 CTD MESH:C029753 aflatoxin B2 results in increased methylation of ADD2 intron PMID:30157460 10087 Add2 adducin 2 gene CHEBI:18258 3,3',5-triiodo-L-thyronine increases expression ISO RGD:736575 E RGD:6480464 20140408 CTD MESH:D014284 Triiodothyronine results in increased expression of ADD2 mRNA PMID:23397585 10087 Add2 adducin 2 gene CHEBI:25812 ozone multiple interactions EXP E RGD:6480464 20230704 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ADD2 mRNA PMID:27106289 10087 Add2 adducin 2 gene CHEBI:27385 tetrachloromethane decreases expression ISO RGD:2042 E RGD:6480464 20190507 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ADD2 mRNA PMID:30723492 10087 Add2 adducin 2 gene CHEBI:27684 phenylmercury acetate decreases expression ISO RGD:736575 E RGD:6480464 20160119 CTD MESH:D010662 Phenylmercuric Acetate results in decreased expression of ADD2 mRNA PMID:26272509 10087 Add2 adducin 2 gene CHEBI:27684 phenylmercury acetate multiple interactions ISO RGD:736575 E RGD:6480464 20161025 CTD MESH:D010662 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADD2 mRNA PMID:27188386 10087 Add2 adducin 2 gene CHEBI:27856 acetamide decreases expression ISO RGD:2042 E RGD:6480464 20200519 CTD MESH:C030686 acetamide results in decreased expression of ADD2 mRNA PMID:31881176 10087 Add2 adducin 2 gene CHEBI:28088 genistein decreases expression EXP E RGD:6480464 20200804 CTD MESH:D019833 Genistein results in decreased expression of ADD2 mRNA PMID:32186404 10087 Add2 adducin 2 gene CHEBI:28088 genistein multiple interactions ISO RGD:736575 E RGD:6480464 20120412 CTD MESH:D019833 [Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ADD2 mRNA PMID:16963248 10087 Add2 adducin 2 gene CHEBI:28197 daidzein multiple interactions ISO RGD:736575 E RGD:6480464 20120412 CTD MESH:C004742 [Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ADD2 mRNA PMID:16963248 10087 Add2 adducin 2 gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:736575 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of ADD2 mRNA PMID:33212167 10087 Add2 adducin 2 gene CHEBI:28619 acrylamide decreases expression ISO RGD:2042 E RGD:6480464 20180410 CTD MESH:D020106 Acrylamide results in decreased expression of ADD2 mRNA PMID:28959563 10087 Add2 adducin 2 gene CHEBI:28694 copper atom increases expression ISO RGD:2042 E RGD:6480464 20151013 CTD MESH:D003300 Copper deficiency results in increased expression of ADD2 mRNA PMID:26033743 10087 Add2 adducin 2 gene CHEBI:28694 copper atom multiple interactions ISO RGD:2042 E RGD:6480464 20151013 CTD MESH:D003300 [Copper co-treated with Dietary Sucrose] results in increased expression of ADD2 mRNA PMID:26033743 10087 Add2 adducin 2 gene CHEBI:28748 doxorubicin decreases expression ISO RGD:736575 E RGD:6480464 20181113 CTD MESH:D004317 Doxorubicin results in decreased expression of ADD2 mRNA PMID:29803840 10087 Add2 adducin 2 gene CHEBI:29678 sodium arsenite affects methylation ISO RGD:736575 E RGD:6480464 20171114 CTD MESH:C017947 sodium arsenite affects the methylation of ADD2 gene PMID:28589171 10087 Add2 adducin 2 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:736575 E RGD:6480464 20240702 CTD MESH:C017947 sodium arsenite results in decreased expression of ADD2 mRNA PMID:38568856 10087 Add2 adducin 2 gene CHEBI:29678 sodium arsenite increases expression EXP E RGD:6480464 20240206 CTD MESH:C017947 sodium arsenite results in increased expression of ADD2 mRNA PMID:37682722 10087 Add2 adducin 2 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:736575 E RGD:6480464 20190611 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ADD2 mRNA PMID:30453624 10087 Add2 adducin 2 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:736575 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ADD2 promoter PMID:27901495 10087 Add2 adducin 2 gene CHEBI:29866 arsenite(3-) increases expression EXP E RGD:6480464 20210504 CTD MESH:C015001 arsenite results in increased expression of ADD2 mRNA PMID:33053406 10087 Add2 adducin 2 gene CHEBI:30052 copper(0) increases expression ISO RGD:2042 E RGD:6480464 20151013 CTD MESH:D003300 Copper deficiency results in increased expression of ADD2 mRNA PMID:26033743 10087 Add2 adducin 2 gene CHEBI:30052 copper(0) multiple interactions ISO RGD:2042 E RGD:6480464 20151013 CTD MESH:D003300 [Copper co-treated with Dietary Sucrose] results in increased expression of ADD2 mRNA PMID:26033743 10087 Add2 adducin 2 gene CHEBI:30563 silicon dioxide increases expression ISO RGD:736575 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in increased expression of ADD2 mRNA PMID:25895662 10087 Add2 adducin 2 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2042 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ADD2 mRNA PMID:16483693 10087 Add2 adducin 2 gene CHEBI:31941 oxaliplatin multiple interactions ISO RGD:2042 E RGD:6480464 20161213 CTD MESH:C030110 [oxaliplatin co-treated with Topotecan] results in decreased expression of ADD2 mRNA PMID:25729387 10087 Add2 adducin 2 gene CHEBI:32234 titanium dioxide decreases expression ISO RGD:2042 E RGD:6480464 20181113 CTD MESH:C009495 titanium dioxide results in decreased expression of ADD2 mRNA PMID:30012374 10087 Add2 adducin 2 gene CHEBI:33007 chromium(6+) multiple interactions ISO RGD:736575 E RGD:6480464 20240702 CTD MESH:C074702 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of ADD2 mRNA PMID:38479592 10087 Add2 adducin 2 gene CHEBI:33216 bisphenol A decreases expression EXP E RGD:6480464 20230207 CTD MESH:C006780 bisphenol A results in decreased expression of ADD2 mRNA PMID:32156529 10087 Add2 adducin 2 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2042 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in decreased expression of ADD2 mRNA PMID:25181051 10087 Add2 adducin 2 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:736575 E RGD:6480464 20220208 CTD MESH:C006780 bisphenol A results in decreased expression of ADD2 mRNA; bisphenol A results in decreased expression of ADD2 protein PMID:33670352|PMID:37567409 10087 Add2 adducin 2 gene CHEBI:33216 bisphenol A increases expression ISO RGD:2042 E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in increased expression of ADD2 mRNA PMID:30816183|PMID:32145629|PMID:32528016|PMID:34947998 10087 Add2 adducin 2 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:2042 E RGD:6480464 20230307 CTD MESH:C006780 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ADD2 mRNA PMID:36041667 10087 Add2 adducin 2 gene CHEBI:33418 graphite affects expression ISO RGD:2042 E RGD:6480464 20181113 CTD MESH:D006108 Graphite affects the expression of ADD2 mRNA PMID:29933104 10087 Add2 adducin 2 gene CHEBI:34031 1,1-dichloroethene increases expression EXP E RGD:6480464 20170725 CTD MESH:C029297 vinylidene chloride results in increased expression of ADD2 mRNA PMID:26682919 10087 Add2 adducin 2 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases expression EXP E RGD:6480464 20191112 CTD MESH:C543008 bisphenol S results in decreased expression of ADD2 mRNA PMID:30951980 10087 Add2 adducin 2 gene CHEBI:34372 4,4'-sulfonyldiphenol multiple interactions ISO RGD:2042 E RGD:6480464 20230307 CTD MESH:C543008 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ADD2 mRNA PMID:36041667 10087 Add2 adducin 2 gene CHEBI:34575 bisphenol F multiple interactions ISO RGD:2042 E RGD:6480464 20230307 CTD MESH:C008745 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ADD2 mRNA PMID:36041667 10087 Add2 adducin 2 gene CHEBI:34631 chlorpyrifos decreases expression EXP E RGD:6480464 20230606 CTD MESH:D004390 Chlorpyrifos results in decreased expression of ADD2 mRNA PMID:37019170 10087 Add2 adducin 2 gene CHEBI:34778 glycitein multiple interactions ISO RGD:736575 E RGD:6480464 20141104 CTD MESH:C086566 [Genistein co-treated with daidzein co-treated with glycitein] results in decreased expression of ADD2 mRNA PMID:16963248 10087 Add2 adducin 2 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:736575 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ADD2 mRNA PMID:37042841 10087 Add2 adducin 2 gene CHEBI:35455 1-naphthyl isothiocyanate decreases expression ISO RGD:2042 E RGD:6480464 20190507 CTD MESH:D015058 1-Naphthylisothiocyanate results in decreased expression of ADD2 mRNA PMID:30723492 10087 Add2 adducin 2 gene CHEBI:35456 cadmium dichloride increases expression ISO RGD:2042 E RGD:6480464 20210504 CTD MESH:D019256 Cadmium Chloride results in increased expression of ADD2 mRNA PMID:33453195 10087 Add2 adducin 2 gene CHEBI:35842 antirheumatic drug decreases expression ISO RGD:736575 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in decreased expression of ADD2 mRNA PMID:24449571 10087 Add2 adducin 2 gene CHEBI:39867 valproic acid decreases expression ISO RGD:736575 E RGD:6480464 20160119 CTD MESH:D014635 Valproic Acid results in decreased expression of ADD2 mRNA PMID:23179753|PMID:24935251|PMID:26272509 10087 Add2 adducin 2 gene CHEBI:39867 valproic acid decreases methylation ISO RGD:736575 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in decreased methylation of ADD2 gene PMID:29154799 10087 Add2 adducin 2 gene CHEBI:39867 valproic acid increases expression ISO RGD:736575 E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid results in increased expression of ADD2 mRNA PMID:19101580 10087 Add2 adducin 2 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:736575 E RGD:6480464 20161025 CTD MESH:D014635 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADD2 mRNA PMID:27188386 10087 Add2 adducin 2 gene CHEBI:45716 vorinostat multiple interactions ISO RGD:736575 E RGD:6480464 20161213 CTD MESH:C111237 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADD2 mRNA PMID:27188386 10087 Add2 adducin 2 gene CHEBI:46024 trichostatin A decreases expression ISO RGD:736575 E RGD:6480464 20140909 CTD MESH:C012589 trichostatin A results in decreased expression of ADD2 mRNA PMID:24935251 10087 Add2 adducin 2 gene CHEBI:4791 endosulfan decreases expression ISO RGD:2042 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of ADD2 mRNA PMID:29391264 10087 Add2 adducin 2 gene CHEBI:53444 potassium dichromate affects expression EXP E RGD:6480464 20140610 CTD MESH:D011192 Potassium Dichromate affects the expression of ADD2 mRNA PMID:23608068 10087 Add2 adducin 2 gene CHEBI:6078 ivermectin decreases expression ISO RGD:736575 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ADD2 protein PMID:32959892 10087 Add2 adducin 2 gene CHEBI:6121 ketamine decreases expression ISO RGD:2042 E RGD:6480464 20121218 CTD MESH:D007649 Ketamine results in decreased expression of ADD2 mRNA PMID:20080153 10087 Add2 adducin 2 gene CHEBI:63041 manganese(II) chloride increases expression ISO RGD:2042 E RGD:6480464 20190219 CTD MESH:C025340 manganese chloride results in increased expression of ADD2 mRNA PMID:28801915 10087 Add2 adducin 2 gene CHEBI:63632 topotecan decreases expression ISO RGD:2042 E RGD:6480464 20160315 CTD MESH:D019772 Topotecan results in decreased expression of ADD2 mRNA PMID:25729387 10087 Add2 adducin 2 gene CHEBI:63632 topotecan multiple interactions ISO RGD:2042 E RGD:6480464 20160315 CTD MESH:D019772 [oxaliplatin co-treated with Topotecan] results in decreased expression of ADD2 mRNA PMID:25729387 10087 Add2 adducin 2 gene CHEBI:63921 2-butoxyethanol increases expression EXP E RGD:6480464 20120412 CTD MESH:C017096 n-butoxyethanol results in increased expression of ADD2 mRNA PMID:19812364 10087 Add2 adducin 2 gene CHEBI:64090 tert-butyl hydroperoxide increases expression ISO RGD:736575 E RGD:6480464 20120412 CTD MESH:D020122 tert-Butylhydroperoxide results in increased expression of ADD2 mRNA PMID:15336504 10087 Add2 adducin 2 gene CHEBI:6809 methamphetamine increases expression ISO RGD:2042 E RGD:6480464 20151215 CTD MESH:D008694 Methamphetamine results in increased expression of ADD2 mRNA PMID:19564919 10087 Add2 adducin 2 gene CHEBI:7590 nitrofen increases expression ISO RGD:2042 E RGD:6480464 20210810 CTD MESH:C007350 nitrofen results in increased expression of ADD2 mRNA PMID:33484710 10087 Add2 adducin 2 gene CHEBI:78510 dorsomorphin multiple interactions ISO RGD:736575 E RGD:6480464 20161228 CTD MESH:C516138 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADD2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADD2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADD2 mRNA PMID:27188386 10087 Add2 adducin 2 gene CHEBI:8502 6-propyl-2-thiouracil increases expression ISO RGD:2042 E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in increased expression of ADD2 mRNA PMID:24780913|PMID:36843608 10087 Add2 adducin 2 gene CHEBI:91108 SB 431542 multiple interactions ISO RGD:736575 E RGD:6480464 20161220 CTD MESH:C459179 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADD2 mRNA; [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADD2 mRNA; [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADD2 mRNA PMID:27188386 10087 Add2 adducin 2 gene CHEBI:9495 thiram decreases expression ISO RGD:736575 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of ADD2 mRNA PMID:38568856 10088 Add3 adducin 3 gene CHEBI:10429 beta-lapachone increases expression ISO RGD:735411 E RGD:6480464 20241001 CTD MESH:C014638 beta-lapachone results in increased expression of ADD3 mRNA PMID:38218311 10088 Add3 adducin 3 gene CHEBI:116509 diuron decreases expression ISO RGD:2043 E RGD:6480464 20141223 CTD MESH:D004237 Diuron results in decreased expression of ADD3 mRNA PMID:25152437 10088 Add3 adducin 3 gene CHEBI:1391 3,4-methylenedioxymethamphetamine decreases expression EXP E RGD:6480464 20160210 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ADD3 mRNA PMID:26251327 10088 Add3 adducin 3 gene CHEBI:1391 3,4-methylenedioxymethamphetamine increases methylation EXP E RGD:6480464 20160210 CTD MESH:D018817 N-Methyl-3,4-methylenedioxyamphetamine results in increased methylation of ADD3 promoter PMID:26251327 10088 Add3 adducin 3 gene CHEBI:15354 choline multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D002794 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADD3 gene PMID:20938992 10088 Add3 adducin 3 gene CHEBI:15367 all-trans-retinoic acid increases expression ISO RGD:735411 E RGD:6480464 20160607 CTD MESH:D014212 Tretinoin results in increased expression of ADD3 mRNA PMID:16054129|PMID:16140955|PMID:23724009|PMID:23830798|PMID:33167477 10088 Add3 adducin 3 gene CHEBI:16236 ethanol increases expression EXP E RGD:6480464 20190507 CTD MESH:D000431 Ethanol results in increased expression of ADD3 mRNA PMID:30319688 10088 Add3 adducin 3 gene CHEBI:16240 hydrogen peroxide increases expression ISO RGD:735411 E RGD:6480464 20120515 CTD MESH:D006861 Hydrogen Peroxide results in increased expression of ADD3 mRNA PMID:18951874 10088 Add3 adducin 3 gene CHEBI:16243 quercetin decreases expression ISO RGD:735411 E RGD:6480464 20121009 CTD MESH:D011794 Quercetin results in decreased expression of ADD3 mRNA PMID:21632981 10088 Add3 adducin 3 gene CHEBI:16412 lipopolysaccharide multiple interactions ISO RGD:735411 E RGD:6480464 20221101 CTD MESH:D008070 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ADD3 mRNA PMID:35811015 10088 Add3 adducin 3 gene CHEBI:16469 17beta-estradiol decreases expression ISO RGD:735411 E RGD:6480464 20121218 CTD MESH:D004958 Estradiol results in decreased expression of ADD3 mRNA PMID:23019147 10088 Add3 adducin 3 gene CHEBI:16469 17beta-estradiol increases expression ISO RGD:735411 E RGD:6480464 20130122 CTD MESH:D004958 Estradiol results in increased expression of ADD3 mRNA PMID:19167446|PMID:21185374 10088 Add3 adducin 3 gene CHEBI:16643 L-methionine multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D008715 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADD3 gene PMID:20938992 10088 Add3 adducin 3 gene CHEBI:17059 2-methylcholine affects expression ISO RGD:735411 E RGD:6480464 20121113 CTD MESH:C044887 beta-methylcholine affects the expression of ADD3 mRNA PMID:21179406 10088 Add3 adducin 3 gene CHEBI:17243 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:735411 E RGD:6480464 20240702 CTD MESH:C016599 mono-(2-ethylhexyl)phthalate results in decreased expression of ADD3 mRNA PMID:38685446 10088 Add3 adducin 3 gene CHEBI:177802 Cuprizon increases expression ISO RGD:2043 E RGD:6480464 20210907 CTD MESH:D003471 Cuprizone results in increased expression of ADD3 mRNA PMID:26577399 10088 Add3 adducin 3 gene CHEBI:178012 FR900359 affects phosphorylation ISO RGD:735411 E RGD:6480464 20240305 CTD MESH:C000607068 FR900359 affects the phosphorylation of ADD3 protein PMID:37730182 10088 Add3 adducin 3 gene CHEBI:17833 gentamycin decreases expression ISO RGD:2043 E RGD:6480464 20211207 CTD MESH:D005839 Gentamicins results in decreased expression of ADD3 mRNA PMID:33387578 10088 Add3 adducin 3 gene CHEBI:17833 gentamycin increases expression ISO RGD:2043 E RGD:6480464 20161228 CTD MESH:D005839 Gentamicins results in increased expression of ADD3 mRNA PMID:22061828 10088 Add3 adducin 3 gene CHEBI:23414 copper(II) sulfate decreases expression ISO RGD:735411 E RGD:6480464 20120814 CTD MESH:D019327 Copper Sulfate results in decreased expression of ADD3 mRNA PMID:19549813 10088 Add3 adducin 3 gene CHEBI:2504 aflatoxin B1 increases expression ISO RGD:2043 E RGD:6480464 20140610 CTD MESH:D016604 Aflatoxin B1 results in increased expression of ADD3 mRNA PMID:23630614 10088 Add3 adducin 3 gene CHEBI:2504 aflatoxin B1 increases methylation ISO RGD:735411 E RGD:6480464 20190219 CTD MESH:D016604 Aflatoxin B1 results in increased methylation of ADD3 intron PMID:30157460 10088 Add3 adducin 3 gene CHEBI:25812 ozone multiple interactions EXP E RGD:6480464 20220809 CTD MESH:D010126 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ADD3 mRNA PMID:34911549 10088 Add3 adducin 3 gene CHEBI:25812 ozone multiple interactions ISO RGD:735411 E RGD:6480464 20231031 CTD MESH:D010126 [Air Pollutants results in increased abundance of Ozone] which affects the expression of ADD3 mRNA PMID:35430440 10088 Add3 adducin 3 gene CHEBI:27375 vincaleukoblastine affects response to substance ISO RGD:735411 E RGD:6480464 20120412 CTD MESH:D014747 ADD3 protein affects the susceptibility to Vinblastine PMID:16217747 10088 Add3 adducin 3 gene CHEBI:27385 tetrachloromethane decreases expression EXP E RGD:6480464 20120412 CTD MESH:D002251 Carbon Tetrachloride results in decreased expression of ADD3 mRNA PMID:17484886 10088 Add3 adducin 3 gene CHEBI:27470 folic acid multiple interactions EXP E RGD:6480464 20121113 CTD MESH:D005492 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ADD3 gene PMID:20938992 10088 Add3 adducin 3 gene CHEBI:27568 selenium atom decreases expression ISO RGD:735411 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in decreased expression of ADD3 mRNA PMID:19244175 10088 Add3 adducin 3 gene CHEBI:27732 caffeine affects phosphorylation ISO RGD:735411 E RGD:6480464 20221004 CTD MESH:D002110 Caffeine affects the phosphorylation of ADD3 protein PMID:35688186 10088 Add3 adducin 3 gene CHEBI:27744 glyphosate increases methylation ISO RGD:2043 E RGD:6480464 20240206 CTD MESH:C010974 Glyphosate results in increased methylation of ADD3 gene PMID:31011160 10088 Add3 adducin 3 gene CHEBI:27881 resveratrol multiple interactions ISO RGD:735411 E RGD:6480464 20130122 CTD MESH:C059514 [Coumestrol co-treated with resveratrol] results in increased expression of ADD3 mRNA PMID:19167446 10088 Add3 adducin 3 gene CHEBI:27899 cisplatin increases expression ISO RGD:735411 E RGD:6480464 20170516 CTD MESH:D002945 Cisplatin results in increased expression of ADD3 mRNA PMID:27392435|PMID:27594783 10088 Add3 adducin 3 gene CHEBI:27899 cisplatin multiple interactions ISO RGD:735411 E RGD:6480464 20170516 CTD MESH:D002945 [Cisplatin co-treated with jinfukang] results in increased expression of ADD3 mRNA PMID:27392435 10088 Add3 adducin 3 gene CHEBI:27928 parathion increases expression ISO RGD:2043 E RGD:6480464 20120412 CTD MESH:D010278 Parathion results in increased expression of ADD3 mRNA PMID:19784758 10088 Add3 adducin 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP E RGD:6480464 20121009 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ADD3 mRNA PMID:21570461 10088 Add3 adducin 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:2043 E RGD:6480464 20220111 CTD MESH:D013749 Tetrachlorodibenzodioxin affects the expression of ADD3 mRNA PMID:34747641 10088 Add3 adducin 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:2043 E RGD:6480464 20211207 CTD MESH:D013749 Tetrachlorodibenzodioxin results in decreased expression of ADD3 mRNA PMID:33387578 10088 Add3 adducin 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP E RGD:6480464 20120412 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ADD3 mRNA PMID:19465110 10088 Add3 adducin 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735411 E RGD:6480464 20120918 CTD MESH:D013749 Tetrachlorodibenzodioxin results in increased expression of ADD3 mRNA PMID:21802500 10088 Add3 adducin 3 gene CHEBI:28119 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D013749 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADD3 mRNA; AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of ADD3 mRNA] PMID:17942748|PMID:19465110 10088 Add3 adducin 3 gene CHEBI:2825 aristolochic acid A decreases expression ISO RGD:735411 E RGD:6480464 20210608 CTD MESH:C000228 aristolochic acid I results in decreased expression of ADD3 mRNA PMID:33212167 10088 Add3 adducin 3 gene CHEBI:28619 acrylamide decreases expression ISO RGD:735411 E RGD:6480464 20210406 CTD MESH:D020106 Acrylamide results in decreased expression of ADD3 mRNA PMID:32763439 10088 Add3 adducin 3 gene CHEBI:28694 copper atom multiple interactions EXP E RGD:6480464 20120814 CTD MESH:D003300 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADD3 mRNA PMID:15467011 10088 Add3 adducin 3 gene CHEBI:28714 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression EXP E RGD:6480464 20120412 CTD MESH:D019328 Buthionine Sulfoximine results in increased expression of ADD3 mRNA PMID:15878706 10088 Add3 adducin 3 gene CHEBI:28748 doxorubicin affects response to substance ISO RGD:735411 E RGD:6480464 20120412 CTD MESH:D004317 ADD3 protein affects the susceptibility to Doxorubicin PMID:16217747 10088 Add3 adducin 3 gene CHEBI:28794 coumarin decreases phosphorylation ISO RGD:735411 E RGD:6480464 20221004 CTD MESH:C030123 coumarin results in decreased phosphorylation of ADD3 protein PMID:35688186 10088 Add3 adducin 3 gene CHEBI:28869 menadione affects expression ISO RGD:735411 E RGD:6480464 20120412 CTD MESH:D024483 Vitamin K 3 affects the expression of ADD3 mRNA PMID:20044591 10088 Add3 adducin 3 gene CHEBI:29678 sodium arsenite decreases expression ISO RGD:735411 E RGD:6480464 20211012 CTD MESH:C017947 sodium arsenite results in decreased expression of ADD3 mRNA PMID:34032870 10088 Add3 adducin 3 gene CHEBI:29678 sodium arsenite increases expression EXP E RGD:6480464 20190409 CTD MESH:C017947 sodium arsenite results in increased expression of ADD3 protein PMID:29044176 10088 Add3 adducin 3 gene CHEBI:29865 benzo[a]pyrene affects methylation ISO RGD:735411 E RGD:6480464 20190219 CTD MESH:D001564 Benzo(a)pyrene affects the methylation of ADD3 5' UTR; Benzo(a)pyrene affects the methylation of ADD3 promoter PMID:27901495|PMID:30157460 10088 Add3 adducin 3 gene CHEBI:29865 benzo[a]pyrene decreases expression EXP E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ADD3 mRNA PMID:22228805 10088 Add3 adducin 3 gene CHEBI:29865 benzo[a]pyrene decreases expression ISO RGD:735411 E RGD:6480464 20121009 CTD MESH:D001564 Benzo(a)pyrene results in decreased expression of ADD3 mRNA PMID:20106945|PMID:21632981 10088 Add3 adducin 3 gene CHEBI:29865 benzo[a]pyrene increases expression EXP E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ADD3 mRNA PMID:22228805 10088 Add3 adducin 3 gene CHEBI:29865 benzo[a]pyrene increases expression ISO RGD:735411 E RGD:6480464 20120918 CTD MESH:D001564 Benzo(a)pyrene results in increased expression of ADD3 mRNA PMID:21802500 10088 Add3 adducin 3 gene CHEBI:29865 benzo[a]pyrene increases methylation ISO RGD:735411 E RGD:6480464 20201006 CTD MESH:D001564 Benzo(a)pyrene results in increased methylation of ADD3 exon; Benzo(a)pyrene results in increased methylation of ADD3 promoter PMID:27901495 10088 Add3 adducin 3 gene CHEBI:29865 benzo[a]pyrene multiple interactions EXP E RGD:6480464 20120918 CTD MESH:D001564 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADD3 mRNA; AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ADD3 mRNA] PMID:22228805|PMID:27858113 10088 Add3 adducin 3 gene CHEBI:29866 arsenite(3-) multiple interactions ISO RGD:735411 E RGD:6480464 20220405 CTD MESH:C015001 arsenite inhibits the reaction [G3BP1 protein binds to ADD3 mRNA] PMID:32406909 10088 Add3 adducin 3 gene CHEBI:30052 copper(0) multiple interactions EXP E RGD:6480464 20120814 CTD MESH:D003300 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ADD3 mRNA PMID:15467011 10088 Add3 adducin 3 gene CHEBI:30563 silicon dioxide decreases expression ISO RGD:735411 E RGD:6480464 20160315 CTD MESH:D012822 Silicon Dioxide analog results in decreased expression of ADD3 mRNA PMID:25895662 10088 Add3 adducin 3 gene CHEBI:30614 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:735411 E RGD:6480464 20140805 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ADD3 mRNA PMID:20018196 10088 Add3 adducin 3 gene CHEBI:30614 benzo[a]pyrene diol epoxide I increases expression ISO RGD:735411 E RGD:6480464 20140805 CTD MESH:D015123 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of ADD3 mRNA PMID:19150397 10088 Add3 adducin 3 gene CHEBI:31206 ammonium chloride affects expression ISO RGD:2043 E RGD:6480464 20120412 CTD MESH:D000643 Ammonium Chloride affects the expression of ADD3 mRNA PMID:16483693 10088 Add3 adducin 3 gene CHEBI:32234 titanium dioxide decreases methylation EXP E RGD:6480464 20241001 CTD MESH:C009495 titanium dioxide results in decreased methylation of ADD3 promoter PMID:35295148 10088 Add3 adducin 3 gene CHEBI:32506 4,4'-diaminodiphenylmethane increases expression ISO RGD:2043 E RGD:6480464 20160315 CTD MESH:C009505 4,4'-diaminodiphenylmethane results in increased expression of ADD3 mRNA PMID:25380136 10088 Add3 adducin 3 gene CHEBI:32509 pirinixic acid increases expression EXP E RGD:6480464 20140610 CTD MESH:C006253 pirinixic acid results in increased expression of ADD3 mRNA PMID:18301758|PMID:23811191 10088 Add3 adducin 3 gene CHEBI:32509 pirinixic acid multiple interactions EXP E RGD:6480464 20120412 CTD MESH:C006253 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ADD3 mRNA PMID:19710929 10088 Add3 adducin 3 gene CHEBI:32888 gamma-hexachlorocyclohexane affects expression ISO RGD:2043 E RGD:6480464 20120412 CTD MESH:D001556 Hexachlorocyclohexane affects the expression of ADD3 mRNA PMID:17785943 10088 Add3 adducin 3 gene CHEBI:33216 bisphenol A decreases expression ISO RGD:2043 E RGD:6480464 20191210 CTD MESH:C006780 bisphenol A results in decreased expression of ADD3 mRNA PMID:30816183|PMID:34947998|PMID:38750585 10088 Add3 adducin 3 gene CHEBI:33216 bisphenol A decreases methylation ISO RGD:735411 E RGD:6480464 20220308 CTD MESH:C006780 bisphenol A results in decreased methylation of ADD3 gene PMID:31601247 10088 Add3 adducin 3 gene CHEBI:33216 bisphenol A increases expression ISO RGD:2043 E RGD:6480464 20150310 CTD MESH:C006780 bisphenol A results in increased expression of ADD3 mRNA PMID:25181051 10088 Add3 adducin 3 gene CHEBI:33216 bisphenol A increases expression ISO RGD:735411 E RGD:6480464 20230307 CTD MESH:C006780 bisphenol A results in increased expression of ADD3 protein PMID:34186270|PMID:37567409 10088 Add3 adducin 3 gene CHEBI:33216 bisphenol A multiple interactions ISO RGD:735411 E RGD:6480464 20180116 CTD MESH:C006780 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ADD3 mRNA PMID:28628672 10088 Add3 adducin 3 gene CHEBI:33234 vitamin E decreases expression ISO RGD:735411 E RGD:6480464 20161228 CTD MESH:D024502 Vitamin E results in decreased expression of ADD3 mRNA PMID:19244175 10088 Add3 adducin 3 gene CHEBI:34031 1,1-dichloroethene decreases expression EXP E RGD:6480464 20170725 CTD MESH:C029297 vinylidene chloride results in decreased expression of ADD3 mRNA PMID:26682919 10088 Add3 adducin 3 gene CHEBI:34317 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:2043 E RGD:6480464 20140408 CTD MESH:C023035 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of ADD3 mRNA PMID:23196670 10088 Add3 adducin 3 gene CHEBI:34372 4,4'-sulfonyldiphenol decreases methylation ISO RGD:735411 E RGD:6480464 20220308 CTD MESH:C543008 bisphenol S results in decreased methylation of ADD3 gene PMID:31601247 10088 Add3 adducin 3 gene CHEBI:34565 benzo[b]fluoranthene increases expression EXP E RGD:6480464 20160119 CTD MESH:C006703 benzo(b)fluoranthene results in increased expression of ADD3 mRNA PMID:26377693 10088 Add3 adducin 3 gene CHEBI:34565 benzo[b]fluoranthene multiple interactions EXP E RGD:6480464 20170516 CTD MESH:C006703 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADD3 mRNA PMID:27858113 10088 Add3 adducin 3 gene CHEBI:34687 dibutyl phthalate decreases expression ISO RGD:2043 E RGD:6480464 20120412 CTD MESH:D003993 Dibutyl Phthalate results in decreased expression of ADD3 mRNA PMID:21266533 10088 Add3 adducin 3 gene CHEBI:34795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:735411 E RGD:6480464 20180116 CTD MESH:D015056 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ADD3 mRNA PMID:28628672 10088 Add3 adducin 3 gene CHEBI:35033 triphenyl phosphate affects expression ISO RGD:735411 E RGD:6480464 20240604 CTD MESH:C005445 triphenyl phosphate affects the expression of ADD3 mRNA PMID:37042841 10088 Add3 adducin 3 gene CHEBI:35455 1-naphthyl isothiocyanate increases expression ISO RGD:2043 E RGD:6480464 20160315 CTD MESH:D015058 1-Naphthylisothiocyanate results in increased expression of ADD3 mRNA PMID:25380136 10088 Add3 adducin 3 gene CHEBI:35456 cadmium dichloride decreases expression ISO RGD:735411 E RGD:6480464 20240702 CTD MESH:D019256 Cadmium Chloride results in decreased expression of ADD3 mRNA PMID:38568856 10088 Add3 adducin 3 gene CHEBI:35559 furan increases expression ISO RGD:2043 E RGD:6480464 20170516 CTD MESH:C039281 furan results in increased expression of ADD3 mRNA PMID:27387713 10088 Add3 adducin 3 gene CHEBI:35696 cobalt dichloride increases expression ISO RGD:735411 E RGD:6480464 20120814 CTD MESH:C018021 cobaltous chloride results in increased expression of ADD3 mRNA PMID:19376846 10088 Add3 adducin 3 gene CHEBI:35807 N-nitrosodimethylamine increases expression ISO RGD:2043 E RGD:6480464 20160315 CTD MESH:D004128 Dimethylnitrosamine results in increased expression of ADD3 mRNA PMID:25380136 10088 Add3 adducin 3 gene CHEBI:35842 antirheumatic drug increases expression ISO RGD:735411 E RGD:6480464 20161228 CTD MESH:D018501 Antirheumatic Agents results in increased expression of ADD3 mRNA PMID:24449571 10088 Add3 adducin 3 gene CHEBI:36904 elemental selenium decreases expression ISO RGD:735411 E RGD:6480464 20120412 CTD MESH:D012643 Selenium results in decreased expression of ADD3 mRNA PMID:19244175 10088 Add3 adducin 3 gene CHEBI:38746 parathion-methyl affects expression ISO RGD:2043 E RGD:6480464 20120412 CTD MESH:D008743 Methyl Parathion affects the expression of ADD3 mRNA PMID:19784758 10088 Add3 adducin 3 gene CHEBI:38746 parathion-methyl decreases expression ISO RGD:2043 E RGD:6480464 20120412 CTD MESH:D008743 Methyl Parathion results in decreased expression of ADD3 mRNA PMID:19784758 10088 Add3 adducin 3 gene CHEBI:38746 parathion-methyl increases expression ISO RGD:2043 E RGD:6480464 20120412 CTD MESH:D008743 Methyl Parathion results in increased expression of ADD3 mRNA PMID:19784758 10088 Add3 adducin 3 gene CHEBI:38940 sunitinib increases expression ISO RGD:735411 E RGD:6480464 20191210 CTD MESH:C473478 Sunitinib results in increased expression of ADD3 mRNA PMID:31533062 10088 Add3 adducin 3 gene CHEBI:3908 coumestrol increases expression ISO RGD:735411 E RGD:6480464 20130409 CTD MESH:D003375 Coumestrol results in increased expression of ADD3 mRNA PMID:19167446 10088 Add3 adducin 3 gene CHEBI:3908 coumestrol multiple interactions ISO RGD:735411 E RGD:6480464 20130409 CTD MESH:D003375 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADD3 mRNA; [Coumestrol co-treated with resveratrol] results in increased expression of ADD3 mRNA PMID:19167446 10088 Add3 adducin 3 gene CHEBI:39481 chloroprene increases expression ISO RGD:2043 E RGD:6480464 20130514 CTD MESH:D002737 Chloroprene results in increased expression of ADD3 mRNA PMID:23125180 10088 Add3 adducin 3 gene CHEBI:39867 valproic acid affects expression EXP E RGD:6480464 20120412 CTD MESH:D014635 Valproic Acid affects the expression of ADD3 mRNA PMID:17963808 10088 Add3 adducin 3 gene CHEBI:39867 valproic acid affects expression ISO RGD:735411 E RGD:6480464 20151013 CTD MESH:D014635 Valproic Acid affects the expression of ADD3 mRNA PMID:25979313 10088 Add3 adducin 3 gene CHEBI:39867 valproic acid increases expression ISO RGD:735411 E RGD:6480464 20200915 CTD MESH:D014635 Valproic Acid results in increased expression of ADD3 mRNA PMID:32623605 10088 Add3 adducin 3 gene CHEBI:39867 valproic acid increases methylation ISO RGD:735411 E RGD:6480464 20180410 CTD MESH:D014635 Valproic Acid results in increased methylation of ADD3 gene PMID:29154799 10088 Add3 adducin 3 gene CHEBI:39867 valproic acid multiple interactions ISO RGD:735411 E RGD:6480464 20200915 CTD MESH:D014635 CEBPA protein affects the reaction [Valproic Acid results in increased expression of ADD3 mRNA] PMID:32623605 10088 Add3 adducin 3 gene CHEBI:4031 cyclosporin A decreases expression ISO RGD:735411 E RGD:6480464 20150825 CTD MESH:D016572 Cyclosporine results in decreased expression of ADD3 mRNA PMID:20106945|PMID:25562108|PMID:27989131 10088 Add3 adducin 3 gene CHEBI:41774 tamoxifen increases expression ISO RGD:2043 E RGD:6480464 20120717 CTD MESH:D013629 Tamoxifen results in increased expression of ADD3 protein modified form PMID:17901229 10088 Add3 adducin 3 gene CHEBI:41879 dexamethasone increases expression ISO RGD:735411 E RGD:6480464 20160705 CTD MESH:D003907 Dexamethasone results in increased expression of ADD3 mRNA PMID:25047013 10088 Add3 adducin 3 gene CHEBI:41879 dexamethasone multiple interactions ISO RGD:735411 E RGD:6480464 20180116 CTD MESH:D003907 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ADD3 mRNA PMID:28628672 10088 Add3 adducin 3 gene CHEBI:45863 paclitaxel affects response to substance ISO RGD:735411 E RGD:6480464 20161213 CTD MESH:D017239 ADD3 protein affects the susceptibility to Paclitaxel PMID:16217747 10088 Add3 adducin 3 gene CHEBI:46024 trichostatin A increases expression ISO RGD:2043 E RGD:6480464 20171010 CTD MESH:C012589 trichostatin A results in increased expression of ADD3 mRNA PMID:12445420 10088 Add3 adducin 3 gene CHEBI:46195 paracetamol increases expression ISO RGD:2043 E RGD:6480464 20211207 CTD MESH:D000082 Acetaminophen results in increased expression of ADD3 mRNA PMID:33387578 10088 Add3 adducin 3 gene CHEBI:46195 paracetamol increases expression ISO RGD:735411 E RGD:6480464 20121009 CTD MESH:D000082 Acetaminophen results in increased expression of ADD3 mRNA PMID:22230336 10088 Add3 adducin 3 gene CHEBI:46345 5-fluorouracil affects response to substance ISO RGD:735411 E RGD:6480464 20120412 CTD MESH:D005472 ADD3 protein affects the susceptibility to Fluorouracil PMID:16217747 10088 Add3 adducin 3 gene CHEBI:46650 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:735411 E RGD:6480464 20221101 CTD MESH:C039961 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of ADD3 mRNA PMID:35811015 10088 Add3 adducin 3 gene CHEBI:4791 endosulfan decreases expression ISO RGD:2043 E RGD:6480464 20180828 CTD MESH:D004726 Endosulfan results in decreased expression of ADD3 mRNA PMID:29391264 10088 Add3 adducin 3 gene CHEBI:4903 17alpha-ethynylestradiol decreases expression ISO RGD:2043 E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in decreased expression of ADD3 mRNA PMID:15576828|PMID:17557909 10088 Add3 adducin 3 gene CHEBI:4903 17alpha-ethynylestradiol increases expression EXP E RGD:6480464 20120412 CTD MESH:D004997 Ethinyl Estradiol results in increased expression of ADD3 mRNA PMID:17942748 10088 Add3 adducin 3 gene CHEBI:4903 17alpha-ethynylestradiol multiple interactions EXP E RGD:6480464 20120412 CTD MESH:D004997 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ADD3 mRNA PMID:17942748 10088 Add3 adducin 3 gene CHEBI:49553 copper(II) chloride decreases expression ISO RGD:735411 E RGD:6480464 20240702 CTD MESH:C029892 cupric chloride results in decreased expression of ADD3 mRNA PMID:38568856 10088 Add3 adducin 3 gene CHEBI:49662 indometacin multiple interactions ISO RGD:735411 E RGD:6480464 20180116 CTD MESH:D007213 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ADD3 mRNA PMID:28628672 10088 Add3 adducin 3 gene CHEBI:50594 carbon nanotube decreases expression EXP E RGD:6480464 20161228 CTD MESH:D037742 Nanotubes, Carbon analog results in decreased expression of ADD3 mRNA; Nanotubes, Carbon results in decreased expression of ADD3 mRNA PMID:25554681 10088 Add3 adducin 3 gene CHEBI:50859 bexarotene increases expression ISO RGD:735411 E RGD:6480464 20170303 CTD MESH:C095105 bexarotene results in increased expression of ADD3 mRNA PMID:17178900 10088 Add3 adducin 3 gene CHEBI:51348 tetraphene multiple interactions EXP E RGD:6480464 20170516 CTD MESH:C030935 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADD3 mRNA PMID:27858113 10088 Add3 adducin 3 gene CHEBI:51687 chrysene multiple interactions EXP E RGD:6480464 20170516 CTD MESH:C031180 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ADD3 mRNA PMID:27858113 10088 Add3 adducin 3 gene CHEBI:53001 nickel sulfate decreases expression ISO RGD:735411 E RGD:6480464 20120717 CTD MESH:C029938 nickel sulfate results in decreased expression of ADD3 mRNA PMID:18651567 10088 Add3 adducin 3 gene CHEBI:6078 ivermectin decreases expression ISO RGD:735411 E RGD:6480464 20210907 CTD MESH:D007559 Ivermectin results in decreased expression of ADD3 protein PMID:32959892 10088 Add3 adducin 3 gene CHEBI:63623 succimer multiple interactions EXP E RGD:6480464 20120918 CTD MESH:D004113 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ADD3 mRNA PMID:21641980 10088 Add3 adducin 3 gene CHEBI:63632 topotecan affects response to substance ISO RGD:735411 E RGD:6480464 20120412 CTD MESH:D019772 ADD3 protein affects the susceptibility to Topotecan PMID:16217747 10088 Add3 adducin 3 gene CHEBI:64090 tert-butyl hydroperoxide decreases expression ISO RGD:735411 E RGD:6480464 20120412 CTD MESH:D020122 tert-Butylhydroperoxide results in decreased expression of ADD3 mRNA PMID:15336504 10088 Add3 adducin 3 gene CHEBI:64317 isoprenaline decreases expression EXP E RGD:6480464 20121113 CTD MESH:D007545 Isoproterenol results in decreased expression of ADD3 mRNA PMID:21335049 10088 Add3 adducin 3 gene CHEBI:6651 malathion increases expression ISO RGD:2043 E RGD:6480464 20120412 CTD MESH:D008294 Malathion results in increased expression of ADD3 mRNA PMID:19784758 10088 Add3 adducin 3 gene CHEBI:6773 Mesaconitine decreases expression ISO RGD:2043 E RGD:6480464 20231031 CTD MESH:C019470 mesaconitine results in decreased expression of ADD3 protein PMID:37182599 10088 Add3 adducin 3 gene CHEBI:72544 flavonoids decreases expression ISO RGD:2043 E RGD:6480464 20170303 CTD MESH:D005419 Flavonoids results in decreased expression of ADD3 mRNA PMID:18035473 10088 Add3 adducin 3 gene CHEBI:72754 bisphenol AF increases expression ISO RGD:735411 E RGD:6480464 20250114 CTD MESH:C583074 bisphenol AF results in increased expression of ADD3 protein PMID:34186270 10088 Add3 adducin 3 gene CHEBI:73755 1,2-dimethylhydrazine decreases expression EXP E RGD:6480464 20200804 CTD MESH:D019813 1,2-Dimethylhydrazine results in decreased expression of ADD3 mRNA PMID:22206623 10088 Add3 adducin 3 gene CHEBI:75249 potassium chromate decreases expression ISO RGD:735411 E RGD:6480464 20160705 CTD MESH:C027373 potassium chromate(VI) results in decreased expression of ADD3 mRNA PMID:22714537 10088 Add3 adducin 3 gene CHEBI:77012 methylseleninic acid increases expression ISO RGD:735411 E RGD:6480464 20140304 CTD MESH:C008493 methylselenic acid results in increased expression of ADD3 mRNA PMID:12517777 10088 Add3 adducin 3 gene CHEBI:80630 irinotecan decreases expression ISO RGD:735411 E RGD:6480464 20181113 CTD MESH:D000077146 Irinotecan metabolite results in decreased expression of ADD3 mRNA; Irinotecan results in decreased expression of ADD3 mRNA PMID:15956246 10088 Add3 adducin 3 gene CHEBI:8069 phenobarbital affects expression EXP E RGD:6480464 20130514 CTD MESH:D010634 Phenobarbital affects the expression of ADD3 mRNA PMID:23091169 10088 Add3 adducin 3 gene CHEBI:8069 phenobarbital affects expression ISO RGD:735411 E RGD:6480464 20121009 CTD MESH:D010634 Phenobarbital affects the expression of ADD3 mRNA PMID:19159669 10088 Add3 adducin 3 gene CHEBI:81555 Enterolactone multiple interactions ISO RGD:735411 E RGD:6480464 20151103 CTD MESH:C029497 [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ADD3 mRNA PMID:19167446 10088 Add3 adducin 3 gene CHEBI:81922 flusilazole increases expression ISO RGD:2043 E RGD:6480464 20170725 CTD MESH:C061365 flusilazole results in increased expression of ADD3 mRNA PMID:28263823 10088 Add3 adducin 3 gene CHEBI:8502 6-propyl-2-thiouracil decreases expression ISO RGD:2043 E RGD:6480464 20150310 CTD MESH:D011441 Propylthiouracil results in decreased expression of ADD3 mRNA PMID:24780913 10088 Add3 adducin 3 gene CHEBI:920 2,4-dinitrotoluene affects expression ISO RGD:2043 E RGD:6480464 20120412 CTD MESH:C016403 2,4-dinitrotoluene affects the expression of ADD3 mRNA PMID:21346803 10088 Add3 adducin 3 gene CHEBI:9495 thiram decreases expression ISO RGD:735411 E RGD:6480464 20240702 CTD MESH:D013893 Thiram results in decreased expression of ADD3 mRNA PMID:38568856 10088 Add3 adducin 3 gene CHEBI:9516 thapsigargin decreases expression ISO RGD:2043 E RGD:6480464 20221101 CTD MESH:D019284 Thapsigargin results in decreased expression of ADD3 protein PMID:35544339 10088 Add3 adducin 3 gene CHEBI:9763 trovafloxacin decreases expression EXP E RGD:6480464 20221101 CTD MESH:C080163 trovafloxacin results in decreased expression of ADD3 mRNA PMID:35537566 10088 Add3 adducin 3 gene CHEBI:9986 vinclozolin affects expression ISO RGD:2043 E RGD:6480464 20